https://rjrindex.com/articles/trends-and-disparities-in-lung-cancer-and-respiratory-failure-mortality-in-the-us-a-24-year-retrosp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adjuvant-systemic-cancer-therapies-on-health-related-quality-of-life-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-elevated-expression-of-ililrb4i-and-itsc22d3i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-obesity-biomarkers-and-breast-cancer-risk-in-nigeria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influenza-and-covid-19-vaccination-uptake-among-cancer-survivors-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-cost-and-insurance-on-receipt-of-guideline-concordant-mammography 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-prognostic-implications-of-her2-low-in-early-stage-male-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-single-arm-phase-iii-study-to-assess-the-efficacy-and-safety-of-wsd0922 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-first-line-1l-domvanalimab-dom-zimberelimab-zim-and-chemotherapy-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-cardiac-monitoring-and-outcomes-in-patients-with-her2-positive-breast-cancer-treated-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osimertinib-plus-repotrectinib-phase-i-trial-in-tki-resistant-non-small-cell-lung-cancer-nsclc-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-adverse-effect-profile-of-pd-1-and-ctla-4-inhibitors-and-its-variation-with-race-and-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-temozolomide-on-dendritic-cell-vaccine-for-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-decisional-needs-of-patients-considering-first-line-treatment-of-advanced-egfr-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-neoadjuvant-therapy-in-advanced-melanoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-associated-with-an-exceptional-response-to-immunotherapy-in-patients-with-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologists-preferences-for-first-line-1l-treatment-of-alk-positive-metastatic-nsclc-in-the-us-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aiding-data-retrieval-in-clinical-trials-with-large-language-models-the-apollo-11-consortium-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/autoimmune-conditions-and-breast-implant-illness-in-breast-cancer-patients-with-implant-based-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-hpv-dna-dynamics-and-neoadjuvant-chemotherapy-with-or-without-nivolumab-in-viral-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-patterns-in-the-prospective-randomized-controlled-multicenter-phase-iii-esopec-trial-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/managing-the-invisible-treatment-approaches-after-pathological-complete-response-pcr-to-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-combined-monitoring-of-sii-and-pni-in-evaluating-the-prognostic-impact-on-advanced-driver-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-trial-evaluating-addition-of-adjuvant-chemotherapy-to-ovarian-function-suppression-end-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frontline-brentuximab-vedotin-bv-and-chp-in-patients-pts-with-peripheral-t-cell-lymphoma-ptcl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-alectinib-in-pediatric-and-adult-patients-with-alk-altered-advanced-solid-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionable-gene-alterations-in-resected-non-small-cell-lung-cancer-aga-r-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pregnancy-associated-breast-cancer-tumor-infiltrating-lymphocytes-tilting-the-balance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-circulating-tumor-dna-based-minimal-residual-disease-ctdna-mrd-guided-adjuvant-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retracted-disability-adjusted-life-years-from-human-papillomavirus-related-oral-cavity-and-pharynx 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-regorafenib-plus-temozolomide-with-or-without-radiotherapy-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-in-patients-with-early-stage-microsatellite-instable-msi-hmismatch-repair-deficient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/irradiated-tumor-volume-as-a-predictor-of-local-recurrence-and-radionecrosis-in-lung-cancer-with-bra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tissue-free-circulating-tumor-dna-assay-and-patient-outcome-in-a-phase-iii-trial-of-folfox-based-adj-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-by-baseline-tumor-burden-using-the-6-and-12-score-in-emerald-1-a-phase-3-study-of-durvalum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-trends-in-second-primary-malignancy-in-patients-with-renal-cell-carcinoma-a-retrospective-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/successful-induction-of-tumor-directed-immune-responses-in-high-grade-serious-ovarian-carcinoma-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-ocular-conditions-and-risk-of-ocular-events-in-patients-pts-with-relapsedrefractory-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-therapeutic-vaccine-for-fibrolamellar-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-efficacy-of-gemox-lenvatinib-after-gemox-sorafenib-failure-in-unresectable-fibrolame 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-mental-health-interventions-on-anxiety-depression-and-quality-of-life 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-the-combination-of-systemic-and-locoregional-therapy-on-tumor-recurrence-and-survival-afte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-radiation-necrosis-with-concurrent-antibody-drug-conjugates-and-radiotherapy-in-her2-positiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-gene-signature-for-the-efficacy-of-pazopanib-in-solitary-fibrous-tumor-a-spanish-group-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-association-between-peak-post-infusion-absolute-lymphocyte-count-alc-and-delayed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-endpoint-results-of-the-phase-3b-asc4start-trial-of-asciminib-asc-vs-nilotinib-nil-in-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanism-of-deptor-in-promoting-gemcitabine-resistance-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-preliminary-results-of-a-randomized-phase-ii-trial-evaluating-induction-toripalimab-plus-chemoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/claudin182-cldn182-expression-and-efficacy-in-pancreatic-ductal-adenocarcinoma-pdac-results-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-trial-of-sys6010-combined-with-syh2051-in-patients-with-advanced-gastrointestinal-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-directed-intratumoral-immunotherapy-for-cutaneous-carcinomas-interim-results-from-an-ongoing-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multidisciplinary-approach-for-treatment-choice-in-cancer-patients-with-cardiovascular-diseases-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/logic-gated-allogeneic-tmod-chimeric-antigen-receptor-t-cell-car-t-therapy-targeting-epidermal-gr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/engineered-aav-vectors-with-dual-tumor-specific-promoters-for-safer-and-more-effective-cancer-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-clinical-study-of-9mw2921-a-novel-trop-2-antibody-drug-conjugate-adc-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-trastuzumab-based-therapy-in-her2-positive-advanced-gastric-cancer-evidence-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unique-mutational-landscape-and-therapeutic-implications-in-non-small-cell-lung-cancer-with-comorbid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revolutionizing-bladder-cancer-follow-up-personalized-urinary-ctdna-analysis-for-detecting-minimal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rasbraf-testing-of-circulating-cell-free-dna-cfdna-in-rasbraf-wild-type-rasbraf-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-eutideron-etoposide-and-bevacizumab-in-patients-with-brain-metastases-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-the-ep4-antagonist-vorbipiprant-combined-with-anti-pd-1-immunotherapy-safety-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advanced-lung-cancer-inflammation-index-ali-as-a-prognostic-marker-for-locally-advanced-and-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-afatinib-plus-chemotherapy-with-genomic-profiling-in-osimertinib-refractory-egfr-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-daratumumab-for-treating-multiple-myeloma-in-patients-with-high-risk-cytogenetic-facto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trend-analysis-of-risk-factors-for-early-onset-primary-colorectal-cancer-a-population-based-time-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-short-course-radiotherapy-scrt-followed-by-consolidation-chemotherapy-with-folfo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/teluride-006-an-adaptive-phase-23-study-of-eik1001-a-toll-like-receptor-78-tlr78-agonist-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triple-negative-breast-cancer-insights-from-the-mexican-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-age-of-diagnosis-and-survival-period-for-individuals-of-asian-indianpakistani-origin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-longitudinal-spatial-omics-to-demonstrate-in-situ-epstein-barr-virus-reduction-in-responders-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-and-patterns-of-recurrence-and-the-impact-of-adjuvant-radiation-in-early-stage-pt1-2-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-guided-treatment-stratification-for-nasopharyngeal-carcinoma-patients-a-retrospective-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-algorithm-for-accurate-diagnosis-of-oral-cancer-and-precancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-neutropenia-in-oncology-insights-into-clinical-characteristics-and-outcomes-from-a-brazi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-assessment-of-end-of-life-care-among-patients-with-gastrointestinal-cancers-who-died-inpatient-at 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reassessing-colorectal-cancer-recurrence-in-solid-organ-transplant-recipients-implications-for-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-treated-with-dabrafenib-and-trametinib-who-developed-pyrexia-syndrome-and-sever 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-benzydamine-and-alternative-mouthwashes-in-the-management-of-oral-mucositis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematologic-and-systemic-complications-of-bispecific-antibodies-insights-from-a-national-inpatient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-body-mass-index-change-and-insulin-resistance-with-survival-during-induction-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-and-hospice-utilization-in-patients-with-refractory-or-relapsed-diffuse-large-b-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-patient-anxiety-at-pre-and-post-consultation-with-gynecologic-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-blockade-in-combination-with-bevacizumab-and-nab-paclitaxel-for-second-line-treatment-in-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/itp53i-genomic-alterations-including-targetable-itp53i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vabametkib-in-met-exon-14-skipping-non-small-cell-lung-cancer-efficacy-and-safety-from-the-open-lab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-initial-vs-delayed-docetaxel-therapy-in-veterans-with-metastatic-hormone-sensitive-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expand-1-a-phase-iii-study-with-anv600-a-novel-pd-1-targeted-il-2r-vgh-agonist-in-monotherapy-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiac-involvement-in-erdheim-chester-disease-a-systematic-review-of-presentation-management-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-nomogram-for-predicting-treatment-and-prognosis-in-primary-gastric-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-continuous-temperature-monitoring-at-a-community-cancer-center-towards-a-new-standard-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-generative-ai-models-for-development-of-patient-education-quizzes-on-hormone-related-symp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-ak117-combined-with-cetuximab-or-ak104-in-the-treatment-of-recurrent-or-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-second-primary-malignancies-spms-in-head-and-neck-cancer-survivors-stratified-by-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-stage-at-diagnosis-as-an-indicator-of-cancer-screening-efficacy-in-diverse-populations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-expansions-of-or502-an-antibody-targeting-leukocyte-immunoglobulin-like-receptor-b2-lilrb2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-regional-trends-in-female-genital-neoplasm-mortality-in-the-united-states-from-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-covid-19-pandemic-on-inpatient-outcomes-for-cancer-patients-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-and-outcomes-of-rash-peripheral-neuropathy-pn-and-hyperglycemia-hg-during-first-lin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activating-aml-patients-through-empowering-cancer-communication-strategies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-expanding-medicaid-contracts-at-dana-farber-cancer-institute 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concomitant-treatment-with-2nd-generation-hormone-therapy-and-177lut-psma-versus-177lut-psma-alone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-proteome-molecular-sequencing-based-prognostic-nomogram-in-metastatic-castrate-resistant-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-estradiol-se2-levels-in-premenopausal-prem-women-receiving-neoadjuvant-ovarian-function-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-following-enzalutamide-resistance-in-metastatic-castration-sensitive-versus-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-cell-transplantation-for-acute-leukemia-patients-not-in-complete-remission 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-therapy-following-osimertinib-in-metastatic-egfr-mutated-non-small-cell-lung-cancer-at-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-prostate-cancer-patients-hospitalized-with-viral-respiratory-illnesses-a-national-popul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-lifestyle-factors-and-pathological-characteristics-in-patients-with-early-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-the-5-year-mark-adherence-to-and-continuation-of-extended-adjuvant-endocrine-therapy-in-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strategic-planning-to-transform-pancreatic-cancer-care-a-comprehensive-interdisciplinary-roadmap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intervention-adherence-engagement-and-tool-utilization-in-the-breast-cancer-weight-loss-bwel-tria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-results-of-the-french-multicenter-randomized-share-trial-comparing-whole-breast-irradiation-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-azacitidine-in-the-treatment-of-elderly-patients-with-higher-risk-myelodyspla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcome-of-sacituzumab-govitecan-sg-in-her2-negative-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-survival-benefit-with-immunotherapy-in-combination-with-adjuvant-chemoradiation-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-neoadjuvant-immunotherapy-for-mismatch-repair-deficient-colorectal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exposure-to-magnetic-resonance-imaging-mri-procedures-in-relation-to-increased-risk-of-early-onset 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-12-study-of-dcc-3009-monotherapy-in-patients-with-advanced-gastrointestinal-str 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-in-gist-trial-13-162-phase-ii-study-of-imatinib-in-combination-with-binimetinib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-of-melphalanhepatic-delivery-system-with-circulating-tumor-dna-ctdna-monito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-ctdna-and-hematologic-ratios-as-markers-of-disease-progression-in-early-versus-late-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-extracellular-vesicles-as-biomarkers-of-primary-versus-acquired-resistance-to-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/informing-the-gravid-void-a-population-based-study-of-live-birth-rates-after-oncologic-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-adverse-outcomes-septicemias-healthcare-complications-coagulopathies-and-cardiac-arrhyt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatocellular-carcinoma-patients-with-portal-vein-thrombosis-treated-with-robotic-radiosurgery-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-sustained-and-local-delivery-of-intraperitoneal-il-2-using-encapsulated-cells-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-publication-timelines-insights-from-high-impact-oncology-journals 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-dynamic-blood-flow-device-with-conjugated-affinity-ligands-on-glass-substrate-to-capture-circ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-pharmacokinetics-pk-of-ts-1-combined-with-cisplatin-in-advanced-cancer-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-the-evolving-role-of-sup18sup-f-fdg-petct-in-evaluating 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-effectiveness-of-fuzuloparib-in-patients-with-ovarian-cancer-a-nationwide-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-survival-outcomes-in-ovarian-carcinosarcoma-compared-to-serous-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-survival-outcomes-in-uterine-carcinosarcoma-a-population-based-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-sleep-quality-and-quality-of-life-among-patients-newly-diagnosed-with-head-and-neck-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-uptake-of-targeted-agents-by-raceethnicity-in-patients-receiving-first-line-treatment-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-receipt-of-chemotherapy-at-the-end-of-life-among-patients-with-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-of-early-onset-cancers-15-49-years-1990-2021-and-projection-to-2040 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-dose-13-bis-2-chloroethyl-1-nitrosourea-bcnu-chemoembolization-for-treatment-naive-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vulnerability-cartography-a-narrative-review-of-the-historical-epidemiological-and-biocultural-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-breast-cancer-diagnosis-stages-in-high-risk-patients-using-a-population-genetic-screenin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-histology-agnostic-biomarkers-in-pure-squamous-cell-carcinomas-of-the-genitourinary-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intensive-surveillance-and-aggressive-multi-modal-treatment-for-liver-metastases-from-uveal-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-screening-for-high-risk-patients-a-quality-improvement-initiative-to-improve-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trick-mcc-final-results-from-the-proof-of-concept-investigator-initiated-study-of-combination-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dna-methylation-biomarkers-of-cardiotoxicity-risk-in-breast-cancer-patients-treated-with-anthracycli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-staging-system-for-cancer-cachexia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-agent-para-toluenesulfonamide-for-the-management-of-malignant-pleural-effusions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-taxane-based-chemotherapy-in-small-bowel-adenocarcinoma-sba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-cannabis-use-on-patient-outcomes-post-immune-checkpoint-inhibitor-ici-therapy-in-a-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-trastuzumab-safety-in-tailored-dose-dense-anthracycline-containing-adjuvant-chemotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-tr64-a-vegfrcsf1rc-kit-small-molecule-inhibitor-for-the-treatment-of-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-survival-in-patients-undergoing-surgery-for-pancreatic-ductal-adenocarcinoma-using-liq 2026-08-24 monthly 0.7 https://rjrindex.com/articles/big-data-analysis-of-outcomes-in-non-small-cell-lung-cancer-at-a-regional-cancer-institute-with-a-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-the-power-of-diagnostic-metrics-to-competency-based-medical-education-cbme-implementati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-cell-free-dna-ccfdna-fragmentomics-for-early-detection-of-colorectal-carcinoma-a-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-role-of-baseline-levels-and-early-changes-of-systemic-inflammatory-indexes-for-avelumab-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-educational-experiences-through-standardization-of-inpatient-hematology-curriculums 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-live-true-single-circulating-tumor-cell-comprehensive-genomics-to-show-clonal-evolution-and-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-toripalimab-in-high-risk-renal-cell-carcinoma-after-tumor-resection-tuoad-rcc-a-prospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cosiporfin-sodium-dvdms-mediated-photodynamic-therapy-pdt-versus-treatment-of-physicians-choice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-predictive-tool-for-detection-of-ctdna-in-pancreatic-adenocarcinoma-using-nationwide-compre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-competence-and-confidence-in-thoracic-oncology-a-pilot-study-on-the-impact-of-self-assess 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-skin-toxicity-as-a-predictor-of-response-in-urothelial-carcinoma-patients-treated-with-enf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intelligent-sers-navigation-system-to-guide-lung-cancer-surgery-through-intraoperative-metabolic-aci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-impact-of-socioeconomic-factors-on-survival-and-treatment-outcomes-in-primary-intraocu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-derived-b-cell-epitopes-classifiers-for-early-detection-of-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-unseen-burden-of-ctcl-caregiving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-obesity-on-car-t-cell-therapy-outcomes-in-diffuse-large-b-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomics-profiling-for-prediction-of-immunotherapy-response-in-advanced-pleural-mesothelioma-sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vasculogenic-mimicry-as-a-potential-indicator-of-drug-resistance-and-prognosis-in-renal-cell-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-surgically-resected-pulmonary-large-cell-neuroendocrine-carcinoma-a-single-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ngs-testing-for-patient-selection-in-left-sided-rasbraf-wild-type-metastatic-colorectal-cancer-rece 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiomic-signatures-as-predictors-of-pathological-response-to-neoadjuvant-chemoimmunotherapy-in-surg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-enrichment-of-cd7cxcr3-car-t-cells-in-infusion-products-with-remission-in-relapsed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-outcomes-with-the-detection-of-endemic-burkitt-lymphoma-t-cell-receptor-tcr-complementar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-assessment-from-liquid-biopsy-of-mutations-in-cd20-a-pilot-study-using-a-pete-enrichme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-imeti-gene-mrna-expression-in-metastatic-colorectal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-extent-of-surgical-resection-on-survival-outcomes-in-patients-with-idh-mutant-anaplastic-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-prevalence-of-germline-mutations-in-young-onset-biliary-tract-cancer-btc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anemia-as-a-predictive-factor-for-brain-metastases-a-propensity-score-matched-retrospective-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-surufatinib-sur-plus-paclitaxel-pac-as-second-line-2l-treatment-for-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-a-phase-ii-study-of-rc48-in-combination-with-tislelizumab-as-pre-transurethral-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-nivolumab-plus-ipilimumab-versus-immune-checkpoint-inhibitor-and-tyrosine-kin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-expansion-study-of-ff-10832-liposomal-gemcitabine-antitumor-activity-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-free-survival-as-a-surrogate-endpoint-for-overall-survival-in-resectable-esophageal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-preprocedural-clinical-factors-and-ct-radiomics-to-predict-hepatocellular-carcinoma-response-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/repurposing-itraconazole-for-secondary-prevention-of-metaplasia-and-primary-prevention-of-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-racial-disparities-in-biliary-tract-cancer-with-sepsis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-perioperative-and-neoadjuvant-therapies-in-gastric-and-gastroesophageal-gej-adenocarci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-power-of-parp-inhibitors-a-meta-analysis-on-newly-diagnosed-advanced-ovarian-cancer-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-open-label-trial-of-mov18-ige-in-patients-with-advanced-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-disparities-in-survival-outcomes-for-early-onset-gastric-cancer-a-comprehensive-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-followed-by-capox-combined-with-tislelizumab-and-bevacizumab-or-cetuximab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-profiling-of-patients-with-metastatic-luminal-her2-low-and-her2-0-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscapes-of-hrher2-metastatic-breast-cancer-insights-from-ctdna-profiling-in-the-us-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-value-of-acneiform-rash-grade-in-metastatic-colorectal-cancer-patients-treated-with-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-and-nivolumab-in-refractory-microsatellite-stable-metastatic-colorectal-cancer-and-impa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-quantile-regression-forest-for-early-detection-of-sarcopenia-in-oncogeriatric-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/older-onset-hereditary-breast-and-ovarian-cancer-hboc-syndrome-patients-and-clinical-value-of-germ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-checkpoint-inhibitors-in-smokers-vs-non-smokers-a-large-real-world-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-rna-sequencing-atlas-of-intestinal-injury-induced-by-different-clinical-treatments-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-telehealth-means-i-get-distance-from-the-hospital-so-i-dont-feel-so-much-like-a-patient-a-qu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/general-practitioner-led-vs-surgeon-led-colon-cancer-survivorship-care-a-randomized-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/communication-of-uncertainties-about-recent-cancer-drugs-in-large-language-models 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-folate-receptor-alpha-fra-folr1-expression-in-pan-tumor-samples-from-over 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multimodal-deep-learning-model-for-early-prediction-of-pancreatic-cancer-progression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-imwg-and-pangea-risk-models-predicting-mgus-to-multiple-myeloma-progression-in-a-safet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1-dose-escalation-trial-of-omtx705-a-novel-anti-fibroblast-activation-protein 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-safety-of-belzutifan-in-von-hippel-lindausyndrome-a-single-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-targeted-therapy-for-nras-mutated-melanoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extended-endocrine-therapy-after-5-years-of-adjuvant-lhrh-agonist-in-premenopausal-patients-with-nod 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-results-of-jnj-78278343-pasritamig-in-metastatic-castration-resistant-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-an-anti-telomerase-cd4-t-helper-vaccine-ucpvax-with-or-without-temozolomide-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-tumor-associated-macrophages-tams-and-therapeutic-resistance-to-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-newborn-screening-for-cancer-risk-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precemtabart-tocentecan-m9140-an-anti-ceacam5-adc-with-exatecan-payload-in-patients-with-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ropeginterferon-alfa-2b-for-pre-fibrotic-primary-myelofibrosis-and-dipss-lowintermediate-risk-myelo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-tumor-activity-of-bh-30643-a-novel-macrocyclic-kinase-inhibitor-in-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-from-a-phase-1-study-of-incb123667-a-selective-cdk2-inhibitor-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospital-outcomes-in-patients-with-neuroendocrine-tumors-and-atrial-fibrillationflutter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/daratumumab-plus-bortezomib-lenalidomide-and-dexamethasone-dvrd-in-patients-with-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telisotuzumab-adizutecan-abbv-400-temab-a-in-combination-with-fluorouracil-leucovorin-and-budig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fixed-duration-subcutaneous-sc-mosunetuzumab-mosun-in-patients-with-previously-untreated-high-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arc101-p1-101-a-first-in-human-phase-1-study-of-arc101-a-next-generation-t-cell-engager-tce-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-five-year-analysis-of-gastric-cancer-mortality-disparities-in-the-midwest-region-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/c3nira-randomized-phase-ii-study-of-carboplatin-cabazitaxel-cetrelimab-anti-pd-1-induction-follow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-and-safety-of-tqb2102-in-patients-with-her2-low-expressing-recurrentmetastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-chemo-immunotherapy-versus-chemotherapy-in-colon-cancer-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-investigators-cis-practice-patterns-for-patients-with-hormone-receptor-positive-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-neuroendocrine-tumor-related-mortality-1999-2020-a-cdc-wonder-database-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-dordaviprone-onc201-in-prospective-clinical-trials-of-adult-and-pediatric-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-the-cyber-shift-the-trends-of-electronic-health-record-ehr-engagement-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pynnacle-phase-2-clinical-trial-of-rezatapopt-in-patients-with-advanced-solid-tumors-harboring-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-report-of-efficacy-and-safety-results-from-a-phase-2-trial-evaluating-bnt327pm8002-plus-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-the-olaparib-and-azd6738-an-atmatr-inhibitor-in-isocitrate-dehydrogenase-idh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-serious-immune-related-adverse-events-among-cancer-patients-receiving-immune-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-trial-of-c019199-an-oral-tme-modulator-targeting-csf-1rddrsvegfr2-in-relapsed-or-refrac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-study-of-the-efficacy-and-safety-of-stereotactic-body-radiation-therapy-sbrt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opera-01-a-randomized-open-label-phase-3-study-of-palazestrant-op-1250-monotherapy-vs-standard 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-rechallenge-after-trastuzumab-deruxtecan-related-interstitial-lung-disease-a-multi-instit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-apatinib-in-patients-with-advanced-or-refractory-chordoma-a-single-arm-open-labe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-trends-in-race-and-gender-disparities-in-the-incidence-of-osteosarcoma-leiomyosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-treatment-outcomes-for-peritoneal-surface-malignancies-in-low-and-middle-income-countries 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-computational-approach-for-survival-prediction-via-fusion-of-whole-slide-images-and-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimization-of-the-idisco-protocol-for-3d-reconstruction-of-cancer-samples-using-light-sheet-micros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-a-podcast-curriculum-pc-to-improve-hematology-oncology-fellow-hof-knowledge-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-and-implementing-a-fellow-driven-communication-skills-curriculum-in-hematologyoncology-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanism-study-of-reversing-tumor-immune-desertification-and-immunotherapy-resistance-by-low-dose-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-in-metastatic-renal-cell-carcinoma-rcc-impact-on-prognosis-and-response-to-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-with-iegfri-iher2i-alterations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-treatment-with-disitamab-vedotin-monotherapy-in-patients-with-her2-overexpressing-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-among-patients-with-locally-advanced-or-metastatic-urothelial-cancer-lamuc-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clear-cell-renal-cancer-metabolism-secrets-behind-fatty-acid-synthesis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-analysis-of-bulk-and-single-cell-rna-sequencing-data-to-identify-an-oxidative-phosphoryla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-subsequent-treatment-after-combination-therapy-in-non-clear-cell-renal-cell-carcinoma-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbiota-proteomics-profiles-in-muscle-invasive-bladder-carcinoma-related-to-response-to-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-multicenter-open-label-dose-escalation-study-of-t-1201-a-small-molecule-drug-conjugate-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-maintenance-therapy-in-patients-pts-with-advanced-urothelial-carcinoma-uc-in-japan-sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-patient-preferences-for-bacillus-calmette-guerin-bcg-and-pd-l1-inhibitors-in-high-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-treatment-outcomes-of-enfortumab-vedotin-dose-reduction-in-metastatic-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-in-combination-with-cetuximab-and-chemotherapy-as-first-line-treatment-for-rasbraf-wild 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-response-prediction-in-metastatic-colorectal-cancer-by-a-novel-genomic-and-transcriptomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distribution-of-non-metastatic-and-metastatic-disease-in-incidentally-detected-and-screening-detecte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-germline-analysis-in-young-adults-of-latin-american-descent-with-early-onset-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-affecting-clinical-investigators-cis-selection-of-cdk46-inhibitors-cdkis-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-1-dose-escalation-and-dose-expansion-trial-to-evaluate-the-safety-tolerability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cohort-study-of-the-effect-of-traditional-chinese-medicine-combined-with-western-medicine-standard 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-outpatient-car-t-therapy-in-a-community-based-medical-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-of-colorectal-cancer-related-mortality-among-patients-with-comorbid-type-2-diabetes-in-the-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-on-optimizing-serum-based-lung-cancer-diagnosis-using-a-multi-biomarker-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-impact-of-lymphocytopenia-during-chemoradiation-in-locally-advanced-nsclc-patients-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-rate-disparities-in-breast-cancer-with-obesity-insights-from-cdc-wonder-analysis-of-two-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-evaluation-of-neoadjuvant-chemotherapy-without-radiotherapy-combined-with-sintil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pear-glio-clinical-evaluation-of-an-ai-driven-functional-precision-medicine-platform-for-therapeuti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-association-between-cycles-of-fertility-treatments-with-gonadotropins-and-cancer-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-wider-a-phase-3b-trial-of-ribociclib-rib-endocrine-therapy-et-as-adjuvant-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retifanlimab-with-bevacizumab-and-hypofractionated-radiotherapy-to-treat-recurrent-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cerebrospinal-fluid-derived-ctdna-and-ctc-based-molecular-analysis-highlighting-the-sampling-proximi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-efficacy-of-intrathecal-chemotherapy-in-patients-with-leptomeningeal-metastases-a-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-treatment-outcomes-in-head-and-neck-cancer-patients-with-brain-metastases-hnc-bm-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histopathologic-and-demographic-features-of-non-small-cell-lung-cancer-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-single-cell-transcriptomics-to-reveal-cd226-upregulation-and-enhancement-of-cd19-car-t-functio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/statewide-burden-and-trends-of-liver-cancer-mortality-attributable-to-high-bmi-in-the-us-1991-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/punch03-a-phase-ii-study-of-disitamab-vedotin-combined-with-tislelizumab-and-bacillus-calmette-guer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-lung-cancer-incidence-and-treatment-across-the-us-2019-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-blockade-in-combination-with-epigenetic-therapy-to-antagonize-tumor-mesenchymal-program-and-dri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-incidence-and-impact-of-sepsis-in-patients-hospitalized-with-cholangiocarcinoma-findings-from-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-trial-comparing-conversion-surgery-with-palliative-chemotherapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-durvalumab-with-arterial-chemotherapy-in-major-portal-invaded-hepatocellular-carcinoma-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-trial-of-radium-223-dichloride-and-cabozantinib-in-patients-with-advanced-renal-cell-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/independent-validation-of-a-16-protein-test-to-assess-malignant-potential-of-small-uveal-melanocytic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/animated-patients-guide-to-melanoma-assessing-patient-understanding-shared-decision-making-and-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidimensional-spatially-resolved-immunologic-hallmarks-of-response-to-neoadjuvant-immune-checkpo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neighborhood-disadvantage-and-residential-isolation-on-cognitive-outcomes-in-cancer-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-therapy-in-small-intestinal-leiomyosarcoma-a-comparative-analysis-of-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-with-gene-fusions-navigating-the-genomic-landscape-and-treatment-selection-in-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-protein-energy-malnutrition-on-inpatient-mortality-healthcare-cost-and-clinical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-impacting-treatment-with-abemaciclib-endocrine-therapy-in-high-risk-early-stage-hrher2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mcm2-expression-in-locally-advanced-hormone-receptor-positive-her2-negative-hrher2-early-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/faith-trial-feasibility-and-safety-of-anlotinib-plus-benmelstobart-in-patients-with-previously-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telimet-nsclc-04-a-phase-2-open-label-randomized-global-study-of-2-telisotuzumab-vedotin-regimen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-kros-101-a-small-molecule-gitr-ligand-agonist-on-t-effector-cells-t-reg-cells-and-intra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multidimensional-approach-to-improve-care-and-outcomes-for-people-with-inflammatory-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-outcomes-of-patients-with-colorectal-cancer-in-a-racially-diverse-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-mgus-risk-of-progression-and-overall-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-changes-in-target-protein-expression-following-treatment-in-nsclc-simultaneous-evaluation-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-clinical-and-molecular-phenotype-of-cancer-of-unknown-primary-cup-with-a-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-analysis-based-on-markers-of-progression-in-melanoma-a-single-center-comparison-of-surviva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/towards-a-standard-of-care-comparing-stenting-and-ligation-in-parotid-duct-management-for-oral-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-preoperative-imaging-detected-extranodal-extension-in-head-and-neck-squamous-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kidney-disease-related-mortality-trends-and-disparities-among-patients-with-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-assessment-of-thyroiditis-in-patients-undergoing-chimeric-antigen-receptor-t-cell-therapy-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-non-retinoblastoma-eye-cancer-in-204-countries-and-territories-1990-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/egfr-missense-mutations-to-predict-skeletal-metastasis-in-lung-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dysregulation-of-dna-damage-repair-in-lung-cancer-driven-by-imtapi-loss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neurologic-adverse-effects-associated-with-the-use-of-t-cell-engager-therapy-in-multiple-myeloma-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-first-line-serplulimab-in-patients-with-metastatic-or-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-qualitative-analysis-of-uncertainty-in-cancer-diagnosis-and-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-analysis-of-her2-expression-in-metastatic-breast-cancer-insights-from-a-uae-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-hotspots-of-intra-and-transchromosomal-fusions-in-liposarcomas-by-rna-sequencing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-disparities-in-cardio-oncology-breast-cancer-patients-from-a-single-institution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcome-of-comprehensive-genomic-profiling-cgp-driven-personalized-treatment-in-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-pembrolizumab-in-advanced-head-and-neck-squamous-cell-carcinoma-a-systematic-review-and-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-in-survivors-of-childhood-cancer-diagnosed-with-subsequent-thyroid-cancer-a-report-from-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-predictors-of-response-to-pd-l1-blockade-in-patients-with-oncogene-driver-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vincristine-and-topotecan-versus-carboplatin-etoposide-and-vincristine-based-chemotherapy-for-oc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-erythrocyte-antibody-conjugates-on-cancers-resistant-to-checkpoint-blockade-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-mid-treatment-positron-emission-tomography-adaptive-radiotherapy-in-stage-iii-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-androgen-receptor-ligand-binding-domain-mutations-ar-lbdm-in-circulating-tumor-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-satisfaction-with-telehealth-as-an-element-of-hybrid-decentralized-clinical-trials-dcts-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-medicaid-expansion-on-outcomes-for-patients-with-gastric-cancer-in-louisian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-evaluation-of-machine-learning-techniques-for-the-diagnosis-of-gastric-cancer-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-and-systematic-review-of-radiomics-imaging-for-predicting-pathological-complete-respon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-outcomes-of-sepsis-in-patients-hospitalized-with-esophageal-cancer-a-nationwide-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-time-varying-patient-reported-symptoms-and-quality-of-life-in-cancer-patients-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-anti-bcma-vs-anti-gprc5d-bite-therapy-in-relapsedrefractory-multiple-myelo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elephas-01-elephas-02-and-elephas-04-multi-institutional-observational-prospective-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medium-dose-of-tpf-chemotherapy-with-concurrent-radiotherapy-and-immunotherapy-for-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-a-senescence-associated-gene-signature-with-prognosis-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-treatment-strategies-for-gastric-cancer-a-retrospective-real-world-study-in-china 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-facilitators-and-practice-patterns-for-next-generation-sequencing-testing-use-for-non-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-impact-of-incidental-pulmonary-embolism-in-solid-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-breast-cancer-recurrence-understanding-patient-and-caregiver-perspectives-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relative-depth-of-invasion-rdi-index-and-clinicopathologic-predictive-factors-for-identifying-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmet-educational-needs-challenges-and-potential-benefits-in-expanding-prescriber-bases-in-oncolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-management-practices-in-responders-to-venetoclax-for-newly-diagnosed-acute-myeloi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-preoperational-circulating-tumor-dna-detection-in-early-stage-nsclc-using 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-lair-1-targeting-antibody-drug-conjugate-for-hematologic-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-randomized-trial-of-exercise-creatine-supplementation-to-augment-the-adaptations-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-related-toxicities-of-antibody-drug-conjugates-in-breast-cancer-a-bayesian-network-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-loop-electrosurgical-excision-procedure-with-positive-margins 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neoadjuvant-chemotherapy-on-survival-outcome-in-advanced-endometrial-cancer-in-hispanic-vs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/muc5ac-profiling-as-a-biomarker-for-predicting-post-recurrence-outcomes-and-guiding-precision-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-analysis-of-artificial-intelligence-driven-convolutional-neural-network-architectures-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-in-a-phase-iii-study-of-prospective-radiation-therapy-imrt-cetuximab-for-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-temozolomide-and-capecitabine-chemotherapy-used-in-neuroendocrine-and-endocrine-tumours 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subtype-specific-trends-in-lung-cancer-incidence-and-survival-a-seer-analysis-2004-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-related-cancer-mortality-in-the-us-1999-2020-a-cdc-wonder-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-toxicity-profiles-of-bispecific-antibodies-a-nationwide-multiyear-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-imetelstat-in-transfusion-dependent-lower-risk-myelodysplastic-syndromes-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-food-deserts-to-clinical-trial-deserts-challenges-in-access-to-breast-cancer-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-inflation-adjusted-costs-and-reimbursements-for-breast-cancer-procedures-a-decade-of-decl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-and-recommendations-for-surveillancefollow-up-of-breast-cancer-undergoing-adjuvant-hormonot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-onco-a-personalized-navigation-support-for-oncology-clinical-trials-in-quebec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-pro-ctcae-in-oncology-clinical-trials-insights-from-a-targeted-literature-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mammographic-screening-and-time-to-breast-cancer-diagnosis-among-immigrants-and-long-term-residents 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-drug-eluting-bead-transarterial-chemoembolization-combined-with-hepatic-arter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/community-opinion-leaders-and-traditional-healers-perceptions-and-experiences-on-the-need-for-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-oncoquebec-an-oncology-clinical-trials-search-engine-on-clinical-trial-recruitment-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-predictors-of-brain-metastases-in-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mevrometostat-an-enhancer-of-zeste-homolog-2-ezh2-inhibitor-in-combination-with-enzalutamide-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-postmastectomy-radiotherapy-on-health-related-quality-of-life-and-safety-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-first-line-osimertinib-in-nsclc-patients-with-egfr-mutations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/connecting-clinical-trials-with-patients-using-patient-navigation-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuromorphological-effects-of-simultaneous-exercise-during-neo-adjuvant-chemotherapy-in-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-prostate-cancer-pca-outcomes-after-primary-prostatectomy-among-latinos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-the-surgeons-learning-curve-impact-pentafecta-outcomes-in-radical-prostatectomy-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-pet-as-a-way-to-choose-oligometastatic-patients-for-intermittent-androgen-deprivation-extended 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-radiation-dose-in-multi-isocentric-volumetric-arc-based-total-body-irradiation-on-oncologi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/community-based-patient-navigation-and-preventative-care-among-women-surviving-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-major-adverse-cardiovascular-and-cerebrovascular-events-outcomes-among-hospita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-impact-of-treatment-before-or-after-surgery-in-patients-with-stage-ii-iiib-resectable-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-of-matched-ctdna-and-tissue-from-patients-with-less-common-cancers-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nivolumab-plus-ipilimumab-for-patients-with-pre-treated-type-b3-thymoma-and-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-with-gemcitabine-plus-cisplatin-followed-by-radical-liver-resection-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-repeat-screening-for-colorectal-cancer-using-the-multi-target-stool-dna-test-real-worl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-iii-study-of-gfh375-a-highly-selective-and-potent-oral-kras-g12d-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tropion-lung14-a-phase-3-study-of-osimertinib-datopotamab-deruxtecan-dato-dxd-as-first-line-1l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-ctdna-monitoring-of-erher2-high-risk-breast-cancer-during-adjuvant-endocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-related-macular-degeneration-in-individuals-with-clonal-hematopoiesis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subgroup-analysis-of-the-phase-2-part-of-the-ringside-phase-23-trial-of-varegacestat-for-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-mechanisms-driving-cd20-loss-in-patients-with-relapsed-or-refractory-large-b-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-infections-cardiac-events-neurological-toxicity-and-cytokine-response-syndrome-crs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-breast-cancer-screening-for-the-brazilian-unified-health-system-sus-a-warning-of-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-low-dose-dasatinib-50mg-in-chronic-myeloid-leukemia-chronic-phase-cml-cp-in-lmic-ar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-dose-escalation-study-to-evaluate-safety-and-feasibility-of-neoadjuvant-camrelizumab-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-branched-chain-amino-acid-metabolic-interactions-between-hibadh-tumor-cells-and-bcat1-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-car-t-cell-therapy-in-dlbcl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-ctdna-mrd-and-mvi-in-predicting-postoperative-recurrence-of-hepatocellular-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-status-of-medical-oncology-in-china-de-smog-a-nationwide-questionnaire-based-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-ctdna-analyses-for-the-evoke-1-study-in-metastatic-non-small-cell-lung-cancer-mnsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-tumor-microenvironment-profiling-at-single-cell-level-in-patients-with-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retracted-randomized-trial-of-relevance-of-time-of-day-of-immunochemotherapy-for-progression-free-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2dx-genomic-test-in-her2-positive-breast-cancer-treated-with-15-weeks-of-neoadjuvant-paclitaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-class-pd-1il-2-bispecific-antibody-ibi363-in-patients-pts-with-advanced-immunotherapy-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discovery-of-potent-degraders-of-pan-kras-based-on-a-novel-kras-binder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-pre-treatment-assessment-of-trastuzumab-deruxtecan-t-dxd-antibody-target-her2-and-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-findings-from-a-multi-institutional-quality-study-using-cfir-to-explore-gaps-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-in-combination-with-ivonescimab-and-chemotherapy-as-first-line-1l-therapy-in-patients-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/giredestrant-g-with-atezolizumab-atezo-andor-abemaciclib-abema-in-patients-pts-with-erhe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-phase-1-dose-escalation-data-for-emiltatug-ledadotin-emi-le-a-novel-b7-h4-directed-dolasy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-the-response-and-resistant-features-to-the-claudin182-specific-car-t-cell-ct041-in-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-co-inheritance-of-kmt2c-germline-mutations-on-the-phenotype-of-msi-lmss-lynch-syndrome-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-5-year-remission-and-survival-after-treatment-with-ciltacabtagene-autoleucel-cilta-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-frontline-therapy-for-diffuse-large-b-cell-lymphoma-dlbcl-in-older-adults-a-glofitamab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sasanlimab-in-combination-with-bacillus-calmette-guerin-bcg-in-bcg-naive-high-risk-non-muscle-inv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-longitudinal-immune-cell-monitoring-in-patients-with-extensive-stage-small-cell-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/origami-2-a-randomized-phase-3-study-of-amivantamab-vs-cetuximab-both-in-combination-with-folfox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/msln-and-cldn182-dual-target-car-t-therapy-enhancing-cancer-treatment-with-improved-efficacy-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beamion-pantumor-1-a-phase-ii-multicenter-multicohort-open-label-trial-to-evaluate-the-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-in-pediatric-participants-with-relapsed-or-refractory-microsatellite-instability-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inotch1i-mutation-and-survival-analysis-of-tislelizumab-in-advanced-or-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-zipalertinib-in-nsclc-patients-with-egfr-exon-20-insertion-mutations-who-received-prior 2026-08-24 monthly 0.7 https://rjrindex.com/articles/major-adverse-cardiovascular-events-mace-in-cancer-patients-treated-with-tirzepatide-compared-to-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keynote-859-45-year-median-follow-up-of-pembrolizumab-plus-chemotherapy-for-previously-untreated-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/debio-0123-a-highly-selective-wee1-inhibitor-in-combination-with-carboplatin-c-and-etoposide-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-concurrent-chronic-lymphocytic-leukemia-and-non-small-cell-lung-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/descriptive-analysis-of-the-pcp-onc-cares-program-integrating-primary-care-into-oncology-in-a-value 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-detection-using-a-realtime-breath-analyzer-a-pilot-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-analysis-of-gastric-cancer-in-uzbekistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alectinib-in-children-and-adolescents-with-solid-or-cns-tumors-harboring-alk-fusions-a-data-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rna-based-fusion-ngs-panel-testing-for-the-improved-classification-of-soft-tissue-sarcomas-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-post-transplant-survival-in-patients-with-newly-diagnosed-acute-myeloid-leukemia-recei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-combination-therapy-of-ponatinib-and-blinatumomab-in-philadelphia-chromosome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-concomitant-congenital-abnormalities-among-newborns-with-cancer-a-population-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-prospective-randomized-controlled-trial-of-tislelizumab-combined-with-platinum-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-efficacy-of-tislelizumab-with-or-without-chemotherapy-versus-chemotherapy-alo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-and-histopathological-evaluation-of-tertiary-lymphoid-structures-and-associatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-socioeconomic-and-demographic-factors-on-treatment-related-time-intervals-in-oral-cavity-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-a-phase-iia-trial-of-apg-157-in-oral-cavity-and-oropharyngeal-dysplasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-classification-of-laryngeal-dysplasia-and-lymphocytic-activity-quantification-from-routine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-recurrence-and-mortality-among-survivors-of-childhood-cancer-a-report-from-the-childh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-therapeutic-target-discovery-with-multi-omics-effect-of-unbiased-phosphoproteomic-and-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-ctdna-with-recurrence-in-patients-with-stage-ii-iv-colorectal-cancer-the-v-corre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-metastatic-lung-squamous-cell-carcinoma-mlusc-to-identify-patients-with-dif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymphatic-mapping-to-the-inguinal-region-in-patients-with-lower-extremity-melanoma-undergoing-radica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-populational-change-in-prognosis-of-patients-diagnosed-with-locally-advanced-melanoma-last-glimps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-egfr-tkis-treatment-challenge-in-nsclc-changes-in-survival-after-covid-19-infection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-feeding-tube-utilization-in-base-of-tongue-adenoid-cystic-carcinoma-treated-with-neutron 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-and-meta-analysis-of-neoadjuvant-anti-pd-l1-inhibitors-in-head-and-neck-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/waterpipe-smoking-as-deregulator-of-rna-m6a-modification-and-promotor-of-epithelial-mesenchymal-tran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-and-racial-disparities-in-sebaceous-gland-carcinoma-of-the-eyelid-a-seer-database-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-mass-index-and-somatic-variants-in-biliary-tract-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-mortality-risk-in-patients-with-malignant-melanoma-and-type-2-diabetes-mellitus-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-disparities-in-early-mortality-of-metastatic-melanoma-patients-a-seer-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-classification-of-cancer-types-using-genomic-profiling-data-from-the-australi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improved-detection-of-circulating-tumor-dna-in-patients-with-leiomyosarcoma-with-fragment-size-restr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-combination-therapy-in-her2-positive-advanced-gynecological 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perceptions-of-vietnamese-women-regarding-hpv-self-collection-a-cross-sectional-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-circulating-tumor-dna-methylation-levels-to-predict-pathological-and-radiological-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trastuzumab-deruxtecan-in-hr-negative-her2-low-advanced-breast-cancer-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/platinum-or-non-platinum-therapy-in-post-olaparib-recurrent-ovarian-cancer-analysis-in-matched-coho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thymidine-kinase-activity-as-a-prognostic-tool-in-blood-samples-of-primary-ovarian-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-findings-from-the-alva-epro-platform-pilot-study-a-novel-approach-to-collecting-quality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-disparities-in-survival-among-stage-iii-iv-melanoma-patients-in-the-era-of-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-survivors-perspectives-on-a-clinical-decision-tool-to-facilitate-individualized-exerc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aging-and-global-cancer-burden-a-population-based-comparative-situation-analysis-and-predictions-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-impact-of-race-ethnicity-and-bmi-on-neoadjuvant-hormonal-treatment-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mevrometostat-in-combination-with-enzalutamide-for-androgen-receptor-pathway-inhibitor-arpi-naive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bothersome-hot-flashes-following-relugolix-and-stereotactic-body-radiotherapy-for-localized-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-ph-like-b-lineage-acute-lymphoblastic-leukemia-in-the-era-of-novel-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytomolecular-mechanisms-of-relapse-after-frontline-flt3-inhibitor-flt3i-based-therapy-in-flt3-mut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-profiles-and-mapping-the-patient-journey-in-japan-with-a-large-scale-digital-survey-of-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reflex-precision-oncology-consultation-to-increase-comprehensive-genomic-profiling-rates-in-non-smal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-clonal-hematopoiesis-ch-of-short-variants-svs-detected-in-liquid-biopsies-lbx-in-gen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-availability-of-radiotherapy-services-across-nigeria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-food-insecurity-and-financial-hardship-with-healthcare-utilization-among-adults-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-177lut-psma-in-metastatic-castrate-resistant-prostate-cancer-in-the-post-chemotherapy-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trajectories-of-clinical-encounters-among-long-term-lung-cancer-survivors-a-seer-medicare-cluster-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-alcohol-dependence-on-the-efficacy-of-immune-checkpoint-inhibitors-a-comprehensive-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/living-beyond-cancer-the-long-term-impact-of-breast-cancer-diagnosis-on-cognitive-function 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-adrenocortical-cancer-mortality-in-the-us-from-1999-to-2020-regional-demographic-and-geo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-esophageal-and-gastric-carcinomas-at-a-safety-net-healthcare-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-much-does-your-medication-cost-assessing-patient-attitudes-towards-the-costs-of-oncology-med 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-place-based-inequities-in-lung-cancer-care-trends-in-geographic-hotspots-of-late-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-digital-health-platform-in-improving-psa-and-blood-pressure-levels-in-members-living-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-oncology-interest-in-persons-with-a-cancer-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/itp53i-multihit-mutations-in-142-patients-with-mpn-or-aml-comparative-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-validation-of-six-androgen-production-uptake-and-conversion-genes-apuc-6-in-the-chaar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-unheard-narratives-integrating-narrative-medicine-into-electronic-medical-records-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pregnancy-history-and-recency-of-childbirth-on-long-term-outcomes-in-young-patients-with-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-insurance-status-among-asian-americans-with-cancer-a-disaggregated-analysis-by-ethni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-in-cancer-care-experience-from-a-tertiary-care-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-brain-metastases-on-survival-rates-in-patients-with-metastatic-testicular-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-delivery-of-palliative-care-in-administrative-billing-claims-data-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-recist-criteria-in-resource-limited-settings-guatemala-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-induced-peripheral-neuropathy-in-breast-cancer-prevalence-and-predictors-in-an-indian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diversity-and-representation-in-head-and-neck-cancer-trials-following-the-2010-affordable-care-act 2026-08-24 monthly 0.7 https://rjrindex.com/articles/star-01-a-randomized-phase-iii-clinical-trial-comparing-pd-1-combined-with-apatinib-and-soxpd-1-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-outcomes-in-patients-pts-with-renal-impairment-in-the-phase-3-dreamm-7-and-dre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-lymphocyte-count-dynamics-on-the-predictive-value-of-tumor-mutational-burden-tmb-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/travel-impacts-for-patients-with-cancer-living-in-the-rural-mountain-west 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-patients-satisfied-with-the-information-in-an-informed-consent-form-questionnaire-based-study-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fusing-quality-improvement-and-education-frameworks-to-reduce-delays-in-tumor-genotyping-at-communit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-nationwide-trends-in-multiple-myeloma-mm-autologous-stem-cell-transplants-ascts-chim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomized-controlled-trial-comparing-palliative-stereotactic-body-radiotherapy-vs-pall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-adjuvant-anti-pd-1-antibodies-and-interferon-in-patients-with-nail-apparatus-melanoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-after-discontinuation-of-retifanlimab-in-patients-with-advanced-or-metastatic-mer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-and-employment-outcomes-in-people-with-melanoma-receiving-adjuvant-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-elinzanetant-on-sleep-disturbances-and-quality-of-life-in-women-undergoing-adjuvant-endocr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-l1-as-a-biomarker-in-gastric-cancer-concordance-between-ihc-methods 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-supportive-and-palliative-care-referral-at-a-comprehensive-cancer-center-a-seven-year-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-nalirifox-liposomal-irinotecan-5-fluorouracil-leucovorin-and-oxaliplatin-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-mutational-and-molecular-profile-of-pancreatic-cancer-a-comprehensive-genomics-approa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/functional-role-of-gli2-in-cancer-associated-fibroblasts-for-modulation-of-the-fibrotic-tumor-microe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-importance-of-algorithms-when-determining-homologous-recombination-deficiency-status-in-ovarian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-pancreatic-cancer-mortality-in-older-adults-with-diabetes-mellitus-in-the-united-states-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perceptions-of-work-stress-burnout-and-burnout-management-strategies-among-oncologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-open-label-phase-1-results-of-misetionamide-gp-2250-a-small-molecule-antineoplastic-targe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-immunotherapy-for-stage-ii-iii-nsclc-patients-a-retrospective-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-combined-with-interstitial-lung-disease-controversial-role-of-preexisting-hypertension 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pregnancy-and-infant-outcomes-post-cd19-directed-car-t-therapy-tisagenlecleucel-tisa-cel-andor-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-axicabtagene-ciloleucel-axi-cel-for-the-treatment-of-relapsedrefractory-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/awareness-knowledge-and-attitudes-toward-breast-cancer-polygenic-risk-scores-for-precision-prevent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuro-oncology-anywhere-242-pilot-study-evaluating-telehealth-and-in-person-assessments-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-evolution-of-breast-cancer-genetic-testing-comparative-outcomes-of-nccn-asco-and-universal-gu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-germline-cftr-mutations-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-utility-of-dna-methylation-signatures-in-tissue-and-biofluids-for-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-pediatric-obesity-related-cancers-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-tumoral-molecular-landscape-of-long-term-survivors-with-isocitrate-dehydrogenase-wildtype-gliobl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-endoscopic-treatment-with-mucosal-resection-radiofrequency-ablation-and-cry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-review-of-a-novel-blood-test-use-in-rural-alabama-for-multi-cancer-detection-analyzing-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nci-10479-a-phase-i-dose-escalation-expansion-trial-of-sunitinib-malate-plus-lutetium-lu-177-dota 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-survival-in-locally-advanced-esophago-gastric-cancers-treated-with-perioperat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-neuroblastoma-incidence-and-mortality-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/australasian-gastro-intestinal-trials-group-agitg-stopnet-a-randomized-study-of-cessation-of-soma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-dose-dense-anthracycline-and-cyclophosphamide-in-combination-with-carboplatin-paclitaxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-outcomes-of-esophageal-cancer-hospitalizations-a-trend-analysis-2008-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-and-safety-of-neoadjuvant-chemotherapy-in-combination-with-pembrolizumab-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-pathological-complete-response-and-outcomes-in-hormone-receptor-positive-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-role-of-consolidative-chest-radiotherapy-after-chemo-immunotherapy-in-extensive-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/codex2-a-novel-scoring-system-for-cdx2-loss-in-colon-cancer-unraveling-prognostic-insights-and-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ryz101-sup225sup-ac-dotatate-in-patients-with-estrogen-receptor-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-study-to-identify-disparities-in-outcomes-for-patients-pts-with-early-stage-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-demographic-and-socioeconomic-factors-on-survival-outcomes-in-patients-with-waldenstrom-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-early-versus-late-initiation-of-immunotherapy-in-extensive-stage-small-cell-lung-cancer-affect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-trastuzumab-and-trastuzumab-adjunct-chemotherapy-her2-amplified-colorectal-cancer-a-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deciphering-colorectal-cancer-progression-through-integrative-epigenomic-analysis-for-precision-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peripheral-myeloid-derived-suppressor-cell-as-a-biomarker-for-diagnosing-and-predicting-the-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-lung-cancer-care-for-the-underserved-real-world-results-of-sbrt-in-a-safety-net-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-observational-study-of-fruquintinib-in-combination-with-irinotecan-and-capecitabine-as-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-radiomic-features-on-prediction-of-progression-free-survival-in-patients-with-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-the-estrogen-receptor-alpha-esr1-and-aromatase-expression-in-non-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/web-based-analysis-of-multiparameter-cytometry-datasets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-open-label-study-evaluating-the-efficacy-safety-and-pharmacokinetics-of-luveltamab-ta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/doxorubicin-based-chemotherapy-vs-gemcitabinedocetaxel-in-uterine-leiomyosarcoma-ulms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-and-oncologic-outcomes-of-nivolumab-ipilimumab-vs-pembrolizumab-in-malignant-melan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-analysis-of-phase-ii-trial-of-nivolumab-in-patients-with-recurrent-or-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-combination-of-regorafenib-avelumab-in-patients-with-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-inhibitors-combined-with-radiotherapy-and-gm-csf-sequentially-followed-by-il-2-regimen-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytokine-mediated-hypersensitivity-reactions-to-carboplatin-in-early-triple-negative-breast-cancer-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/should-we-treat-tp53-mutated-high-risk-myeloid-neoplasms-in-older-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/master-protocols-in-oncology-opportunities-challenges-and-strategic-approaches-to-design-and-impl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-ovarian-cancer-an-accurate-high-throughput-extracellular-vesicle-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-analysis-of-pre-treatment-dihydropyrimidine-dehydrogenase-idpydi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-subtyping-and-insights-into-sarcoma-biology-and-prognosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improvemf-update-phase-11b-trial-of-imetelstat-imeruxolitinib-rux-in-patients-pts-with-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ceralasertib-cerala-olaparib-ola-in-patients-pts-with-homologous-recombination-repair-hrr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telisotuzumab-adizutecan-abbv-400-temab-a-a-c-met-protein-targeting-antibody-drug-conjugate-adc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arches-5-year-follow-up-overall-survival-os-analysis-of-enzalutamide-enza-plus-androgen-depriva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/db-1311bnt324-a-novel-b7h3-adc-in-patients-with-heavily-pretreated-castrate-resistant-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-survival-outcomes-and-predictors-of-benefit-from-ovarian-function-suppression-in-premenopaus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/db-1310-a-her3-targeted-adc-in-pts-with-advanced-solid-tumors-preliminary-results-from-the-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-patients-treated-with-tarlatamab-in-extensive-stage-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/daratumumab-bortezomib-lenalidomide-and-dexamethasone-dvrd-vs-vrd-in-transplant-ineligible-ti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-study-of-asp-1929-photoimmunotherapy-in-combination-with-pembrolizumab-versus-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-adherence-to-cdk46-inhibitors-in-breast-cancer-through-remote-therapeutic-monitoring-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-economics-of-cancer-immunotherapy-a-five-year-medicare-b-expenditure-analysis-of-checkpoint-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updates-to-core-008-a-phase-2-multi-arm-multi-cohort-study-to-evaluate-intravesical-cretostimogene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cetuximab-plus-dalpiciclib-in-patients-with-hpv-negative-anti-pd-1-resistant-recurrent-or-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-quality-improvement-initiative-to-improve-fertility-counseling-and-referral-procedures-for-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-inflammation-with-depression-in-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-sup177sup-lu-psma-iampt-for-rlt-in-mcrpc-first-prospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-clinician-expert-perspectives-on-the-impactful-symptoms-of-head-and-neck-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dupilumab-for-bullous-pemphigoid-induced-by-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-off-label-mapk-inhibitor-therapy-in-children-with-severerefractory-langerhans-cell-histio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dipeptidyl-peptidase-9-dpp9-depletion-from-hepatocytes-in-mice-to-retard-tumour-growth-increase-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-assessment-of-colitis-related-adverse-events-in-multiple-myeloma-patients-treated-with-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-open-label-study-to-improve-compliance-and-time-of-treatment-after-obtaining-complete-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-clinical-trial-of-autologous-t-cells-genetically-engineered-with-a-chimeric-receptor-to-targ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-predictors-of-brain-metastases-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-longitudinal-analysis-of-social-networks-and-patient-reported-outcomes-among-young-adult-cancer-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-administration-of-cue-101-a-novel-hpv16-e7-phla-il2-fc-fusion-protein-before-curative-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stratification-of-vulvar-squamous-cell-carcinoma-vscc-by-hpv-and-p53-status-to-guide-excision-cct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-study-of-chemoimmunotherapy-with-or-without-eflornithine-dfmo-in-relapsedref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-safety-and-efficacy-data-of-sup212sup-pbvmt01-in-mc1r-expres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-askb589-plus-chemotherapy-for-advanced-gastric-or-gastroesophageal-cancers-results-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-mortality-of-pancreatic-cancer-in-adults-aged-70-and-older-across-204-nations-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cadonilimab-in-recurrentmetastatic-solid-tumors-including-ici-treated-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-of-mutant-selective-pi3ka-inhibitor-rly-2608-in-combination-with-fulvestrant-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secure-a-dose-escalationexpansion-study-to-assess-the-anti-tumor-efficacy-of-sup67 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-artificial-intelligences-ai-clinical-reasoning-with-skin-cancer-multiple-choice-questi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-dose-expansion-study-of-dsp107-a-first-in-class-bi-specific-4-1bb-t-cell-engager-with-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-induction-aumolertinib-followed-by-aumolertinib-and-concurrent-radiotherapy-rt-in-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indirect-comparison-of-linvoseltamab-versus-elranatamab-for-triple-class-exposed-tce-relapsedrefr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-safety-lead-in-and-dose-expansion-trial-of-ivosidenib-plus-durvalumab-and-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proposed-changes-to-the-pathologic-staging-for-colon-cancer-cc-ajcc-colon-cancer-expert-panel-aj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-in-chronic-lymphocytic-leukemia-patients-characteristics-and-survival-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carfilzomib-lenalidomide-and-dexamethasone-krd-as-maintenance-therapy-after-autologous-stem-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-the-ox40-agonist-bgb-a445-with-or-without-tislelizumab-an-anti-pd-1-monoclonal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypoxia-responsive-cea-car-t-cells-therapy-for-relapsed-or-refractory-non-small-cell-lung-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-pre-cancerous-advanced-adenomas-of-the-colon-in-long-distance-runners 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-osemitamab-tst001-plus-nivolumab-and-capox-for-advanced-ggej-cancer-transtar102-upd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibition-in-ebv-associated-gastric-cancer-a-multi-center-international-retrospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-role-of-the-oral-microbiome-in-saliva-sputum-bronchoalveolar-fluid-and-tissue-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-inhibition-of-her2-and-vegf-pathways-in-breast-cancer-a-meta-analysis-of-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintaining-momentum-in-cancer-health-equity-examining-native-hawaiian-and-pacific-islander-us-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eon-phase-ii-trial-of-etigilimab-mph313-in-combination-with-nivolumab-in-patients-with-recurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trodelvy-use-in-advanced-triple-negative-breast-cancer-in-australia-tracie-study-design-and-inter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-weight-change-and-bmi-as-prognostic-markers-of-survival-outcomes-in-sacituzumab-govite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-outcomes-of-patients-with-gastrointestinal-stromal-tumor-at-institu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-renal-cell-carcinoma-a-novel-cfdna-fragmentomics-based-liquid-biopsy-assay 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-non-burkitt-non-hodgkins-lymphoma-nhl-1990-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/refining-intermediate-risk-ir-stratification-in-patients-pts-with-metastatic-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paraneoplastic-syndromes-in-non-small-cell-lung-carcinoma-a-systematic-review-of-case-reports-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-to-neoadjuvant-treatment-initiation-tti-for-resectable-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-multi-center-phase-12-study-of-a-selective-fgfr23-inhibitor-cgt4859-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-rectal-cancer-with-yptnm-vs-ptnm-staging-after-neoadjuvant-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-and-barriers-of-second-line-therapy-selection-in-hrher2-metastatic-breast-cancer-among-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-stas-in-stage-1-egfr-mutated-nsclc-and-prognostic-implications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-edil3-cafs-on-lymph-node-metastasis-through-disruption-of-lymphatic-endothelial-barriers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-the-efficacy-and-safety-of-disitamab-vedotin-rc48-in-chinese-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gauging-sustainable-cancer-ca-prevention-in-lynch-syndrome-ls-attitudes-toward-dietary-interven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-for-colon-adenocarcinoma-in-a-hospital-based-cancer-registry-in-cali-colombia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-multi-feature-immune-scoring-prognostic-model-for-stage-ii-and-iii-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-studies-of-dzd8586-in-cllsll-patients-after-covalent-or-non-covalent-btk-inhibitors-and-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triplet-therapy-with-braf-inhibitor-anti-egfr-agent-and-mek-inhibitor-in-v600e-braf-mutant-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-liposomal-irinotecan-combined-with-cadonilimab-as-second-line-treatment-for-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-dose-optimization-update-with-ezh2ezh1-inhibitor-tulmimetostat-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-immunotherapy-in-hormone-receptor-positive-breast-cancer-a-systematic-review-and-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-integrative-analysis-of-circulating-and-tumor-microenvironment-tme-determinants-of-patient-resp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stratified-analysis-of-mesothelioma-mortality-a-21-year-atlas-of-trends-and-demographic-shifts-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-predictors-of-response-to-immunotherapy-in-patients-with-extensive-stage-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-followed-by-systemic-therapy-and-tislelizumab-in-mss-rectal-cancer-with-liver-metastase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-with-statins-and-cdk46-inhibitors-in-patients-with-metastatic-hrher2-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keeping-an-eye-on-immune-effector-cell-associated-neurotoxicity-syndrome-icans-outcomes-and-predi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-cancer-system-characteristics-and-global-pan-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-and-cancer-in-america-from-declining-mortality-to-emerging-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-response-bias-in-recist-11-impact-on-non-target-lesion-assessment-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sunburst-plot-a-tool-for-interpretation-and-prediction-of-inter-reader-variability-relationships-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guide-t-a-three-tier-markmap-driven-platform-for-streamlined-breast-cancer-trial-navigation-and-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicogenomic-landscape-and-outcomes-of-metastatic-colorectal-cancer-patients-with-pathogenic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-body-mass-index-on-immunotherapy-outcomes-and-complications-in-solid-tumor-patients-a-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-association-of-blood-to-tissue-tumor-mutation-burden-tmb-ratio-with-overall-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-regional-trends-in-multiple-myeloma-and-cardiovascular-disease-related-mortality-amo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dabrafenib-and-trametinib-vs-anti-pdl1-for-the-adjuvant-treatment-of-locally-advanced-braf-mutant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomized-trial-of-radiotherapy-optimization-for-low-risk-her2-positive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-adherence-to-an-onoff-regimen-for-lenalidomide-in-patients-with-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melanoma-and-pregnant-women-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-atezolizumab-with-carboplatin-plus-pemetrexed-followed-by-maintenance-atezolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-tumor-fraction-tf-to-predict-response-to-nivolumab-in-recurrent-or-metastatic-rm-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-one-year-enough-extended-adjuvant-dabrafenib-plus-trametinib-for-chinese-patients-with-resected 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-early-stage-cutaneous-desmoplastic-melanoma-a-national-cancer-database-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-laryngeal-cancer-incidence-and-mortality-a-comprehensive-analysis-of-long-term-and-recent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-outcomes-in-patients-with-hematological-malignancies-developing-therapy-relat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-gastrostomy-and-clinical-outcomes-including-septicemia-weight-loss-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-ttmv-hpv-dna-testing-for-surveillance-in-hpv-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-liver-toxicity-management-and-outcomes-in-ici-treated-patients-with-advanced-or-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-ngs-as-a-longitudinal-follow-up-tool-in-the-clinical-management-of-oscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-application-of-the-painvision-system-for-quantitative-assessment-of-chemotherapy-induced-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antitumor-effect-of-prag-therapy-in-a-triple-negative-breast-cancer-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-healthcare-utilization-of-nivolumab-for-recurrent-andor-metastatic-squ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomic-profiling-of-lrrc15-in-triple-negative-breast-cancer-tnbc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-germline-homologous-recombination-deficiency-mutations-with-her2-status-conversion-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-low-dose-rapamycin-on-the-therapeutic-response-to-radio-immunotherapy-in-hepatocellular-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-peripheral-neuropathy-and-associated-supportive-treatment-in-breast-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-assisted-exploration-of-novel-non-invasive-biomarkers-of-ici-therapy-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-open-label-first-in-human-study-of-the-anti-gpc3-t-cell-engager-sar444200-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immunotherapy-or-antiangiogenic-agents-based-treatment-strategies-versus-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-molecular-landscape-of-rare-tumors-through-the-ccdi-cog-molecular-characterization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-smox-gene-expression-with-immune-checkpoint-therapy-response-in-patients-with-non-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-applicability-of-axillary-surgery-omission-in-real-world-breast-cancer-patients-insi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-study-of-177lu-rosptamab-plus-standard-of-care-vs-standard-of-care-alone-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-sequences-and-outcomes-in-patients-with-mcrpc-in-us-urology-clinics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-value-of-integrating-urology-and-oncology-real-world-data-for-understanding-prostate-cancer-mana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dosing-decitabine-and-venetoclax-for-terminal-differentiation-to-improve-outcomes-in-tp53-mutant-mds 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infectious-complications-in-relapsedrefractory-multiple-myeloma-patients-treated-with-bispecific-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-genomic-alterations-on-outcomes-in-patients-with-metastatic-castration-resistant-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modulation-of-enhancer-of-zeste-homolog-2-ezh2-pharmacodynamic-pd-markers-and-tumor-gene-express 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-ipteni-deletion-itmprss2i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-adenocarcinoma-to-neuroendocrine-tumor-a-therapy-driven-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tlr9-agonists-as-a-potential-therapeutic-option-for-b-all-patients-with-low-p53-expression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dyslipidemia-in-long-term-survivors-of-testicular-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-emerging-role-of-pharmacists-in-optimizing-therapeutic-substitutions-within-the-us-oncology-netw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-pre-biopsy-steroids-on-diagnostic-yield-in-diffuse-large-b-cell-lymphoma-dlbcl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimation-of-population-attributable-fractions-based-on-integrated-global-cancer-incidence-data-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-high-variant-allele-frequencies-vaf-of-dna-damage-repair-ddr-mutations-muts-in-liqu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-mastocytosis-statistics-and-impact-of-secondary-malignancy-on-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-rf-for-brain-metastases-bm-in-patients-pts-with-metastatic-breast-cancer-mbc-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-split-dose-lymphocyte-adjusted-rabbit-atg-in-allogeneic-stem-cell-transplant-recipients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerating-phase-2-clinical-development-with-real-world-data-rwd-an-external-control-arm-eca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-palliative-chemotherapy-in-hospitalized-patients-with-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-and-timeliness-of-next-generation-sequencing-testing-for-patients-with-resected-or-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-assessment-of-health-related-quality-of-life-in-early-phase-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spillover-effects-of-medicaid-expansion-on-insurance-coverage-diagnosis-and-survival-among-low-inc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delivery-of-b7h3-targeted-car-t-cells-in-injectable-silk-hydrogels-and-effects-on-the-efficacy-in-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-combined-with-capecitabine-for-postoperative-adjuvant-therapy-of-biliary-malignant-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-real-world-study-of-trastuzumab-combined-with-pirotinib-or-pertuzumab-as-a-neoadjuvant-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcatheter-arterial-chemoembolization-plus-donafenib-and-sintilimab-for-unresectable-hepatocellul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tocilizumab-in-fibrolamellar-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcome-of-localized-therapy-for-residual-or-recurrent-oligo-melanoma-or-renal-cell-cancer-rcc-fol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-observational-study-on-the-usage-of-glp-1-in-breast-cancer-patients-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-adar1-mediated-a-to-i-rna-editing-and-non-editing-functions-in-radioresistance-of-esopha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-geriatric-oncology-in-switzerland-results-from-a-nationwide-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-er-staining-patterns-and-heterogeneity-of-er-positive-her2-negative-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-risk-stratified-clinical-pathways-for-cancer-care-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/appropriate-treatment-for-stage-1-and-2-her-2-positive-and-triple-negative-breast-cancer-by-immigrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-and-cumulative-impact-of-metabolic-syndrome-traits-on-cardiovascular-renal-and-mortal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravesical-sacituzumab-tirumotecan-in-participants-with-intermediate-risk-non-muscle-invasive-blad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-mortality-trends-in-waldenstrom-marcroglobulinemia-a-21-year-analysis-1999-2020-using-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-key-molecular-drivers-of-survival-and-therapeutic-targets-in-glioblastoma-through-integr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-integration-strategy-for-small-cell-lung-cancer-in-extensive-stage-rise-with-up-to-10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-patient-advocacy-focused-rehabilitation-pilot-program-real-life-experience-in-enhancing-quality-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-exercise-program-in-breast-cancer-survivors-group-vs-individual-training-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-treatment-with-traditional-chinese-medicine-renshen-yangrong-tang-granules-for-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-receipt-of-palliative-interventions-across-disaggregated-hispanic-subgroups-with-late 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-atezolizumab-and-bevacizumab-with-or-without-transarterial-chemoembolization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/towards-personalized-management-of-intraductal-papillary-mucinous-neoplasms-with-multimodal-artifici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-outcomes-for-patients-diagnosed-with-small-cell-lung-cancer-between-a-university-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-race-gender-and-socioeconomic-status-on-ewing-sarcoma-survival-over-two-decades 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-novel-mirna-biomarkers-with-ca19-9-to-enhance-early-detection-of-pancreatic-ductal-adenoca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-disability-adjusted-life-years-dalys-and-mortality-rates-of-pancreatic-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iia-clinical-trial-of-abp1011t-monotherapy-in-patients-with-advanced-malignant-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venous-thrombosis-prophylaxis-in-oncology-knowledge-practice-and-attitude-study-among-oncologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medical-students-interest-and-exposure-to-oncology-in-nigeria-implications-for-workforce-developme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-prevalence-of-pancreatic-cancer-in-adults-aged-70-and-older-a-global-burden-of-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/renal-cell-carcinoma-survival-in-the-immunotherapy-era-a-comprehensive-analysis-of-healthcare-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-identification-of-facilitators-and-barriers-in-the-pre-emergency-care-pathway-by-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diverging-paths-identifying-barriers-to-and-increasing-accessibility-of-a-survivorship-program-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-dysbiosis-as-a-potential-guide-for-immunotherapy-discontinuation-after-2-years-in-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-trial-of-a-supportive-oncology-care-at-home-intervention-for-patients-with-cancer-receivi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-acceleration-among-adolescent-and-young-adult-patients-with-ewing-sarcoma-and-osteosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-the-presence-of-malignant-ascites-and-survival-outcomes-of-gastric-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-an-ngs-low-pass-based-method-to-detect-genomic-instability-as-a-parp-inhibitor-predictive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monitoring-populations-of-tumor-macrophage-fusion-cells-in-blood-prognosticates-pfs-and-os-in-pan-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-of-hepatocellular-carcinoma-a-single-institution-experience-at-mount-sina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-of-the-safety-and-efficacy-of-intraperitoneal-imnn-001-in-combination-with-neoadj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-observational-analysis-examining-liquid-biopsies-with-tissue-biopsies-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-by-dna-mismatch-repair-mmr-status-in-patients-pts-with-high-risk-endometrial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-use-of-educational-videos-in-a-medical-oncology-sarcoma-clinic-to-improve-patient-kno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-survival-prospective-longitudinal-insights-into-quality-of-life-after-hepatectomy-for-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-mortality-in-lung-cancer-patients-in-the-era-of-immunotherapy-and-targeted-therapy-a-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-tagged-a-phase-2-study-using-low-dosemetronomic-trabectedin-gemcitabine-and-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-gut-microbiota-gm-and-antibiotic-atb-use-on-immunotherapy-efficacy-in-patients-with-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-class-kif11-degrader-antibody-conjugate-dac-as-a-potential-therapy-targeting-a-broad-sp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-large-language-model-llm-based-multi-agent-framework-for-risk-stratification-and-treatment-recom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-properties-of-a-novel-ctdna-assay-for-lung-cancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-seer-stat-analysis-of-epidemiological-and-anatomical-prognostic-indicators-of-mesothelioma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-evaluation-of-neoadjuvant-chemoradiotherapy-plus-thymalfasin-and-tislelizumab-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-bat8006-a-folate-receptor-a-fra-antibody-drug-conjugate-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-unmet-supportive-care-needs-in-diverse-adolescent-and-young-adult-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-perioperative-complications-on-ctdna-based-mrd-detection-and-prognosis-insights-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-ctdna-profiling-to-identify-long-term-survivors-in-phase-i-immunotherapy-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-real-world-treatment-patterns-and-outcomes-of-zanubrutinib-and-acalabrutinib-in-cllsll-at 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-informed-precision-oncology-clinical-trial-to-evaluate-the-utility-of-ctdna-genomic-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-of-pembrolizumab-in-addition-to-neoadjuvant-platinum-based-chemotherapy-napc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-prospective-study-to-evaluate-the-efficacy-of-resection-for-initially-unresectable-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endometrial-cancer-mortality-in-the-us-insights-into-inequities-across-demographics-and-regions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-s2302-pragmatica-lung-a-pragmatic-trial-designed-to-increase-participant-representation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-dk2-sup10sup-egfr-a-tumor-targeted-il2-x-il10-dual 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-clinical-outcomes-of-early-stage-triple-negative-breast-cancer-treated-with-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-expressing-pattern-of-multiple-biomakers-and-dynamic-change-of-claudin182-expression-after-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-and-ii-study-of-ribociclib-with-trastuzumab-plus-endocrine-therapy-in-hrher2-advanced-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/laparoscopic-versus-open-liver-resection-for-colorectal-liver-metastasis-an-individual-participant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugates-treatment-response-score-adc-trs-for-sequencing-trastuzuamb-deruxtecan-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dato-base-a-phase-ii-study-of-datopotamab-deruxtecan-for-patients-with-breast-cancer-brain-metastas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gold-complex-2g-and-its-role-in-immunogenic-cell-death-and-antitumor-immunity-in-malignant-pleural-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/napistar-1-01-an-international-phase-iii-trial-of-the-novel-adc-tub-040-in-platinum-resistant-ovar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-multicenter-open-label-study-of-ub-vv111-in-combination-with-rapamycin-in-relapsedrefra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cemiplimab-with-platinum-doublet-chemotherapy-and-cetuximab-in-locoregionally-advanced-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allo-316-in-advanced-clear-cell-renal-cell-carcinoma-ccrcc-updated-results-from-the-phase-1-trave 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-endocrinopathy-in-cancer-patients-receiving-immune-checkpoint-inhibitor-therapy-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibrafi-v600e-papillary-thyroid-cancer-updated-analysis-of-real-world-patient-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/starlite-2-phase-2-study-of-nivolumab-plus-sup177sup-lutetium-labeled 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-qls31905-in-patients-with-advanced-solid-tumors-updated-data-from-phase-1-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-biomarkers-of-therapeutic-response-to-antibody-drug-conjugates-in-metastatic-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zl-1310-a-dll3-adc-in-patients-with-extensive-stage-small-cell-lung-cancer-ph1-trial-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-transportation-need-and-missed-visits-among-patients-receiving-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-tumor-informed-ctdna-based-molecular-residual-disease-mrd-with-clinical-outcomes-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vaccination-by-homologous-antigenic-loading-with-doc1021-as-adjuvant-therapy-for-glioblastoma-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alectinib-as-neoadjuvant-treatment-in-potentially-resectable-stage-iii-alk-positive-nsclc-final-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-cardiovascular-outcomes-of-carfilzomib-in-relapsed-or-refractory-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dietary-risk-factors-associated-with-colorectal-polyp-risk-and-potential-for-progression-to-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cemiplimab-in-cutaneous-basal-cell-carcinoma-of-the-head-and-neck 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monitoring-botensilimab-and-balstilimab-induced-t-cell-dynamics-in-refractory-mismatch-repair-profi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-assessment-of-carboplatin-with-etoposide-and-high-dose-ifosfamide-in-reecur-an-internation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-key-predictors-of-msimmr-status-in-colorectal-cancer-insights-from-a-real-world-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-insights-in-skin-melanoma-a-study-of-differential-diagnostic-tissue-markers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-safety-of-adjuvant-therapy-in-patients-with-high-risk-melanoma-harboring-braf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-due-to-laryngeal-carcinoma-a-systemic-analysis-of-the-global-burden-of-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-study-of-neoadjuvant-tislelizumab-combined-with-tp-regimen-for-the-comprehensive-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-8-year-single-institution-review-of-demographic-trends-and-treatment-patterns-among-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-impact-of-metronomic-therapy-methotrexate-and-celecoxib-and-cisplatin-based-radiochemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-role-of-tp53-mutations-in-mutyh-associated-colorectal-cancers-mutyh-crcs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-two-decade-review-of-thyroid-cancer-mortality-among-older-adults-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standard-dose-vs-fixed-dose-capecitabine-in-patients-with-advanced-gastrointestinal-and-metastatic-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-unmet-cancer-survivor-needs-in-a-background-of-comprehensive-and-free-health-care-a-cro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-atezolizumab-immune-related-adverse-events-based-on-the-us-faers-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-effectiveness-and-acceptability-of-single-session-acupuncture-with-infusion-therapy-at-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tislelizumab-in-combination-with-other-chemotherapy-agents-in-patients-with-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-immune-related-of-pembrolizumab-adverse-events-based-on-the-us-faers-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-relative-dose-intensity-rdi-of-perioperative-flot-in-resectable-and-locally-advanced-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diffusing-capacity-for-carbon-monoxide-dlco-change-and-outcome-in-advanced-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-records-to-timelines-a-llm-based-approach-for-summarizing-oncology-patient-history 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cerebrospinal-fluid-proteome-during-chemotherapy-for-childhood-leukemia-identifying-pathways-associ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-risk-factors-of-immune-mediated-liver-injury-caused-by-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypothyroidism-related-to-immunotherapy-in-elderly-adults-analysis-of-a-colombian-oncology-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/waveline-010-zilovertamab-vedotin-plus-r-chp-versus-r-chop-in-untreated-diffuse-large-b-cell-lympho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-as-a-predictor-of-in-hospital-outcomes-in-solid-tumours-with-cardiovascular-comorbidities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-in-unmet-supportive-care-needs-and-outcomes-among-older-ambulatory-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-preferences-of-patients-caregivers-and-physicians-in-follicular-lymphoma-fl-a-global 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-hla-class-i-expression-on-the-tumor-immune-microenvironment-and-prognosis-in-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-from-diagnosis-to-surgery-for-stage-i-non-small-cell-lung-cancer-among-native-hawaiians-and-oth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-place-of-death-and-racial-disparities-in-the-reporting-odds-ratio-of-cardiovascular-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/additive-clinical-utility-of-tissue-biomarkers-of-microsatellite-instability-msi-status-and-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/designing-a-novel-proactive-cv-clinic-model-to-address-cardiovascular-risk-in-prostate-cancer-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cardiovascular-mortality-among-patients-with-hematological-malignancies-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-associated-with-surgical-resection-rate-and-survival-prognosis-after-conversion-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-epic-slicerdicer-to-assess-pregnancy-rates-in-adolescent-and-young-adult-patients-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-in-adolescents-and-young-adults-associated-with-hepatobiliary-cancer-a-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-access-to-shelter-arrangement-and-adherence-to-breast-cervical-and-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-analysis-of-vb1016-and-atezolizumab-in-advanced-hpv16-positive-cervical-cancer-linking 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-due-to-endometrial-cancer-in-the-united-states-a-retrospective-analysis-from-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-hifu-treatment-on-liver-metastasis-of-colorectal-cancer-in-mice-and-its-impact-on-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-dose-expansion-study-of-zg006-a-trispecific-t-cell-engager-targeting-cd3dll3dll3-as-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-and-immunohistochemical-profiling-of-endometrial-carcinomas-insights-into-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-effectiveness-of-circulating-tumor-dna-in-recurrent-early-stage-non-small-cell-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-and-demographic-trends-in-mortality-from-breast-cancer-and-respiratory-diseases-in-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-early-onset-gastrointestinal-cancers-a-comprehensive-analysis-of-us-cancer-statistics-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-hidden-burden-prevalence-and-disparities-of-cancer-diagnosed-in-emergency-and-hospita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-conflicts-of-interest-in-clinical-trials-published-in-jco-a-large-language-model-assist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-survivorship-related-communication-gaps-to-develop-a-community-health-worker-led-interven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recombinant-human-adenovirus-type-5-h101-combined-with-anti-pd-1-monoclonal-antibody-in-the-treatm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-outcomes-of-patients-pts-with-lower-risk-myelodysplastic-syndrome-lr-mds-receivi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/celecoxib-vs-placebo-in-combination-with-chemotherapy-for-non-small-cell-lung-cancer-a-systematic-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-risk-factors-course-of-disease-and-clinical-outcomes-of-neuroendocrine-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-mixed-methods-feasibility-study-to-evaluate-and-assess-the-clinical-utility-of-multidisciplinary-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduced-length-of-stay-as-an-alternative-to-full-outpatient-car-t-services 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-prognostic-accuracy-in-lung-cancer-brain-metastases-through-histopathologic-feature-integr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/out-of-pocket-cost-modeling-of-europa-trial-arms-for-adjuvant-breast-cancer-therapy-five-days-of-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/athena-breast-a-real-world-pilot-of-an-artificial-intelligence-ai-chatbot-using-therapy-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-treatment-patterns-for-early-breast-cancer-among-healthcare-professionals-and-concordance-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-ihc-and-ai-based-evaluation-of-her2-low-and-ultra-low-expression-in-breast-cancer-speci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-utilization-at-the-fourth-most-populous-province-in-indonesia-a-single-centre-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-use-of-healthcare-resources-and-clinical-characteristics-of-patients-with-castr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/verification-of-the-breastest-assay-in-an-australian-population-a-novel-liquid-biopsy-assay-measuri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-an-electronic-medical-record-emr-best-practice-advisory-bpa-to-facilitate-oncofertili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-locoregional-recurrence-among-patients-with-breast-cancer-treated-with-breast-conservi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-in-metastatic-hormone-sensitive-prostate-cancer-mhspc-insights-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-dna-repair-genetic-alterations-identified-by-circulating-tumor-dna-on-sensitivity-to-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-efficacy-of-alk-inhibitors-in-alk-positive-non-small-cell-lung-cancer-a-real-world-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-demographics-and-outcomes-of-breast-cancer-in-females-undergoing-mastectomy-in-rural 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-bowel-symptoms-following-relugolix-and-stereotactic-body-radiotherapy-for-localized-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-care-capacity-in-cote-divoire-insights-from-a-novel-multidisciplinary-provider-surve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ccr8-positive-tregs-and-their-correlation-with-immunotherapy-response-in-advanced-non-small-cell-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-in-hospital-outcomes-between-total-parenteral-nutrition-and-enteral-feeding-in-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/raceethnicity-reporting-and-representation-in-clinical-trials-presented-at-the-american-society-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-second-primary-hematological-malignancy-post-car-t-cell-therapy-in-relapsedrefractory-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-vte-incidence-in-lung-cancer-a-comprehensive-assessment-of-the-khorana-score 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-paradox-in-non-small-cell-lung-cancer-nsclc-patients-on-immune-checkpoint-inhibitors-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-multiple-myeloma-analysis-from-1980-to-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antitumoral-immunity-in-colorectal-liver-metastases-histopathological-growth-patterns-and-tertiary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pertuzumab-plus-trastuzumab-pt-in-patients-pts-with-bladder-bc-and-ovarian-cancer-oc-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-t-cell-subsets-and-vessel-features-in-matched-primary-colorectal-tumors-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-window-of-opportunity-study-for-preoperative-brigatinib-in-resectable-anaplastic-lymphoma-kinase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-outcomes-of-cdk46-inhibitors-plus-endocrine-therapy-versus-chemotherapy-in-hrher2-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-and-surgery-in-patients-with-stage-iiib-iiic-n3-non-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-highly-sensitive-ctdna-assay-to-map-the-evolution-of-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-mastectomy-surveillance-a-patient-reported-survey-of-110-women-with-li-fraumeni-syndrome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-long-course-versus-short-course-chemoradiotherapy-combined-with-immunotherapy-for-pmmrm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rurality-and-screening-colonoscopy-participation-in-patients-with-lynch-syndrome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-the-efficacy-of-anti-her-2-targeted-therapy-and-ctdna-status-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/signatera-ctdna-in-stage-ii-crc-a-retrospective-comparison-with-traditional-risk-factors-for-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-positivehormone-positive-vs-her2-positivehormone-negative-breast-cancer-clinical-presentatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-radiological-characteristics-of-intermediate-and-high-risk-cases-in-the-brazilian-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discrepancies-between-germline-and-somatic-laboratories-in-the-reporting-of-germline-cancer-predispo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accurate-differentiation-of-malignant-and-benign-gastric-lesions-using-cell-free-dna-biomarkers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-u-net-encoder-decoder-for-accurate-automated-ctc-detection-from-images-of-peripher 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-cadonilimab-pd-1ctla-4-bispecific-antibody-in-patients-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-pemetrexed-based-regimens-in-primary-central-nervous-system-lymphoma-a-single-center-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-phase-ii-study-of-cabozantinib-cabo-with-nivolumab-nivo-and-ipilimumab-ipi-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/challenges-in-hiv-diffuse-large-b-cell-lymphoma-in-afro-caribbean-patients-in-a-nyc-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-outcomes-of-lung-abscess-in-hospitalized-lung-cancer-patients-insights-from-the-nati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fibroblast-growth-factor-receptor-3-ifgfr3i-alteration-status-and-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/driving-precision-oncology-in-lung-cancer-patient-stratification-through-comprehensive-genomic-prof 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-of-a-screening-trial-for-evaluating-oncogenic-drivers-in-japanese-patients-with-surg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-radiotherapy-and-survival-outcomes-in-pn2-non-small-cell-lung-cancer-with-positive-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-outcomes-of-minimally-invasive-surgery-and-open-surgery-for-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-in-combination-with-penpulimab-and-chemotherapy-as-first-line-treatment-for-extensive-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-in-resectable-small-cell-lung-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-comparing-chemoradiation-with-durvalumab-vs-chemoradiation-alone-in-locally-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/boolean-network-modeling-the-first-step-toward-a-new-understanding-of-breast-cancer-heterogeneity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thrombotic-events-and-mortality-associated-with-bispecific-antibodies-in-lung-cancer-a-systematic-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trajectories-of-patient-reported-cognitive-function-and-age-related-conditions-in-a-longitudinal-obs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-cardioprotective-therapies-in-preventing-cardiotoxicity-in-breast-cancer-patients-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-differences-in-tumor-immune-microenvironment-between-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-board-exam-outcomes-a-structured-exam-preparation-curriculum-for-hematologyoncology-fel-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-3-year-cancer-specific-and-overall-survival-for-metastatic-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lenvatinib-plus-pembrolizumab-and-chemotherapy-versus-chemotherapy-in-advanced-metastatic-gastroeso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-major-adverse-cardiovascular-and-cerebrovascular-events-and-healthcare-resourc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-cardiovascular-disease-mortality-among-pancreatic-cancer-patients-in-the-us-1999-2023-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modifiable-risk-factors-genetic-characteristics-and-survival-in-early-onset-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-new-therapies-and-outcomes-in-brazilian-patients-with-metastatic-non-small-cell-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-risk-of-pathogenic-germline-variants-among-164774-adult-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-survival-and-role-of-chemotherapy-in-patients-with-adrenocortical-carcinoma-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-primary-malignancy-in-patients-with-diffuse-large-b-cell-lymphoma-dlbcl-receiving-chimeric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-of-low-doses-versus-standard-dose-enzalutamide-in-advanced-prostate-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunological-correlates-from-phase-i-study-of-carv3-team-e-in-patients-with-recurrent-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-report-of-memory-avoidance-whole-brain-radiotherapy-to-treat-brain-metastases-a-prospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-age-in-the-clinical-risk-stratification-of-patients-with-idh-mutant-gliomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-hodgkin-lymphomas-in-a-turkish-pediatric-cancer-center-a-developing-country-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-donafenib-combined-with-pd-l1-inhibitors-plus-tace-for-unresectable-hepatoce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-resource-use-in-the-management-of-advanced-epithelial-ovarian-cancer-in-canada 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-and-bulk-transcriptomic-analysis-of-skin-kaposi-sarcoma-lesions-differences-by-disease-char 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-combination-therapy-versus-monotherapy-in-advanced-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mfolfirinox-efficacy-as-rescue-regimen-for-patients-with-metastatic-refractory-colorectal-cancer-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-novel-oral-medication-delivery-device-on-patient-engagement-and-discontinuation-in-indiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insurance-coverage-of-germline-genetic-testing-for-ovarian-pancreatic-and-early-onset-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-next-generation-rna-sequencing-based-mammaprint-and-blueprint-analysis-in-clinical-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/visual-capturing-and-profiling-of-circulating-tumor-cells-from-breast-cancer-patients-blood-via-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-safety-and-efficacy-of-crispraacas12b-supmaxsup-modifi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanism-of-the-synergistic-enhancement-of-response-to-immunotherapy-in-advanced-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/darolutamide-plus-androgen-deprivation-therapy-adt-in-patients-with-high-risk-biochemical-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-recurrence-risk-stratification-in-surgically-resected-non-small-cell-lung-cancer-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-with-ose2101-plus-folfiri-vs-folfiri-alone-after-folfirinox-ffx-induction-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patients-digital-health-needs-and-the-potential-impact-of-a-digital-health-navigator-on-the-oncolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-onset-osteopeniaosteoporosis-among-long-term-survivors-of-breast-cancer-role-of-hormone-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlative-and-spatial-transcriptomic-analysis-of-olaparib-and-durvalumab-in-patients-with-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-ifebemtinib-in10018-combined-with-garsorasib-d-1553-in-kras-g12c-mutant-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iberdomide-bortezomib-and-dexamethasone-ibervd-in-transplant-ineligible-tne-newly-diagnosed-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-a-tumor-naive-circulating-tumor-dna-ctdna-test-to-predict-outcomes-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-pre-existing-autoimmune-disease-on-outcomes-in-patients-treated-with-cd-19-targeting-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-importance-of-time-to-treatment-in-early-onset-colon-cancer-a-national-cancer-database-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/public-awareness-adherence-and-cost-effectiveness-of-cancer-screening-programs-insights-from-nati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-spatial-profiling-of-advanced-solid-tumors-and-lymphomas-from-a-phase-1-trial-of-copanlisib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-summary-of-the-c406-cart-efficacy-and-safety-for-an-her-2-positive-breast-cancer-populatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/haic-plus-tae-combined-with-tislelizumab-and-surufatinib-in-unresectable-intrahepatic-cholangiocarci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup212sup-pbvmt-a-net-therapy-in-somatostatin-receptor-2-sstr2-exp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-of-triple-class-exposed-tce-patients-with-relapsedrefr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-i-study-of-alpelisib-and-sacituzumab-govitecan-sg-in-patients-with-her2-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-and-barriers-to-breast-and-cervical-cancer-screening-in-rural-nigerian-communities-an-eth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-phase-1-study-of-mycophenolate-mofetil-with-chemoradiation-in-newly-diagnosed-glioblast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-nab-paclitaxel-and-cisplatin-as-first-line-treatment-for-metastatic-triple-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-results-of-a-phase-2-study-of-cisplatin-sensitized-radiation-therapy-and-pembrolizumab-for-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-periodontal-microbiome-on-response-to-immunotherapy-in-patients-with-advanced-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-analysis-of-responders-from-the-phase-3-ev-302-trial-of-enfortumab-vedotin-plus-pembroli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/growth-recovery-in-patients-with-ibrafi-altered-pediatric-low-grade-gli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-2-study-of-hdaci-chidamide-and-pd-1-inhibitor-for-advanced-urothelial-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-adjuvant-pembrolizumab-in-clinical-stage-iibc-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enterprise-level-ai-screening-for-oncology-trials-improving-patient-identification-with-oncollm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-tqb2102-a-novel-bispecific-anti-her2-antibody-drug-conjugate-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-plus-carboplatinpaclitaxel-followed-by-durvalumab-with-or-without-olaparib-as-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-neoadj-osimertinib-osi-chemotherapy-ct-vs-ct-alone-in-resectable-r-epidermal-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-anlotinib-plus-penpulimab-as-first-line-treatment-for-persistent-recurrent-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-docetaxel-as-a-radiosensitizer-in-patients-with-head-and-neck-cancer-unsuitable-for-cispl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onitt-a-phase-i-study-of-nanoliposomal-irinotecan-with-talazoparib-or-temozolomide-in-children-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-salivary-cd44-and-total-protein-levels-in-patients-with-oral-cavity-dysplasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-second-primary-cancer-incidence-by-primary-colorectal-cancer-location 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-vs-chemotherapy-run-in-followed-by-pembrolizumab-plus-nab-paclitaxel-in-metastatic-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-age-specific-trends-in-the-incidence-of-human-papillomavirus-associated-oropharyngeal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-medicare-advantage-ma-on-timely-initiation-of-pembrolizumab-among-dmmrmsi-h-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-specific-survival-prediction-models-for-de-novo-metastatic-breast-cancer-using-machine-learning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-ibrca12i-copy-number-loss-assessment-in-circulating-tumor-dn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-medicine-in-colorectal-mucinous-adenocarcinoma-mac-machine-learning-based-prognostic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-precision-oncology-for-haitian-breast-cancer-patients-through-deep-learning-enabled-comput 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-pre-treatment-readiness-tool-for-soft-tissue-and-bone-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-as-a-predictor-for-mammaprint-risk-group-from-pathology-slides-in-chinese-early-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melanoma-dormancy-predictors-of-relapse-in-resected-early-stage-cutaneous-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guard-01-a-prospective-study-of-efbemalenograstim-alfa-as-primary-prophylaxis-for-concurrent-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-non-breast-cancer-related-mortality-in-breast-cancer-and-dependence-on-disease-characteristi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dinutuximab-beta-for-the-treatment-of-ewing-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cdk-inhibitors-and-radiation-therapy-in-breast-cancer-hematologic-toxicity-and-survival-implication 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-novel-muc1-c-targeted-near-infrared-imaging-agent-for-fluorescence-guided-surgery-of-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interplatform-and-cross-cohort-meta-analysis-of-tumor-transcriptomics-to-predict-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-profiles-of-lutetium-177-and-enzalutamide-a-pharmacovigilance-study-and-dispropo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-alphafold-2-to-predict-stabilizing-mutations-for-the-r337h-variant-in-the-tetramerization-dom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-survival-mortality-determinants-and-demographic-factors-in-pancreatic-carcinoma-an-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-and-regional-burden-of-high-bmi-related-pancreatic-cancer-from-1990-to-2021-an-analysis-of-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-phase-ii-study-of-surufatinib-in-combination-with-gemcitabine-and-nab-pac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-donafenib-as-postoperative-adjuvant-therapy-in-patients-at-high-risk-of-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-patient-pt-characteristics-and-therapy-choice-across-treatment-tx-groups-in-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-microenvironment-phenotypes-across-tumor-vascular-and-immune-compartments-from-ramuciruma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preferred-first-line-1l-treatment-for-metastatic-urothelial-carcinoma-muc-after-prior-immune-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-oncology-in-pediatric-brain-tumors-real-world-experience-from-a-middle-income-country 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-prediction-and-prognostic-analysis-on-immunotherapy-and-tkis-combination-treated-mrcc-by-cu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-nephrectomy-on-the-clinical-outcomes-of-first-line-immunotherapy-and-tyrosine-kinase-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-application-of-a-novel-split-type-robotic-system-carina-platform-for-esophageal-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-perioperative-tisle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/womens-breast-cancer-mortality-trends-the-impact-of-lifestyle-factors-from-the-2021-global-burden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clobazam-as-an-add-on-treatment-for-medically-refractory-brain-tumor-related-epilepsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recast-re-evaluating-conditions-for-active-surveillance-suitability-as-treatment-for-dcis-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-vorasidenib-in-idh-mutant-gliomas-tolerability-adverse-events-and-acce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-study-of-whole-body-mri-wbmri-as-part-of-a-multimodality-screening-program-for-indiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-racial-and-temporal-disparities-in-cancer-and-respiratory-failure-mortality-in-the-us-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-preliminary-safety-results-of-an-observational-phase-ii-study-of-concurrent-use-of-aspirin-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/late-effects-in-high-risk-neuroblastoma-survivors-who-received-mibg-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experience-and-safety-of-chemotherapy-and-immunotherapy-in-patients-with-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-tx-patterns-and-decision-drivers-in-chinese-patients-pts-with-locally-advanced-cervica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-derived-method-for-rapidly-constructing-cervical-organoids-with-native-immune-and-mutation-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extended-vs-standard-lymphadenectomy-in-patients-of-pancreatic-head-adenocarcinoma-undergoing-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-effectiveness-of-laws-requiring-human-papillomavirus-vaccination-on-cervical-cancer-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-predictive-models-in-women-with-advanced-epithelial-ovarian-cancer-triaged-to-primary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-tolerability-and-toxicity-profile-of-nivolumab-in-a-black-population-with-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-registry-for-uveal-melanoma-in-lebanon-10-year-single-center-experience-of-a-major-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-patients-with-locally-advanced-and-metastatic-cutaneous-squamous-cell-carcinoma-cscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyses-of-clinical-and-biologic-determinants-of-melanoma-bone-metastasis-mel-bone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-valvular-heart-disease-in-adult-survivors-of-childhood-cancer-a-report-from-the-childhoo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-safety-of-two-year-fixed-duration-vs-continuous-immune-checkpoint-inhibitor-therapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-lung-cancer-surgical-quality-insights-from-a-national-quality-improvement-collaborative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-health-related-quality-of-life-among-individuals-living-with-non-small-cell-lung-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-myeloablative-and-reduced-intensity-conditioning-for-allogeneic-pbsct-in-mds-with-increase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-hospitalizations-with-lutetium-lu-177-vipivotide-tetraxetan-in-veterans-with-underlyi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-for-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-relevance-of-aurora-kinase-a-iaurkai-expression-in-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-fracture-following-androgen-receptor-pathway-inhibitors-arpis-a-population-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/independent-effects-of-comorbidities-and-race-on-breast-cancer-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implications-of-homologous-recombination-repair-pathway-mutations-on-the-immune-microenvironment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-patients-perspectives-a-qualitative-study-of-reasons-for-subcutaneous-preference-vs-intrave 2026-08-24 monthly 0.7 https://rjrindex.com/articles/canadian-cancer-trials-group-cctg-ind234223-pc-bets-prostate-cancer-biomarker-enrichment-and-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncology-risk-score-as-predictor-of-unplanned-readmissions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-current-state-of-cancer-survivorship-care-and-barriers-at-an-nci-designated-cancer-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-transcriptomic-classification-of-glioblastoma-associations-with-survival-and-tumor-microe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gemini-nsclc-study-integrated-longitudinal-multi-omic-biomarker-profiling-study-of-non-small-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gotistobart-in-combination-with-pembrolizumab-in-patients-with-advanced-melanoma-who-have-progressed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-whole-pelvic-vs-bladder-only-radiation-in-muscle-invasive-bladder-cancer-a-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-analysis-for-injected-and-non-injected-lesions-and-of-the-safety-and-efficacy-of-superficia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolutionary-divergence-of-the-hla-b-genotype-as-a-predictor-of-immune-checkpoint-inhibitor-ici-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-models-to-predict-skeletal-related-events-in-bone-metastasis-from-advanced-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-tenosynovial-giant-cell-tumor-an-analysis-of-the-surveillance-epidemiology-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-evaluation-of-a-multi-cancer-early-detection-assay-using-nmr-based-molecular-signatures 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-in-clinical-trials-for-fda-approved-drugs-in-colon-cancer-a-post-covid-era-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/albumin-myosteatosis-gauge-as-a-prognostic-biomarker-in-patients-treated-with-immune-checkpoint-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-related-mortality-of-incarcerated-populations-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-fluoropyrimidine-and-platinum-based-chemotherapy-regimens-in-combination-with-immunoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/jak-inhibitor-for-the-treatment-of-steroid-refractory-and-life-threatening-immune-related-adverse-ev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-and-clinical-relevance-of-metabolic-signature-subtypes-in-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-cytogenetic-associations-and-outcomes-in-multiple-myeloma-with-chromosome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-comparative-analysis-of-cardiovascular-cv-safety-and-time-to-next-treatment-ttnt-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-management-of-positive-sentinel-lymph-nodes-in-breast-cancer-patients-after-the-american 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pd-l1-high-expression-on-the-prognosis-of-patients-with-locally-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-insights-into-hrher2-early-stage-breast-cancer-neoadjuvant-therapy-responses-by-mammap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-age-of-onset-and-prognosis-of-p53-mutant-myeloid-malignancies-in-african-americans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-outcome-of-cardiovascular-risk-factors-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-the-use-of-hypomethylating-agents-prior-to-reduced-intensity-conditioning-allogeneic-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-of-exceptional-responders-er-and-non-responders-nr-to-androgen-receptor-pathway-inhibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-survival-outcomes-of-patients-with-poor-prognosis-metastatic-germ-cell-tumours-gct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-systemic-inflammation-in-early-stage-breast-cancer-in-the-canto-cohort-sim-cant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-survival-outcomes-among-histological-subtypes-of-pulmonary-adenocarcinoma-a-nationwide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-dose-adjusted-epoch-r-in-diffuse-large-b-cell-lymphoma-and-primary-medias 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-non-burkitt-non-hodgkin-lymphoma-related-mortality-in-the-united-states-over-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-jk06-a-5t4-antibody-drug-conjugate-in-patients-with-unresectable-locally-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-results-from-rebirth-a-phase-ii-study-of-risk-based-bladder-sparing-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-to-evaluate-the-safety-and-tolerability-of-the-antibody-drug-conjugate-adc-mesoc2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-hypofractionated-radiotherapy-plus-tislelizumab-with-anlotinib-followed-by-adjuvant-tisl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omx-0407-a-novel-spectrum-selective-small-molecule-kinase-inhibitor-in-advancedmetastatic-solid-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-metaplasia-in-adenocarcinoma-of-the-lung-a-national-cancer-database-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-treatment-strategies-of-cdk46-inhibitors-combined-with-endocrine-therapy-in-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-dose-escalation-study-of-the-safety-and-pharmacokinetics-of-pas-004-a-macrocyclic-mek-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifts-in-the-landscape-of-colorectal-cancer-burden-a-systematic-analysis-using-the-global-burden-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-asco-clinical-guidelines-authorship-and-institutional-representation-using-hemoncorg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-imprinttn-signature-with-survival-outcomes-by-race-in-basal-type-triple-negative-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-patients-with-her2-positive-invasive-lobular-carcinoma-in-the-altto-trial-big 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-impact-of-adjuvant-chemotherapy-regimens-for-small-t1miab-node-negative-pn0-triple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-to-predict-treatment-response-of-immune-checkpoint-inhibitors-from-pretreatment-chest 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-natural-language-processing-to-understand-financial-toxicity-in-cancer-care-a-thematic-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-patients-messages-about-radiologypathology-reports-insights-for-ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-survival-outcomes-in-adults-with-acute-megakaryoblastic-leuk-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-eligibility-criteria-in-randomized-controlled-trials-for-chronic-lymphocytic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-adverse-events-related-to-immunosuppressive-treatments-among-patients-with-head-and-neck-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-into-disease-progression-in-endometrial-cancers-the-role-of-cell-proliferation-pathway-mut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravenous-selenium-to-prevent-oral-mucositis-in-patients-with-lymphoma-or-myeloma-undergoing-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-associated-with-distant-recurrence-in-patients-with-intimal-sarcoma-at-a-tertiary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-impact-and-mortality-outcomes-of-palliative-care-integration-among-cancer-patients-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-cachexia-and-anorexia-in-hospitalized-female-patients-with-breast-cancer-a-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transfusion-related-cost-and-time-burden-offsets-in-patients-with-myelofibrosis-treated-with-pacriti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biological-determinants-of-immune-exclusion-in-non-small-cell-lung-cancer-an-analysis-of-the-precis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-and-financial-toxicity-among-patients-with-gynecological-cancers-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-trial-of-intratumoral-adenovirus-interleukin-12-it-advil-12-and-atezolizumab-in-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-cancer-related-fatigue-on-quality-of-life-of-1262-patients-with-breast-cancer-receiving-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutational-signature-differences-in-paired-tissues-of-triple-negative-breast-cancer-receiving-neoadj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-fih-phase-1-study-of-cusp06-a-cadherin-6-cdh6-directed-antibody-drug-conjugate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-regimen-and-cisplatin-dose-effects-on-survival-in-neoadjuvant-treatment-of-urothelial-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-lenvatinib-plus-everolimus-in-advanced-extra-pancreatic-neuroendocrine-tumors-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ng11-2-phase-ib-trial-to-preventreduce-severe-oral-mucositis-induced-by-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-safety-and-efficacy-results-from-a-first-in-human-phase-12-study-of-sar445877-an-anti-pd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obx-115-engineered-tumor-infiltrating-lymphocytes-til-with-regulatable-membrane-bound-il15-mbil15 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-analysis-of-disitamab-vedotin-combined-therapy-for-her2-expressing-platinum-sensitive-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-cell-of-origin-gene-rearrangements-and-frontline-treatment-on-incidence-of-secondary-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-encore-multicenter-prospective-registry-of-sequential-antibody-drug-conjugates-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peptide-receptor-radionuclide-therapy-lu-177-prrt-in-neuroendocrine-tumors-net-single-instituti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-antitumor-virotherapy-pre-clinical-evaluation-of-tumor-targeting-efficacy-and-safety-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-pathology-based-ai-spatial-biomarker-to-predict-outcomes-for-immune-checkpoint-inhibitors-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonevo-preoperative-abemaciclib-for-cisplatin-ineligible-muscle-invasive-bladder-cancer-mibc-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-matrix-trial-a-multicenter-randomized-phase-ii-study-of-atr-inhibition-via-tuvusertib-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-monitoring-in-participants-pts-with-ovarian-cancer-treated-with-neoa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-clinical-study-investigating-the-neoadjuvant-treatment-of-her2-low-expressing-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dreamm-7-study-of-belantamab-mafodotin-plus-bortezomib-and-dexamethasone-bvd-vs-daratumumab-plus-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-significance-of-cognitive-function-assessment-in-treatment-naive-high-grade-glioma-patients-on-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obx-115-engineered-tumor-infiltrating-lymphocyte-til-cell-therapy-with-regulatable-membrane-bound-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-a-multi-modal-ataraxis-ai-platform-for-recurrence-prediction-in-early-stage-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-temperature-controlled-hand-foot-cryotherapy-to-prevent-chemotherapy-induced-polyneuropa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-a1811-plus-adebrelimab-in-unresectable-or-metastatic-triple-negative-breast-cancer-results-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-hyperglycemia-on-in-hospital-outcomes-on-gastric-and-esophageal-cancer-patients-suffering 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-with-anti-pd-1-or-pd-l1-in-advanced-ovarian-cancer-oc-a-meta-analysis-of-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mrd-negativity-after-end-of-induction-in-the-phase-3-phallcon-trial-a-post-hoc-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-phase-3-open-label-randomized-2-arm-study-comparing-the-clinical-efficacy-and-safety-of-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-clinicogenomic-profiling-of-signet-ring-cell-carcinoma-across-multiple-organ-sites 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-with-ivosidenib-in-chinese-patients-with-idh1-mutated-intrahepatic-chol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-and-factors-associated-with-financial-toxicity-among-gastrointestinal-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-protein-biomarkers-for-early-detection-of-pancreatic-ductal-adenocarcinoma-using-longitudinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-ctdna-testing-trends-and-associated-outcomes-in-patients-pts-with-early-stage-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-and-overall-survival-os-for-zanidatamab-chemotherapy-in-her2-positive-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-to-evaluate-the-safety-pharmacokinetics-and-efficacy-of-the-first-in-class-cyclin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-phase-ii-study-of-adebrelimab-plus-carboplatin-and-albumin-bound-taxanol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-median-follow-up-update-of-pure-01-a-phase-2-study-of-neoadjuvant-pembrolizumab-followed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-pain-and-symptom-management-in-cancer-a-data-driven-analysis-of-care-delivery-psychosoci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-randomized-study-comparing-ultra-low-dose-immunotherapy-to-standard-cytotoxic-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/8-year-outcomes-of-enzalutamide-enza-versus-a-non-steroidal-anti-androgen-nsaa-for-metastatic-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-the-interleukin-6-il-6-receptor-blocking-antibody-sarilumab-sari-in-combinat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-olomorasib-a-second-generation-kras-g12c-inhibitor-plus-cetuximab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-claudin182-expression-pd-l1-and-prognostic-implications-in-gastric-and-gastroesoph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-integration-of-microbiome-and-exosome-profiles-for-precision-diagnostics-and-therapeutics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/state-level-trends-and-associated-disparities-in-melanoma-burden-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dietary-compounds-and-patterns-associated-with-immune-checkpoint-inhibitor-ici-outcomes-in-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-bh011-after-intravesical-administration-in-patients-with-cis-andor-papillary-non-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dalpiciclib-dalp-plus-endocrine-therapy-et-as-adjuvant-treatment-for-hrher2-early-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-and-meta-analysis-of-pd-1-and-pd-l1-inhibitors-in-triple-negative-breast-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-jnj-79635322-jnj-5322-a-novel-next-generation-trispecific-antibody-tsab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-iii-trial-evaluating-bnt142-a-first-in-class-mrna-encoded-bispecific-antibod 2026-08-24 monthly 0.7 https://rjrindex.com/articles/broad-implementation-of-ai-for-lymph-node-assessment-insights-from-a-head-to-head-comparison-of-two 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immune-checkpoint-blockade-therapy-in-combination-with-tace-for-resectable-hepatocellula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cafelkibart-lm-108-an-anti-ccr8-monoclonal-antibody-in-combination-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/idov-safe-an-intravenously-deliverable-oncolytic-vaccinia-virus-for-solid-tumors-refractory-to-stan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-systemic-therapy-for-resectable-colorectal-peritoneal-metastases-a-multicenter-random 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-lucicebtide-st101-in-glioblastoma-patients-by-antagonism-of-cebpv-dependent-mesenchymal-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radical-surgery-with-adjuvant-therapy-in-advanced-oral-tongue-cancer-survival-trends-and-functional 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-allogeneic-anti-cd19-car-t-therapy-for-patients-with-cd19-relapsedrefractory-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncopro-a-us-national-initiative-supporting-implementation-of-remote-symptom-monitoring-with-electr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-study-of-casdozokitug-an-il-27-targeting-antibody-in-combination-with-toripal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-validation-of-end-of-treatment-ctdna-mrd-by-phased-seq-in-dlbcl-patients-from-a-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifiable-renal-lesion-diagnostic-mdct-enhancement-criteria-for-pathology-prediction-and-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-immunotherapy-response-for-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-targeted-therapies-in-oncology-the-role-of-alectinib-in-managing-alk-positive-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-clinical-trial-of-quaratusugene-ozeplasmid-gene-therapy-and-atezolizumab-maintenance-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-erk-signaling-and-tumor-microenvironment-in-braf-altered-gliomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-lazertinib-with-or-without-chemotherapy-for-patients-with-epidermal-growth-factor-recept 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-pharmacological-interventions-in-alveolar-soft-part-sarcoma-a-network-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-omic-liquid-biopsy-for-the-earlier-detection-of-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/productivity-of-national-cancer-institute-k-awardees-and-their-transition-to-independent-funding 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-specific-unmet-needs-among-older-patients-with-cancer-enrolled-in-an-outpatient-palliative-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-dysplasia-detection-in-inflammatory-bowel-disease-a-comprehensive-meta-analysis-of-dye-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-a-3-component-genomic-instability-score-to-individual-biomarker-scores-in-classifying 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-an-ultra-sensitive-sequencing-platform-to-detect-mutant-ikrasi-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uncovering-the-tumor-microenvironment-tme-exploring-survival-and-immunotherapy-io-response-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-control-trial-to-validate-mitigation-of-chemotherapy-induced-peripheral-neuropathy-by-lim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerating-and-de-risking-late-pre-clinical-drug-development-with-the-zebrafish-tumor-xenograft-z 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-pegargiminase-targeting-the-fanconi-anemia-pathway-and-its-role-in-dna-double-stran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-differential-epigenetic-landscapes-in-subtypes-of-appendiceal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-different-egfr-scores-and-their-relationship-with-prognosis-in-patients-with-urotheli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-generated-health-data-as-a-risk-stratification-tool-real-world-multidisciplinary-care-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-camrelizumab-combined-with-radiotherapy-as-neoadjuvant-therapy-for-locally-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-melanoma-cells-through-g-quadruplex-formation-mechanism-and-enhanced-efficacy-of-t-oligo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-5-hydroxymethylcytosine-profiling-for-the-assessment-of-colorectal-cancer-biology-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-based-clinicogenomic-analysis-of-advanced-head-and-neck-cancer-patients-treated-with-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographics-socioeconomic-and-treatment-patterns-for-adenocarcinoma-with-cartilaginous-and-osseou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd1-inhibitors-with-concomitant-palliative-radiotherapy-for-treatment-of-older-patients-with-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-targets-singular-promise-a-comprehensive-analysis-of-bispecific-antibodies-in-solid-tumor-onc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effcacy-and-safety-results-of-a-multi-center-phase-iii-study-of-utidelone-capsule-a-novel-oral-mic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-head-and-neck-cancers-hncs-genetic-heterogeneity-immune-landscape-and-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-radioiodine-rai-versus-no-radiodine-therapy-for-patients-with-low-risk-differentiate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-anlotinib-plus-third-generation-egfr-tkis-in-advanced-non-small-cell-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-intestinal-microbiome-alteration-with-resistant-potato-starch-rps-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-and-gender-influence-on-adverse-events-for-melanoma-patients-a-comprehensive-review-and-meta-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-characterization-of-her2-alterations-in-non-small-cell-lung-cancer-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/caregiver-distress-caring-for-those-who-care-for-our-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-glp-1-agonists-sglt-2-inhibitors-and-other-glucose-lowering-medications-on-cardiorenal-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-comparative-effectiveness-of-clinical-trial-participation-on-hospital-outcomes-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/marketing-cancer-care-a-content-analysis-of-ethical-compliance-in-television-advertising-by-top-ran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-teratoma-histology-in-postchemotherapy-residual-lesions-of-non-seminoma-testicular-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-for-cancer-patients-out-of-pocket-costs-by-cancer-diagnosis-in-traditional-medic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-assessment-of-pre-and-post-neoadjuvant-suvs-via-18f-fdg-petct-in-esophageal-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initiation-of-high-dose-chemotherapy-at-rising-tumor-markers-compared-with-radiographic-progression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-intensity-modulated-radiotherapy-and-3d-conformal-radiotherapy-in-the-treatment-of-eso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-rurality-with-guideline-concordant-survivorship-care-receipt-among-medicare-beneficia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-cost-effectiveness-of-genetic-testing-in-high-risk-families-with-confirmed-germline-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-trends-in-latin-american-oncology-clinical-trial-sites 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telehealth-utilization-in-neuro-oncology-a-single-institution-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-pilot-trial-of-a-neuromodulatory-digital-therapeutic-for-individuals-with-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-telehealth-utilization-on-adherence-to-endocrine-therapies-in-privately-insured-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gh9d2-t-cell-activation-ghdtca-with-ict01-combined-with-azacitidine-venetoclax-av-for-olderunfit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-pathway-gene-expression-and-response-to-hormonal-therapy-in-prostate-cancer-swog-s1216 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-a-phase-2-study-timdarpacept-imm01-combined-with-azacitidine-aza-as-the-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-tumor-growth-modeling-and-informed-neural-networks-as-early-predictive-clinical-endpoints 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-modeling-by-tumor-type-comparing-performance-and-feature-importance-of-machine-learning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-preventable-acute-care-events-a-study-on-which-patients-experience-emergency-visits-and-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/awareness-of-gestational-surrogacy-among-female-patients-treated-for-cancer-a-national-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-time-ai-based-computer-aided-detectiondiagnosis-ai-cad-for-breast-ultrasound-a-prospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deepseal-empowering-clinical-researchers-to-analyze-clinicogenomic-data-with-an-intuitive-chat-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/who-benefits-from-gilteritinib-combination-therapy-amongst-flt3-supmutsup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-from-a-21-year-analysis-of-mortality-due-to-hypertension-and-esophageal-cancer-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-pharmacokinetics-pk-pharmacodynamics-pd-and-preliminary-efficacy-of-hlx301-a-bispecif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immune-checkpoint-inhibitor-ici-associated-autoimmune-hemolytic-anemia-aiha-on-mortali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-ds-2243-an-hla-a02ny-eso-directed-bispecific-t-cell-engager-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-out-of-pocket-cost-after-car-t-cell-therapy-in-commercially-insured-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quilt-3076-phase-1-study-of-memory-like-cytokine-enriched-natural-killer-m-cenk-cells-plus-n-803 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-clinicopathological-features-and-outcomes-of-hormone-positive-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mevrometostat-in-combination-with-enzalutamide-in-patients-with-metastatic-castration-resistant-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-sacituzumab-induced-severe-or-febrile-neutropenia-and-g-csf-utilization-and-cost-for-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup177sup-lu-vipivotide-tetraxetan-psma-vs-cabazitaxel-in-metastatic-castration-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-risk-of-physical-functional-impairment-and-health-care-utilization-in-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-considerate-to-evaluate-patient-experience-in-a-cancer-center-psychometric-and-healthcare-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-benmelstobart-plus-anlotinib-versus-sunitinib-in-advanced-renal-cell-carcinoma-subgroup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-primary-refractory-metastatic-renal-cell-carcinoma-receiving-seco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iib-study-of-olaparib-and-astx727-in-brca-12-and-hrd-mutated-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiographic-ground-glass-nodules-features-and-immune-profiles-in-early-stage-lung-adenocarcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/balancing-tumor-control-and-toxicity-sbrt-strategies-for-ultra-central-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-small-cell-lung-cancer-incidence-and-projections-of-future-burden-through-2050 2026-08-24 monthly 0.7 https://rjrindex.com/articles/importance-of-bulky-lymph-node-involvement-in-locally-advanced-anal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-outcomes-by-inpatient-and-outpatient-infusion-of-axicabtagene-ciloleucel-axi-cel-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-and-trend-of-pancreatic-cancer-in-high-income-countries-a-30-year-analysis-of-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-predictors-of-16000-multi-omic-traits-and-associations-with-breast-cancer-survival-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alk-positive-anaplastic-large-cell-lymphoma-statistics-and-survival-trends 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-cd73-on-immune-escape-via-tryptophan-metabolic-reprogramming-in-diffuse-large-b-cell-lymph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/limited-versus-expanded-multigene-germline-genetic-testing-among-adolescents-and-young-adults-aya 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-modalities-and-survival-outcomes-in-patients-with-hepatocellular-carcinoma-with-brain-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scrna-seq-profiles-to-identify-hes1-associated-with-acth-secreting-tumors-and-the-distinct-microenvi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colonoscopy-quality-indicators-for-colorectal-cancer-precursors-sessile-serrated-lesion-and-adenoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-germline-hereditary-cancer-syndrome-variants-and-associated-cancers-in-a-healthcar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-individual-and-joint-effects-of-air-pollution-exposure-on-plasma-proteome-among-vulnerable-elder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-cd4pd-1cxcr6-t-cells-on-the-response-of-immune-checkpoint-inhibitor-therapy-in-brain-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biliary-tract-cancers-a-large-burden-for-little-rhode-island 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-tarlatamab-therapy-for-relapsed-small-cell-lung-cancer-biomarker-identification-and-addr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-haic-or-lenvatinib-combined-with-sintilimab-as-neoadjuvant-therapy-for-high-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-plus-lenvatinib-in-women-with-advanced-or-recurrent-uterine-carcinosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-stratified-analysis-of-socioeconomic-disparities-in-non-small-cell-lung-cancer-outcomes-a-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-circulating-tumor-dna-ctdna-detection-by-phased-seq-after-axicabtagene-ciloleu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hyperthermic-intraperitoneal-chemotherapy-hipec-for-primary-advanced-stage-or-recurrent-ovarian-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-hospital-outcomes-for-uterine-and-ovarian-cancer-patients-a-national-inpatien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-the-efficacy-and-safety-of-donafenib-combined-with-tace-as-adjuvant-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-a-second-primary-cancer-diagnosis-on-health-related-quality-of-life-in-african-america 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-oncology-adherence-application-real-world-pilot-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-practice-patterns-and-outcomes-for-metastatic-uveal-melanoma-treated-regionally-versus-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypersensitivity-reactions-to-platinums-systematic-review-of-efficacy-and-safety-of-desensitization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-gastric-cancer-among-people-with-brca-pathogenic-gene-variants-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-pd-1-inhibitor-tislelizumab-plus-sox-for-locally-advanced-gastric-or-gastro-oesophage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-experience-of-pik3ca-and-akt-inhibitors-in-patients-with-hormone-receptor-positive-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-free-survival-in-hr-positive-her2-negative-breast-cancer-cdk46-inhibitors-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-the-efficacy-of-cdk46-inhibition-in-the-management-of-metastatic-her2hr-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lymph-node-characteristics-on-clinical-outcomes-in-clinical-n2-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strategic-efforts-for-optimal-outcomes-in-patients-with-low-anterior-resection-syndrome-lars-at-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-large-centre-study-of-pathological-and-clinical-characteristics-of-signet-ring-and-mucinous-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spyk04-a-novel-raf-mek-molecular-glue-dose-escalation-de-in-first-in-human-study-for-mapk-pathwa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-phase-1-clinical-trial-of-anti-pd-1-ab-plus-intrahepatic-injection-of-oncolytic-virus-oh2-comb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-lung-cancer-and-cardiovascular-disease-related-mortality-among-older-adul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-immune-profiling-approach-for-immuno-oncology-unveiling-biomarkers-and-therapeutic-targe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-update-on-the-results-of-ibi110-anti-lag-3-antibody-plus-sintilimab-anti-pd-1-antibody-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-in-gastrointestinal-cancers-with-pre-existing-autoimmune-disorders 2026-08-24 monthly 0.7 https://rjrindex.com/articles/niraparib-plus-pd-1-inhibitor-for-patients-previously-treated-with-immune-checkpoint-inhibitor-for-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-recombinant-interleukin-15-in-combination-with-nivolumab-and-ipilimumab-in-subjects 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarcopenia-and-postoperative-outcomes-in-patients-with-peritoneal-carcinomatosis-undergoing-cytoredu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-basket-study-to-evaluate-the-tissue-agnostic-efficacy-of-anti-pd1-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-dzd8586-a-non-covalent-bbb-penetrant-lynbtk-dual-inhibitor-as-monotherapy-in-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-manageable-toxicity-of-mogamulizumab-in-a-real-world-north-american-cohort-of-adult-t-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-profiling-to-identify-a-functionally-high-risk-smoldering-multiple-myeloma-patient-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-result-of-a-phase-ib-study-efficacy-and-safety-of-fg-m108-plus-gemcitabine-and-nab-pacl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-the-uptake-of-free-cancer-screening-services-in-rural-india-using-machine-learning-tools 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-efficacy-and-mechanism-of-action-of-combined-pan-raf-and-mek-inhibition-in-halting-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-cancer-risk-prediction-in-asymptomatic-adults-using-urinary-glycosaminoglycan-profiling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-ib-dose-expansion-study-to-assess-the-efficacy-of-cd137fap-agonist-bi-765179-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-gut-microbiome-composition-in-the-ibd-crc-pathway-a-retrospective-study-of-428-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-survive-study-standard-surveillance-vs-intensified-liquid-biopsy-based-surveillance-in-early-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lorlatinib-dose-modifications-on-adverse-event-outcomes-in-the-phase-3-crown-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/able-32-a-randomized-controlled-phase-3b-clinical-trial-of-nadofaragene-firadenovec-vncg-versus-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-guided-adaptive-first-line-chemoimmunotherapy-for-non-small-cell-lung-cancer-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-of-pd-l1-expression-on-live-single-circulating-tumor-cells-with-pd-l1-in-tumor-tissue-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-23-study-of-bicycle-toxin-conjugate-zelenectide-pevedotin-bt8009-targeting-nectin-4-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/solti-2201-across-trop2-trial-a-phase-ii-study-to-identify-predictive-biomarkers-of-sacituzumab-gov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bispecific-innate-cell-engager-ice-afm24-in-combination-with-atezolizumab-in-patients-with-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-and-impact-of-b7-h3-icd276i-expression-across-dise 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparable-efficacy-and-safety-of-taletrectinib-for-advanced-ros1-non-small-cell-lung-cancer-across 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zongertinib-in-her2-altered-breast-cancer-preclinical-activity-and-preliminary-results-from-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-prognostic-value-of-post-surgery-circulating-tumor-dna-and-tumor-stroma-ratio-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toll-like-receptor-7-tlr7-agonists-and-ox40-agonists-injection-combined-with-sbrt-in-advanced-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-large-language-model-llm-based-clinical-abstraction-of-electronic-health-records-eh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treating-the-untended-real-world-insights-into-enfortumab-vedotin-plus-pembrolizumab-for-frail-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-time-clinical-validation-of-a-blood-cell-free-mrna-based-geneverify-test-for-screening-and-ear 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-deep-versatile-classifier-for-accurate-subtyping-of-lung-adenocarcinoma-using-hematoxylin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-and-survival-in-oncogene-addicted-resected-stage-iiian2-non-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outpatient-administration-of-car-t-cell-therapy-a-university-of-arizona-cancer-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-circulating-tumor-dna-driven-risk-adapted-systematic-therapy-in-nasopharyngeal-carcinoma-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-ldh-as-a-prognostic-biomarker-of-early-treatment-failure-in-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-cjrb-101-a-live-biotherapeutic-product-in-combination-with-pembrolizumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-investigating-the-safety-tolerability-and-preliminary-efficacy-of-hx009-in-post-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-report-of-a-single-arm-single-center-retrospective-analysis-investigating-pd-l1-plus-chemother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-based-prediction-of-claudin-182-expression-and-immune-phenotype-to-guide-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/petosemtamab-mcla-158-with-pembrolizumab-as-first-line-1l-treatment-of-pd-l1-recurrentmetastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-gender-equity-in-cancer-research-across-north-africa-a-comprehensive-analysis-of-womens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-assessment-of-response-to-chemotherapy-via-ctdna-in-soft-tissue-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-rasolute-302-a-phase-3-multicenter-global-open-label-randomized-study-of-dara 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patritumab-deruxtecan-her3-dxd-in-resistant-iegfri-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-traditional-nlp-methods-and-llm-based-extraction-for-identifying-biomarkers-in-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acr246-a-first-in-next-generation-5t4-adc-as-a-potential-choice-of-treating-5t4-positive-solid-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-characteristics-of-early-progressors-eps-and-long-term-progression-free-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ideate-pantumor02-a-phase-1b2-study-to-evaluate-the-efficacy-and-safety-of-ifinatamab-deruxtecan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imlunestrant-with-or-without-abemaciclib-in-advanced-breast-cancer-abc-safety-analyses-from-the-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-rapid-progression-on-cdk46-inhibitor-cdki-for-metastatic-hrher2-breast-cancer-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-a-phase-ii-study-of-perioperative-disitamab-vedotin-rc48-adc-plus-cadonilimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imyci-amplification-as-a-prognostic-biomarker-in-osteosarcoma-a-report-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-glucagon-like-peptide-1-receptor-agonists-on-morbidity-and-mortality-in-multiple-myeloma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-real-world-recurrence-in-high-risk-hr-non-muscle-invasive-bladder-cancer-nmibc-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-to-evaluate-the-efficacy-and-safety-of-glsi-100-gp2-gm-csf-in-breast-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artemide-lung03-a-phase-3-randomized-double-blind-multicenter-global-study-of-rilvegostomig-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/communication-skills-training-program-for-medical-staff-in-cancer-genomic-testing-a-mixed-methods-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-post-surgical-mrd-status-with-neoadjuvant-ctdna-dynamics-genomic-mutations-and-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myc-amplification-and-protein-expression-as-prognostic-markers-in-pediatric-and-young-adult-osteosar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-chemotherapy-in-patients-with-high-risk-rhabdomyosarcoma-long-term-survival-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-activity-of-ebc-129-a-first-in-class-anti-n256-glycosylated-ceacam5-and-ceacam6-antibody 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-patient-characteristics-treatment-patterns-and-clinical-outcomes-of-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-enfortumab-vedotin-pembrolizumab-ev-p-based-treatment-toxicity-treatment-discont 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ember-lung-electronic-medical-record-boosting-molecular-testing-in-early-stage-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-hospital-outcomes-of-patients-admitted-with-chronic-obstructive-pulmonary-disease-exacerbation-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-induction-immunochemotherapy-followed-by-definitive-chemoradiotherapy-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-mgmt-methylation-on-overall-survival-in-solid-tumors-a-systematic-review-and-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tolerance-to-cd46-inhibitor-therapy-as-first-line-therapy-among-er-patients-with-metastatic-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-treatment-and-survival-outcomes-for-early-stage-nsclc-in-veterans-insights-from-cancer-cube 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-electronic-medical-records-for-early-lung-cancer-diagnosis-an-evaluation-of-the-c-the-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inflammatory-bowel-disease-and-risk-of-cancer-a-nationwide-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-chemotherapy-outcomes-among-patients-with-stage-ii-early-onset-colon-cancer-in-alberta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-oncologic-outcomes-in-elderly-patients-with-localized-anal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-minimal-comprehensive-somatic-panel-to-aid-clinical-decision-making-in-a-low-cost-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-oropharyngeal-cancer-mortality-in-the-united-states-a-retrospective-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-overall-survival-in-patients-with-brain-metastases-from-her2-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-into-hpv-mediated-oropharyngeal-squamous-cell-carcinoma-a-northern-nevada-epidemiological 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-and-effectiveness-of-avelumab-in-immune-compromised-ic-and-non-ic-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-mortality-in-brazil-from-2004-to-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outpatient-treatment-related-toxicity-after-hospital-discharge-among-patients-receiving-lifileucel-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radioimmunotherapy-associated-myeloid-neoplasms-real-world-multicenter-retrospective-study-using-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-vs-conventional-doxorubicin-as-first-line-therapy-in-advanced-soft-tissue-sarcomas-a-tert 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-gut-microbiota-with-therapy-efficacy-and-prognosis-in-biliary-tract-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-elevated-ca19-9-and-cancer-associated-macrophages-in-blood-with-outcomes-in-pancreati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/siglec15-as-a-potential-therapeutic-target-for-the-treatment-of-fibrosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-pathological-characteristics-of-primary-duodenal-adenocarcinoma-and-the-construction-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-disability-adjusted-life-years-dalys-of-gastric-cancer-among-elderly-70-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-setup-margin-and-biology-tracking-zone-variations-on-dosimetric-plan-quality-and-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-socioeconomic-and-treatment-patterns-in-malignant-brenner-tumors-a-national-cancer-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-non-invasive-metabolomic-biomarker-for-detecting-cervical-intraepithelial-neoplasia-and-cervical-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-artificial-intelligence-based-computed-tomography-methods-in-detecting-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-surgical-intervention-with-30-day-re-admission-and-outcomes-in-patients-hospitalized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-cervical-cancer-outcomes-and-national-cancer-system-characteristics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-donafenib-combined-with-tace-as-adjuvant-therapy-in-patients-with-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-anemic-patients-with-early-onset-breast-cancer-an-analysis-of-the-national-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characteristics-and-their-clinical-significance-in-a-large-cohort-of-biliary-tract-cancers-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-transarterial-radioembolization-in-hepatocellular-carcinoma-patients-with-la 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-treatment-patterns-amp-outcomes-in-sub-saharan-africa-findings-from-a-multi-insti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-advanced-ovarian-cancer-treated-with-neoadjuvant-chemotherapy-versus-primary-cy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-metastatic-sites-on-response-to-immunotherapy-in-patients-with-advanced-or-recurrent-endom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-genetic-testing-in-patients-with-uterine-serous-carcinoma-at-a-tertiary-academic-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-a-suspicion-of-cancer-clinic-in-lung-cancer-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-patient-voices-in-oncology-the-role-of-patient-advocacy-in-medical-education-and-researc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impactmf-randomized-open-label-phase-3-trial-of-imetelstat-ime-versus-best-available-therapy-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-molecular-landscape-and-survival-outcomes-of-metastatic-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytoreductive-nephrectomy-for-patients-with-metastatic-non-clear-cell-renal-cell-carcinoma-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neooptimize-phase-ii-trial-of-adaptive-switching-of-neoadjuvant-folfirinox-ffx-to-gemcitabinenab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/renal-cancer-mortality-and-disability-worldwide-insights-from-the-global-burden-of-disease-1990-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-targeted-therapies-on-overall-survival-in-advanced-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-in-er-positiveher2-negative-non-metastatic-invasive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-and-disparities-of-covid-19-on-hematological-malignancies-a-database-study-focused-on-hospit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-and-cost-effectiveness-of-a-molecular-biomarker-for-immune-checkpoint-inhibitor-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugates-and-pneumonitis-risk-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-study-of-171-cases-of-mucinous-ovarian-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-study-to-evaluate-treatment-with-induction-therapy-with-nivolumab-plus-ipilimuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conducting-stoma-free-intersphincteric-resection-for-ultra-low-rectal-cancers-by-selective-delayed-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-circulating-tumor-cells-with-cns-metastatic-patterns-and-survival-outcomes-in-her2-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exposure-to-di-2-ethylhexyl-phthalate-and-hormone-receptor-positive-breast-cancer-incidence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-patient-self-reported-confidence-on-psychosocial-outcomes-in-the-context-of-lymphoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd79b-targeted-antibody-drug-conjugate-adc-shr-a1912-in-combination-with-rituximab-gemcitabine-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glucagon-like-peptide-1-receptor-agonists-with-cancer-risk-in-obesity-adults-with-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-geographic-and-facility-specific-trends-in-malignant-neoplasms-of-the-bile-duct-mortal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-previously-described-polygenic-risk-scores-for-prostate-cancer-in-a-population-with-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-clinical-and-molecular-outcomes-of-first-second-and-third-generation-tyrosine-kinase-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-treatment-efficacy-and-safety-of-tyrosine-kinase-inhibitors-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-and-drivers-of-delayed-care-among-cancer-survivors-across-the-lifespan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/summarizing-utilization-of-integrative-oncology-assessments-within-inpatient-and-outpatient-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-worker-driven-distress-screening-among-gynecologic-oncology-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-radiation-pneumonitis-mortality-risk-among-patients-with-underlying-lung-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/climate-change-and-cancer-an-ecological-evaluation-of-climate-risks-for-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-disparities-in-hepatocellular-carcinoma-mortality-across-different-racial-groups-in-the-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-needs-and-systemic-inflammation-associated-with-cancer-survival-among-a-historically-marginal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dedicated-resources-for-veteran-clinical-trial-participation-the-prostate-cancer-analysis-for-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-and-socioeconomic-disparities-in-survival-outcomes-among-patients-under-65-years-with-intrahe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-economic-impact-of-active-e-health-support-in-patients-with-advanced-and-metastatic-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-patient-reported-outcomes-epro-in-patients-with-advanced-melanoma-receiving-immune-chec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pregnancy-during-cancer-treatment-a-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-a-simple-outpatient-prognostic-model-for-prediction-of-survival-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-from-endocrine-neoplasms-in-the-united-states-a-cdc-wonder-analysis-1999-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-study-of-a-pooled-synthetic-long-peptide-mutant-kras-vaccine-combined-with-balstilimabbo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1pd-l1-inhibitors-as-second-line-therapy-for-advanced-unresected-esophageal-squamous-cell-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-yijing-buqi-yangxue-prescription-on-the-proliferation-and-related-signal-transduction-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-digital-intervention-to-enhance-engagement-with-oral-oncolytic-treatments-and-assess-patient-exper 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-the-hpv-ebv-and-ttv-viral-rna-in-the-plasma-of-patients-with-solid-and-hematologic-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-characterization-of-interleukin-enhanced-factor-2-ilf2-in-triple-negative-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sars-cov-2-mrna-bnt162b2-vaccination-on-survival-outcomes-in-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-programmed-death-1-inhibitors-and-nimotuzumab-in-combination-with-induction-chemotherapy-for-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-metabolite-profiling-of-ffpe-tissue-to-analyze-metabolic-changes-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-biomarkers-for-immune-related-adverse-events-pd-l1-and-somatic-mutations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-informed-ctdna-for-recurrence-and-survival-prediction-in-hpv-independent-head-and-neck-squamou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-registry-for-acral-melanoma-in-lebanon-a-12-year-single-center-experience-in-the-mena 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-young-onset-colorectal-cancer-vs-late-onset-colorectal-cancer-patients-on-phase-1-matche 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-treatment-patterns-and-patient-characteristics-in-the-advanced-and-metastatic-esophageal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belantamab-mafodotin-pomalidomide-dexamethasone-bpd-vs-daratumumab-bortezomib-dexamethason 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-signals-of-inflation-reduction-act-impact-on-small-molecule-versus-biologic-post-approval-onco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monitoring-concordance-with-evidence-based-guidelines-in-the-treatment-of-stage-i-to-iiia-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-exosome-derived-lncrna-on-mal-supsup-ctl-apoptosis-in-remode 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delays-in-cancer-treatment-initiation-in-brazil-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-care-resource-utilization-hcru-and-costs-in-insured-patients-with-advanced-lung-cancer-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ispopi-mutations-in-veterans-with-metastatic-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-metastatic-castration-resistant-prostate-cancer-clinical-trials-between-2005-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-ischemic-stroke-in-prostate-cancer-patients-epidemiology-outcomes-and-key-insights-from-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-in-the-rio-grande-valley-telemedicine-as-a-solution-in-the-disruption-in-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/continuous-financial-toxicity-screening-in-community-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-race-on-the-association-between-structural-racism-and-the-quality-of-non-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-obesity-and-metabolic-syndrome-on-survival-in-acute-promyelocytic-leukemia-a-real-world-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-policy-effects-the-influence-of-medicaid-expansion-on-geospatial-hotspots-of-incidence-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/harnessing-diversity-examining-the-feasibility-of-conducting-oncology-trials-in-south-africa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-survival-among-younger-breast-cancer-patients-a-seer-database-analysis-2000-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immigration-status-on-survival-amongst-early-stage-1amp2-her2-positive-and-triple-nega 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-person-cancer-care-analyzing-patient-needs-and-service-utilization-at-inova-schar-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-precision-oncology-in-soft-tissue-sarcomas-the-role-of-itrac-in-metastatic-risk-stratific 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-vitro-profiling-of-idrx-42-against-secondary-and-tertiary-mutations-apal-found-in-tki-resistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-global-phase-3-study-to-assess-the-efficacy-and-safety-of-intratumoral-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-anti-egfr-and-anti-vegf-antibodies-on-survival-in-braf-supv600esup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neutrophil-to-lymphocyte-ratio-nlr-as-an-independent-prognostic-marker-in-mutyh-associated-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-in-young-adults-what-social-behavior-factors-may-be-responsible 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicogenomic-analysis-of-iegfri-mutant-lung-cancers-for-identificati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-between-extended-and-standard-infusion-in-patients-with-chemotherapy-induced-febrile-neut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-application-of-a-novel-multidisciplinary-pharmacovigilance-pv-clinic-in-patients-pts-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-ttmv-hpv-dna-kinetics-in-induction-chemotherapy-in-hpv-positive-head-and-neck-sq 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-profile-of-pembrolizumab-for-primary-pulmonary-nut-carcinoma-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomic-profiling-from-over-300-leiomyosarcoma-samples 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-the-clinical-impact-of-tissue-reflex-testing-for-liquid-biopsy-iesr1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pulmonary-toxicities-in-patients-pts-with-metastatic-breast-cancer-mbc-treated-with-trastuzumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-ml-model-predictive-for-chemotherapy-toxicity-and-termination-in-a-real-world-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-incidence-of-thrombosis-and-cardiovascular-adverse-events-associated-with-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nf1-and-non-nf1-associated-malignant-peripheral-nerve-sheath-tumors-mpnst-the-university-of-texa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-analysis-of-anti-her2-therapy-induced-cardiotoxicity-in-breast-cancer-patients-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-landscape-and-effectiveness-of-patient-retention-strategies-in-cancer-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neutrophil-to-lymphocyte-ratio-as-a-clinical-biomarker-for-immune-checkpoint-inhibitor-response-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-study-of-tislelizumab-combined-with-concurrent-chemoradiotherapy-in-the-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-circulating-tumor-dna-detection-for-long-term-survival-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-cell-effector-cytokine-signature-as-predictor-of-survival-and-toxicity-in-metastatic-nsclc-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuroendocrine-marker-expression-in-dendritic-cell-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acoustic-biomarkers-and-ai-transforming-nsclc-detection-and-personalized-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-non-invasive-machine-learning-model-for-predicting-tertiary-lymphoid-structures-and-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plp-powered-exosomal-therapeutics-redefining-immune-activation-in-therapy-resistant-tumor-microenvi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-niraparib-in-men-with-dna-repair-gene-deficient-clinically-localized-prostate-cancer-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-clinico-genomic-evaluation-of-the-human-epidermal-growth-factor-receptor-2-her2-in-uro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-with-nimotuzumab-in-the-second-line-treatment-of-advanced-esophageal-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-role-of-hla-supertypes-in-pmmr-mcrc-patients-receiving-folfoxiribev-ate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-associated-myocarditis-incidence-risk-factors-and-clinical-outcomes-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/linvoseltamab-linvo-carfilzomib-cfz-in-patients-pts-with-relapsedrefractory-multiple-myelom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hippocampal-avoidance-whole-brain-radiotherapy-with-dose-escalation-on-metastases-a-prospective-ran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-survival-outcomes-in-sarcomatoid-hepatocellular-carcinomas-in-the-era-of-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-immunotherapy-with-nivolumab-and-ipilimumab-for-metastatic-melanoma-real-world-outcomes-from-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-and-lenvatinib-in-the-treatment-of-recurrent-platinum-resistant-ovarian-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-poor-risk-non-seminomatous-germ-cell-tumors-nsgct-adapted-by-tumor-marker-decline-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncoshare-lung-novel-three-way-linkage-of-neighboring-academic-and-community-medical-centers-to-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-cell-leukemia-updates-on-demographics-and-prognostication 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-arm-prospective-study-evaluating-the-relationship-of-ctdna-molecular-complete-response-mcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunosarc2-cohort-7a-a-spanish-sarcoma-group-geis-phase-ib-trial-of-epirubicin-and-ifosfamide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-serplulimab-in-combination-with-chemotherapy-for-locally-advanced-gastric-or-gastro-esop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/music-therapy-versus-cognitive-behavioral-therapy-for-anxiety-in-cancer-survivors-a-telehealth-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-to-evaluate-the-safety-and-efficacy-of-bb-1701-in-subjects-with-her2-expression-loc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-based-mrd-detection-in-unresectable-nsclc-undergoing-curatively-intended-chemoradiotherapy-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-induction-chemotherapy-and-identification-of-tumor-heterogeneity-through-a-comprehensive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-in-patients-with-muscle-invasive-bladder-cancer-mibc-who-received-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-precision-medicine-trial-leveraging-tissue-and-blood-based-tumor-genomics-to-optimize-treatment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-tislelizumab-combined-with-disitamab-vedotin-rc48-for-patients-with-her-2-expressing-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-study-evaluating-telisotuzumab-adizutecan-abbv-400-temab-a-in-combination-with-budigal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-camrelizumab-plus-chemotherapy-in-patients-with-advanced-non-squamous-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eortc-2129-bcg-elacestrant-for-treating-erher2-breast-cancer-patients-with-ctdna-relapse-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-active-chromatin-cell-free-dna-cfdnaac-assay-for-early-detection-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-ibii-study-to-evaluate-the-safety-and-efficacy-of-atezolizumab-plus-beva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-analysis-of-affinity-trial-quantification-of-tumor-specific-antibodies-and-immune-cell-act 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-based-radiomics-for-prediction-of-isocitrate-dehydrogenase-subtype-in-glioblastoma-multiforme-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-fusion-of-radiomic-pathomic-and-clinical-biomarkers-on-multi-scale-tumor-biology-and-os 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onkoras-101-a-phase-1a1b-open-label-study-evaluating-the-safety-tolerability-pharmacokinetics-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soho-02-phase-iii-trial-of-bay-2927088-in-patients-with-locally-advanced-or-metastatic-nsclc-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-risk-factors-of-type-1-and-type-2-endometrial-cancer-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-in-hrher2-metastatic-breast-cancer-mbc-with-co-occurring-ipik3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-evaluation-of-the-efficacy-of-anti-pvr-antibody-drug-conjugates-combined-with-anti-pd-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-elinzanetant-for-vasomotor-symptoms-associated-with-adjuvant-endocrine-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-ori-c101-an-armored-gpc3-directed-car-t-in-patients-with-advanced-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunoprofiling-a-prospective-multi-cohort-study-to-characterize-circulating-immune-response-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-immunotherapy-with-or-without-chemotherapy-versus-braf-plus-mek-inhibitors-for-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-the-prospective-randomized-controlled-trial-vog-01-neoadjuvant-endocrine-therapy-ribocic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nugena-nurse-led-genetic-counselling-and-awareness-a-proof-of-concept-to-implementation-of-geneti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-mortality-rates-in-the-united-states-population-suffering-from-hodgkins-versus-non-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-radiological-tumor-burden-to-sub-stratify-imdc-risk-groups-in-metastatic-renal-cell-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-events-of-interest-aeis-with-zanubrutinib-vs-fixed-duration-combination-of-venetoclax-ob 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-powered-analysis-of-the-tumor-immune-microenvironment-in-lung-squamous-cell-carcinomas-with-and-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-stamp-seq-to-enable-spatial-transcriptomics-through-single-nucleus-in-situ-tagging-and-explor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop2-targeted-petct-with-sup68sup-ga-my6349-for-the-diagnosis-of-prim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-associated-clinicogenomic-correlates-of-outcomes-to-immune-checkpoint-inhibitors-alone-or-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-different-pd-1-inhibitors-combined-with-chemotherapy-in-locally-advanced-head 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-ic-followed-by-concomitant-radiotherapy-and-weekly-cisplatin-ccrt-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-hoc-analysis-of-rashes-reported-in-patients-pts-with-ibrafi-alt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drug-eluting-beads-loaded-with-irinotecan-transarterial-chemoembolization-debiri-tace-combined-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-immune-checkpoint-inhibitors-and-concurrent-radiation-therapy-for-the-treatment-of-ext 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-dynamic-changes-in-tumor-infiltrating-lymphocytes-til-after-neoadjuvant-admini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/irinotecan-temozolomide-and-naxitamab-plus-gm-csf-hits-and-naxitamab-plus-gm-csf-and-ifosfamide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-impact-of-the-baseline-systemic-proteome-in-patients-with-ir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neutrophil-to-lymphocyte-ratio-as-a-predictor-of-response-and-toxicity-in-t-cell-engager-therapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop2-targeted-petct-with-sup68sup-ga-my6349-for-detecting-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strategies-to-achieve-racial-equity-in-cardio-oncology-care-for-women-with-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-early-onset-colorectal-cancer-implications-for-research-and-clinical-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-based-next-generation-sequencing-in-advanced-non-small-cell-lung-cancer-nsclc-significance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-to-evaluate-the-feasibility-and-efficacy-of-sequential-abemaciclib-and-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-tumor-informed-circulating-tumor-dna-analysis-in-monitoring-recurrence-following-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-circulating-growth-differentiation-factor-15-and-the-cancer-phenotype-in-the-proacc-1-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-all-patients-with-primary-retroperitoneal-sarcoma-benefit-from-resection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-molecular-biomarker-for-longitudinal-monitoring-of-therapeutic-efficacy-in-a-real-world-cohort-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-fine-particulate-matter-exposure-on-breast-cancer-mortality-a-county-level-analysis-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-of-developing-multisystem-immunotherapy-related-adverse-events-among-patients-with-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-smoking-on-immunotherapy-outcomes-in-cancer-a-multi-center-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-outcomes-of-metastatic-prostate-cancer-hospitalizations-2008-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-patients-with-lung-cancer-at-a-large-safety-net-health-system-implications-for-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/21-gene-expression-assay-in-postpartum-vs-non-postpartum-breast-cancer-and-correlation-with-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-adjuvant-endocrine-therapy-on-outcomes-in-estrogen-receptor-low-positive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bci-biomarker-performance-in-premenopausal-women-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-zimberelimab-and-cetuximab-plus-nab-paclitaxel-and-cisplatin-neo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-recist-choi-modified-choi-mchoi-and-viable-tumor-volume-vtv-in-predicting-clinical-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-and-treatment-efficacy-in-dmmrmsi-h-rectal-cancer-a-real-world-cohort-from-seve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-to-evaluate-the-efficacy-and-safety-of-wztl-002-a-third-generation-anti-cd19-car-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-prognostic-implications-of-the-tcr-repertoire-in-leiomyosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-palliative-care-use-and-clinical-outcomes-among-hospitalized-lung-cancer-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuro-oncology-anywhere-preliminary-results-from-a-decentralized-clinical-trial-aimed-at-improving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improved-survival-with-sodium-glucose-cotransporter-2-inhibitors-and-immune-checkpoint-inhibitors-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-metabolic-connectivity-in-patients-with-multiple-myeloma-receiving-bcma-car-t-cell-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-cancer-and-screening-tests-in-the-population-of-the-pantanal-a-rural-region-of-bra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-sequential-analysis-for-optimal-selection-between-ird-and-krd-regimen-in-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advanced-ensemble-stacking-model-employing-cfdna-fragmentation-for-early-detection-of-esophageal-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-and-impact-of-radiographic-pathological-and-spirometric-emphysema-on-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hivreo-recommendations-on-the-management-of-people-living-with-hiv-and-cancer-plwhc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-in-target-discovery-cure-ai-prediction-of-tigit-and-pd-l1-as-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-lung-cancer-screening-using-low-dose-computed-tomography-ldct-scan-in-a-community-hospi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-characteristics-and-outcomes-among-adolescent-and-young-adult-patients-with-metastatic-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-in-multiple-myeloma-and-cardiovascular-disease-in-the-us-1999-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-parameters-on-whole-body-diffusion-weighted-mri-wb-dwmri-and-psma-petct-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-in-triple-negative-breast-cancers-tnbc-treated-with-talimogene-laherparepvec-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-pre-transplant-biological-aging-markers-and-clinical-outcomes-in-allogeneic-hema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-based-radiomic-signature-and-its-association-with-genomic-complexity-in-breast-tumor-heterogenei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-validation-of-a-novel-multimodal-ai-prognostic-tool-integrating-digital-pathology-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-engagement-in-accelerating-care-level-activation-of-precision-medicine-with-patient-educatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-her2neu-655-genotyping-in-managing-trastuzumab-induced-cardiotoxicity-risk-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-side-effects-of-targeted-therapies-high-throughput-association-studies-leveraging-the-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enabling-national-identification-of-lung-cancer-screening-eligibility-with-large-language-models 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-chemotherapy-use-and-clinical-outcomes-in-young-brca-carriers-with-t1n0-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-deep-learning-ct-response-assessment-and-interpretable-components-with-overall-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-in-motion-how-fitbit-data-reflects-patients-with-cancers-functional-status-in-the-all-of-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-related-neutropenia-as-a-predictor-of-response-to-adjuvant-palbociclib-in-the-pallas-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-novel-nomogram-to-predict-clinically-significant-prostate-cancer-using-exodx-urinar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-demographics-and-outcomes-in-young-versus-average-onset-hospitalized-gastroi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proton-pump-inhibitors-and-the-risk-of-adverse-renal-events-and-all-cause-mortality-in-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-real-world-event-free-survival-rwefs-in-early-stage-triple-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-immunotherapy-for-advanced-gastric-and-gastroesophageal-junction-cancer-a-modelling-cost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-multi-omic-biosignature-for-identification-of-early-stage-invasive-breast-cancer-patients-who 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toripalimab-with-chemoradiotherapy-followed-by-toripalimab-maintenance-therapy-for-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-bedroom-renewed-air-as-anti-inflammatory-adjuvant-therapy-in-cancer-survivors-breaths-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potent-antitumor-activity-of-the-kras-supg12dsup-inhibitor-mrtx1133-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-treatment-sequencing-in-hepatocellular-carcinoma-impact-of-radioembolization-timing-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-analysis-of-the-effectiveness-of-pembrolizumab-by-type-of-associated-treatment-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-smokers-with-early-onset-breast-cancer-an-analysis-of-the-national-inpatient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparative-study-of-the-real-world-safety-and-effectiveness-of-metronomic-cyclophosphamide-and-be 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-pembrolizumab-plus-olaparib-for-the-treatment-of-patients-with-persistentrecurr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/duration-and-de-escalation-of-folfirinox-as-first-line-chemotherapy-in-advanced-pancreatic-adenocarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-trends-in-vulvovaginal-cancer-mortality-in-the-united-states-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-serous-carcinoma-subgroup-in-frusica-1-fruquintinib-plus-sintilimab-in-treated-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-proteo-metabolic-panel-for-detection-of-asymptomatic-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-gender-responsive-cancer-control-a-mixed-methods-evaluation-of-the-leadership-program-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-envafolimab-combined-with-capecitabine-and-lenvatinib-as-postoperative-adjuvant-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-and-mechanism-of-stf-31-combined-with-cisplatin-in-overcoming-platinum-resistance-in-ovarian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-safety-and-efficacy-of-selective-internal-radiation-therapy-for-hepatocellular-carcinoma-a-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-patient-reported-outcomes-epro-based-alerts-deployed-in-clinical-practice-to-inform-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insurance-disparities-among-subgroups-of-hispanic-americans-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-down-barriers-role-of-artificial-intelligence-in-patient-friendly-breast-cancer-education 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-the-use-and-quality-of-palliative-and-end-of-life-care-between-asian-and-non-asian-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envafolimab-monotherapy-or-combination-therapy-in-elderly-patients-with-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-immunohistochemistry-and-imaging-mass-cytometry-technologies-for-detection-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-nsaids-use-and-oncological-outcomes-in-non-small-cell-lung-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exclusion-of-people-from-oncology-clinical-trials-based-on-functional-status-and-other-criteria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-genetically-engineered-isalmonella-typhimuriumi-secreting-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-rates-after-anti-pd1-discontinuation-for-advanced-melanoma-a-systematic-review-and-singl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-profiling-of-solid-tumor-microenvironment-using-imaging-mass-cytometry-with-high-plex-panels 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-classification-of-uncertain-histologies-based-on-cfdna-fragmentomic-analysis-in-patients-with-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-changes-and-its-prognostic-significance-after-chemotherapy-in-patients-with-de-novo-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immune-checkpoint-inhibitors-in-patients-with-unresectable-metastatic-colon-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-genetic-role-of-skin-gut-microbial-axis-in-pan-cancer-development 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-transcatheter-arterial-infusion-of-immune-checkpoint-inhibitors-in-locoregion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-machine-learning-with-the-immunohistochemical-expression-of-ambra1-and-loricrin-to-identif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-patients-with-braf-mutated-melanoma-with-or-without-brain-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-gastrointestinal-stromal-tumors-treated-with-imatinib-and-sunitinib-in-nep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-safety-for-bone-marrow-protection-of-trilaciclib-for-patients-with-locally-advanced-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-trends-in-incidence-and-prevalence-of-pancreatic-cancer-among-older-adults-70-a-30-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/micro-mosaicism-of-ibrafi-v600e-oncogene-in-normal-skin-samples-of-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burnout-professional-fulfillment-and-associated-factors-in-academic-oncology-physicians 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-role-of-professional-cancer-societies-in-spreading-awareness-about-oncology-to-undergr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-for-patients-with-congenital-hepatoblastoma-have-they-changed-since-2013 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-prevalence-of-coronary-artery-calcification-among-patients-undergoing-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/descriptive-epidemiology-of-waldenstrom-macroglobulinemia-wm-demographics-outcomes-and-predicto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-treated-for-monomorphic-b-cell-post-transplant-lymphoproliferative-disorder-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/one-year-impact-of-a-large-scale-pilot-multimodal-personalized-early-cancer-detection-and-prevention 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-mitoxantrone-hydrochloride-liposome-with-cyclophosphamide-vincristine-and-prednison 2026-08-24 monthly 0.7 https://rjrindex.com/articles/escalating-impact-of-alcohol-related-cancer-mortality-in-the-us-a-call-for-action 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-scale-clinical-validation-of-a-blood-based-multi-cancer-early-detection-test-across-differen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-a-multidomain-mhealth-based-intervention-in-enhancing-recovery-and-quality-of-life 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-patients-with-bladder-cancer-and-lymph-node-metastases-analysis-based-on-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-sintilimab-versus-pembrolizumab-in-the-treatment-of-advanced-or-recurrent-ped 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-interim-analysis-of-phase-iii-study-on-neoadjuvant-chemotherapy-versus-perioperative-toripalimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-fruquintinib-fruq-efficacy-after-regorafenib-rego-and-trifluridine-tipira 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-tumor-microenvironment-and-neoadjuvant-therapy-response-in-her2-positive-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-hoc-analysis-evaluating-selinexor-maintenance-therapy-in-patients-with-itp53i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiotoxicity-in-early-breast-cancer-risk-factors-and-predictors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comorbidity-burden-and-risk-factors-rfs-for-peripheral-neuropathy-pn-and-their-prevalence-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/should-toxicity-be-taken-into-account-in-determining-chemotherapy-backbone-in-her2-positive-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-landscape-of-chromosomal-instability-in-uterine-leiomyosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efbemalenograstim-alfa-for-primary-prophylaxis-of-chemotherapy-induced-neutropenia-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-adjuvant-immunotherapy-after-neoadjuvant-immunotherapy-combined-with-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-envafolimab-plus-carboplatin-and-etoposide-as-first-line-treatment-for-extens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-variations-survival-patterns-and-mortality-determinants-in-small-cell-lung-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synkir-car-t-cell-advanced-research-star-101-phase-1-clinical-trial-for-patients-with-advanced-mes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-with-fruquintinib-versus-placebo-after-adjusting-for-subsequent-anticancer-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiologic-trends-in-colorectal-cancer-age-related-variations-and-site-specific-patterns-over-tw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/codon-167-missense-mutations-in-von-hippel-lindau-syndrome-genotype-phenotype-correlations-in-a-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-preoperative-management-of-patients-with-giant-cell-tumors-in-limb-bones-using-denosumab-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-intestinal-exfoliome-and-prevotellaceae-with-toxicity-and-clinical-outcome-during-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivonescimab-pd-1vegf-bispecific-antibody-combined-with-haic-for-first-line-treatment-of-unresecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consolidative-camrelizumab-following-definitive-concurrent-chemoradiotherapy-with-involved-field-irr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-her2-heterogeneity-in-early-stage-and-locally-advanced-her2-positive-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-glycemic-index-and-glycemic-load-of-the-diet-insulin-and-breast-cancer-a-case 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-predictors-of-chronic-immune-related-adverse-events-iraes-following-anti-pd-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-esym-symptom-monitoring-program-on-nurse-telephone-encounters-across-six-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-experience-of-preoperative-gemcitabine-and-cisplatin-plus-durvalumab-followed-by-resection-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-efficacy-and-safety-of-biweekly-gemcitabine-and-docetaxel-gemdoc-in-heavily 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-stem-cell-transplantation-in-t-cell-acute-lymphoblastic-leukemia-adults-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/egl-121-a-first-in-human-phase-12-trial-of-egl-001-in-adult-patients-with-selected-advanced-andor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psa-and-alkaline-phosphatase-changes-in-the-eortc-1333-peace-3-study-evaluating-the-addition-of-six 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-ctdna-using-personalized-structural-variants-to-forecast-recurrence-in-localized-soft-tiss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-stem-cell-transplantation-related-outcomes-in-myelodysplastic-syndromes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanzalintinib-zanza-nivolumab-nivo-relatlimab-rela-in-patients-pts-with-previously-untre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cobra-assessment-of-the-efficacy-of-sup64sup-cu-sar-bispsma-using-hist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-genetic-characteristics-of-soft-tissue-sarcomas-associated-with-the-development-of-chemoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-potential-of-multi-cancer-early-detection-screening-in-reducing-cancer-incidence-and-mortality-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-evidence-in-nccn-harmonized-guidelines-for-sub-saharan-africa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-colorectal-cancer-patient-response-to-neoadjuvant-chemotherapy-using-the-microorganospher 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-response-to-durvalumab-and-olaparib-in-mtnbc-using-a-novel-pd-l1-expression-biomarker-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-safety-profile-of-adagrasib-in-kras-g12c-mutated-solid-tumors-a-single-arm-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-social-determinants-of-health-sdoh-and-outcomes-of-early-onset-colorectal-cancer-eo-cr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-anti-pd-1-plus-ifosfamide-carboplatin-and-etoposide-ice-in-second-line-classical-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/seasonal-impact-of-anti-pd-1-treatment-initiation-in-non-small-cell-lung-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/procedure-considerations-for-image-guided-intratumoral-immunotherapy-a-retrospective-study-of-357-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-burden-on-outcomes-after-immune-versus-conventional-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-application-of-deep-learning-dl-based-mri-with-liquid-biomarkers-for-immune-effector-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biosafety-analysis-from-the-skin-cancer-cohorts-in-the-ignyte-clinical-trial-of-rp1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-large-language-models-to-assess-adherence-to-asco-patient-oncologist-communication-standards 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methotrexate-doxorubicin-and-cisplatin-versus-methotrexate-doxorubicin-and-cisplatin-ifosfamid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-plus-chemotherapy-vs-chemotherapy-in-iegfri-mutant-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-psma-petct-derived-predictive-markers-for-sup177sup-lu-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-double-blind-placebo-controlled-study-to-assess-the-efficacy-and-safety-of-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impower010-genomic-profiling-and-clinical-outcomes-with-adjuvant-atezolizumab-in-early-stage-non-sm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-the-dose-escalation-stage-of-a-phase-i-trial-of-an-anti-ccr8-antibody-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-of-sunitinib-plus-nivolumab-in-extraskeletal-myxoid-chondrosarcoma-results-from-the-geis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endocrine-therapy-omission-in-estrogen-receptor-low-1-10-early-stage-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-pemetrexed-and-pembrolizumab-in-patients-pts-with-recurrent-andor-metastatic-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hyperthermic-intraperitoneal-chemotherapy-combined-with-cytoreductive-surgery-versus-cytoreductive-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-guided-adjuvant-chemotherapy-escalation-in-stage-iii-colon-cancer-primary-analysis-of-the-ctd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop2-overexpression-as-predictor-of-outcome-in-patients-with-early-triple-negative-breast-cancer-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-surgical-resection-in-early-onset-colorectal-cancer-patients-with-liver-limited-diseas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-dose-escalation-trial-of-stx-001-an-lnp-encapsulated-self-replicating-mrna-expressing-il-12 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-benefit-of-cytoreductive-surgery-during-imatinib-im-therapy-in-patients-with-metastatic-gastro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/testing-and-treatment-patterns-in-ikrasi-mutant-mnsclc-results-from-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-patients-diagnosed-with-cancer-in-the-inpatient-and-outpatient-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hexagon-hn-phase-23-randomized-study-of-the-hexavalent-ox40-agonist-inbrx-106-in-combination-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-lymphovascular-invasion-on-the-prognosis-in-pt1-2n0-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-major-adverse-cardiovascular-and-cerebrovascular-events-outcomes-among-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-features-and-intratumor-microbiome-in-surgically-resected-pancreatic-head-body-and-tail 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-artificial-intelligence-powered-spatial-analysis-of-tumor-microenvironment-to-predict-the-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-tumor-extracellular-matrix-density-with-recurrence-in-invasive-lobular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-curative-surgery-and-outcome-in-a-multicenter-randomized-phase-iii-trial-comparing-conver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-letter-of-condolence-proposing-a-post-mortem-consultation-to-the-relatives-of-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trastuzumab-deruxtecan-in-gastrointestinal-malignancies-a-systemic-review-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-pancreatic-cancer-a-single-center-retrospective-study-in-a-large-healthcare-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-overall-survival-in-patients-lost-to-follow-up-after-incidental-neoplasm-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-clinical-trial-of-abp1019a-monotherapy-in-patients-with-advanced-malignant-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-radionuclide-therapy-on-survival-outcomes-for-de-novo-metastatic-gastroenteropancreatic-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-an-in-silico-clinical-trial-intelligence-solution-to-predict-outcomes-of-tinengotinib-a-pote 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-stage-iiiiia-urothelial-bladder-cancer-treated-with-systemic-therapy-a-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analyses-to-evaluate-the-role-of-tigit-as-a-target-in-first-line-1l-gastric-gastroesop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-patterns-and-the-value-of-postoperative-adjuvant-radiotherapy-in-esophageal-squamous-cell-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-botensilimab-and-agen1423-an-anti-cd73-tgfv-trap-bifunctional-antibody-with-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/de-escalation-of-axillary-surgery-in-breast-cancer-patients-with-1-2-positive-sentinel-nodes-after-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-occurrence-of-other-cancers-in-patients-with-chronic-lymphocytic-leukemia-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-nations-uneven-battle-trends-and-regional-disparities-in-cancer-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-future-is-here-now-use-of-proteomic-testing-in-pulmonary-nodule-management-in-an-underserved-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tigos-ls-an-open-label-randomized-study-of-bms-986489-vs-durvalumab-as-consolidation-therapy-follo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-sodium-glucose-co-transporter-2-inhibitors-with-cardiac-outcomes-and-mortality-in-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-n-terminal-telopeptide-of-type-i-collagen-in-the-evaluation-of-bone-metastasis-degree 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoradiotherapy-combined-with-tislelizumab-for-locally-advanced-rectal-cancer-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-the-association-between-agent-orange-exposure-and-the-progression-of-monoclona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dlbcl-associated-pim1-mutation-and-its-impact-on-anxa2-localization-and-lymphomagenesis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-pediatric-cns-malignancies-across-204-countries-from-1990-to-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iiia-dose-finding-study-of-triplet-regimen-of-relatlimab-rela-ipilimumab-ipi-and-nivolu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitivity-of-age-and-family-history-fh-criteria-for-determining-pancreatic-cancer-pc-surveilla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimated-prevalence-of-pathogenic-variants-in-patients-with-breast-colon-andor-endometrial-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-profiling-of-tumor-derived-extracellular-vesicle-rna-a-sensitive-approach-for-early-detecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-in-lung-cancer-a-retrospective-cohort-analysis-of-cardiovascular-safet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perfume-trial-phase-ii-trial-of-binimetinib-in-patients-with-ibrafi-fu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-we-casting-the-net-wide-enough-applying-the-proposed-lung-cancer-screening-criteria-in-single-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-surrogate-endpoints-in-muscle-invasive-bladder-cancer-mibc-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cascade-conversations-empowering-cancer-genetic-testing-through-cascade-chatbots 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-regional-trends-in-cardiovascular-disease-and-hodgkin-lymphoma-related-mortality-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serplulimab-versus-placebo-plus-chemotherapy-as-first-line-treatment-for-extensive-stage-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-tarlatamab-treatment-for-small-cell-lung-cancer-using-an-outpatient-care-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-variation-in-molecular-profiles-of-tumors-from-metastatic-colon-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pralsetinib-in-ireti-fusion-positive-solid-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rapid-analysis-and-response-evaluation-of-combination-anti-neoplastic-agents-in-rare-tumors-rare-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-testing-of-an-unselected-gastric-cancer-cohort-uncovering-germline-mutations-and-their-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-of-mortality-due-to-mesothelioma-among-older-adults-in-the-united-states-a-cdc-wond 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-germline-brca-12-genes-pathogenetic-variants-from-ultrasound-images-of-healthy-ovarie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-anlotinib-plus-benmelstobart-combined-with-nab-paclitaxel-and-cisplatin-as-first 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-biopsy-requirement-on-patient-enrollment-to-phase-i-trials-in-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-survival-outcomes-and-impact-of-treatment-modalities-in-rectal-squamous-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-indulgent-lifestyle-practices-the-driving-determinants-behind-the-rising-cancer-rates-in-young-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burkitt-lymphoma-incidence-in-relation-to-hiv-prevalence-in-united-states-a-regression-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-patients-living-with-hiv-with-lung-cancer-and-treated-with-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-in-lung-cancer-hospitalizations-identifying-critical-predictors-for-improved-patient-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-risk-stratification-for-disease-progression-after-allo-sct-in-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-psychosocial-wellbeing-and-concern-for-death-and-dying-insights-from-a-psycho-oncolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-promising-potential-of-luspatercept-in-transfusion-dependent-lower-risk-myelodysplasti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-peripheral-blood-immune-cells-composition-and-pathway-expression-between-non-hispanic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-preferences-for-survivorship-educational-programs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/well-being-pathway-we-path-an-italian-integrative-oncology-community-based-program-for-cancer-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-study-cohorts-visualizing-patient-experience-informed-by-patient-reported-outcomes-pros-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-breast-tumors-and-the-tumor-immune-landscape-in-young-diverse-participants-of-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diversities-and-disparities-in-endometrial-carcinoma-ec-clinical-pathological-features-and-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparity-in-the-incidence-and-mortality-of-young-adults-with-breast-cancer-a-nationwide-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacotherapy-as-an-adjunct-to-behavioral-weight-loss-treatment-in-survivors-of-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-nih-and-federal-cancer-research-funding-across-different-cancer-types 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ascomind-is-instant-asco-abstract-analysis-possible-with-ai-agents 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-clinical-and-socioeconomic-factors-on-survival-outcomes-in-non-small-cell-lung-cancer-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-diagnostics-in-prostate-cancer-treatment-predict-a-phase-2-multi-arm-biomarker-based-st-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-lung-cancer-screening-and-outcomes-a-comprehensive-study-of-texas-counti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-life-efficacy-and-safety-data-of-lorlatinib-treatment-in-ros-1-positive-advanced-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ffpe-rna-based-ddpcr-assay-an-effective-and-efficient-confirmation-for-imeti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-antibody-drug-conjugates-adcs-in-metastatic-bladder-cancer-analysis-of-10204-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-complemented-with-mini-patient-derived-xenografts-to-guide-individualized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-prediction-models-for-5-year-and-10-year-ipsilateral-breast-tumor-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-axillary-us-and-mri-in-early-stage-breast-cancer-potential-to-prevent-unnecessary-axil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalised-artificial-intelligence-based-approach-to-assessing-objective-response-to-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impacting-quality-of-life-and-pancreatic-cancer-survivorship-through-a-telehealth-intervention 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-access-to-cancer-screening-through-national-telehealth-based-lung-and-colorectal-cancer-sc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologists-perspectives-on-challenges-using-chemotherapy-immune-checkpoint-inhibitors-and-target 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-iv-magnesium-supplementation-in-reducing-adverse-cisplatin-associated-kidney-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-artificial-intelligence-to-expert-physician-assessments-of-real-world-oncology-cases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-of-suicide-among-cancer-patients-a-seer-database-analysis-from-2000-to-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-socioeconomic-factors-of-follicular-thyroid-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-pelareorep-in-activating-anti-tumor-immunity-in-pdac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-features-of-acquired-resistance-to-immunotherapy-in-advanced-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-envafolimab-plus-platinum-based-chemotherapy-as-neoadjuvant-therapy-in-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-postoperative-nomogram-for-predicting-survival-in-gallbladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-monocentric-analysis-of-escat-gene-actionability-detection-in-non-specific-molecular-profile-nsmp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-advanced-stage-endometrial-cancer-by-residual-disease-and-mmr-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-large-language-models-to-facilitate-guideline-directed-therapy-of-genitourinary-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-automatic-ai-model-for-tumoral-burden-detection-and-segmentation-on-whole-body-mri-the-dipcan-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-patient-reported-outcomes-pros-in-unselected-men-receiving-talazoparib-tala-enzalutamide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-ai-driven-auditing-of-mammography-reports-for-bi-rads-compliance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-il-trial-to-assess-the-impact-of-v2-adrenergic-receptor-v2-ar-blockade-in-metastatic-tripl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dara-vcd-outcomes-of-frontline-therapy-for-light-chain-amyloidosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-trends-in-early-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-open-label-multicenter-first-in-human-study-of-the-safety-tolerability-pharmacokinet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-c019199-in-combination-with-sintilimab-in-patients-with-locally-recurrent-or-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multisite-randomized-trial-of-an-advanced-pneumatic-compression-device-vs-usual-care-for-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-low-dose-capecitabine-and-erlotinib-in-treatment-of-recurrent-or-metastatic-head-and-neck-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nanoemulsions-loaded-with-5-fluorouracil-and-curcumin-as-a-strategy-for-enhancing-anticancer-activit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-radiotherapy-combined-with-neoadjuvant-chemotherapy-and-an-anti-pd-1ctla-4-bispecific-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-statins-on-the-mortality-of-long-term-survivors-of-nasopharyngeal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-prediction-of-30-90-and-180-day-readmissions-in-head-and-neck-cancer-using-a-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-impact-of-novel-agents-in-patients-with-stage-iv-de-novo-hrveher2-ve-breast-cancer-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-two-decades-of-thyroid-carcinoma-survival-impact-of-gender-ethnicity-and-income-dispar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colon-adjuvant-chemotherapy-based-on-evaluation-of-residual-disease-circulate-north-america-nrg-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-analysis-of-cancer-symptom-clusters-and-inflammatory-biomarkers-insights-into-quality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-lung-cancer-in-smokers-using-mirna-profiles-and-a-hybrid-deep-learning-framework 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-risk-factors-predictive-of-anti-pd1-immune-checkpoint-inhibitor-associated-pulmonary-toxicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-multicenter-trial-of-the-combination-of-chidamide-and-toripalimab-in-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-dice-of-clinical-trials-in-oncology-strategies-from-mathematical-permutation-combination-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-janus-kinase-1-jak1-inhibitor-itacitinib-for-treatment-refractory-sarcomas-leiom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-study-on-the-impact-of-intestinal-low-dose-radiation-on-the-efficacy-and-prognosis-of-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-breast-cancer-across-racial-socioeconomic-and-regional-groups-in-the-us-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fecal-microbiota-transplantation-fmt-for-opioid-induced-constipation-oic-a-prospective-multice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-gender-disparities-in-oncology-and-hematology-education-insights-from-social-media-engag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-comprehensive-transcriptome-testing-in-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-bubble-effect-impact-of-asco-digital-promotion-on-ijournal-of-clinical-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-health-related-social-needs-hrsns-screening-and-targeted-intervention-through-patient-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determining-primary-or-delayed-surgery-approach-in-fibrolamellar-carcinoma-of-the-liver-based-on-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-metabolic-signatures-in-epithelial-ovarian-cancer-diagnosis-the-application-of-nextgen-metab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-platinum-resistance-in-recurrent-endometrial-cancer-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-sequencing-of-biliary-tract-cancer-uncovering-the-genomic-origins-of-evolutionary-traj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-mammaprint-and-clinical-outcomes-by-race-among-5000-individuals-with-hrher2-early-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-medical-debt-with-cancer-incidence-rates-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pamiparib-in-patients-with-newly-diagnosed-advanced-ovarian-cancer-a-single-arm-prospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-anti-steap1psma-adc-dxc008-assessment-of-anti-tumor-efficacy-pharmacokinetic-and-toxicity-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-scalp-cooling-in-patients-receiving-trastuzumab-deruxtecan-for-metastatic-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-hereditary-tumor-risk-in-individuals-with-sdha-germline-variants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-trial-of-cognitive-behavioral-therapy-and-bright-light-therapy-for-insomnia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-and-predictive-role-of-her2-amplificationoverexpression-and-iher2i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pyrotinib-in-the-first-line-treatment-of-her2-positive-advanced-breast-cancer-results-from-the-pret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmasking-the-link-between-sleep-apnea-and-lung-cancer-risk-a-retrospective-propensity-matched-coho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-or-up-front-triple-combination-with-durvalumab-tremelimumab-and-bevacizumab-for-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-intracerebroventricular-icv-delivery-of-bivalent-chimeric-antigen-receptor-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-and-efficacy-data-of-icp-248-a-novel-bcl2-inhibitor-in-patients-with-relapsed-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-racial-representation-in-clinical-trials-an-analysis-of-53-asco-plenary-and-late-breaking 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retlirafusp-alfa-a-bifunctional-anti-pd-l1tgf-vrii-agent-plus-nab-paclitaxel-and-carboplatin-in-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-a-first-in-class-pd-1il-2-supa-biassup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/one-button-push-fully-automated-psma-pet-quantification-correlation-with-progression-free-and-ove 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-open-label-first-in-human-study-of-abbv-969-a-dual-variable-antibody-drug-conjugate-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipilimumab-and-nivolumab-after-disease-progression-on-single-agent-immunotherapy-in-mismatch-repair 2026-08-24 monthly 0.7 https://rjrindex.com/articles/harnessing-ehr-for-goals-of-care-the-role-of-electronic-alerts-for-care-optimization-in-gynecologic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-associated-checkpoint-as-a-prognostic-biomarker-in-metastatic-renal-cell-carcinoma-mrcc-resul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-circulating-chromatin-profiling-for-epigenomic-characterization-of-mechanisms-of-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isatuximab-isa-subcutaneous-sc-via-an-on-body-delivery-system-obds-vs-isa-intravenous-iv-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-open-label-study-of-brentuximab-vedotin-bv-pembrolizumab-pembro-in-patients-pts-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-multicenter-phase-12-study-of-peluntamig-pt217-an-anti-dll3anti-cd47-bispecific 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-outcomes-in-wsg-adapt-according-to-natalee-and-monarche-risk-criteria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-clinical-update-of-ima203-an-autologous-tcr-t-targeting-prame-in-patients-with-pd1-refracto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elacestrant-ela-combinations-with-ribociclib-ribo-and-everolimus-eve-in-patients-pts-with-er 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mk-1084-for-kras-g12c-mutated-mut-metastatic-non-small-cell-lung-cancer-mnsclc-results-from-kan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-to-confirm-safety-and-efficacy-of-mb-105-an-autologous-cd5-directed-car-t-cell-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-ozuriftamab-vedotin-ba3021-a-conditionally-binding-ror2-adc-in-patients-with-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-b7h3-car-t-cells-administered-intracranially-in-recurrent-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-pembrolizumab-and-lenvatinib-in-recurrent-or-persistent-clear-cell-ovarian-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/titanium-an-open-label-global-multicenter-phase-12-study-of-azd5492-a-first-in-class-subcutaneou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rematch2201-a-phase-ii-study-on-reducing-surgical-margins-in-hpv-negative-advanced-hnscc-with-neoad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-genomic-alterations-in-circulating-tumor-dna-ctdna-with-clinical-response-to-teliso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-myelodysplastic-syndrome-and-myeloproliferative-neoplasms-in-patients-with-stable-coronary-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lacutamab-in-patients-with-relapsed-and-refractory-sezary-syndrome-long-term-follow-up-from-the-tel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-shr-1826-a-c-met-directed-antibody-drug-conjugate-adc-in-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-phase-1-study-of-the-selective-protein-degrader-asp4396-in-patients-with-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd-19-car-t-cell-therapy-in-adult-b-cell-all-patients-a-systematic-review-of-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/darolutamide-plus-goserelin-for-androgen-receptor-positive-salivary-gland-cancers-results-of-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rinatabart-sesutecan-rina-s-for-patients-with-advanced-endometrial-cancer-first-disclosure-from-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-jskn016-a-bispecific-anti-trop2her3-antibody-drug-conjugate-adc-antitum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-clinical-characteristics-of-patients-pts-with-neuroendocrine-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-nodal-burden-after-neoadjuvant-chemotherapy-nac-with-circulating-tumor-ctdna-for-surg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-hemophagocytic-lymphohistiocytosis-in-patients-with-hiv-related-lymphomas-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-future-workforce-planning-by-developing-novel-metrics-of-complexity-in-cancer-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-ksq-004ex-autologous-tumor-infiltrating-lymphocytes-engineered-to-inactivate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-social-needs-and-mortality-risk-among-united-states-veterans-with-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-geographic-information-system-gis-based-analysis-of-county-level-economic-and-social-vulnerabili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/label-free-detection-of-visceral-pleural-invasion-in-lung-adenocarcinoma-using-multiphoton-microscop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-toripalimab-plus-axitinib-in-renal-cell-carcinoma-with-tumor-thro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-whole-brain-low-dose-radiotherapy-combined-with-immune-checkpoint-inhibitor-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-first-in-human-study-of-atx-559-an-oral-inhibitor-of-dhx9-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-ibrutinib-versus-other-covalent-bruton-tyrosine-kinase-inhibitors-cbtkis-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-tumor-response-on-1-month-ct-as-a-predictor-of-2-year-local-control-following-sbrt-in-pulmonar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-prognostic-significance-of-distant-and-locoregional-recurrence-on-survival-in-surgicall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/r-spondin-3-as-an-independent-biomarker-and-potential-therapeutic-target-for-colon-cancer-immunother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionability-landscape-and-biomarker-utility-in-a-colorectal-cancer-alliance-cohort-initial-result 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-vitro-efficacy-of-cdk9-inhibitor-tambiciclib-sls009-in-asxl1-mutated-colorectal-cancer-cell-lin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeted-agents-for-the-treatment-of-hormone-receptor-positive-human-epidermal-growth-factor-recep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lodestar-a-single-arm-phase-ii-study-of-rucaparib-in-solid-tumors-with-pathogenic-germline-or-somat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-the-number-of-positive-lymph-nodes-lymph-node-ratio-and-log-odds-of-positive-lymph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-carcinoembryonic-antigen-with-survival-in-patients-with-colorectal-liver-metastases-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-8-gene-signature-with-early-recurrence-in-resected-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-in-her2-positive-advanced-breast-cancer-abc-with-active-cns-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-assessment-of-breast-cancer-using-clinical-and-pathological-variables-of-more-than-1-mill 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-based-circulating-tumor-dna-analysis-as-an-ultrasensitive-biomarker-in-pediatric-sarcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-clinicopathological-features-in-early-onset-breast-cancer-patients-with-and-without-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sglt2-inhibitors-in-patients-with-multiple-myeloma-and-diabetes-mellitus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-the-incidence-of-multiple-myeloma-in-the-middle-east-and-north-africa-over-the-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-observational-study-to-describe-the-clinical-characteristics-management-and-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunologic-targeting-of-native-and-mutated-esr1-receptor-for-treatment-of-hormone-receptor-expressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-multifunctional-biocatalytic-nanoenzyme-auc-at-scof-mn-on-photodynamic-immunoactivation-casca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-3-randomized-study-of-low-dose-intralesional-cemiplimab-versus-primary-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-immune-related-adverse-event-reporting-among-multidisciplinary-cancer-programs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-cohort-2-trial-in-progress-vabametkib-plus-lazertinib-for-patients-with-egfr-mutant-nsclc-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-exploratory-study-nct06208826-on-maintenance-immunotherapy-in-patients-with-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvantadjuvant-pembrolizumab-and-surgery-cesium-131-in-recurrent-hnscc-a-multicenter-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hyperlipidemia-as-adverse-event-of-lorlatinib-a-multicenter-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibiia-study-of-bat8010bat1006-an-anti-her2-monoclonal-antibody-exatecan-conjugate-combine-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fall-risk-assessment-by-qtug-device-in-geriatric-cancer-patients-on-chemotherapy-at-a-tertiary-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-validation-of-the-cancer-and-aging-research-group-fall-risk-score-for-older-adults-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-medicaid-expansion-with-five-year-survival-after-cancer-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-relationship-between-multi-agent-immunosuppressive-therapy-for-immune-related-adverse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/industry-promotion-of-oncology-drugs-with-accelerated-approval-that-failed-confirmatory-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-expression-profiling-plus-integrated-multidisciplinary-approach-to-detect-new-generation-risk-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-access-and-communication-of-rural-cancer-patients-through-enhanced-usage-of-patient-portal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-role-of-progastricsinpepsinogen-c-pgc-in-gastric-carcinogenesis-a-south-asian-outl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/falcon-exact-sciences-multicancer-early-detection-mced-real-world-evidence-rwe-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-adverse-symptoms-to-predict-response-to-treatment-among-patients-in-the-i-spy-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-uptake-of-cervical-cancer-screening-feasibility-and-acceptability-of-menstrual-blood-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-surufatinib-monotherapy-as-a-third-line-treatment-for-advanced-hepatocell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guide-g-an-artificial-intelligence-powered-platform-for-dynamic-nccn-guideline-visualization-in-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-combined-therapy-with-pemetrexed-and-bevacizumab-in-recurrent-and-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proton-pump-inhibitors-and-clinical-outcomes-in-hepatocellular-carcinoma-patients-a-propensity-scor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mirnas-expression-as-predictive-biomarkers-in-recurrentmetastatic-cervical-cancer-the-nrg-oncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/doacs-vs-warfarin-rethinking-anticoagulation-strategies-for-portal-vein-thrombosis-prophylaxis-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-alterations-identified-in-a-phase-1-study-of-fostamatinib-plus-paclitaxel-in-platinum-resi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individual-and-contextual-factors-associated-with-incidence-of-ovarian-cancer-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-based-genomic-profiling-and-real-world-outcomes-in-cancer-of-unknown-primary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuroendocrine-neoplasm-a-10-year-retrospective-review-of-a-single-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-copd-exacerbations-on-survival-outcomes-in-non-small-cell-lung-cancer-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-temporal-trends-in-stroke-related-mortality-in-women-with-breast-cancer-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-pirfenidone-in-the-primary-prophylaxis-of-lung-cancer-in-idiopathic-pulmonary-fibrosis-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-of-machine-learning-models-in-glioma-classification-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meat-consumption-and-colorectal-cancer-risk-a-comprehensive-meta-analysis-of-red-processed-and-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-silico-evaluation-of-the-interaction-of-p-gp-and-3a4-substrates-with-the-wee1-inhibitor-debio-012 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-anlotinib-combined-with-gemcitabine-and-docetaxel-for-recurrent-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-genomic-characterization-of-ipalb2i-mutated-pancreatic-adenoca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-and-survival-analysis-in-gallbladder-adenocarcinoma-gba-key-findings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/successful-intervention-to-bridge-the-knowledge-gap-in-recognizing-and-managing-chemotherapy-hyperse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-enhanced-literature-review-comparing-advanced-pancreatic-and-gastric-cancer-trial-outcomes-by-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-perspectives-on-nonmelanoma-skin-cancer-care-insights-into-treatment-barriers-and-healthc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibrca12i-and-ipalb2i-short-variants-svs-contributed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-firstline-immunotherapy-and-tyrosine-kinase-inhibitors-combinations-versus-sunitinib-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-tp53-as-an-indicator-of-poor-survival-in-neoadjuvant-treated-triple-negative-breast-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-baffr-car-t-to-treat-b-cell-leukemialymphoma-and-auto-immune-diseases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-darolutamide-in-combination-with-androgen-deprivation-therapy-for-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nucleophosmin-inpm1i-genomic-alterations-ga-in-acute-myeloid-leuk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-in-metastatic-castration-resistant-prostate-cancer-mcrpc-a-retrospective-electro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-associations-between-serum-dehydroepiandrosterone-sulfate-dheas-and-race-among-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-of-i-icdk12i-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-ngs-of-malignant-effusions-and-comparison-to-blood-liquid-biopsy-ctdna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-declining-but-divided-fight-against-genital-organ-neoplasms-who-is-still-left-behind 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-angptl3-apo-ciii-leptin-and-lipid-levels-in-patients-with-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-immune-profiling-of-breast-cancer-from-pregnancy-to-postpartum-insights-into-the-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interferon-signaling-and-outcomes-in-triple-negative-breast-cancer-tnbc-in-finxx-calgb-40603-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-primary-tumor-transcriptomes-in-patients-subsequently-treated-with-parp-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/difference-in-survival-outcomes-between-de-novo-vs-therapy-related-neuroendocrine-cancer-of-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-systematic-biopsies-in-suspected-prostate-carcinoma-patients-and-analysis-of-gleason-grade-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-lymphodepletion-pre-ld-and-day-30-m1-immune-cell-counts-on-outcomes-of-car-t-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-dna-damage-response-in-atmbrca2-carriers-to-inform-hereditary-cancer-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/site-specific-analysis-of-treatment-modalities-and-survival-in-brain-metastases-from-neuroendocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-functional-connectivity-in-brain-tumor-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-intracranial-hemorrhage-with-doacs-vs-lmwh-in-patients-with-cancer-associated-thrombosis-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exome-analysis-of-over-5000-esophagogastric-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gabrp-as-a-biomarker-for-predicting-anti-pd1-therapeutic-efficacy-in-advanced-gastric-cancer-wjog10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-the-covid-19-pandemic-on-staging-and-treatment-patterns-in-non-small-cell-lung-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunorare-sup5sup-a-national-platform-of-5-academic-phase-ii-trials-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-dose-dense-versus-standard-neoadjuvant-chemotherapy-for-her2-negative-breast-cancer-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-subsequent-therapy-in-patients-pts-with-primary-advanced-or-recurrent-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteomic-signatures-of-biofluid-derived-extracellular-vesicles-for-benign-and-malignant-ovarian-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-anlotinib-and-penpulimab-anti-pd1-combined-with-gemox-in-first-line-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-assessment-of-breast-cancer-risk-following-hormonal-therapy-in-endometriosis-a-global-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-induced-modulation-of-brain-glucose-metabolism-in-leukemia-patients-a-retrospective-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iaib-study-of-talazoparib-in-combination-with-tazemetostat-in-metastatic-castration-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-treatment-patterns-and-survival-outcomes-of-spermatocytic-seminoma-a-national-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/change-in-practice-patterns-over-time-for-endocrine-therapy-et-and-radiation-therapy-rt-in-women 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experiences-and-preferences-of-cancer-survivors-across-the-immunotherapy-journey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-abiraterone-and-androgen-receptor-inhibitors-arpis-in-metastatic-castratio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-occurrence-of-acute-leukemias-and-myelodyplastic-neoplasms-as-seen-at-the-ke 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-bone-marrow-transplant-recipients-with-and-without-diabetes-a-propensity-matched-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-palliative-care-outcomes-in-academic-versus-community-centers-for-advanced-non-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-trial-of-health-coaching-based-navigation-after-breast-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onpoint-development-of-an-open-navigator-through-precision-oncology-informatics-technology-to-suppo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metaplastic-breast-cancer-clinical-and-prognostic-features 2026-08-24 monthly 0.7 https://rjrindex.com/articles/levels-of-immune-responses-in-tertiary-lymphoid-structures-of-non-small-cell-lung-cancer-nsclc-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiple-immune-related-adverse-events-among-patients-with-melanoma-patterns-and-risk-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutational-profiling-of-appendiceal-tumors-from-diagnostic-specimens-and-circulating-tumor-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-to-improve-efficiency-in-io-clinical-trials-comprehensive-analysis-of-a-decade-long-reporting-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-half-dose-dual-targeted-therapy-in-advanced-solid-tumors-with-ngs-proven-actionable-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/united-states-treatment-pattern-response-to-carboplatin-and-cisplatin-shortages 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-body-mass-index-on-the-prognostic-impact-of-progesterone-receptor-in-postmenopausal-erher 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systemic-trend-analysis-of-young-onset-esophageal-cancer-in-american-population-2012-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-great-circle-distance-on-breast-cancer-survival-in-ncdb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-dual-vs-triple-oral-metronomic-chemotherapy-using-methotrexate-celecoxib-with-or-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atropisomeric-pyrrolopyrimidine-inhibitor-as-a-targeted-approach-for-ret-tyrosine-kinase-in-neurobla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-tolerability-of-intraventricular-carv3-team-e-t-cells-following-lymphodepleting-chemother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-a-biopsychosocial-model-of-fatigue-in-patients-with-neuroendocrine-neoplasms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-neoadjuvant-nivolumab-and-sox-in-resectable-gastricgastroesophageal-junction-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stromal-sarcoma-nos-a-national-cancer-database-analysis-of-patient-demographics-and-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-characterization-of-klk2-mrna-expression-in-prostate-cancer-pc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bria-imt-checkpoint-inhibitor-phase-iii-survival-results-compared-to-benchmark-trials-in-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bolstering-access-to-clinical-trials-sociodemographic-characteristics-of-patients-enrolled-in-inter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-the-bispecific-outpatient-safe-step-up-boss-program-for-elranatamab-in-ambulatory-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-and-surgery-for-rectal-cancer-omission-of-radiation-in-clinical-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-outcomes-of-obecabtagene-autoleucel-obe-cel-stratified-by-age-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-based-music-therapy-intervention-in-cancer-patients-undergoing-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dreamm-8-study-of-belantamab-mafodotin-plus-pomalidomide-and-dexamethasone-bpd-vs-pomalidomide-plu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-powered-quantification-of-tumor-infiltrating-lymphocytes-from-hampe-stained-images-in-ovarian-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neladalkib-nvl-655-a-highly-selective-anaplastic-lymphoma-kinase-alk-inhibitor-compared-to-ale 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-risk-of-venous-and-arterial-thrombosis-in-polycythemia-vera-patients-with-secondary-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-and-late-recurrence-in-high-risk-hormone-receptor-positive-her2-negative-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thymosin-alpha-1-enhanced-prag-regimen-a-novel-approach-to-boosting-immune-dynamics-and-therapeutic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-mutational-landscape-of-indian-core-binding-aml-an-answer-to-the-unfavorable-outcome-in-a-favora 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-effectiveness-of-urine-dna-for-minimal-residual-disease-mrd-monitoring-of-urothelial-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tacti-004-a-double-blinded-randomized-phase-3-trial-in-patients-with-advancedmetastatic-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-in-targeted-therapy-of-gliomas-in-a-community-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-hrqol-outcomes-with-darolutamide-in-the-phase-3-aranote-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benchmarking-clinical-reasoning-and-accuracy-of-large-language-models-on-breast-oncology-multiple-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cutaneous-toxicity-and-clinical-outcomes-with-enfortumab-vedotin-and-pembrolizumab-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elacestrant-combinations-in-patients-pts-with-erher2-locally-advanced-or-metastatic-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-equal-study-utilizing-plasma-egfr-cfdna-detection-as-an-accessible-screening-tool-for-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-ocular-toxicities-in-patients-with-relapsedrefractory-multiple-myeloma-treated-with-be 2026-08-24 monthly 0.7 https://rjrindex.com/articles/litespark-029-a-phase-2-randomized-open-label-study-of-belzutifan-plus-fulvestrant-in-participant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/basecamp-1-an-approach-to-improve-patient-screening-efficiency-and-to-provide-large-datasets-for-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-genomic-landscape-of-estrogen-receptor-er-low-versus-er-positive-er-and-er-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-zavondemstat-tach101-a-first-in-class-kdm4-inhibitor-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-alliancea091802-randomized-trial-of-avelumab-plus-cetuximab-vs-avelumab-alone-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triplet-therapy-for-flt3-mutated-acute-myeloid-leukemia-in-puerto-rico-a-retrospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-btm-3566-in-relapsedrefractory-mature-b-cell-lymphomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/suprame-a-phase-3-trial-comparing-ima203-an-engineered-t-cell-receptor-expressing-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frontline-treatment-strategies-in-peripheral-t-cell-lymphoma-a-network-meta-analysis-of-efficacy-ou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-sirolimus-in-combination-with-metronomic-chemotherapy-choanome-in-children-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-tirumotecan-sac-tmt-in-combination-with-tagitanlimab-anti-pd-l1-in-first-line-1l-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-transfer-learned-hierarchical-variational-autoencoder-model-for-computational-design-of-anticancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-to-evaluate-the-safety-and-efficacy-of-xnw5004-a-selective-ezh2-inhibitor-in-sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-the-hfa-icos-cardiovascular-toxicity-risk-tool-in-chronic-myeloid-leukemia-patients-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-ribociclib-rib-endocrine-therapy-et-vs-combination-chemotherapy-combo-ct-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-pemigatinib-for-pre-treated-glioblastoma-or-other-gliomas-with-activating-fgfr1-3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-a-phase-12-study-of-7mw3711-a-novel-b7-h3-antibody-drug-conjugate-adc-incorporating-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-liver-transplant-recipients-with-and-without-diabetes-a-propensity-matched-analysis-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-vs-sunitinib-for-first-line-treatment-of-advanced-renal-cell-carcinoma-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-sequential-intravesical-gemcitabine-and-docetaxel-versus-bacillus-calmette-guerin-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/everest-2-initial-data-of-the-logic-gated-tmod-chimeric-antigen-receptor-t-cell-car-t-therapy-a2b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bladder-cancer-mortality-among-smokers-trends-and-disparities-in-us-adults-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-xalute-phase-3-study-of-xaluritamig-vs-investigators-choice-of-cabazitaxel-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/irinotecan-liposome-combined-with-anlotinib-as-second-line-treatment-in-patients-with-small-cell-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-phase-i-trials-across-solid-tumors-and-hematological-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-clinical-trial-on-combined-neo-adjuvant-intravenous-plus-intracranial-administration-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-liv-1-expression-with-clinical-efficacy-in-patients-with-advanced-breast-cancers-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imm2510-an-anti-pd-l1vegf-bispecific-antibody-fusion-protein-in-patients-with-rr-sts-a-phase-ib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-tucatinib-trastuzumab-and-capecitabine-ttc-following-trastuzumab-deruxtecan-t-dxd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-tumor-informed-cfdna-whole-genome-sequencing-to-capture-residual-disease-during-neoadju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pooled-analysis-of-clinical-outcomes-with-anti-pd1-based-neoadjuvant-immunotherapy-neoit-in-cuta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/substudy-c-of-the-canadian-cancer-trials-group-cctg-ind234-pc-bets-prostate-cancer-biomarker-en 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-obesity-on-the-survival-outcomes-among-indian-women-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-with-sacituzumab-govitecan-sg-based-therapy-in-metastatic-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-hv01-a-recombinant-human-il-21-expressing-oncolytic-vaccinia-virus-as-monotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-adar1-loss-in-lung-cancer-on-anti-tumor-immunity-and-tumor-cell-growth-via-the-rig-imda5-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-the-triglyceride-glucose-index-for-the-efficacy-of-immunotherapy-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-p57-in-cgas-sting-mediated-innate-sensing-and-immunotherapy-response-in-hepatocellular-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-conversion-surgery-after-immune-checkpoint-inhibitor-based-combination-therapy-in-initia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genome-wide-association-study-of-neurocognitive-outcomes-among-childhood-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-analysis-of-metastatic-merkel-cell-carcinoma-patients-pre-and-post-immunotherapy-era-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clonal-evolution-of-primary-lesions-vs-brain-metastasis-of-egfr-mutated-nsclc-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-and-long-term-survival-in-stage-iv-lung-adenocarcinoma-as-predicted-by-serial-3-d-explant-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-patients-with-stage-iii-melanoma-treated-with-adjuvant-immunotherapy-with-a-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-outcomes-of-aspiration-pneumonia-in-white-american-patients-hospitalized-with-nasop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-ipilimumab-plus-nivolumab-in-metastatic-merkel-cell-carcinoma-a-systematic-review-and-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-survival-outcome-comparison-of-a-minority-rich-population-with-dlbcl-treated-with-car-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proceade-pantumor-a-phase-1b2-multicenter-study-of-precemtabart-tocentecan-m9140-an-anti-ceaca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-cardiotoxicity-of-acalabrutinib-versus-chemoimmunotherapy-in-chronic-lymphocytic-leukem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-combined-with-sintilimab-as-first-line-treatment-in-patients-with-advanced-non-clear-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-ntrk-testing-strategies-for-detecting-ntrk-fusions-in-solid-tumors-in-china 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-accuracy-and-efficiency-of-large-language-models-for-chart-review-in-cancer-genetics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-followed-by-capox-and-tislelizumab-in-mss-locally-advanced-rectal-cancer-with-resectabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hif1a-macrophages-as-key-mediators-of-immune-suppression-and-recurrence-in-early-stage-small-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mesothelioma-showdown-surgery-vs-chemo-when-the-numbers-dont-agree 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-disease-and-gastrointestinal-cancers-mortality-trends-and-persistent-disparities-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-treatment-patterns-and-outcomes-of-hiv-associated-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fragmentation-of-cell-free-dna-cfdna-in-locally-advanced-rectal-cancer-larc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-value-of-septin-9-methylation-assay-in-the-diagnosis-of-early-stage-colorectal-cancer-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-second-line-therapy-with-serplulimab-lenvatinib-and-paclitaxel-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-muscle-mass-loss-on-survival-during-neoadjuvant-chemoradiotherapy-in-patients-with-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-disparities-in-cancer-biomarker-knowledge-and-access-across-canada 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-withdrawal-for-fda-accelerated-approvals-of-anticancer-drugs-1992-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/step-1-a-sickkids-pilot-providing-upfront-financial-support-for-pediatric-and-adolescent-patients-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-darolutamide-versus-abiraterone-acetate-plus-prednisone-in-combination-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cells-and-clinical-outcomes-in-men-with-metastatic-hormone-sensitive-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-clinical-harm-and-financial-waste-from-failure-to-deploy-personalized-medicine-for-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-post-mastectomy-radiation-therapy-for-patients-with-breast-cancer-after-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ia-study-to-estimate-the-radiochemical-and-radiation-safety-of-of-sup68sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promoting-resilience-in-stress-management-within-patients-with-early-stage-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-winpro-trial-a-window-of-opportunity-study-of-endocrine-therapy-with-and-without-prometrium-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-low-income-patients-with-early-onset-breast-cancer-an-analysis-of-the-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-incidence-and-five-year-relative-survival-analysis-of-classical-hodgkin-lymphoma-in-childr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-and-ethnic-disparities-in-breast-cancer-and-cardiovascular-disease-related-mortality-in-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-patients-with-hyperlipidemia-and-early-onset-breast-cancer-an-analysis-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-second-line-lenvatinib-after-progression-on-immunotherapy-in-advanced-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-hiv-and-age-on-sociodemographic-characteristics-inpatient-metrics-and-complications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-robotic-navigation-system-for-ct-guided-lung-ablation-first-efficacy-and-safety-evaluation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kaposi-sarcoma-herpesvirus-kshv-subtypes-and-impact-on-survival-in-107-patients-with-kaposi-sarcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-predictive-role-of-trail-gene-expression-in-immune-checkpoint-inhibitor-ici-treated-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-guideline-concordant-cancer-care-for-patients-with-limited-english-proficiency-a-mixed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-malignant-peripheral-nerve-sheath-tumor-of-the-trachea-mediastinum-and-other-respirato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activity-and-toxicity-of-human-mesenchymal-stem-cells-derived-from-anti-pd1-integrated-ipscs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-triple-negative-breast-cancer-survival-a-2000-2021-retrospective-seer-analysis-of-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ocular-toxicity-and-tolerability-of-bcma-directed-antibody-drug-conjugate-adc-therapy-in-relapsed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-gene-mutations-tmb-and-pd-l1-in-relation-to-ici-response-in-hnscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/research-on-cancer-related-cognitive-impairment-a-national-institutes-of-health-nih-grant-portfol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-ibi110-and-sintilimab-in-combination-with-chemotherapy-in-resectable-locally-advanced-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-lip-oral-and-pharyngeal-cancer-across-three-decades-an-age-adjusted-gbd-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-efficacy-of-oral-5-fu-in-combination-with-pembrolizumab-and-cisplatin-as-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folate-deficiency-anemia-in-patients-on-parp-inhibition-insights-from-a-large-single-center-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guard-02-safety-and-efficacy-of-prophylactic-use-of-novel-long-acting-g-csf-efbemalenograstim-a-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-standard-versus-extended-interval-dosing-of-pd-1pd-l1-immune-checkpoint-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-fusobacterium-nucleatum-on-nf-kbhif-1accl20-pathway-and-m2-macrophages-infiltration-in-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/left-atrial-appendage-closure-laac-in-cancer-patients-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-derived-ilt5-and-suppression-of-t-cell-immunity-in-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-analysis-from-nej045a-study-safety-and-efficacy-of-durvalumab-plus-carboplatin-and-etoposid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-cd28-klrg1cd8-t-cells-as-prognostic-indicators-in-advanced-nsclc-chemoimmunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-high-performance-blood-based-dna-methylation-test-for-early-detection-of-gastrointestinal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-of-the-noggo-perception-phase-ii-investigational-study-of-pembrolizumab-in-combinatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-complete-blood-cell-count-derived-inflammatory-biomarkers-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-mitotic-circulating-tumor-cells-with-clinical-outcomes-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-implementation-of-molecular-oncology-test-e-consult-at-the-va-north-texas-health-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/major-adverse-cardiovascular-complications-event-outcomes-in-liver-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-regional-mortality-trends-in-patients-with-hypertension-and-hepatobiliary-cancer-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-external-beam-radiotherapy-on-hepatic-parenchymal-resection-rate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-primary-malignancies-cancer-specific-survival-and-disparities-in-enucleation-an-overvie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/textbook-outcomes-in-liver-surgery-a-decade-of-experience-at-a-cancer-dedicated-centre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dosing-tolerability-and-adverse-events-aes-in-dihydropyrimidine-dehydrogenase-idpy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-copy-number-variations-cnv-patterns-and-pseudotime-trajectories-in-high-grade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-novel-interdisciplinary-pharmacology-curriculum-in-a-hematologyoncology-fellows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-of-2l-adc-strategies-in-triple-negative-breast-cancer-tnbc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/presentation-progression-and-survival-in-placental-site-trophoblastic-tumors-a-population-based-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-impact-of-substance-use-and-mental-health-disorders-on-cancer-care-in-urban-underserve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-invasive-pd-l1-prediction-in-nsclc-patients-using-3d-self-supervised-deep-learning-and-radiomics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-alkbh5-with-cisplatin-ga-nanodrug-to-investigate-platinum-sensitivity-in-resistant-ovarian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mesonephric-like-adenocarcinoma-a-single-institution-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-systemic-therapy-vs-locoregional-therapies-in-hepatocellular-carcinoma-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-large-language-model-processed-unstructured-clinical-data-versus-manual-physician-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-the-prognostic-value-of-oncotype-rs-and-mammaprint-mp-in-postmenopausal-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-prostate-cancer-on-outcomes-of-patients-hospitalized-with-acute-myocardial-injury-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-effects-of-financial-toxicity-on-quality-of-life-among-hematopoietic-stem-cell-transpl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cdk46-inhibitor-toxicity-in-geriatric-subgroups-evidence-from-the-faers-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-relationship-between-insomnia-vasomotor-symptoms-and-nocturia-in-patients-receiving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-risks-of-surgeries-and-complications-in-von-hippel-lindau-disease-with-belzutifan-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-gastrointestinal-cancer-and-metabolic-syndrome-mortality-in-the-us-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-challenges-for-precision-medicine-and-evidence-based-oncology-in-genitourinary-tumors-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modeling-progression-and-treatment-of-aml-using-the-thales-qsp-software-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-and-validation-of-potential-diagnostic-plasma-biomarkers-for-diffuse-gliomas-by-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-brain-radiotherapy-and-intrathecal-injection-of-thiotepa-combined-with-systemic-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pregnancy-and-miscarriage-before-epithelial-ovarian-cancer-eoc-diagnosis-in-patients-carrying-germ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-peri-operative-study-of-fianlimab-cemiplimab-chemotherapy-versus-cemiplimab-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/possibility-of-using-the-combination-of-everolimussorafenib-medications-in-the-treatment-of-childre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-aspyre-lung-on-cytology-specimens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multisite-validation-of-biomechanical-computed-tomography-for-osteoporosis-assessment-and-fracture-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modeling-the-economic-impact-of-a-ciz1b-biomarker-blood-test-for-lung-cancer-screening-in-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-observational-study-to-compare-speech-and-swallowing-outcomes-in-different-types-of-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-perceived-interpersonal-support-and-quality-of-life-among-adult-patients-with-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-survey-of-patients-understanding-on-the-genetic-tests-for-cancer-genetic-syndromes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-cytoplasmic-ar-v7-circulating-tumor-cell-ctc-detection-add-utility-in-predicting-ar-pathway-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-device-to-simultaneously-collect-standard-core-biopsies-and-dislodged-cancer-cells-from-soli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-overall-survival-os-with-talazoparib-tala-enzalutamide-enza-as-an-initial-treatment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-pediatric-oncology-outcomes-in-the-occupied-palestinian-territories-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-barriers-to-implementing-survivorship-support-programs-for-oncology-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-liver-cirrhosis-on-demographics-and-outcomes-following-esophagogastroduodenoscopy-for-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-and-cost-implications-for-collection-and-storage-of-excess-autologous-hematopoietic-stem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/likelihood-of-colorectal-cancer-screening-by-poor-health-status-a-cross-sectional-analysis-of-the-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-role-of-cytarabine-based-regimens-in-mantle-cell-lymphoma-a-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd58-alterations-and-their-role-in-regulating-antitumor-immune-responses-in-diffuse-large-b-cell-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-metabolic-tumor-volume-for-predicting-cytokine-release-syndrome-and-treatment-response-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/propensity-score-ps-comparison-between-lisocabtagene-maraleucel-liso-cel-plus-ibrutinib-combinat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivoreach-integrated-study-to-demonstrate-similarity-of-jpb898-to-reference-nivolumab-in-combinatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-model-to-predict-future-breast-cancer-risk-after-er-positive-and-her 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-of-young-onset-breast-cancer-and-the-role-of-germline-pathogenic-variants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-and-spectrum-of-brca-pathogeniclikely-pathogenic-variants-in-the-hispanic-population-of-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-patterns-for-second-primary-malignancies-among-human-papillomavirus-hpv-associated-first-prim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-autoimmune-hepatitis-non-infectious-gastroenteritis-and-colitis-among-patients-with-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-retrospective-analysis-of-the-mutation-and-co-mutation-landscape-of-erbb2-in-advanced-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-overview-of-survival-and-demographic-disparities-in-primary-peritoneal-carcinoma-insights-from-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-biomarker-analysis-from-a-phase-ii-trial-of-intensive-chemotherapy-combined-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-and-safety-of-disitamab-vedotin-monotherapy-versus-chemotherapy-in-bladder-preser 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-value-of-multiple-molecular-tumor-board-reviews-for-sequential-next-generation-sequenc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-pd-l1-expression-and-pd-1-cd8-t-cells-to-predict-immunotherapy-outcomes-in-esophageal-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-daprodustat-compared-to-standard-recombinant-human-erythropoietin-rhepo-in-treatin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-apatinib-and-chemotherapy-as-neoadjuvant-therapy-for-triple-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ex-vivo-liver-resection-and-auto-transplantation-for-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/full-coverage-therapy-for-converting-unresectable-advanced-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-demographic-profiles-and-predictors-of-survival-in-epithelioid-trophoblastic-tumors-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-dynamics-and-targeted-therapies-associated-with-genetic-mutations-in-patients-with-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/employing-novel-pan-cancer-targets-for-immunotherapy-in-leukemias-and-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-isatuximab-subcutaneous-sc-plus-carfilzomib-and-dexamethasone-isa-kd-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-hrqol-with-paclitaxel-plus-ramucirumab-ptx-ram-switch-maintenance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-crc-now-a-disease-of-young 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iesr1i-mutations-and-associated-alterations-in-patients-with-estrogen-receptor-er 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-nec-gfpc-01-2022-a-multicenter-phase-ii-study-evaluating-the-efficacy-and-safety-of-the-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-apg-157-monotherapy-in-patients-with-locally-advanced-squamous-cell-carcinoma-of-head-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/completed-phase-1a-dose-escalation-study-of-the-first-oral-enpp1-inhibitor-rbs2418-immunotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bariatric-surgery-and-risk-of-gastrointestinal-and-hormone-sensitive-cancers-in-patients-with-metabo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-sacituzumab-govitecan-sg-plus-nivolumab-n-in-patients-pts-with-muscle-invasive-urothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carica-papaya-leaf-extract-cple-versus-placebo-to-improve-chemotherapy-induced-thrombocytopenia-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomic-analysis-of-the-immunoadapt-trial-neoadjuvant-endocrine-therapy-combined-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-asandeutertinib-ty-9591-in-advanced-nsclc-patients-with-egfr-positive-mutation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-adapted-therapy-guided-by-human-papillomavirus-hpv-circulating-tumor-dna-in-patients-with-hpv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-cancer-burden-in-developing-countries-a-comprehensive-analysis-of-globocan-data-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brain-metastasis-incidence-trend-analysis-and-impact-on-survival-using-seer-database-2010-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-clinical-trial-barriers-in-lung-cancer-patient-reported-impact-of-resources-on-trial-par 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-neoadjuvant-pembrolizumab-infusion-and-pathologic-complete-response-among-patients-with-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inhaled-kb707-a-novel-hsv-based-immunotherapy-as-a-monotherapy-in-patients-with-advanced-solid-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-mutation-as-a-prognostic-factor-in-metastatic-non-small-cell-lung-cancer-nsclc-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-mgmt-status-with-survival-in-low-and-high-grade-idh-mutant-astrocytomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypofraction-radiotherapy-followed-by-immune-checkpoint-inhibitors-for-locally-advanced-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-egfr-mutations-in-non-small-cell-lung-cancer-in-hawaii-a-multi-center-epidemiology-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-peripheral-eosinophilia-as-a-biomarker-post-car-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-lutetium-177-vipivotide-tetraxetan-in-advanced-castration-resistant-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-177-lutetium-dotatate-177lu-dotatate-in-olfactory-neuroblastoma-onb-a-case-series 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analytical-validation-of-episeek-an-epigenomic-blood-based-assay-for-multicancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-cytarabine-consolidation-in-older-patients-with-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neo-era-01-a-multi-center-single-arm-phase-ii-study-with-neoadjuvant-therapy-of-haic-gemox-comb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-dose-escalation-study-of-gcc19cart-a-novel-car-t-cell-therapy-for-metastatic-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-controlled-pivotal-trial-of-microbubble-enhanced-transcranial-focused-ul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-xnw27011-a-claudin-182-targeting-antibody-drug-conjugate-with-topoisomerase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-lurbinectedin-plus-atezolizumab-as-second-line-treatment-for-advanced-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-pt-characteristics-treatment-patterns-and-overall-survival-os-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-larotrectinib-in-patients-with-non-primary-central-nervous-system-trk-fusion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-lenvatinib-plus-pembrolizumab-in-patients-with-recurrentmetastatic-salivary-gla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-double-blind-phase-23-study-of-ficerafusp-alfa-bca101-or-placebo-in-c-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-first-line-immune-checkpoint-inhibitors-with-chemotherapy-in-advanced-ebv-assoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-opioid-use-prior-to-pancreatic-cancer-diagnosis-on-overall-survival-insights-from-see 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-hepatic-artery-infusion-chemotherapy-and-transarterial-chemoembolization-combined-with-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-alternating-magnetic-field-therapy-on-quality-of-life-among-cancer-survivors-with-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-a-muscadine-grape-extract-supplement-to-decrease-fatigue-among-older-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-sexual-dysfunction-among-men-with-cancer-before-the-initiation-of-systemic-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multivariate-model-to-predict-delay-in-diagnosis-and-treatment-of-breast-cancer-in-pakistan-a-ret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-inflammatory-bowel-disease-on-outcomes-of-colorectal-cancer-patients-undergoing-open-resec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-the-impact-of-nivolumab-amp-ipilimumab-combination-therapy-vs-dabrafenib-amp-trametin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-in-combination-with-rc148-versus-albumin-bound-paclitaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-screening-and-detection-following-uspstf-recommendations-for-ages-45-49-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-induction-chemoimmunotherapy-ici-with-cemiplimab-in-combination-with-cisplatin-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-intraoperative-ex-vivo-electrical-impedance-measurements-for-oral-squamous-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-evaluating-68ga-fapi-pet-uptake-heterogeneity-as-a-predictor-of-t-dxd-treatment-respo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-durvalumab-doxorubicin-and-ifosfamide-in-recurrent-andor-metastatic-pulmonary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methylation-specific-epigenetic-and-ctdna-biomarkers-in-prognosis-of-advanced-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-emp2-in-triple-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-driven-approaches-for-predicting-t-cell-mediated-immunity-and-beyond 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u01-substudy-01a-phase-12-study-of-pembrolizumab-plus-ifinatamab-deruxtecan-i-dxd-or-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-randomized-controlled-study-about-oral-nutrition-supplement-in-local-advanced-nasophar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-antibody-drug-conjugate-target-expression-on-tumor-derived-extracellular-vesicles-circu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-trial-of-exercise-as-first-line-therapy-for-hormone-receptor-hr-positive-advanced-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-propensity-score-matched-analysis-for-time-to-trabectedin-failure-in-advanced-myxoid-liposarcoma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adaptive-ai-driven-clinical-decision-making-in-oncology-through-digital-twins-and-large-scale-imagin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/measuring-pancreatic-cancer-spatial-conformation-to-predict-recurrence-risk-after-total-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-tolerability-of-dostarlimab-in-combination-antiretroviral-therapy-refractory-hiv-associat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcatheter-aortic-valve-replacement-in-cancer-patients-with-chest-radiation-therapy-risks-and-ou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-and-association-with-treatment-outcomes-during-pediatric-car-t-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-b-cell-responses-in-high-grade-serous-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-obesity-paradox-in-triple-negative-breast-cancer-patients-receiving-neoadjuvant-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-dependent-prediction-model-using-modified-deepsurv-algorithm-for-dynamic-risk-assessment-of-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-associated-with-outcomes-from-optimize-1-cd40-agonist-mitazalimab-with-mfolfirinox-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/host-immune-classifier-to-predict-survival-with-chemoimmunotherapy-in-pd-l1-50-metastatic-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-serplulimab-with-concurrent-chemoradiotherapy-in-resectable-esophagogastric-junction-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-cardiovascular-outcomes-among-cancer-patients-receiving-immune-checkpoint-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-effectiveness-of-azacitidine-plus-venetoclax-versus-intensive-chemotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-review-of-relapse-after-allogeneic-stem-cell-transplant-for-myeloid-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venetoclax-duration-outcomes-analysis-in-mdsaml-within-a-community-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-infiltration-of-hematopoietic-stem-cells-hsc-with-cell-proliferation-and-patient-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-stage-i-triple-negative-breast-cancer-tnbc-treated-with-or-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-preventable-acute-care-events-a-study-on-reducing-emergency-visits-and-hospitalizations-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-efficacy-of-targeted-microwave-ablation-in-patients-with-prostate-cancer-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intensification-of-androgen-deprivation-therapy-adt-in-metastatic-hormone-sensitive-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-marrow-polyclonal-plasma-cells-in-myeloma-post-treatment-implications-on-outcome-and-effect-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-malignant-and-premalignant-conditions-in-lgbtqia-individuals-on-gender-affirming-hormo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-armed-oncolytic-adenovirus-on-immunotherapy-for-primary-and-metastatic-brain-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-kit-mutations-with-risk-of-central-nervous-system-cns-metastasis-met-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tobacco-smoking-as-a-risk-for-cutaneous-squamous-cell-carcinoma-in-skin-of-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-molecular-resistance-mechanisms-in-therapy-naive-nsclc-patients-a-retrospective-2-year-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-cabozantinib-or-lenvatinib-following-atezolizumab-plus-bevacizumzb-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-ctdna-and-other-biomarkers-in-patients-with-curatively-resected-stage-i-iii-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-class-tmbim6-therapeutics-overcoming-limitations-in-current-oncology-therapies-through-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-disparities-in-pancreatic-cancer-mortality-a-nationwide-analysis-from-1968-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-pevonedistat-in-combination-with-carboplatin-and-paclitaxel-in-advanced-intrahep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-rc48-adc-combined-with-pd-1-inhibitors-for-patients-with-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-surufatinib-s-plus-kn046-k-and-chemotherapy-in-first-line-1l-advanced-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-observational-phase-ii-clinical-study-evaluating-hepatic-artery-infusion-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-histopathologic-biomarker-for-predicting-frontline-immunotherapy-combination-outcomes-in-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/communication-skills-training-cst-in-hematologyoncology-fellowships-results-from-a-multi-institu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-survival-outcomes-among-histological-subtypes-of-non-small-cell-lung-cancer-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-follicular-lymphoma-patients-hospitalized-with-viral-respiratory-illnesses-a-national-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-picture-of-biomarker-testing-in-metastatic-bladder-cancer-a-comprehensive-assessment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-lysis-syndrome-on-clinical-outcomes-and-healthcare-burden-in-chimeric-antigen-recept 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-salvage-radiotherapy-in-relapsedrefractory-large-b-cell-lymphoma-patients-following-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-enrollment-of-demographic-subgroups-in-us-clinical-trial-sites 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-her3-in-nsclc-leveraging-continuing-education-to-bridge-the-gaps-between-evidence-and-pra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-for-dmmrmsi-h-colorectal-cancer-navigating-rapidly-evolving-oncologic-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sapanisertib-and-serabelisib-piktor-with-paclitaxel-and-a-diet-substudy-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lurbinectedin-for-small-cell-lung-cancer-sclc-response-patterns-and-survival-outcomes-by-line-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-tumor-informed-ctdna-to-de-escalate-treatment-or-monitoring-in-metastatic-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-socioeconomic-disparities-in-colorectal-cancer-incidence-following-bariatric-surgery-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-thrombocytopenia-and-splenomegaly-in-locally-advanced-rectal-cancer-patients-receiving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-longer-the-better-how-tokenized-linkage-can-extend-observable-time-for-cancer-patients-in-heal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-in-patients-with-metastatic-bladder-cancer-a-cross-regional-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-sarcoma-care-in-a-developing-country-impact-of-centralization-and-long-term-international 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-nab-paclitaxel-based-chemotherapy-with-or-without-pd-1pd-l1-blockade-in-secon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-surgery-on-the-prognosis-of-patients-with-locally-advanced-vulva-cancer-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-mitoxantrone-hydrochloride-liposome-with-tislelizumab-in-patients-with-relapsed-or-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-incretin-mimetic-therapy-on-weight-change-in-patients-with-cancer-a-pan-cancer-analysis-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-profile-of-low-grade-diffuse-glioma-in-patients-followed-at-the-national-cancer-institute-be 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-genetic-testing-for-hereditary-cancer-syndromes-among-newly-diagnosed-patients-with-solid-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/engineering-pbae-nanoparticles-for-immunological-reprogramming-in-clinically-relevant-humanized-mous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-personalized-medicine-in-primary-bladder-adenocarcinoma-pab-a-machine-learning-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-counseling-gc-in-the-era-of-next-generation-sequencing-ngs-to-diagnose-microsatellite-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/where-you-live-and-who-you-are-the-unequal-face-of-cancer-and-diabetes-mortality-in-the-united-stat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-aperiodic-dynamics-and-transcriptomic-alterations-and-a-neural-signature-of-gli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-an-ai-enabled-prediction-of-prostate-cancer-pca-using-urine-based-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-of-indeterminate-potential-mutations-in-neuroendocrine-tumor-patients-cluster 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparisons-of-survival-outcomes-of-antibody-drug-conjugates-in-metastatic-breast-cancer-a-network 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-doris-a-cancer-focused-ai-knowledge-platform-for-diagnosis-and-treatment-information 2026-08-24 monthly 0.7 https://rjrindex.com/articles/larotrectinib-resistance-in-trk-fusion-cancers-analysis-of-a-tumor-agnostic-global-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atezolizumab-and-stereotactic-body-radiation-in-metastatic-recurrent-or-persistent-cervical-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-the-relationship-between-glutaminase-expression-and-features-of-the-immune-tumor-microenvi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-germline-and-somatic-landscape-of-uterine-leiomyosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-a-patient-ambassador-program-to-improve-clinical-trial-knowledge-and-intent-to-discuss-gy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-survivorship-in-brazil-from-providers-perspectives 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-timing-of-diagnosis-and-breastfeeding-on-postpartum-breast-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microrna-based-signatures-of-early-and-late-immune-related-adverse-events-to-anti-pd1-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-study-on-splenic-radiation-dose-constraints 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-mortality-of-gastric-cancer-among-older-adults-70-from-1990-to-2021-across-204 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-phase-2b-study-of-selinexor-in-combination-with-carfilzomib-daratumumab-or-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-indian-dlbcl-ready-for-prime-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-following-upfront-surgery-vs-neoadjuvant-chemotherapy-for-triple-negative-and-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opioid-knowledge-and-concerns-challenges-among-physicians-in-turkey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-myelodysplastic-syndrome-in-patients-treated-with-parp-inhibitors-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptional-dynamics-of-cd74-b-cells-in-tertiary-lymphoid-structures-and-effects-on-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicodemographic-predictors-of-enrollment-and-outcomes-in-early-phase-oncology-clinical-trials-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-second-line-treatment-in-patients-with-nsclc-and-targetable-mutations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overcoming-acquired-venetoclax-resistance-in-acute-myeloid-leukemia-through-cell-metabolism-targetin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-transplant-measures-of-geriatric-assessment-domains-and-outcomes-of-allogeneic-hematopoietic-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-treatment-mri-to-predict-pathological-complete-response-in-triple-negative-breast-cancer-follow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-predictors-of-treatment-free-remission-in-chronic-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-analysis-of-cfdna-samples-from-black-patients-with-metastatic-castration-resistant-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dipcan-a-multidimensional-approach-to-precision-oncology-harnessing-genomic-clinical-pathologica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-timely-chemotherapy-initiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metabolic-only-response-assessment-for-omission-of-residual-node-radiation-therapy-rnrt-for-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-effectiveness-and-safety-of-disitamab-vedotin-for-her2-expressing-advanced-or-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-atezolizumab-plus-bevacizumab-for-advanced-hepatocellular-carcinoma-in-relation-to-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-clinical-benefit-of-trastuzumab-deruxtecan-t-dxd-and-sacituzumab-govitecan-sg-in-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-biomarker-trial-of-pepinemab-to-enhance-nivolumab-or-ipilimumab-activity-in-resectable-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-geriatric-8-frailty-guideline-treatment-treatment-adherence-and-overall-survi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-chatgpt-4o-in-management-of-gynecologic-oncologic-patients-in-the-emergency-departmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soundtrack-e-a-phase-12-open-label-multicenter-study-to-evaluate-the-safety-and-efficacy-of-azd0 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-socioeconomic-disparities-in-molecular-testing-and-targeted-therapy-utilization-among-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infectious-complications-of-cd20-x-cd3-bispecific-antibody-therapy-in-patients-with-b-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-outcomes-of-breast-cancer-subtypes-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-the-rkip-snail-yy1-axis-on-immune-evasion-in-gbm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myeloablative-fractionated-busulfan-conditioning-regimen-with-sorafenib-for-allogeneic-stem-cell-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-sacituzumab-govitecan-in-heavily-pretreated-metastatic-her2-negative-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-casdatifan-plus-cabozantinib-expansion-cohort-of-phase-1-arc-20-study-in-previously-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-rilvegostomig-rilve-plus-chemotherapy-ctx-in-advanced-biliary-tract-cancer-btc-pri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-prediction-of-cytokine-release-syndrome-post-car-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1a1b-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-anti-tumor-activity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-surgeons-decision-to-multidisciplinary-tumor-board-consensus-evaluating-treatment-plan-modifi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-molecular-characterization-of-pediatric-soft-tissue-sarcomas-a-report-from-the-cog-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-real-world-progression-free-survival-rwpfs-using-a-multimodal-machine-learning-ml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-colorectal-cancer-incidence-and-mortality-in-appalachian-kentucky 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alpha3-a-pivotal-phase-2-study-of-first-line-1l-consolidation-with-cemacabtagene-ansegedleucel-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-artificial-intelligence-ai-to-optimize-multidisciplinary-tumor-board-workflows-at-osf-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-tumor-activity-of-corest-inhibitor-jbi-802-dual-epigenetic-modifier-of-lsd1hdac6-an-opport 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-improving-adjuvant-endocrine-therapy-persistence-improve-survival-outcomes-for-patients-with-ear 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-artificial-intelligence-assistance-software-for-her2-low-and-her2-ultralow-ihc-interpretation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infusion-product-characteristics-to-predict-response-to-tumor-infiltrating-lymphocyte-til-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-and-trends-in-gastric-cancer-incidence-mortality-and-stage-specific-trends 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-trial-of-trastuzumab-deruxtecan-and-biology-driven-selection-of-neoadjuvant-treatment-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-factors-influencing-turnaround-time-tat-for-tissue-comprehensive-genomic-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologic-outcomes-of-organ-preservation-in-patients-with-rectal-adenocarcinoma-treated-with-total-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-single-nucleotide-polymorphisms-snps-in-ipdcd1i-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-analysis-of-dnv3-plus-toripalimab-and-chemotherapy-in-advanced-melanoma-an-open 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-screening-in-high-risk-never-smokers-with-artificial-intelligence-lc-shield-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cemiplimab-rwlc-survivorship-and-epidemiology-case-interim-results-from-a-prospective-study-of-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emiltatug-ledadotin-emi-le-a-b7-h4-directed-dolasynthen-antibody-drug-conjugate-adc-being-inves 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-dzd6008-a-4-supthsup-generation-egfr-tki-with-ful 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-ev-103-cohort-h-neoadjuvant-treatment-with-enfortumab-vedotin-ev-monotherapy-in-cisplatin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-kras-g12c-inhibitors-in-metastatic-non-small-cell-cancer-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-evaluating-the-safety-and-efficacy-of-ivermectin-in-combination-with-balstilimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/romiplostim-for-chemotherapy-induced-thrombocytopenia-cit-in-colorectal-gastroesophageal-and-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-sup68sup-ga-ny104-petct-with-sup18sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-incidence-and-therapeutic-regimen-altering-effects-of-immune-checkpoint-inhibitor-associated-per 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melatonin-for-alleviating-cancer-related-fatigue-in-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-cfdna-levels-and-ctdna-detection-rates-in-patients-with-stage-ii-colon-cancer-screened 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alisertib-in-combination-with-endocrine-therapy-in-patients-with-hormone-receptor-positive-hr-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epha2-sirna-in-dopc-nanoliposomes-epharna-a-phase-i-clinical-trial-in-patients-with-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-nivoipi-vs-gemcitabine-carboplatin-gem-carbo-chemotherapy-for-previou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/versatile-002-overall-survival-of-hpv16-positive-recurrentmetastatic-head-and-neck-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-the-efficacy-and-safety-of-iruplinalkib-wx-0593-in-alk-positive-advanced-lung-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/magnetic-resonance-imaging-mri-radiomics-as-predictor-of-clinical-outcomes-to-neoadjuvant-immunoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-single-arm-open-label-clinical-trial-to-evaluate-the-combination-of-cadonilimab-injecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chimeric-antigen-receptor-t-cell-therapy-related-cardiovascular-adverse-effects-a-national-inpatien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup177sup-lu-psma-617-with-ipilimumab-ipi-and-nivolumab-nivo-in-metastatic-cast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-impact-of-sbrt-on-dendritic-cells-in-the-tumor-microenvironment-of-triple-negative-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-the-completed-dose-finding-part-of-phase-2-study-of-the-innate-cell-engager-acimtamig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-artificial-intelligence-ai-as-a-clinical-decision-support-tool-for-lung-cancer-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop-2-expression-and-its-prognostic-impact-on-endometrial-cancer-a-real-world-data-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oregovomab-in-combination-with-non-platinum-chemotherapy-for-the-treatment-of-parp-inhibitor-and-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-patients-with-b-cell-precursor-acute-lymphoblastic-leukemia-receiving-inotuzumab-ozogami 2026-08-24 monthly 0.7 https://rjrindex.com/articles/testosterone-replacement-therapy-for-fatigue-sexual-dysfunction-and-quality-of-life-in-older-men-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-transarterial-therapy-combined-with-donafenib-plus-programmed-cell-death-prot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-risk-of-cytokine-release-syndrome-associated-with-the-use-of-antineoplastic-agents-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-egr1-mediated-glutamine-metabolic-reprogramming-through-mtor-signaling-pathway-on-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trastuzumab-deruxtecan-in-her-2-expressing-solid-tumors-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-zg005-a-bispecific-antibody-targeting-pd-1-and-tigit-as-monotherapy-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-center-study-on-the-role-of-acsl4-in-invasion-and-metastasis-of-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-camrelizumab-cam-plus-low-dose-apatinib-combined-with-gemcitabine-and-cisplatin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-of-induction-chemotherapy-ict-followed-by-chemoradiotherapy-for-locally-advanced-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-grade-serous-ovarian-cancer-differentiation-and-invasion-post-chemotherapy-role-of-nrf2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-fibroblast-activation-protein-inhibitor-fapi-o4-petct-versus-flurodeoxygl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-testing-in-primary-advanced-or-recurrent-endometrial-cancer-a-cost-effectiveness-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-obesity-paradox-in-endometrial-cancer-epidemiology-of-obesity-among-endometrial-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-usage-patterns-and-training-needs-of-generative-artificial-intelligence-among-onco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-diffuse-large-b-cell-lymphoma-mortality-among-older-adults-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/test-performance-of-a-dna-methylation-based-liquid-biopsy-biomarker-for-detection-and-classification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-prognostic-nutritional-index-pni-and-racial-disparities-in-dlbcl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-utility-of-one-step-nucleic-acid-amplification-in-detecting-sentinel-lymph-node-metastases-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-fgfr-status-from-hampe-images-using-digital-pathology-to-identify-patients-for-early-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipilimumabnivolumab-versus-standard-of-care-in-non-clear-cell-renal-cancer-results-of-the-sunnifor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-pd-l1-expression-and-irasi-mutations-and-association-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamics-of-the-tumor-marker-tm-cancer-antigen-153-ca-153-and-its-association-with-overall-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-implication-of-resting-natural-killer-cells-in-mesothelioma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rechallenge-with-epidermal-growth-factor-receptor-inhibitors-for-metastatic-colorectal-cancer-a-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-the-occurrence-of-second-primary-malignancies-spms-in-early-onset 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imm27m-a-humanized-fc-engineered-anti-ctla-4-antibody-in-patients-with-advanced-solid-tumors-a-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-ipik3cai-mutation-detection-methods-in-the-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-circulating-methylated-septin-9-for-pathologic-complete-response-to-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-profiling-of-hormone-receptor-positive-her2-negative-hrher2-metastatic-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/increasing-mortality-burden-in-patients-with-hypertension-and-colorectal-cancer-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/i-spy2-endocrine-optimization-pilot-eop-neoadjuvant-lasofoxifene-laso-in-molecularly-selected-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-prediction-of-response-to-neoadjuvant-chemotherapy-from-digitized-hampe-slides-of-pre-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-matters-real-world-evidence-of-increased-immunotherapy-toxicity-in-elderly-patients-from-a-braz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-a-multicomponent-navigation-program-to-reduce-time-intervals-to-treatment-initiation-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-1-dose-escalation-and-expansion-study-evaluating-the-safety-tolerability-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matching-adjusted-indirect-comparison-maic-of-olutasidenib-olu-and-ivosidenib-ivo-in-isocitrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-the-new-classification-of-hormone-receptor-positive-breast-cancer-based-on-the-genom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subgroup-analysis-by-fitness-criteria-of-patients-pts-with-blastic-plasmacytoid-dendritic-cell-neo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-analysis-of-clinical-characteristics-and-survival-outcomes-in-russian-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-single-home-visit-on-distress-in-cancer-patients-undergoing-chemotherapy-a-comparative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-epigenetic-clocks-and-chemotoxicity-in-older-adults-with-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-large-language-models-on-trial-to-patient-matching-efficiency 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-mortality-due-to-myelodysplastic-syndromes-in-the-us-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arima-prediction-model-for-mortality-caused-by-metastatic-cancers-in-the-united-states-population-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-communication-model-to-facilitate-conversations-about-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/app-first-as-a-strategy-to-increase-new-patient-access-and-treatment-of-patients-with-gastrointestin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-immune-related-adverse-events-iraes-and-association-with-symptom-distress-score-by-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-methylated-mgmt-using-radiomic-imaging-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trifluridine-tipiracil-with-bevacizumab-in-refractory-metastatic-colorectal-cancer-with-a-convenient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interactions-between-polygenic-variants-and-clinical-factors-as-predictors-of-breast-cancer-risk-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-global-and-regional-burden-of-breast-cancer-in-females-from-1990-2023-a-systematic-analysis-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-droplet-digital-pcr-ddpcr-assay-to-detect-mgmt-promoter-methylatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/qualifying-adcs-and-multispecific-therapeutic-targets-with-a-novel-agentic-ai-insight-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iv-pharmacovigilance-study-of-biosimilar-drugs-in-cancer-a-colombian-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ia-study-to-estimate-the-radiochemical-and-radiation-safety-of-sup68gsup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-mitochondrial-proteins-as-plasma-biomarkers-for-chromophobe-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-fruquintinib-combined-with-pd-1-inhibitors-and-chemotherapy-in-the-first-line-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-metastatic-urothelial-carcinoma-pts-discontinuing-enfortumab-vedotin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-patient-characteristics-treatment-tx-patterns-and-clinical-outcomes-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-circulating-tumor-dna-analysis-as-predictor-of-efficacy-of-neoadjuvant-therapy-in-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-the-effectiveness-and-toxicity-of-atezolizumab-and-bevacizumab-as-first-line-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/two-decades-of-change-tracking-intrahepatic-cholangiocarcinoma-mortality-in-the-united-states-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-adoptive-tumor-infiltrating-lymphocyte-til-bst02-therapy-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-centre-stratified-open-randomized-comparator-controlled-parallel-group-phase-ii-trial-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-efficacy-and-safety-of-lenvatinib-vs-apatinib-in-combination-with-hepatic-arterial-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-low-value-cancer-treatments-in-medicare-advantage-versus-traditional-medicare-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-capecitabine-by-brcam-status-in-patients-with-early-stage-triple-neg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-abemaciclib-outcomes-in-routine-clinical-practice-experience-of-several-moscow-centers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-expression-network-based-analysis-of-gene-programs-contributing-to-immune-checkpoint-inhibitor-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-2ir-immune-response-score-in-histologic-subtype-urothelial-carcinoma-hsuc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monotherapy-of-envafolimab-in-patients-with-high-tumor-mutational-burden-advanced-solid-tumors-resu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-outcomes-of-lenvatinib-treatment-followed-by-liver-resection-for-large-advanced-hepatocellu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravenous-vitamin-c-as-an-adjunct-to-standard-therapy-in-pancreatic-ductal-adenocarcinoma-a-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-genetic-predisposition-to-low-grade-systemic-inflammation-with-cancer-related-fatigue 2026-08-24 monthly 0.7 https://rjrindex.com/articles/azeliragon-a-rage-inhibitor-in-combination-with-temozolomide-and-radiotherapy-in-patients-with-new 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-phase-ii-study-of-pembrolizumab-plus-lenvatinib-for-patients-with-unresectable-cutaneous-angiosa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-results-of-the-wee1-inhibitor-azenosertib-a-in-combination-with-encorafe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-combination-of-lurbinectedin-and-atezolizumab-in-a-humanized-mouse-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conut-score-as-a-predictor-of-venous-thromboembolism-in-high-risk-hospitalized-cancer-patients-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-focal-adhesion-kinase-to-mitigate-hepatotoxicity-induced-by-pd-1-inhibition-with-or-withou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-benign-cardiac-tumors-and-thromboembolic-events-analysis-of-the-2018-2022-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-genomic-and-pathological-features-and-therapeutic-outcomes-of-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gamma-secretase-inhibitors-and-desmoid-fibromatosis-lessons-from-a-real-world-comprehensive-genomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-concentrations-and-blood-tumor-mutation-burden-as-biomarkers-of-outcomes-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-of-nivolumab-and-ipilimumab-in-rare-cancer-brain-metastases-a-multi-center-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-mutational-burden-pd-1-negative-wntv-catenin-regulators-and-positive-mhc-class-ii-antigen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-autoimmune-diseases-and-characteristics-of-solid-tumor-patients-on-immune-checkpoint-inhibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-gegen-qinlian-tablets-in-attenuating-immune-related-adverse-events-in-nsclc-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-slide-histology-based-deep-learning-model-for-mismatch-repair-deficiency-prediction-in-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exosomal-proteins-as-biomarkers-for-differential-diagnosis-of-pleural-effusion-etiologies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-plasma-methylated-dna-markers-for-detection-hpv-positive-oropharyngeal-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-steroid-for-enhancing-patients-recovery-after-head-and-neck-cancer-surgery-with-free-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-and-clinical-significance-of-high-risk-secondary-cytogenetic-abnormalities-at-first-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-outcomes-and-patients-characteristics-of-malignant-phyllodes-breast-neoplasms-a-tertiary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-surgical-modalities-for-stage-0-to-stage-ii-acral-lentiginous-melanoma-a-national-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-characteristics-of-her2-ihc-0-membrane-staining-breast-cancer-and-implicati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-implications-of-discordant-eber-and-ebv-dna-status-in-nasopharyngeal-carcinoma-in-endemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-chemotherapy-drug-cisplatin-on-the-efficacy-of-b7h3-car-t-cells-in-treating-melanoma-by-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/resistance-mutations-in-lung-cancer-a-perspective-from-the-mexican-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-addition-of-abemaciclib-to-endocrine-therapy-versus-endocrine-therapy-alone-in-hrher2-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-apatinib-following-concurrent-chemoradiotherapy-in-high-risk-nasopharyngeal-carcinoma-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-related-changes-in-salivary-cd44-and-total-protein-in-patients-with-oral-and-oropharyngeal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-care-for-newly-diagnosed-diffuse-large-b-cell-lymphoma-patients-with-poor-survival-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-meta-analysis-of-cisplatin-dosing-schedules-in-definitive-chemoradiotherapy-for-locoregi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-mortality-trends-among-patients-with-lip-and-oral-cavity-cancer-due-to-tobacco-consumption 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-effect-of-neoadjuvant-pd1-alone-pd1ipi-and-pd1lenvatinib-in-the-peripheral-immune-profi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-tracheal-bronchus-and-lung-cancer-attributable-to-occupational-carcinoge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-gallbladder-cancer-related-mortality-in-the-united-states-1999-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/resistance-to-anti-pd-1-immunotherapy-for-stage-iii-and-iv-melanoma-results-from-a-global-multi-sit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-outcome-analysis-of-recurrent-versus-de-novo-metastatic-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-treatment-positron-emission-tomography-image-quality-and-inter-fractional-tumor-uptake-variation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-knowledge-gap-regarding-radiopharmaceuticals-in-patient-communities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/muscle-mass-evaluation-among-ambulatory-cancer-patients-in-china-comparison-of-different-methods-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-minimal-residual-disease-detection-a-tumor-informed-whole-genome-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-fruquintinib-combined-with-envafolimab-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-pancreatic-cancer-fibrosis-based-on-ct-images-and-its-association-with-chemotherapy-ef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-second-line-therapy-by-envafolimab-combined-with-anlotinib-and-s-1-in-pancrea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-comprehensive-cfdna-methylation-signature-for-prognostic-predictive-and-diagnosti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-health-system-for-resolving-breast-cancer-screening-actions-multicenter-randomized-clini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-health-related-quality-of-life-between-low-income-latino-and-white-men-with-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-factors-associated-with-care-outcomes-in-hospitalized-patients-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/project-shirley-fear-of-recurrence-and-risk-communication-in-australian-hr-her2-early-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-racial-disparities-in-oropharyngeal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-first-line-chemotherapy-plus-nivolumab-in-gastric-and-gej-adenocarcinoma-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-gastric-cancer-mortality-in-the-us-a-population-based-analysis-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/30-year-trends-in-racial-disparities-for-early-stage-lung-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-post-allogeneic-hematopoietic-stem-cell-transplant-hsct-maintenance-therapy-in-flt3-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-venetoclax-combined-with-hypomethylating-agents-in-acute-myeloid-leukemia-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-analysis-of-incidence-mortality-and-survival-trends-in-acute-lymphoblastic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/at-risk-cancer-genetic-syndrome-identification-arcagen-id-novel-ehr-integrated-system-to-overcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-barriers-to-timely-nsclc-treatment-a-northern-nevada-perspective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-influencing-completion-of-cancer-therapy-in-heart-transplant-recipients-with-de-novo-maligna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-for-locally-advanced-sinonasal-carcinoma-a-systematic-review-and-meta-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-post-discharge-palliative-care-pilot-clinic-for-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-phenotypes-and-management-of-patients-with-musculoskeletal-immune-related-adverse-events-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-circulating-tumor-dna-dynamics-during-and-after-infusional-therapy-initiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-results-of-esg401-a-trop2-targeting-adc-updated-phase-1-analysis-in-advanced-solid-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-for-clinical-stage-iii-melanoma-a-community-cancer-centers-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-evaluation-of-an-ai-powered-system-for-clinical-trial-eligibility-using-mcode-data-stand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-study-of-safety-and-efficacy-in-vivo-of-a-yttrium-90-resin-microspheres-glue-formulation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accrual-of-historically-underrepresented-patients-with-multiple-myeloma-using-centralized-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-surgical-outcomes-of-neoadjuvant-targeted-therapy-in-anaplastic-and-differentiated-thyr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alliance-a221805-duloxetine-to-prevent-oxaliplatin-induced-chemotherapy-induced-peripheral-neuropat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-co-culture-system-to-validate-results-of-a-phase-i-trial-testing-new-treatment-for-barretts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mid-treatment-positron-emission-tomography-adaptive-radiotherapy-in-stage-iii-non-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/linvoseltamab-linvo-bortezomib-btz-in-patients-pts-with-relapsedrefractory-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/salvovar-a-pragmatic-randomized-phase-iii-trial-comparing-the-salvage-weekly-dose-dense-regimen-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interrogating-the-interleukin-6-il-6il-23t-helper-th17-axis-in-immunotherapy-toxicity-mechani 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-of-fruquintinib-versus-regorafenib-and-trifluridinetipiracil-in-treating-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-biomarkers-as-predictors-of-response-to-mosunetuzumab-in-previously-untreated-follicular-fl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/functional-and-survival-outcomes-in-hpv-positive-oropharyngeal-squamous-cell-cancer-treated-with-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/simrise-a-randomized-phase-iii-trial-evaluating-sim0270-in-combination-with-everolimus-versus-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunorare-sup5sup-a-national-platform-of-5-academic-phase-ii-trials-3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimating-the-access-to-psychotherapy-and-psychological-support-for-cancer-patients-in-nigeria-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-dose-escalation-and-expansion-study-of-zg006-a-trispecific-t-cell-engager-targeting-cd3d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-axitinib-nivolumab-in-mucosal-melanoma-with-pilot-addition-of-stereotactic-body-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-body-mass-index-bmi-on-efficacy-and-safety-of-abemaciclib-in-breast-cancer-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lifileucel-in-patients-with-advanced-melanoma-5-year-outcomes-of-the-c-144-01-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-study-of-adebrelimab-and-bevacizumab-combined-with-cisplatincarboplatin-in-trip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-center-study-of-efficacy-and-safety-of-capivasertib-in-hormone-receptor-positive-hr-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-landscape-of-resistance-to-next-generation-alk-inhibitors-with-evolving-treatment-paradigm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-profiling-to-identify-predictive-biomarkers-and-highlights-the-potential-efficacy-of-il-6r-bl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-lb1410-a-bivalent-tim-3pd-1-bispecific-antibody-in-patients-with-advanced-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-artificial-intelligence-ai-accuracy-a-meta-analysis-of-hallucination-incidence-in-larg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypoxia-inducible-factor-2a-hif-2a-inhibitor-belzutifan-in-von-hippel-lindau-vhl-disease-associa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-mhb088c-a-novel-b7-h3-targeted-adc-in-patients-with-relapsed-extensive-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-cohort-based-prediction-model-for-early-relapse-of-hepatocellular-carcinoma-post-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lurbinectedin-lurbi-atezolizumab-atezo-as-first-line-1l-maintenance-treatment-tx-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-of-mc200710-investigating-therapeutic-vaccine-pds0101-alone-or-with-pembrolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-dose-expansion-study-of-zg006-a-trispecific-t-cell-engager-targeting-cd3dll3dll3-as-mo-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-fedratinib-in-myelofibrosis-patients-after-ruxolitinib-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-encorafenib-and-cetuximab-ec-beyond-progression-in-combination-with-folfiri-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pimicotinib-in-tenosynovial-giant-cell-tumor-tgct-efficacy-safety-and-patient-reported-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-zanidatamab-hrii-compared-to-chemotherapy-in-previously-treated-her2-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-an-academic-precision-oncology-service-in-a-community-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redefining-criteria-for-omitting-axillary-surgery-following-neoadjuvant-systemic-therapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-age-on-financial-toxicity-among-breast-cancer-patients-with-resectable-invasive-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pleomorphic-lobular-carcinoma-in-situ-upgrade-rate-to-invasive-carcinoma-association-with-other-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerating-answers-impact-of-a-quality-improvement-initiative-for-lung-cancer-pathology-practices 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-examination-of-national-changes-in-potentially-avoidable-hospital-visits-after-chemotherapy-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-multi-level-social-determinants-for-disparities-in-survival-and-patient-reported-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/point-of-care-social-needs-screening-and-resource-navigation-for-patients-with-cancer-undergoing-act 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-the-clinic-comprehensive-assessment-of-time-burdens-in-cancer-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-nivolumab-in-advanced-esophageal-carcinoma-a-systematic-review-of-phase-iii-clinical-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-young-onset-colorectal-cancer-patients-with-an-accessible-self-navigable-online-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-lymphatic-ablation-approaches-on-immunotherapy-efficacy-in-esophageal-squamous-cell-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-doacs-in-budd-chiari-syndrome-a-real-world-comparison-from-the-trinetx-global-collaborati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-cancer-support-and-technology-in-breast-cancer-care-developing-a-chatbot-for-underserve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-phase-2-study-of-prolonged-neoadjuvant-immunotherapy-plus-chemotherapy-in-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/equitable-access-for-management-of-pre-invasive-cervical-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-genomic-mechanisms-of-health-disparities-among-adolescentyoung-adult-survivors-of-hodgkin-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-shortcut-from-ovarian-cancer-development-to-metastasis-ii-imycfas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tracking-incidence-and-prognosis-of-lung-cancer-seen-in-kidney-transplant-recipients-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-human-immunodeficiency-virus-on-hepatocellular-carcinoma-outcomes-a-national-inpatient-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-distinct-regimens-for-individuals-with-advanced-egfr-mutated-non-small-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcome-analysis-of-the-two-mcgill-university-associated-hospitals-with-lu-177-prrt-for-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-global-burden-and-trend-of-cervical-cancer-in-g20-countries-age-sex-regional-disparities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacologic-and-pharmacometric-studies-of-factors-affecting-the-pharmacokinetics-and-pharmacodynam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-genomic-testing-in-prostate-cancer-a-comprehensive-system-wide-initiative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oropharynx-cancer-in-the-us-racial-disparities-in-stage-at-presentation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-pfs-assessment-by-blinded-independent-central-review-bicr-versus-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-novel-rna-biomarkers-for-the-differential-diagnosis-of-cutaneous-melanoma-and-nevi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-kidney-cancer-treatment-through-ai-enabled-functional-precision-medicine-the-pear-tree 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-deficiency-signature-hrdsig-in-advanced-cutaneous-melanoma-acm-a-genom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-and-correlates-of-cancer-cachexia-in-the-detroit-research-on-cancer-survivors-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidisciplinary-and-multi-institutional-cancer-symptom-management-strategies-in-the-veterans-affai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-molecular-predictors-of-radiotherapy-combined-with-bevacizumab-on-desmoid-tumor-aggres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-lymph-node-next-generation-sequencing-assist-in-better-predicting-the-prognosis-of-lung-adenocar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-cfdna-fragmentomics-for-early-biliary-tract-cancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insihgt-revived-unified-3d-tissue-profiling-for-spatially-resolved-multi-marker-quantitative-expr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matching-adjusted-indirect-comparison-of-bireociclib-plus-fulvestrant-versus-abemaciclib-plus-fulves 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-role-of-dietary-interventions-in-reducing-chemotherapy-toxicities-in-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disease-response-at-apheresis-and-association-with-long-term-outcomes-following-car-t-cells-for-rela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-adjuvant-regimens-with-single-cytotoxic-agents-among-women-with-stage-ii-iii-her2-positive-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-importance-of-routine-g6pd-screening-in-oncology-patients-a-prospective-comparative-study-in-af 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eribulin-plus-anlotinib-in-advanced-soft-tissue-sarcoma-eras-updates-on-efficacy-and-biomarkers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipcdhgb7i-a-universal-cancer-only-marker-ucom-and-novel-diagnostic-tool-for-div 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-survival-outcomes-in-pancreatic-mucinous-adenocarcinoma-pma-using-machine-learning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-the-association-between-nivolumab-exposure-and-efficacy-in-patients-with-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tops-trainees-in-oncology-programs-a-professional-development-curriculum-for-oncology-fellows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-do-no-harm-evaluating-clinical-skills-for-patient-safety-in-oncology-fellows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-psma-radio-genomics-in-hormone-sensitive-synchronous-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-comparison-of-abatacept-aba-and-half-dose-posttransplant-cyclophosphosphamide-ptcy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-awareness-in-older-adults-with-metastatic-cancer-secondary-analysis-of-a-randomized-cont 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-overall-survival-in-adults-with-cancer-in-the-us-using-machine-learning-approaches-integr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/facilitating-precision-medicine-in-the-community-oncology-setting-artificial-intelligence-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-social-needs-in-an-urban-academic-breast-cancer-survivorship-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-outcomes-of-patients-with-synchronous-cancers-in-west-virginia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-the-implementation-model-of-the-organized-screening-strategy-using-the-pcr-dna-molecular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-proximity-to-health-center-on-adherence-to-nccn-guidelines-in-patients-with-soft-tissue-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-elderly-patients-with-early-stage-triple-negative-breast-cancer-treated-with-the-keynote 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-novel-circulating-tumor-cell-response-stratification-criteria-for-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-event-free-survival-efs-of-stromal-tumor-infiltrating-lymphocytes-stils-pd-l1-expre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fibroblast-activating-protein-fap-expression-and-first-clinical-utility-of-sup68su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-prostate-cancer-in-38-oecd-countries-and-its-trend-from-1990-2021-an-insight-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-acute-side-effects-of-salvage-radiotherapy-in-biochemical-recurrence-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-her2-low-status-on-pathologic-response-after-neoadjuvant-chemotherapy-in-tnbc-a-large-sca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immune-proliferation-gene-signatures-and-stromal-tumor-infiltrating-lymphocytes-sti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-immuno-profiling-predicting-t-and-b-cells-directly-from-hampe-stained-slides 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-effectiveness-of-treatment-cost-calculation-tool-in-improving-patients-understanding 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-overall-survival-in-the-south-african-breast-cancer-and-hiv-outcomes-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fico-scores-and-borrowing-patterns-among-hematology-oncologists-compared-to-other-medicine-subspecia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-vista-expression-in-patients-with-malignant-pleural-mesothelioma-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/definitive-radiation-as-a-nonsurgical-option-after-chemoimmunotherapy-for-stage-iii-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematologic-toxicities-with-axicabtagene-ciloleucel-for-b-cell-lymphomas-in-a-majority-minority-popu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-car-t-in-the-outpatient-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-efficacy-and-safety-of-trifluridine-tipiracil-and-bevacizumabin-refractory-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-factors-for-refractory-metastatic-colorectal-cancer-treated-with-trifluridine-tipirac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncokb-automated-annotation-of-the-pathogenicity-and-treatment-implications-of-germline-mutations-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-immune-checkpoint-inhibitors-as-first-line-therapy-for-untreated-unresectable-pleural-mesoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-of-gastrointestinal-secondary-primary-malignancy-in-chronic-lymphocytic-leukemia-patients-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-deep-learning-for-automated-recognition-of-immune-cells-interacting-with-ctcs-for-progno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whats-weight-got-to-do-with-it-in-hospital-outcomes-in-colorectal-cancer-patients-with-and-without 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-associated-with-advanced-colorectal-neoplasia-in-average-risk-asymptomatic-individ-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-cancer-spectrum-among-breast-cancer-patients-with-tp53-germline-mutatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-clinical-characteristics-and-immunotherapy-outcomes-in-chinese-patients-with-merkel-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-plus-bevacizumab-oxaliplatin-and-capecitabine-as-perioperative-therapy-in-microsatellit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trials-in-progress-alliance-a022104nrg-gi010-a-randomized-phase-iiiii-trial-testing-the-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-and-lifestyle-profiles-of-healthy-aging-survivors-a-report-from-the-childhood-cancer-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-plasma-cell-free-dna-and-tissue-next-generation-sequencing-ngs-in-detecting-genetic-mut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-pembrolizumab-plus-cisplatin-and-5-fu-chemotherapy-followed-by-chemoradiotherapy-in-locall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrk1-3i-point-mutations-in-non-small-cell-lung-cancer-molecular-profiling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-and-immune-characterization-of-adrenergic-stress-signaling-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-analysis-of-neoadjuvant-pd-1-inhibitor-combined-with-chemotherapy-in-various-subanatomical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experience-of-patients-with-hiv-and-squamous-cell-carcinoma-of-the-anal-canal-scac-treated-with-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-as-adjuvant-therapy-following-endoscopic-surgery-for-resectable-recurrent-nasopharyngea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-innovation-to-impact-how-new-therapies-and-racial-disparities-shaped-melanoma-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-existing-cancer-as-a-risk-factor-for-poor-outcomes-after-burn-injury 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-heart-failure-with-abiraterone-versus-enzalutamide-amongst-patients-diagnosed-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-biomarker-based-treatment-strategy-in-patients-with-recurrentmetastatic-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-early-stage-colorectal-cancer-using-multiplexed-extracellular-vesicle-proteomic-biomark 2026-08-24 monthly 0.7 https://rjrindex.com/articles/free-flap-surgery-for-oral-squamous-cell-carcinoma-postoperative-complications-and-its-association 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-evaluating-the-addition-of-cemiplimab-in-braf-mutant-anaplastic-thyroid-cancer-after-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-precision-therapeutics-in-follicular-thyroid-cancer-insights-from-the-aacr-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-patterns-in-car-t-therapy-utilization-inpatient-mortality-and-adverse-event 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-lysis-syndrome-in-lung-cancer-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/missing-data-and-missed-opportunities-inability-to-perform-secondary-analysis-of-prospective-random 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lacutamab-in-patients-with-relapsed-andor-refractory-mycosis-fungoides-long-term-follow-up-and-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-characteristics-and-survival-outcomes-of-pediatric-clear-cell-sarcoma-of-the-kidney-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-an-artificial-intelligence-based-tool-to-predict-financial-toxicity-early-to-facilitate-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-anti-pd-1-rechallenge-in-metastatic-melanoma-a-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pucotenlimab-in-high-microsatellite-instabilitymismatch-repair-defificient-msi-h-dmmr-solid-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-and-transcriptome-landscape-of-actionable-driver-negative-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-transcriptomic-analysis-to-identify-similarities-and-therapeutic-vulnerabilities-in-olfa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-docking-investigating-methotrexate-as-a-potential-target-for-addressing-cardiovascular-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-epidemiology-of-acute-ischemic-stroke-in-breast-cancer-patients-admitted-to-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-and-outcomes-of-breast-cancer-with-leptomeningeal-disease-real-world-experience-in-the-af 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-based-kidney-injury-molecule-1-kim-1-as-a-diagnostic-and-prognostic-indicator-in-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-insights-into-the-prognostic-role-of-mean-platelet-volume-and-ferroptosis-in-immunoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-study-on-the-application-of-fgfr-inhibitors-in-metastatic-bladder-cancer-a-multinational 2026-08-24 monthly 0.7 https://rjrindex.com/articles/javemacs-chart-review-study-of-avelumab-maintenance-in-patients-with-advanced-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-center-experience-with-neoadjuvant-chemoimmunotherapy-versus-chemotherapy-in-patients-with-hi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcome-of-trastuzumab-derutexcan-t-dxd-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-1-trial-with-expansion-cohort-of-botensilimab-agen1181-balstilimab-agen203 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ex-vivo-3d-micro-tumor-testing-platform-for-predicting-clinical-response-to-platinum-based-therapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-hiv-on-outcomes-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-cd19-target 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-due-to-myelodysplastic-syndromes-from-1999-to-2020-a-cdc-wonder-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alcohol-use-and-subsequent-primary-cancer-in-breast-cancer-survivors-a-case-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-controlled-trial-of-intrapleural-drug-loaded-vesicle-perfusion-combined-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-the-efficacy-and-safety-of-regorafenib-monotherapy-and-regorafenib-combination-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-genomic-alterations-in-genes-implicated-in-the-regulation-of-hypoxia-inducible-factor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-ereach-study-a-randomized-study-of-an-ehealth-delivery-alternative-for-cancer-genetic-testing-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predication-of-clinical-outcomes-of-advanced-cutaneous-squamous-cell-carcinoma-to-pd1-inhibition-dir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-of-prognostic-models-for-cardiomyopathy-and-heart-failure-applicable-to-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mrd-driven-strategy-following-isakrd-induction-in-transplant-eligible-ndmm-primary-endpoints-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-primary-malignancy-spm-in-patients-pts-with-multiple-myeloma-mm-receiving-chimeric-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-long-term-toxicities-of-imatinib-in-cml-experience-from-a-tertiary-care-cancer-centre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ipilimumab-combination-therapy-in-advanced-hepatocellular-carcinoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fear-of-recurrence-among-uninsured-and-underrepresented-prostate-cancer-survivors-of-the-mens-healt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-epigenomic-biomarkers-and-baseline-clinical-characteristics-in-patients-with-mcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-integrating-polygenic-risk-scores-with-breast-cancer-risk-assessment-models-resu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-erbb2-activating-mutations-on-enhanced-internalization-and-activity-of-trastuzumab-deruxte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-of-sure-02-a-phase-2-study-of-neoadjuvant-sacituzumab-govitecan-sg-plus-pembrolizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postmarketing-safety-profile-of-chimeric-antigen-receptor-car-t-cell-therapies-in-diffuse-large-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-tumor-mutational-burden-assessment-using-target-enhanced-whole-genome-sequencing-a-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-safety-and-efficacy-study-of-prt3789-in-combination-with-pembrolizumab-in-patients-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-randomized-placebo-controlled-study-of-fisetin-and-exercise-to-mitigate-chemotherapy-rela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-the-efficacy-of-atezolizumab-and-bevacizumab-in-unresectable-hepatocellular-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pros-in-locally-advanced-cervical-cancer-lacc-insights-from-the-outba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complexities-of-managing-refractory-hypoglycemia-in-a-rare-case-of-metastatic-grade-2-pancreatic-neu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outpatient-administration-of-idecabtagene-vicleucel-in-relapsed-refractory-multiple-myeloma-without 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-ai-assisted-pd-l1-cps-scoring-in-immunostained-pan-organ-tumor-whole-slide-images 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-misinformation-and-trust-in-doctors-and-scientists-among-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-of-plk1-inhibitor-onvansertib-in-combination-with-paclitaxel-in-metastatic-triple-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-baseline-plasma-circulating-tumor-dna-ctdna-to-predict-duration-of-endocrine-therapy-et-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longer-follow-up-for-survival-and-safety-from-the-evoke-01-trial-of-sacituzumab-govitecan-sg-vs-do 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-randomized-trial-keynote-630-of-adjuvant-pembrolizumab-pembro-versus-placebo-pbo-for-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/debio-0123-a-highly-selective-wee1-inhibitor-in-adult-patients-with-advanced-solid-tumors-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-unruptured-abdominal-aortic-aneurysm-aaa-diagnosis-on-risk-of-malignant-neoplasms-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-advantages-of-thymosin-a1-combined-with-toripalimab-for-elderly-patients-with-advanced-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fierce-hn-a-multicenter-randomized-double-blind-placebo-controlled-phase-3-study-of-ficlatuzuma-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-in-patients-with-non-hematologic-cancers-prevalence-and-detectability-in-prima 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-pharmacokinetics-and-clinical-activity-of-rg6344-in-patients-with-braf-v600e-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-genetic-mutations-associated-with-pathological-complete-response-in-triple-negative-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-afnt-211-autologous-cd4-supsup-and-cd8 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-monotherapy-in-advanced-her2-positive-or-her2-lowultralow-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vilastobart-xtx101-a-tumor-activated-fc-enhanced-anti-ctla-4-monoclonal-antibody-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-first-line-ibrutinib-plus-venetoclax-in-patients-with-mantle-cell-lymphoma-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-soft-tissue-sarcoma-surveillance-the-role-of-ctdna-testing-in-early-detection-and-monitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/re-evaluation-of-her2-status-and-prognostic-implications-of-ultra-low-and-low-her2-expression-in-est 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-multicenter-phase-3-study-of-vusolimogene-oderparepvec-combined-with-nivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-feasibility-of-personalized-and-tumor-informed-ctdna-assay-for-early-recurrence-detection-in-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-deep-proteomics-into-precision-oncology-for-multi-omics-characterization-of-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/which-systemic-regimen-to-choose-in-cisplatin-ineligible-patients-with-concurrent-radiation-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reframing-hormone-positive-dcis-management-effects-of-adjuvant-therapies-and-surgical-extent-on-any 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-bromodomain-and-extra-terminal-bet-inhibitor-incb057643-in-patients-pts-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipilimumab-and-nivolumab-in-patients-with-metastatic-clear-cell-renal-cell-carcinoma-mccrcc-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn-prognostic-factors-and-outcomes-in-68-mayo-cli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triple-negative-breast-cancer-remodeling-of-the-tissue-immune-microenvironment-by-regulation-of-embr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/worldwide-experience-of-chronic-active-ebv-infection-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-her2-ultralow-heterogeneity-and-optimal-threshold-on-trastuzumab-deruxtecan-t-dxd-effica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-lanreotide-as-a-therapy-for-pheochromocytomas-pcs-and-paragangliomas-pgs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/luminosity-a-phase-2-study-of-telisotuzumab-vedotin-in-patients-with-c-met-protein-overexpressing-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-lm-302-anti-claudin-182-adc-in-combination-with-anti-pd-1-therapy-for-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monocentric-pilot-trial-of-trametinib-in-severe-extracranial-arteriovenous-malformations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-safety-and-efficacy-of-sotorasib-plus-panitumumab-and-folfiri-for-previously-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-combined-with-hypofractionated-radiotherapy-and-chemotherapy-for-locally-recurrent-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-differences-in-non-metastatic-breast-cancer-outcomes-by-tumour-subtype-real-world-data-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-all-oral-regimen-of-decitabine-cedazuridine-dec-c-plus-venetoclax-ven-in-patients-pts-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-histological-subtypes-in-patients-receiving-first-line-treatment-with-enfortumab-vedotinp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nautilus-a-phase-1b2-trial-of-combining-oral-hdac-inhibitor-hdaci-with-mek-inhibitor-meki-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-ib-trial-of-the-sirpa-inhibitor-bi-765063-in-combination-with-the-pd-1-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-study-of-dyp688-an-antibody-drug-conjugate-delivering-a-direct-gq11-inhibitor-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-trastuzumab-pkrb-plus-gedatolisib-in-patients-with-her2-positive-metastatic-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-ribociclib-plus-endocrine-therapy-in-hr-positive-her2-negative-early-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-viral-and-non-viral-etiologies-of-hepatocellular-carcinoma-hcc-in-the-us-over-time-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-trends-and-disparities-in-polycythemia-vera-mortality-in-the-us-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-socioeconomic-disparities-in-testicular-cancer-survival-outcomes-a-seer-database-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shorespan-007-phase-3-study-of-bomedemstat-versus-hydroxyurea-in-essential-thrombocythemia-naive-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rechallenge-with-first-generation-ret-inhibitors-in-ireti-rearranged-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-osimertinib-with-and-without-radiation-therapy-in-egfr-mutated-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-immune-related-adverse-events-irae-in-gastrointestinal-malignancies-gi-m-tumor-speci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delineation-of-immunotherapeutic-predictive-versus-prognostic-transcriptional-programs-to-identify-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-together-with-vincristine-and-temozolomide-naliri-vt-for-patients-with-relaps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-plus-anti-pd-1-or-anti-pd-l1-in-advanced-pd-l1-negative-squamous-cell-lung-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiomic-phenotypes-of-tumor-angiogenesis-compared-with-pd-l1-in-pre-treatment-prediction-of-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-mortality-dynamics-uncovering-critical-disparities-in-us-population-health-201 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-of-colorectal-cancer-in-adolescents-and-young-adults-aya-at-a-tertiar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/axalap-phase-ib-study-of-axatilimab-in-combination-with-olaparib-in-ibrca12i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-racial-disparities-on-efficacy-and-safety-outcomes-for-patients-with-rrmm-receiving-t-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hla-allele-tcr-v-and-j-gene-segment-usage-combinations-and-their-association-with-survival-in-neur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/murine-metastatic-embryonal-rhabdomyosarcoma-survival-and-immune-response-with-a-total-tumor-rna-lip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promoting-resilience-in-stress-management-prism-a-randomized-controlled-trial-of-a-psychosocial-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prevalence-and-outcomes-of-hypercalcemia-in-black-american-patients-hospitalized-with-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-role-of-circulating-tumor-dna-in-pmmr-locally-advanced-rectal-cancer-patients-receiving-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complete-blood-count-as-a-prognostic-tool-for-nsclc-patients-treated-with-immune-checkpoint-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-durvalumab-plus-tremelimumab-versus-standard-chemotherapy-for-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-of-non-small-cell-lung-cancer-in-venezuela-a-multicenter-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-liquid-biopsy-method-for-detecting-androgen-receptor-splice-variant-7-in-circulating-tumor-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nasopharyngeal-carcinoma-outcomes-in-a-predominantly-african-american-population-a-single-center-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-and-outcomes-of-second-primary-cancers-in-colorectal-cancer-patients-by-primary-tumor-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-of-mortality-due-to-laryngeal-cancer-among-older-adults-in-united-states-a-cdc-wond 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-lipid-metabolism-related-gene-signature-associated-with-clinical-and-immune-features-in-lung-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-evaluating-the-safety-and-efficacy-of-autologous-tac-t-cells-in-subjects-with-clau 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-and-benefit-of-adjuvant-chemotherapy-in-early-vs-average-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-predictive-value-of-brca-mutation-on-survival-of-cancer-patients-treated-with-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-multiplex-immunofluorescence-analysis-of-the-tumor-microenvironment-for-predicting-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rare-incidence-of-immune-related-gastritis-and-duodenitis-in-a-single-tertiary-medical-center-a-dia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarc-digital-interim-analysis-of-the-effectiveness-of-digital-health-interventions-on-the-quality-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-tumor-lysis-syndrome-associated-with-kinase-inhibitors-analysis-of-faers-and-real-world-dat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-phase-ii-study-of-anlotinib-and-toripalimab-in-patients-with-advanced-soft-tissue-sarcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-policy-implementations-on-treatment-duration-for-patients-with-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-and-causes-of-early-death-among-patients-with-germ-cell-testis-tumors-gcts-an-intern 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiologic-patterns-and-mortality-outcomes-in-young-lung-cancer-non-smokers-a-national-inpatient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-of-steap1-and-2-in-advanced-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-broad-based-genomic-sequencing-on-survival-outcomes-in-advanced-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-barriers-upfront-expense-payments-to-ease-the-economic-burden-for-clinical-trial-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-phase-2-results-of-pt-112-monotherapy-in-late-line-metastatic-castration-resistant-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omitting-axillary-dissection-in-patients-with-1-2-sentinel-node-positive-breast-cancer-undergoing-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-level-qualitative-exploration-of-factors-influencing-breast-and-cervical-cancer-screening-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumabrelatlimab-versus-nivolumabipilimumab-for-metastatic-melanoma-a-retrospective-propensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rare-alk-clinical-characteristics-and-efficacy-of-targeted-therapy-in-nsclc-with-alk-fusions-other 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-human-whole-slide-image-wsi-and-ai-wsi-assessment-of-tumor-immune-microenvironment-in-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-addition-of-monoclonal-antibodies-to-chemotherapy-in-metastatic-early-onset-colorectal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-toxicity-of-fruquintinib-in-patients-with-colorectal-and-other-cancers-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opinions-of-real-world-clinicians-regarding-visceral-crisis-in-hrher2-mbc-results-from-the-retra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hera-test-a-novel-precision-oncology-tool-using-breast-milk-for-early-detection-of-postpartum-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-potential-benefits-of-trilaciclib-on-blood-product-utilization-and-neutropenic-fever-episodes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-a-selective-parp1-inhibitor-ace-86225106-in-patients-with-advanced-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-review-of-hereditary-leiomyomatosis-and-renal-cell-cancer-at-a-single-institution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progesterone-receptor-expression-and-survival-outcomes-in-metastatic-breast-cancer-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-genetics-evaluation-among-individuals-at-risk-for-lynch-syndrome-across-all-qualifying-indica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-treatment-outcomes-of-small-cell-carcinoma-of-the-small-intestine-colon-and-rectum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-maintenance-therapy-for-metastatic-urothelial-carcinoma-efficacy-analysis-and-sequential-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/crisis-within-a-crisis-a-cdc-wonder-analysis-of-the-pandemics-impact-on-cancer-and-cardiovascular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trem-1-upregulation-as-a-potential-predictive-immune-biomarker-of-pathologic-complete-response-pcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatoprotective-effects-and-safety-profile-of-donafenib-combined-with-transarterial-chemoembolizati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rationale-and-study-design-of-the-kov-hipec-02r-recover-a-randomized-multicenter-open-label-pha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toward-manipulating-sex-hormones-to-modulate-the-adaptive-antitumor-immune-response-in-liver-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-combined-with-gemcitabine-and-cisplatin-in-advanced-biliary-tract-cancer-bicurex-a-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-role-of-immunosurveillance-by-macrophage-in-supporting-therapeutic-strategies-usin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-risk-factors-and-mortality-of-stroke-in-polycythemia-vera-a-single-center-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/legend-a-phase-12-study-of-detalimogene-voraplasmid-eg-70-an-intravesical-monotherapy-for-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progress-in-the-management-of-primary-and-metastatic-cardiac-sarcoma-advancing-multidisciplinary-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/granisetron-transdermal-delivery-system-for-nausea-and-vomiting-prophylaxis-in-her2-positive-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-for-advanced-epithelioid-sarcoma-a-meta-analysis-of-effectiveness-and-safety-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-trends-in-race-and-gender-disparities-in-incidence-based-mortality-in-patients-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-pass-whole-methylome-sequencing-based-liquid-biopsy-for-metastatic-colorectal-cancer-monitoring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-quality-of-life-outcomes-in-patients-with-head-and-neck-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-comprehensive-cancer-network-guideline-compliance-in-an-oncology-value-based-care-program-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-and-utilization-patterns-of-olaparib-in-patients-with-early-stage-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-and-timing-of-first-tumor-next-generation-sequencing-testing-ngs-in-patients-pts-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immunochemotherapy-ict-in-patients-pts-with-metastatic-gastric-cancer-mgc-in-conte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/continuation-of-serplulimab-based-therapy-beyond-first-progression-in-advanced-gastricgastroesophag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-glucagon-like-peptide-1-agonists-on-mgus-progression-in-patients-with-type-2-diabetes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-the-novel-anti-llt1-antibody-zm008-alone-and-in-combination-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-team-efficiency-for-genetic-risk-assessment-medical-oncology-led-germline-testing-for-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-toxicity-profiles-of-two-drug-versus-three-drug-neoadjuvant-chemotherapy-for-locally-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-treatment-patterns-on-clinical-outcomes-in-patients-of-advanced-pancreatic-cancer-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-interruptions-in-chemotherapy-on-survival-for-patients-with-metastatic-or-recurrent-cervic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-and-her3-expression-in-ovarian-cancer-evolution-across-chemotherapy-exposure-and-implications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-medical-oncologists-exploring-the-impact-and-engagement-of-telegram-channels-for-profess 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-assessing-the-efficacy-of-combined-transarterial-chemoembolization-and-microwa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-p53-protein-expression-in-endometrial-carcinoma-using-immunohistochemistry-a-study-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-supportive-care-breast-cancer-clinical-trial-enrollment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transformer-based-deep-learning-model-for-integrated-pathomics-and-radiomics-in-predicting-postopera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-breast-cancer-treatment-on-young-womens-body-image-and-sexual-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-hodgkin-lymphoma-related-mortality-in-the-united-states-over-the-last-three-decad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-dose-escalation-study-of-the-oral-dna-polymerase-theta-inhibitor-polqi-gsk4524101-ni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pronounced-gender-based-and-regional-disparities-in-lung-cancer-mortality-in-the-us-insights-from-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-continuous-zanubrutinib-vs-fixed-duration-venetoclax-in-combination-with-obinutuzumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-a-hyperselection-predictive-biomarker-for-anti-egfr-therapy-benefit-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-composition-and-allostatic-load-in-racially-and-ethnically-diverse-patients-with-metastatic-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-arm-iit-study-of-ha131-hepatic-arterial-infusion-in-combination-with-systemic-therapy-xe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-open-label-randomized-study-of-livmoniplimab-in-combination-with-budigalimab-versus-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-survival-in-malignant-meningiomas-a-machine-learning-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-early-imaging-based-screening-on-outcomes-in-young-patients-with-von-hippel-lindau-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-validation-of-the-risk-estimation-of-tumor-recurrence-after-transplant-retreat-score-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/severe-sarcopenia-and-symptom-burden-prior-to-chemotherapy-among-older-adults-70-with-advanced-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-prediction-of-combined-pre-and-post-operative-ctdna-detection-in-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-as-a-minimal-residual-disease-assessment-and-recurrence-risk-in-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-disparities-in-cardiovascular-mortality-among-breast-cancer-patients-a-25-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-pegylated-sn38-plx38a-and-rucaparib-in-itp53i-wild-type-en 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-experience-of-chemotherapy-combined-with-radiofrequency-ablation-and-immunotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-early-detection-model-based-on-cfdna-methylation-and-fragmentation-features-for-liver-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-frailty-and-healthcare-resource-utilization-in-older-adults-with-pancreatic-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-mixed-method-integration-of-clinician-distress-typologies-in-those-caring-for-seriously-ill-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/needed-leaders-and-leaders-needs-the-creation-of-a-quality-improvement-and-clinical-operations-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunohistochemistry-based-molecular-subtyping-in-muscle-invasive-bladder-cancer-predicting-respons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pelvic-lymph-node-dissection-on-survival-outcomes-in-non-muscle-invasive-bladder-cancer-a-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pet-metabolic-response-in-lugano-comparison-of-qualitative-and-quantitative-outcome-by-independent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-computational-insights-into-non-coding-rna-regulatory-networks-and-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-trends-in-multimorbidity-related-mortality-among-patients-with-cancer-and-myocardial-infar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-health-care-providers-offer-advice-to-adolescents-about-nicotine-containing-product-use 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iia-study-of-adc1-vaccines-targeting-her2her3-combined-with-pembrolizumab-in-patients-with-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-germline-genetic-testing-in-diverse-cancer-types 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protective-effects-of-gallic-acid-against-cadmium-induced-neuroinflammation-in-glioblastoma-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-survival-outcomes-in-adrenocortical-carcinoma-a-comprehensive-analysis-of-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-in-genitourinary-oncology-a-bibliometric-study-and-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-trial-of-high-dose-methotrexate-hdmtx-followed-by-prophylactic-glucarpidase-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standard-versus-extended-pelvic-lymphadenectomy-in-patients-with-bladder-cancer-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-in-thyroid-cancer-patients-with-brain-metastases-a-systematic-review-and-individ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forecasting-incidence-and-mortality-rates-of-prostate-cancer-in-older-adults-using-autoregressive-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-trends-in-adolescents-and-young-adults-with-carcinoma-of-unknown-primary-ins 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-germline-expedited-point-of-care-poc-genetic-testing-through-telehealth-in-the-veteran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/partnering-with-patients-to-deliver-window-of-opportunity-clinical-trials-in-immuno-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-triplet-therapy-based-on-organoid-drug-sensitivity-testing-in-lung-metastatic-hormone-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-urinary-tract-infections-on-in-hospital-outcomes-among-prostate-cancer-patients-an-nis-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-assessment-of-an-algorithm-based-decision-making-platform-for-patient-prioritization-dur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutation-rate-differences-across-populations-and-association-with-performance-disparities-in-patholo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-and-predictors-of-cancer-screening-in-california-ca-prisons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-on-prevention-of-recurrence-in-patients-with-nmibc-for-whom-bcg-vaccine-treatment-failed-by-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-stereotactic-body-radiotherapy-sbrt-vs-sbrt-with-bridge-therapies-for-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extensive-lymph-node-dissection-and-overall-survival-in-colon-cancer-a-systematic-review-and-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-data-from-ph1b-dose-optimization-trial-of-two-doses-of-th1902-sudocetaxel-zend 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benmelstobart-plus-carboplatinpaclitaxel-with-or-without-anlotinib-followed-by-maintenance-benmels 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-of-car-t-cell-therapy-in-lung-cancer-move-forward-or-move-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relapse-patterns-risk-factors-re-resectability-and-survival-after-curative-treatment-for-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-targeted-actinium-225-therapy-in-metastatic-castration-resistant-prostate-cancer-mcrpc-basel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ai-medical-scribes-on-physician-productivity-and-satisfaction-in-medical-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-heterogeneity-in-dmmrmsi-h-endometrial-cancer-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-and-clinical-outcomes-of-cmv-reactivation-in-car-t-therapy-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-network-meta-analysis-nma-of-efficacy-of-zanubrutinib-versus-fixed-duration-acalabrutinib-plus-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-histotme-predicted-immune-subtypes-and-immunotherapy-outcomes-using-human-interpretabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-hercules-study-a-prospective-real-world-evaluation-of-screening-whole-body-mri-swb-mri-for-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-analysis-of-tumor-microenvironment-in-advanced-pancreatic-cancer-unraveling-genomic-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sigvotatug-vedotin-sv-an-investigational-integrin-beta-6-ib6-directed-antibodydrug-conjugate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoactivate-arm-c-phase-ii-trial-of-neoadjuvant-atezolizumab-and-tiragolumab-for-high-risk-operable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cognitive-outcomes-following-proton-vs-photon-radiotherapy-for-cns-non-germinomatous-germ-cell-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dermatologic-prophylaxis-and-impact-on-patient-reported-outcomes-in-first-line-iegfr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/platform-study-of-circulating-tumor-dna-directed-adjuvant-chemotherapy-in-colon-cancer-claudia-colo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-dose-expansion-of-start-001-a-phase-12-study-of-invikafusp-alfa-star0602-a-first-in-cla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/congruence-between-circulating-tumor-dna-and-radiographic-response-during-treatment-of-advanced-sarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-ctdna-monitoring-and-prediction-of-anti-egfr-rechallenge-outcomes-in-rasbraf-wild-type 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-kras-g12c-inhibitor-mk-1084-for-ikrasi-g12c-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-adapted-oncologic-surgery-following-neoadjuvant-immunotherapy-and-chemotherapy-for-resectab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-machine-learning-predictions-of-treatment-response-and-survival-in-advanced-pancreatic-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-tolerability-of-olaparib-temozolomide-and-pembrolizumab-in-a-phase-2-trial-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/head-and-neck-cancer-mortality-unequal-progress-and-emerging-disparities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-anti-cea-car-t-cells-to-prolong-relapse-free-survival-of-colorectal-cancer-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-molecular-characteristics-and-outcomes-of-early-onset-vs-late-onset-colon-cancer-a-sing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-and-evaluation-of-multi-cancer-early-detection-testing-at-the-dana-farber-cancer-inst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-deprivation-therapy-and-quality-of-life-a-concept-map-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-psma-pet-against-chaarted-criteria-in-an-enzamet-sub-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-determinants-of-pneumonitis-in-patients-with-cancer-treated-with-antibody-drug-conjugates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-omics-based-insights-of-trop2-adc-in-non-small-cell-lung-cancer-with-or-without-actiona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-the-cardiovascular-adverse-effects-of-bispecific-antibodies-in-malignant-hematology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/15-year-outcomes-for-women-with-premenopausal-hormone-receptor-positive-early-breast-cancer-bc-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quintessential-2-a-phase-3-study-comparing-efficacy-and-safety-of-arlocabtagene-autoleucel-arlo-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-promise-study-a-presurgical-randomized-clinical-trial-of-cebza-vs-placebo-in-postmenopausal-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iii-study-comparing-stereotactic-body-radiotherapy-sbrt-versus-conventional-pal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-socioeconomic-burden-of-ovarian-cancer-in-11-countries 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-analysis-and-prognostication-of-cholangiocarcinoma-a-seer-database-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-adjuvant-chemotherapy-for-locally-advanced-cervical-carcinoma-an-updated-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbiome-metabolomics-analysis-for-biomarker-identification-in-liver-cancer-among-rio-grande-valle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-of-tumor-informed-ctdna-as-an-early-predictive-indicator-for-relapse-in-advanced-ovarian-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-brazilian-oncology-studies-over-the-last-5-asco-annual-meetings-and-their-representation-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-liver-cell-carcinoma-and-hepatic-failure-related-mortality-in-the-us-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-allostatic-load-and-measures-of-segregation-on-cancer-detection-and-false-positive-rate-af 2026-08-24 monthly 0.7 https://rjrindex.com/articles/successful-accrual-of-a-cluster-randomized-controlled-trial-rct-comparing-an-educationally-enhance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inclusion-of-gestational-surrogacy-in-oncologist-led-fertility-counseling-at-cancer-diagnosis-a-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-peripheral-intravenous-catheters-piv-for-lymphoma-patients-receiving-anthracycline-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-among-oncology-patients-with-distinct-spiritual-well-being-profiles 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiles-in-prostate-cancer-patients-of-varying-measured-socioeconomic-inequality-a-retrosp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-iil7i-germline-variants-with-immune-related-adverse-even 2026-08-24 monthly 0.7 https://rjrindex.com/articles/busulfan-and-cyclophosphamide-vs-busulfan-and-fludarabine-for-myeloablation-in-the-patients-of-acute 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoinduction-therapy-and-its-response-in-jehovahs-witnesses-with-acute-lymphoblastic-leukemia-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/voids-in-regulatory-guidance-for-development-of-theragnostic-radiopharmaceuticals-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-outcomes-of-sabr-in-intermediate-and-high-risk-prostate-cancer-without-adt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-xa-mark-the-spot-monitoring-anti-factor-xa-in-cancer-patients-receiving-low-molecular-weight-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-trial-challenges-in-lmic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gprc5d-and-bcma-bi-specific-car-t-ex-vivo-study-to-simulate-early-to-late-line-multiple-myeloma-mm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-adjuvant-folfox-versus-flot-following-neoadjuvant-flot-in-locally-advanced-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strength-of-evidence-supporting-cancer-drug-approvals-in-china-2017-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/which-neoadjuvant-treatment-is-best-for-locally-advanced-esophageal-cancer-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-randomized-controlled-study-to-evaluate-efficacy-of-argon-beam-coagulation-versus-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-dose-reduction-of-monoclonal-antibodies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institution-study-evaluating-the-fertility-of-young-adults-with-malignancy-treated-with-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-liver-specific-gene-expression-signatures-in-prostate-cancers-prior-to-liver-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-crispr-ko-screening-to-identify-novel-genes-and-pathways-potentially-contributing-to-cisplati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-niraparib-n-abiraterone-acetate-aa-plus-prednisone-p-for-hispaniclatino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trend-in-prostate-cancer-mortality-in-peru-during-the-period-2001-2020-and-its-prediction-to-2030 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-role-of-zeb2-upregulation-in-tam-polarization-and-immune-modulation-in-egfr-tki-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-in-hiv-versus-non-hiv-population-nationwide-analysis-of-mortality-demographics-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-oligoprogressive-egfr-nsclc-in-the-age-of-osimertinib-a-single-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-preoperative-imaging-strategies-in-egfr-mutant-non-small-cell-lung-cancer-nsclc-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-from-a-phase-ii-study-of-dose-adjusted-etoposide-prednisone-vincristine-cyclophos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-suppression-combined-with-elective-nodal-irradiation-and-dose-escalated-prostate-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-non-coding-rna-based-regulatory-networks-in-cancer-metastasis-using-a-heterogeneous-hiera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-conversational-artificial-intelligence-ai-for-outpatient-malignant-bowel-obstruction-mb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-an-artificial-intelligence-model-to-predict-ki67-from-hampe-stained-whole-slides-images-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-obesity-in-hospitalized-pancreatic-cancer-patients-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-molecular-characteristics-of-patients-with-metastatic-pancreatic-ductal-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-trials-to-clinics-real-world-outcomes-of-neoadjuvant-her2-directed-therapy-in-early-stage-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-dosage-modifications-and-impact-on-response-milestone-among-patients-with-cml-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemotherapy-versus-preoperative-chemoradiotherapy-in-resectable-esophageal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-maintenance-olaparib-in-homologous-recombination-deficient-brca-negative-hi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-targetable-iegfri-mutations-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stepwise-ai-prompting-for-multiple-myeloma-imaging-classification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionability-of-genomic-alterations-in-the-molecular-screening-and-therapeutics-most-program-in-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-preference-for-first-line-treatments-of-alk-positive-metastatic-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mirna-mrna-regulatory-network-analysis-of-tumor-associated-mscs-and-cancer-associated-fibroblasts-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-vs-chemotherapy-in-elderly-patients-with-nsclc-a-comparative-analysis-of-survival-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tertiary-lymphoid-structures-and-their-association-with-immune-checkpoint-inhibitor-response-and-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-protein-energy-malnutrition-on-hospitalized-patients-with-breast-cancer-a-united-states-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-guided-adjuvant-radiation-for-patients-with-hpv-related-oropharyngeal-cancer-first-planned-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-on-the-stage-at-diagnosis-and-mortality-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infectious-events-in-patients-treated-for-malignancies-with-t-cell-engagers-immunotherapies-a-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b-study-to-assess-the-safety-of-neoadjuvant-trifluridinetipiracil-with-concurrent-radiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-clinical-characteristics-and-outcomes-of-intracranial-metastases-icm-in-human-papill 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-pyrotinib-for-advanced-salivary-duct-carcinoma-sdc-with-positive-her2-exp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/olink-proteomics-analysis-to-identify-biomarkers-of-radiation-and-immunotherapy-induced-pneumonitis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-acetaminophen-regimen-to-prevent-cytokine-release-syndrome-with-teclistamab-or-talqueta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-alectinib-and-brigatinib-in-alk-positive-non-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-clinical-outcomes-of-her2-positive-metastatic-breast-cancer-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-and-prognosis-of-spindle-cellsclerosing-rhabdomyosarcoma-a-report-from-the-chi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-cohort-study-of-palbociclib-in-hrher2-metastatic-breast-cancer-in-japan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-epacadostat-incb024360-added-to-preoperative-chemoradiation-in-patients-with-loc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-cardiology-referral-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mayhem-under-the-microscope-t-cell-cytotoxicity-and-serial-killers-captured-in-situ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-coronary-artery-calcification-in-breast-cancer-survivors-with-age-matched-controls-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-dynamic-circulating-biomarkers-for-predicting-therapeutic-efficacy-of-prag-regimen-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationships-among-polyunsaturated-fatty-acid-profiles-immune-landscapes-and-immunotherapy-progno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-tissue-resident-adaptive-nk-cells-and-their-association-with-reduced-mortality-acr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-and-prognostic-outcomes-of-hyperthyroidism-induced-by-immune-checkpoint-inhibitor-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-septic-shock-among-bcrabl-positive-chronic-myeloid-leukemia-patients-admitted-for-sep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup177sup-lu-psma-617-consolidation-therapy-post-docetaxel-in-patients-with-de-novo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/procedure-for-pooling-clinical-outcome-data-from-drup-like-clinical-trials-using-the-omop-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-feasibility-study-on-delayed-selective-sentinel-node-biopsy-for-patients-undergoing-mast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-gotistobart-bnt316onc-392-in-combination-with-lutetium-lu-177-vipivotide-tetraxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implications-of-her3-overexpression-in-a-diverse-patient-cohort-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-a-virtual-personalized-medicine-review-board-integration-into-a-major-community-oncol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-dynamic-sentinel-lymph-node-biopsy-in-clinically-node-negative-penile-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-disparities-a-seer-analysis-of-treatment-patterns-and-timelines-for-orbital-embryonal-rhab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-weekend-effect-and-other-predictors-of-mortality-in-tumor-lysis-syndrome-among-hospita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hipec-combined-with-camrelizumab-paclitaxel-and-s-1-for-conversion-therapy-in-patients-with-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathogenic-germline-variants-in-breast-cancer-patients-associated-with-different-her2-expression-lev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-tu2218-tgfv-ri-and-vegf-r2-dual-inhibitor-in-combination-with-pembrolizumab-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/smart-cell-combined-with-pd-1-blockade-and-sox-as-first-line-treatment-for-patients-with-advanced-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-bayesian-population-based-framework-for-detecting-hyperprogressive-disease-on-cancer-immunotherapi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pain-in-cancer-survivors-in-the-us-after-federal-and-state-opioid-prescribing-guidelines-and-laws 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutations-in-homologous-recombination-dna-damage-repair-genes-and-treatment-outcomes-to-immune-check 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutation-profiling-of-appendiceal-cancer-distinguishing-tumor-grades-comprehensive-mutation-landsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-ai-using-host-tumor-and-ghost-biomarker-for-predicting-immunotherapy-efficacy-in-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/late-toxicities-lt-in-patients-affected-by-locally-advanced-la-oropharyngeal-carcinoma-opc-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-mutant-stk11-keap1-and-kras-on-firstline-chemoimmunotherapy-survival-outcomes-in-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-vusolimogene-oderparepvec-rp1-in-primary-melanoma-mel-to-reduce-the-risk-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ocular-toxicities-observed-in-polypeptide-vaccine-trials-for-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-dynamics-and-pathologic-response-to-neoadjuvant-immunotherapy-in-resectable-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-for-immunotherapy-response-assessment-in-lung-cancer-using-pet-ct-reports 2026-08-24 monthly 0.7 https://rjrindex.com/articles/major-pathological-response-to-neoadjuvant-immune-related-therapy-and-influence-on-long-term-surviva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tracking-circulating-tumor-dna-through-liquid-biopsy-after-radiotherapy-for-dynamic-risk-monitoring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pros-in-the-c-post-trial-of-adjuvant-cemiplimab-cemi-vs-placebo-pbo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymph-node-excision-lnex-for-patients-with-stage-iii-melanoma-with-one-clinically-positive-node-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-abemaciclib-temozolomide-and-radiation-in-dipg-pdox-models-insights-from-single-cell-rn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-retrospective-analysis-to-real-world-impact-mismatch-repair-deficiency-detection-in-gliomas-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/21-years-of-tonsillar-cancer-mortality-trends-disparities-and-public-health-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-brain-protein-i3-bri3-to-predict-disease-fate-in-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aurora-a-single-arm-multicentre-phase-ii-clinical-trial-of-atezolizumab-immunotherapy-for-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-perioperative-oral-itraconazole-for-the-management-of-low-risk-basal-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-in-patients-with-liposarcoma-and-rhabdomyosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reflexed-molecular-testing-to-identify-patients-with-biomarkers-associated-with-tumor-agnostic-fda-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-preoperative-segmental-hepatic-arteries-embolization-with-hepatic-artery-resection-in-radic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/design-of-a-phase-1-trial-of-ilisteriai-imonocytogenesi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-sensitive-detection-of-hepatocellular-carcinoma-hcc-with-methylation-signal-enrichment-of-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-landscape-of-kaposi-sarcoma-insights-into-therapeutic-targeting-of-kshv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tt125-802-a-highly-selective-well-tolerated-bromodomain-inhibitor-of-cbpp300-with-anti-tumor-acti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-metaplastic-triple-negative-breast-cancer-response-to-sacituzumab-govite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-optimized-hlh-inflammatory-index-a-novel-prognostic-tool-for-newly-diagnosed-patients-with-diff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-zanubrutinib-zanu-venetoclax-ven-for-treatment-naive-tn-cllsll-results-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-study-of-adjuvant-sacituzumab-tirumotecan-plus-pembrolizumab-vs-treatment-of-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-predictors-and-prognostic-significance-of-pathologic-disease-upstaging-at-radical-cystectom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mct1-mediated-histone-lactylation-modulates-lung-cancer-cell-sensitivity-to-t-cell-mediated-killing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-residual-disease-mrd-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-ctdna-before-and-after-trimodality-therapy-tmt-for-muscle-invasive-bladder-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-tobacco-use-and-cessation-challenges-amongst-patients-with-lung-cancer-elucidating-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-creaformo-004-study-a-phase-ii-study-of-hr070803-plus-5-fluorouracilleucovorin-and-bevacizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-biology-based-novel-therapeutic-agent-targeting-the-lin28 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-kras-mutation-status-on-outcomes-in-peritoneal-metastatic-mucinous-adenocarcinoma-of-the-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-process-evaluation-trial-of-a-telehealth-service-intervention-to-support-uptake-of-breast-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-study-of-anti-pd-1-combined-with-regorafenib-and-raltitrexed-as-third-line-therapy-in-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-hematological-indicators-as-predictors-of-cdk46-inhibitors-efficacy-in-hr-positive-her2-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-epidemiology-of-colorectal-cancer-in-morocco-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-blockade-in-locally-advanced-rectal-cancer-with-deficient-mismatch-repair-dmmr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-govitecan-initial-dose-reduction-in-polish-patients-with-metastatic-triple-negative-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-supportive-care-service-utilization-among-long-term-metastatic-breast-cancer-survivor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-kaposis-sarcoma-in-a-cohort-of-hiv-negative-men-who-have-sex-with-men-an-obse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-according-to-timing-of-immune-checkpoint-inhibitors-administration-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-racial-socioeconomic-and-treatment-disparities-in-peripheral-t-cell-lymphoma-a-compreh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-determinants-and-outcomes-of-hypothyroidism-in-immune-checkpoint-inhibitor-ici-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-activity-of-immune-checkpoint-blockade-in-advanced-perivascular-epithelioid-cell-neoplasms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brexucabtagene-autoleucel-brexu-cel-as-consolidation-treatment-in-adults-with-b-cell-acute-lymphob 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-eo-cancer-trends-in-brazil-a-comprehensive-analysis-of-hospital-based-cancer-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dreamseq-a-phase-iii-trial-of-treatment-sequences-in-brafv600-mutant-m-metastatic-melanoma-mm-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-iib-study-of-atg-037-monotherapy-and-combination-therapy-with-pembrolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ciltacabtagene-autoleucel-cilta-cel-vs-standard-of-care-soc-in-patients-pts-with-relapsedrefr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibi354-an-anti-her2-antibody-drug-conjugate-in-patients-with-locally-advanced-unresectable-or-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tebentafusp-in-metastatic-uveal-melanoma-patients-results-of-the-italian-expanded-access-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dendritic-cell-based-vaccines-ksd-101-against-ebv-associated-lymphoproliferative-diseases-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/percutaneous-hepatic-perfusion-php-with-melphalan-for-treatment-of-liver-metastases-from-uveal-mel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-zanzalintinib-xl-092-in-combination-with-durvalumab-and-tremelimumab-in-unresect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-ivosidenib-in-us-veterans-with-idh1-mutated-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-in-patients-with-hrher2-advanced-or-metastatic-breast-cancer-treated-with-a-cycl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-indocyanine-green-icg-and-handheld-fluorescence-imager-in-the-management-of-early-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-prostate-cancer-risk-groups-by-psma-pet-promise-ppp2-results-from-an-international-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/everest-1-safety-and-efficacy-data-of-a2b530-a-logic-gated-tmod-chimeric-antigen-receptor-t-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-azd0486-a-cd19xcd3-t-cell-engager-in-relapsed-or-refractory-diffuse-large-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-treatment-of-durvalumab-bevacizumab-and-tremelimumab-in-subjects-with-hepatocellular-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-monitoring-of-prostate-specific-membrane-antigen-positive-biochemically-recurrent-prosta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-1-study-of-vosilasarm-ep0062-a-first-in-class-oral-selective-androgen-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defendor-special-effect-of-primary-prophylaxis-with-empegfilgrastim-on-pcr-rate-after-neoadjuvant-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanzalintinib-zanza-nivolumab-nivo-relatlimab-rela-in-patients-pts-with-advanced-solid-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-powered-spatial-analysis-of-tumor-infiltrating-lymphocytes-and-tertiary-lymp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pembrolizumab-in-combination-with-dabrafenib-and-trametinib-dtp-for-ibra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-studies-industry-neglects-characteristics-of-cancer-clinical-trials-conducted-by-federal-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/familial-lung-cancer-a-thirteen-year-prospective-analysis-of-participants-with-germline-egfr-t790m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-in-combination-with-chemotherapy-in-resectable-locally-advanced-head-and-n-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cohort-builder-in-tempus-lens-querying-a-large-oncology-database-with-generative-ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomic-analysis-of-cutaneous-squamous-cell-carcinoma-cscc-and-association-with-response-to-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-text-to-insight-methods-for-validation-of-nlp-extracted-real-world-oncology-data-using-a-human 2026-08-24 monthly 0.7 https://rjrindex.com/articles/substudy-f-of-the-canadian-cancer-trials-group-cctg-ind234-pc-bets-prostate-cancer-biomarker-en 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-dendritic-cells-targeting-mrna-lnp-vaccine-with-potent-anti-tumor-activity-in-vivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-neoadjuvant-therapy-with-induction-immunochemotherapy-and-chemoradiotherapy-followed-by-surger 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envafolimab-plus-docetaxel-in-combination-with-or-without-trilaciclib-versus-docetaxel-in-pretreated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-heterogeneity-between-primary-and-paired-recurrent-breast-cancer-and-its-potential-molecular-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-powered-spatial-analysis-of-tumor-microenvironment-in-non-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-prompt-versus-deferred-sup177sup-lu-psma-617-initi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicity-profile-of-enfortumab-vedotin-with-or-without-pembrolizumab-in-patients-with-metastatic-uro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accuracy-of-artificial-intelligence-models-integrating-machine-learning-and-deep-learning-in-detecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-survival-between-liver-only-metastasis-and-other-metastatic-sites-in-patients-with-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/small-nucleolar-rnas-snornas-expression-and-effects-on-patient-pt-outcomes-in-metastatic-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-pathologic-complete-response-pcr-from-clinicopathologic-variables-and-her2dx-genomic-te 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-fixed-duration-ibrutinib-venetoclax-for-chronic-lymphocytic-leukemia-cllsmall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-radiation-versus-hippocampal-avoidance-whole-brain-radiation-in-patients-with-5-20-brai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/letetresgene-autoleucel-in-advancedmetastatic-myxoidround-cell-liposarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/letetresgene-autoleucel-a-milestone-in-treatment-of-myxoidround-cell-liposarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tamales 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-randomized-comparison-of-magnetic-resonance-imaging-versus-transurethral-resection-for-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/entering-the-era-of-multidimensional-prognostication-for-personalized-risk-assessment-in-stage-iii-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-first-in-human-study-of-for46-fg-3246-an-immune-modulating-antibody-drug-conjugate-targe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trend-and-provider-and-organizational-level-factors-associated-with-early-palliative-care-billing-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-dose-methotrexate-in-children-and-young-adults-with-all-and-lymphoblastic-lymphoma-results-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/challenges-in-assessing-response-in-clinical-trials-for-neurofibromatosis-type-1-plexiform-neurofibr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-models-from-transcriptomic-signatures-of-the-tumor-microenvironment-and-cell-cycle-in-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-open-label-phase-iii-study-of-tilsotolimod-in-combination-with-ipilimumab-versus-ipilim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-treatment-intensification-based-on-residual-disease-in-elderly-patients-with-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complementing-anticancer-therapy-antibody-drug-conjugates-targeting-cd46-as-prostate-cancer-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/selpercatinib-in-ireti-fusion-positive-non-small-cell-lung-cancer-fina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-intensification-based-on-residual-disease-in-elderly-patients-with-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-challenges-in-assessing-response-in-clinical-trials-for-neurofibromatosis-type-1-plexiform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risks-of-organ-preservation-in-rectal-cancer-beyond-distant-metastases-ultimate-local-failure-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-risks-of-organ-preservation-in-rectal-cancer-beyond-distant-metastases-ultimate-local-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distant-metastases-with-nonoperative-management-in-rectal-cancer-challenges-in-defining-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-preservation-in-rectal-cancer-fear-of-risks-versus-the-risks-of-fear 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pertuzumab-retreatment-for-human-epidermal-growth-factor-receptor-2-positive-locally-advancedmetast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-pembrolizumab-in-combination-with-bevacizumab-for-untreated-melanoma-brain-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-pertuzumab-retreatment-for-human-epidermal-growth-factor-receptor-2-positive-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/they-not-like-us-evaluating-the-diverse-strategies-in-locally-advanced-rectal-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-combos-in-metastatic-castration-resistant-prostate-cancer-where-are-we-going-wha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-and-clinical-significance-of-clonal-and-subclonal-driver-mutations-in-high-risk-neuroblast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-plus-docetaxel-versus-docetaxel-for-previously-treated-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sentinel-lymph-node-biopsy-in-early-stage-breast-cancer-asco-guideline-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-chimeric-antigen-receptor-t-cell-products-cemacabtagene-ansegedleucelallo-501-in-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cosmic-021-phase-ib-study-of-cabozantinib-plus-atezolizumab-results-from-the-locally-advanced-or-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/where-is-the-future-of-adjuvant-therapy-for-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risks-of-organ-preservation-in-rectal-cancer-data-from-two-international-registries-on-rectal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-behavior-of-breast-cancer-in-young-ibrcai-carriers-and-prediag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enfortumab-vedotin-a-promising-therapy-for-head-and-neck-cancer-with-potential-links-to-human-papil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-analyses-of-circulating-tumor-dna-and-immunoscore-in-patients-with-stage-iii-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-standard-of-care-idecabtagene-vicleucel-and-ciltacabtagene-autoleucel-in-relapsedrefr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-year-overall-survival-with-nivolumab-plus-relatlimab-in-advanced-melanoma-from-relativity-047 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-osimertinib-plus-antiangiogenic-agents-a-promising-new-paradigm-with-uncertain-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/making-progress-along-the-challenging-road-of-drug-development-for-patients-with-iegfr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fulvestrant-versus-anastrozole-in-endocrine-therapy-naive-women-with-hormone-receptor-positive-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-health-related-quality-of-life-in-transplant-ineligible-patients-with-newly-diagnosed-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-first-hero 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-colorectal-and-pancreatic-cancer-mortality-with-pathogenic-variants-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-neoadjuvant-durvalumab-plus-gemcitabinecisplatin-or-carboplatin-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osimertinib-plus-antiangiogenic-agents-a-promising-new-paradigm-with-uncertain-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geospatial-genomics-operationalizing-multilevel-conceptual-frameworks-of-cancer-health-outcomes-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-patients-with-iegfri-exon-20-mutant-advanced-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-enfortumab-vedotin-a-promising-therapy-for-head-and-neck-cancer-with-potential-links-to-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-naldemedine-for-opioid-induced-constipation-in-patients-with-cancer-a-multicenter-double 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-mobocertinib-versus-platinum-based-chemotherapy-in-patients-with-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-phase-ii-study-of-acalabrutinib-venetoclax-and-obinutuzumab-in-a-treatment-naive-chronic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fertility-preservation-in-people-with-cancer-asco-guideline-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-glofitamab-for-the-treatment-of-relapsedrefractory-mantle-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surrogate-end-points-for-overall-survival-in-neoadjuvant-randomized-clinical-trials-for-early-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-to-predict-mortality-in-older-patients-with-cancer-development-and-external-valida 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glofitamab-for-the-treatment-of-relapsedrefractory-mantle-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-liquid-biopsy-in-relation-to-tissue-based-parameters-in-metastatic-colorectal-cancer-resul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-nivolumab-plus-ipilimumab-versus-chemotherapy-in-resectable-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/i-hope-so-too 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-the-path-to-bladder-cancer-staging-can-magnetic-resonance-imaging-speed-up-time-to-recei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/missed-opportunity-for-sotorasib-dose-optimization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-paclitaxel-ifosfamide-and-cisplatin-as-initial-salvage-chemotherapy-for-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/data-models-and-visuals-how-data-science-methods-can-augment-geriatric-oncology-research 2026-08-24 monthly 0.7 https://rjrindex.com/articles/olaparib-as-treatment-versus-nonplatinum-chemotherapy-in-patients-with-platinum-sensitive-relapsed-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-radiotherapy-cetuximab-for-intermediate-risk-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automatic-for-the-people-what-has-machine-learning-analysis-of-positron-emission-tomography-left-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-randomized-comparison-of-intensified-six-drug-versus-standard-three-drug-chemotherapy-for-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-comparison-of-standard-of-care-idecabtagene-vicleucel-and-ciltacabtagene-autoleucel-in-rela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-based-end-point-for-accelerated-assessment-of-clinical-trials-in-multiple-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-pertuzumab-plus-eribulin-or-taxane-as-first-line-chemotherapy-for-human-epidermal-growth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-first-line-nivolumab-plus-relatlimab-versus-nivolumab-plus-ipilimumab-in-advanced-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-plus-pertuzumab-versus-cetuximab-plus-irinotecan-in-patients-with-irasbra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/botensilimab-fc-enhanced-anti-cytotoxic-lymphocyte-association-protein-4-antibody-plus-balstilimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transoral-robotic-surgery-in-the-multidisciplinary-care-of-patients-with-oropharyngeal-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lessons-from-taxanes-versus-eribulin-for-first-line-metastatic-human-epidermal-growth-factor-recepto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/supervised-exercise-for-patients-with-metastatic-breast-cancer-a-cost-utility-analysis-alongside-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerating-myeloma-drug-development-will-minimal-residual-disease-replace-progression-free-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isatuximab-lenalidomide-bortezomib-and-dexamethasone-induction-therapy-for-transplant-eligible-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-automatic-for-the-people-what-has-machine-learning-analysis-of-positron-emission-tomograp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-selective-tyrosine-kinase-inhibitor-zongertinib-bi-1810631-in-patients-with-advancedmetast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-inferior-control-arms-in-prostate-cancer-trials-the-aranote-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferior-control-arms-in-prostate-cancer-trials-the-aranote-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metronomic-capecitabine-plus-aromatase-inhibitor-as-initial-therapy-in-patients-with-hormone-recepto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timely-reporting-of-patient-reported-outcomes-in-cancer-clinical-trials-an-ethical-imperative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-for-stage-iv-non-small-cell-lung-cancer-with-driver-alterations-asco-living-guideline-vers-3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/larotrectinib-for-newly-diagnosed-infantile-fibrosarcoma-and-other-pediatric-intrki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-intracranial-response-assessment-criteria-in-patients-with-melanoma-brain-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-for-stage-iv-non-small-cell-lung-cancer-without-driver-alterations-asco-living-guideline-v-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-denileukin-diftitox-cxdl-an-improved-purity-formulation-of-denileukin-diftit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-dose-dense-chemotherapy-in-hormone-receptor-positive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concerns-on-potential-risk-of-roxadustat-in-promoting-tumor-progression-double-edged-sword-of-hypox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aiming-targeted-drug-development-at-rare-pediatric-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-concerns-on-potential-risk-of-roxadustat-in-promoting-tumor-progression-double-edged-swor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-elective-discontinuation-of-larotrectinib-in-pediatric-patients-with-trk-fusion-sarcomas-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melanoma-among-adult-survivors-of-childhood-cancer-a-report-from-the-childhood-cancer-survivor-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/datopotamab-deruxtecan-in-advanced-or-metastatic-non-small-cell-lung-cancer-with-actionable-genomic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elective-discontinuation-of-larotrectinib-in-pediatric-patients-with-trk-fusion-sarcomas-and-related 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-chemotherapy-on-resected-intraductal-papillary-mucinous-neoplasm-derived-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-and-overall-survival-in-nrg258-a-randomized-phase-iii-trial-of-chemoradiation-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiofrequency-ablation-versus-stereotactic-body-radiotherapy-for-recurrent-small-hepatocellular-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-with-or-without-ipilimumab-in-patients-with-recurrent-or-metastatic-merkel-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/de-escalation-strategies-with-immune-checkpoint-blockers-in-non-small-cell-lung-cancer-do-we-alread 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-cd30-in-diffuse-large-b-cell-lymphoma-where-does-it-fit-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brentuximab-vedotin-combination-for-relapsed-diffuse-large-b-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/what-is-the-optimal-locoregional-approach-for-recurrent-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-iii-trial-of-mixed-formulation-of-fosrolapitant-and-palonosetron-hr20013-in-prev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-risk-enabled-therapy-after-neoadjuvant-chemotherapy-for-muscle-invasive-bladder-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-the-horizon-of-mronj-research-in-breast-cancer-bone-metastasis-treatments 2026-08-24 monthly 0.7 https://rjrindex.com/articles/abemaciclib-plus-fulvestrant-in-advanced-breast-cancer-after-progression-on-cdk46-inhibition-resul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-adjuvant-chemotherapy-on-resected-intraductal-papillary-mucinous-neoplasm-derived-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-and-surgical-management-of-pediatric-cutaneous-melanoma-and-atypical-spitz-and-non-spitz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-lenvatinib-plus-pembrolizumab-versus-chemotherapy-for-advanced-endometrial-cancer-a-rand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improved-patient-reported-outcomes-with-post-transplant-cyclophosphamide-a-quality-of-life-evaluati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/should-total-neoadjuvant-therapy-be-the-first-line-treatment-for-patients-with-locally-advanced-rect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oxaliplatin-based-versus-alkylating-agent-in-neuroendocrine-tumors-according-to-the-o-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accurate-determinants-of-outcome-in-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-cure-models-for-trial-analysis-and-design 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-should-total-neoadjuvant-therapy-be-the-first-line-treatment-for-patients-with-locally-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-fulvestrant-versus-anastrozole-in-endocrine-therapy-naive-women-with-hormone-receptor-posit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-the-rsclinn-tool-to-predict-prognosis-and-chemotherapy-benefit-for-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-immunotherapy-with-nivolumab-plus-ipilimumab-in-melanoma-of-unknown-primary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-nivolumab-plus-doxorubicin-vinblastine-dacarbazine-as-frontline-therapy-in-older 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-busulfan-plus-fludarabine-compared-with-busulfan-plus-cyclophosphamide-for-aml-undergoing-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-pleural-mesothelioma-asco-guideline-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-accurate-determinants-of-outcome-in-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-controlled-trial-of-a-virtually-delivered-exercise-and-stress-management-program-to-impro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-nucleophosmin-inpm1i-genotypes-on-outcome-of-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pooled-long-term-outcomes-with-nivolumab-plus-ipilimumab-or-nivolumab-alone-in-patients-with-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimating-long-term-survivorship-rates-among-patients-with-resected-stage-iiiiv-melanoma-analyses 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chimeric-antigen-receptor-t-cells-in-colorectal-cancer-pioneering-new-avenues-in-solid-tumor-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-data-driven-estimates-of-recurrence-risk-and-treatment-benefit-in-earl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-annual-versus-biennial-mammographic-screening-and-breast-cancer-screening-interval-eff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hyperthermic-intraperitoneal-chemotherapy-in-platinum-sensitive-recurrent-ovarian-cancer-a-randomiz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/withdrawn-expression-of-concern-dissecting-therapeutic-resistance-to-raf-inhibition-in-melanoma-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-omega-3-low-omega-6-diet-with-fish-oil-for-men-with-prostate-cancer-on-active-surveillance-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promises-and-challenges-of-dietary-intervention-in-patients-with-prostate-cancer-lessons-learned-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-results-from-the-nationwide-just-ask-initiative-to-promote-routine-smoking-assessment-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-for-newly-diagnosed-advanced-ovarian-cancer-asco-guideline-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-in-women-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onvansertib-in-combination-with-chemotherapy-and-bevacizumab-in-second-line-treatment-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-screening-interval-effects-of-proportions-and-biases-on-benefits 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-versus-bendamustine-and-rituximab-in-patients-with-treatment-naive-chronic-lymphocytic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/you-dont-bring-me-flowers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-total-neoadjuvant-therapy-for-locally-advanced-rectal-cancer-induction-or-consolidation-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-gatekeeping-challenges-in-pediatric-and-young-adult-palliative-oncology-and-end-of-life-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intermittent-or-continuous-panitumumab-plus-fluorouracil-leucovorin-and-irinotecan-for-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-acalabrutinib-venetoclax-and-obinutuzumab-in-a-treatment-naive-chronic-lymphocyt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/axillary-surgery-for-patients-with-residual-isolated-tumor-cells-ypn0i-after-neoadjuvant-systemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/annual-versus-biennial-mammographic-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nodal-burden-and-oncologic-outcomes-in-patients-with-residual-isolated-tumor-cells-after-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-modified-infusional-fluorouracil-leucovorin-and-oxaliplatin-with-or-without-radiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reneu-a-pivotal-phase-iib-trial-of-mirdametinib-in-adults-and-children-with-symptomatic-neurofibro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redefining-available-therapy-in-oncology-accelerated-approval-decisions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/human-leukocyte-antigen-mismatching-and-the-role-of-killer-cell-immunoglobulin-like-receptor-mismatc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-human-leukocyte-antigen-mismatching-and-the-role-of-killer-cell-immunoglobulin-like-recept 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comment-on-the-definition-and-interpretation-of-complete-mesocolic-excision-in-the-relarc-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-intensification-with-either-fludarabine-arac-g-csf-and-idarubicin-or-cladribine-plus-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-controlled-trial-of-acceptance-and-commitment-therapy-for-fatigue-interference-with-funct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cyclin-dependent-kinase-46-inhibition-as-a-novel-therapy-for-peritoneal-mucinous-carcinomatosis-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-mek-inhibitor-shows-promise-in-neurofibromatosis-type-1-with-symptomatic-plexiform-neurofibro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-and-somatic-genomic-testing-for-metastatic-prostate-cancer-asco-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-primary-cancer-risks-after-breast-cancer-in-ibrca1i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-significance-of-up-front-stereotactic-radiosurgery-for-non-small-cell-lung-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alk-tyrosine-kinase-inhibitors-induced-weight-gain-more-refined-definition-of-weight-gain-glucagon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-comment-on-the-definition-and-interpretation-of-complete-mesocolic-excision-in-the-relarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-weight-gain-associated-with-alectinib-in-patients-with-alk-non-small-cell-lung-cancer-pooled 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-total-neoadjuvant-therapy-with-selective-nonoperative-management-for-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/significance-of-up-front-stereotactic-radiosurgery-for-non-small-cell-lung-cancer-patients-with-brai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerating-the-future-of-oncology-drug-development-the-role-of-consortia-in-the-delivery-of-preci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-scale-pharmacogenomics-analysis-of-patients-with-cancer-within-the-100000-genomes-project-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-first-line-atezolizumab-in-locally-advanced-or-metastatic-urothelial-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/head-to-head-comparison-of-micro-ultrasound-mpmri-and-psma-petct-with-a-wholemount-histopathology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-indiana-regimen-salvage-high-dose-chemotherapy-in-relapsed-germ-cell-tumors-in-slovakia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-systemic-treatments-for-advanced-non-clear-cell-renal-cell-carcinoma-a-single-arm-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-in-metastatic-renal-cell-cancer-mrcc-with-major-venous-involvement-mvi-a-population-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-post-radiotherapy-psa-as-a-prognostic-and-predictive-biomarker-in-high-risk-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-classification-of-treatment-state-of-patients-with-prostate-cancer-from-structured-medical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-from-a-retrospective-multi-center-analysis-on-first-line-therapy-for-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-liquid-biopsy-in-the-detection-of-homologous-recombination-repair-gene-mutations-hrrm-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-aggressive-variant-prostate-cancer-associated-tumor-suppressor-genes-avpc-tsg-status-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncological-benefit-of-avelumab-maintenance-therapy-for-advanced-or-metastatic-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/downregulation-of-e-selectin-and-contributions-to-immune-restraining-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-treatment-of-pancreatic-metastases-in-metastatic-renal-cell-carcinoma-insights-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-early-stage-urothelial-cancers-using-methylation-patterns-in-urine-cell-free-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-bladder-cancer-molecular-profiling-and-monitoring-based-on-mutational-epigenomic-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accel-ac-225-psma-62-phase-iaibii-clinical-trial-to-characterize-efficacy-safety-tolerability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-2ir-immune-response-score-in-urothelial-carcinoma-uc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cabozantinib-c-in-combination-with-nivolumab-n-and-ipilimumab-i-in-previously-untreated-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-adjuvant-treatment-of-her2-overexpression-in-upper-urinary-tract-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-enfortumab-vedotin-in-patients-with-previously-treated-advanced-head-and-neck-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-worldwide-disparities-in-bladder-cancer-clinical-trial-availability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-phase-12-study-of-tyra-300-in-advanced-urothelial-carcinoma-and-other-sol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-selective-renal-tumor-embolization-combined-with-axitinib-and-reduced-dose-toripalimab-i-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-previously-reported-prognostic-classifications-for-patients-treated-with-seco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/renal-cell-carcinoma-in-kidney-transplant-recipients-receiving-immunosuppression-a-55-year-retrospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-ferroptosis-and-mtor-signaling-in-chromophobe-renal-cell-carcinoma-chrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-lutetium-177-vipivotide-tetraxetan-in-men-with-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-metastatic-castration-resistant-prostate-cancer-mcrpc-at-the-veterans-affairs-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-and-impact-of-a-genome-wide-homologous-recombination-deficiency-signature-hrdsig-on-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-clinical-outcomes-of-metastatic-testicular-cancer-in-a-distinct-demographic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/domain-specific-large-language-model-for-predicting-prostate-cancer-treatment-plan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/formula-01-a-phase-study-of-disitamab-vedotin-rc48-intravenous-injection-combined-with-bcg-intr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-the-benefit-of-salvage-radiation-versus-surveillance-for-biochemically-recurrent-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/grade-and-volume-progression-and-its-association-with-the-decipher-genomic-classifier-using-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/missed-opportunity-proms-as-primary-endpoints-in-bladder-cancer-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/somatic-genomic-landscape-of-prostate-adenocarcinoma-at-a-comprehensive-cancer-center-in-new-mexico 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cabozantinib-real-world-effectiveness-in-the-second-line-setting-of-metastatic-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-in-prostate-cancer-patients-who-received-darolutamide-in-the-aramis-trial-in-spai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-outcomes-with-belzutifan-versus-everolimus-by-baseline-disease-characteristics-and-burden-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-results-of-a-phase-2-study-of-neoadjuvant-chemotherapy-combined-with-tislelizumab-followed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-sacituzumab-tirumotecan-monotherapy-in-patients-with-advanced-urothelial-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-icis-in-advanced-upper-tract-urothelial-cancer-utuc-with-mismatch-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-dose-escalation-and-expansion-study-to-evaluate-the-safety-and-tolerabili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-salvage-cystectomy-after-prior-trimodality-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decipher-score-as-a-predictor-of-response-to-treatment-intensification-in-the-nrg-oncology-rtog-0534 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assess-the-journey-characterizing-muscle-invasive-bladder-cancer-patients-who-receive-neoadjuvant-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-impact-of-prostate-specific-antigen-at-6-months-after-post-prostatectomy-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-subgroups-of-patients-with-intermediate-risk-prostate-cancer-for-whom-active-surveillance-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-open-label-study-of-gemcitabinecisplatin-plus-cemiplimab-regn2810-anti-pd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-immune-effects-of-enfortumab-vedotin-ev-on-peripheral-blood-mononuclear-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-disparities-in-prostate-cancer-in-the-caribbean-results-from-504-patients-from-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-health-inequalities-based-on-socio-economic-factors-and-geographical-location-in-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-fexagratinib-fexa-in-chinese-patients-pts-with-metastatic-or-unresectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-nature-of-progression-on-long-term-active-surveillance-for-confirmed-gleason-grade-group-1-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-first-line-maintenance-1lm-in-patients-pts-with-advanced-urothelial-carcinoma-auc-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-body-composition-on-the-survival-of-patients-with-metastatic-clear-cell-renal-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-pembrolizumab-utilization-and-characteristics-of-patients-being-prescribed-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-survival-post-7-mo-psa-response-stratified-by-response-disease-extent-and-intermittent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-myeloid-derived-suppressor-cell-mdsc-dynamics-with-clinical-response-to-nivolumab-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-stratification-using-the-decipher-22-gene-genomic-classifier-gc-and-digital-pathology-artific 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-first-line-1l-maintenance-treatment-in-patients-with-locally-advanced-or-metastatic-uroth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-urine-enriched-rna-panel-epcam-ttc3-h4c5-to-detect-prostate-cancer-and-differentiate-it-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-primary-care-utilization-on-limiting-racial-disparities-for-prostate-cancer-diagnosi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-molecular-changes-and-perioperative-immunotherapy-in-patients-with-advanced-clea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-metastatic-squamous-cell-carcinoma-patients-receiving-pelvic-exenteration-vs-radical-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-associations-between-genomic-classifier-and-digital-pathology-based-multi-modal-ai-biomar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lenvatinibs-efficacy-in-heavily-pre-treated-metastatic-renal-cell-carcinoma-insights-from-a-europe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-inpatient-outcomes-of-bladder-cancer-2008-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-and-outcomes-of-darolutamide-daro-enzalutamide-enza-and-apalutamide-apa-for-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modulation-of-enhancer-of-zeste-homolog-2-ezh2-pharmacodynamic-markers-and-tumor-gene-expression-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-social-vulnerability-as-a-key-determinant-of-definitive-treatment-for-black-men-with-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timely-brca-mutation-testing-in-patients-with-metastatic-prostate-cancer-a-comparative-analysis-bet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-measuring-steady-state-plasma-level-of-lenvatinib-in-advanced-renal-cell-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-role-of-cancer-associated-fibroblasts-in-t-cell-mediated-proinflammatory-reprogrammin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-time-to-metastasis-ttm-from-prostatectomy-and-survival-in-patients-pts-with-metach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-burden-on-treatment-patterns-and-outcomes-in-patients-with-locally-advanced-or-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-metastatic-bladder-cancer-associated-with-mutations-in-trithorax-group-protein 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-outcomes-12-months-after-initiation-of-darolutamide-in-non-metastatic-castrate-resistant-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-pd-1-expression-on-tumor-infiltrating-regulatory-t-cells-and-resistance-to-first 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-of-enfortumab-vedotin-pembrolizumab-ev-p-in-locally-advanced-la-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-clear-cell-renal-cell-carcinoma-tumor-infiltrating-lymphocytes-under-controlled-hypoxic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-overall-survival-os-with-talazoparib-tala-enzalutamide-enza-as-first-line-treatment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-composition-and-immunotherapy-outcomes-in-patients-with-advanced-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-urotensin-2-plasma-level-in-patients-diagnosed-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-iparp1i-mrna-expression-as-prognostic-of-aggressive-patho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-microbiota-as-a-biomarker-for-the-efficacy-of-pembrolizumab-in-patients-with-advanced-urothelial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-metastases-and-use-of-bone-protective-agents-bpa-for-metastatic-renal-cell-carcinoma-mrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-renal-cell-carcinoma-histology-and-outcomes-insights-from-the-french-kidney-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-platinum-based-chemotherapy-pbt-in-patients-with-metastatic-urothelial-carcinoma-muc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recent-treatment-patterns-in-us-based-real-world-patients-pts-with-metastatic-hormone-sensitive-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-deephrd-interpretability-for-enhanced-clinical-decision-making 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-immunogenicity-of-imyc-i-amplified-metastatic-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-circadian-rhythm-based-medication-timing-adjustments-on-the-efficacy-and-safety-of-nov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/site-specific-disease-progression-in-patients-with-metastatic-renal-cell-carcinoma-treated-with-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-deficiency-signature-hrdsig-and-the-genomic-landscape-of-clinically-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-model-integrating-ct-radiomics-and-circulating-micrornas-to-predict-residual-diseas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-burden-and-healthcare-costs-associated-with-docetaxel-in-patients-with-metastatic-castration-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-health-related-quality-of-life-between-rural-and-urban-bladder-cancer-patients-follow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-first-line-1l-chemotherapy-cycles-in-patients-with-metastatic-urothelial-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-analysis-of-active-surveillance-for-japanese-young-early-stage-prostate-cancer-patients-from-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-clinical-surveillance-guidelines-in-von-hippel-lindau-vhl-disease-evaluating-the-imp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individualized-neoantigen-vaccine-with-nivolumab-plus-cabozantinib-for-translocation-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-invasive-primary-urethral-cancer-a-real-world-multi-institutional-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-treatment-and-survival-outcomes-of-penile-cancer-over-a-decade-in-a-tertiary-mexi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-brca-status-in-patients-with-castrate-resistant-prostate-cancer-undergoing-abiraterone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-and-facilitators-of-first-line-treatment-intensification-ti-in-metastatic-castration-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eortc-gucg-2418-starburst-strategies-for-treatment-adaptation-following-re-evaluation-of-the-blad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-a-phase-iii-study-of-cbp-1018-a-bi-ligand-drug-conjugate-bi-xdc-as-late-lin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nectin-4-targeted-adc-shr-a2102-in-patients-with-advanced-or-metastatic-urothelial-carcinoma-a-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-time-on-treatment-rwtot-with-first-line-1l-enfortumab-vedotin-and-pembrolizumab-evp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-observational-analysis-of-real-world-safety-outcomes-in-sacituzumab-govitecan-sg-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-prostate-specific-antigen-psa-decline-among-early-participants-pts-in-libertas-a-phase-3-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/persian-trial-early-results-from-a-randomized-phase-ii-trial-testing-apalutamide-and-stereotactic-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u03-substudy-03b-pembrolizumab-pembro-and-targeted-therapy-combinations-for-advanced-cle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lenvatinib-plus-tislelizumab-as-first-line-therapy-for-advanced-fumarate-hydratase-deficient-renal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-and-racial-disparities-in-testicular-cancer-related-mortality-among-hivaids-adults-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-abiraterone-in-metastatic-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-loss-of-prlhr-on-aneuploidy-and-initiation-of-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/platelet-to-lymphocyte-ratio-as-a-useful-biomarker-of-recurrence-and-mortality-risks-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-in-patients-with-testicular-cancer-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-fruquintinib-combined-with-serplulimab-as-1-supstsup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-neoadjuvant-intravesical-mitomycin-c-in-nmibc-a-phase-iii-randomized-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-feasibility-of-tumor-infiltrating-lymphocyte-expansion-in-non-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prognostic-biomarker-panel-for-chromophobe-renal-cell-carcinoma-using-immunohistochemistry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-organic-anion-transport-proteins-oatp-and-outcome-in-castration-resistant-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-disparities-in-treatment-tx-patterns-and-clinical-outcomes-among-real-world-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-the-efficacy-and-safety-of-enfortumab-vedotin-in-patients-with-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-liver-metastases-genomic-profiling-and-clinical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-unfavorable-is-aua-unfavorable-intermediate-risk-prostate-cancer-results-from-a-large-institut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/olanzapine-for-managing-side-effects-from-tyrosine-kinase-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-homologous-recombination-repair-alterations-ihrralti-on-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-metastasis-after-prostatectomy-ttm-and-survival-outcomes-in-patients-pts-with-metachrono 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-mirna-signature-for-individual-prognostic-assessment-in-seminoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-suppression-and-recovery-with-aap-after-early-discontinuation-of-lhrh-a-in-high-risk-localized-hr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-from-a-retrospective-multi-center-analysis-on-first-line-therapy-for-metastatic-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-nezastomig-anti-psmacd28-with-or-without-cemiplimab-anti-pd-1-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-systemic-therapy-for-small-cell-lung-cancer-asco-guideline-rapid-recommendation-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-real-world-data-evaluation-of-clinical-outcomes-in-metastatic-hormone-sensitive-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-fksi-23-a-new-bespoke-health-related-quality-of-life-hrqol-questionnaire-for-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-single-arm-study-to-evaluate-the-efficacy-and-safety-of-paclitaxel-hyaluronic-acid-conju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epic-a-phase-ii-trial-of-cemiplimab-plus-standard-of-care-chemotherapy-followed-by-maintenance-cemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immune-checkpoint-inhibitors-ici-for-the-treatment-of-metastatic-penile-squ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-overall-survival-of-aries-trial-evaluating-first-line-avelumab-monotherapy-for-patients-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-tolerability-of-relugolix-in-combination-with-abiraterone-or-apalutamide-for-treatment-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-radiation-therapy-to-the-recurrence-sites-and-oncological-outcomes-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup68sup-ga-fapi-46-petct-for-cancer-imaging-results-of-a-single-center-prospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-significance-of-androgen-receptor-signaling-pathway-in-mcrpc-patients-receiving-olaparib-monothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-prostate-cancer-risk-stratification-using-spatial-single-cell-tumor-profiling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-maintenance-therapy-in-patients-pts-with-advanced-urothelial-carcinoma-uc-in-japan-sub-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathological-complete-response-and-potential-for-bladder-preservation-by-theranostic-instillation-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-gene-expression-signatures-in-prostate-cancer-prior-to-liver-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ocog-rational-a-phase-ii-randomized-trial-of-optimal-recurrence-directed-therapy-rdt-without-or-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-dose-escalation-study-of-the-next-generation-nectin-4-targeting-antibody-drug-conjugate-crb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/approach-to-treatment-of-metastatic-hormone-sensitive-prostate-mhspc-cancer-among-cooperative-onco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-efficacy-of-cisplatin-based-neoadjuvant-chemotherapy-for-muscle-invasive-bladder-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-cd28-x-nectin-4-costimulatory-bispecific-antibody-for-advanced-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/further-optimizing-care-of-patients-with-operable-hormone-receptor-sensitive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modeling-survival-outcomes-of-keynote-564-with-standard-of-care-control-arm-treatment-a-simulation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cognitive-effects-of-androgen-receptor-ar-directed-therapies-for-advanced-cancer-of-the-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-treatment-tx-patterns-in-patients-pts-with-locally-advancedmetasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mevrometostat-pf-06821497-in-combination-with-enzalutamide-in-patients-with-metastatic-castration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-double-blind-placebo-controlled-2-cohort-randomized-study-of-saruparib-azd5305-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastases-directed-therapy-in-addition-to-standard-systemic-therapy-in-oligometastatic-castration-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-of-neoadjuvant-intra-arterial-administration-of-177lulutetium-vipivotide-tetra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-1-study-of-ly3866288-loxo-435-a-potent-highly-isoform-selective-fgfr3-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mass-cytometry-based-deep-immune-cell-profiling-of-metastatic-clear-cell-renal-cell-carcinoma-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omaha-003-a-phase-3-study-of-cyp11a1-inhibitor-opevesostat-versus-next-generation-hormonal-agent-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-molecular-alteration-profiles-to-distinguish-intraductal-carcinoma-of-the-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vorsin-rcc-vorolanib-plus-sintilimab-for-advanced-renal-cell-carcinoma-after-failure-of-prior-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/99mtctc-ipsma-spectct-as-an-alternative-to-pet-imaging-for-decision-making-in-prostate-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multivisceral-surgery-in-patients-with-locally-advanced-castration-naive-and-castration-resistant-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-in-patients-with-metastatic-prostate-cancer-results-from-an-internat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-the-strategies-to-perform-prostate-biopsy-in-mri-positive-patients-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timely-next-generation-sequencing-testing-in-patients-with-metastatic-prostate-cancer-a-comparative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-therapeutic-role-of-lymph-node-dissection-in-variant-histology-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-analysis-in-localized-urothelial-cancer-duart-patients-post-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-immuno-ablation-with-intrabladder-injection-of-n-803-or-intravesical-n-803-plus-bcg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-healthcare-expenditures-and-patient-costs-of-definitive-treatment-modalities-for-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/boosting-survival-in-advanced-urothelial-carcinoma-the-power-of-cbm588-probiotic-and-pembrolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-biomarkers-in-metastatic-castration-resistant-prostate-cancer-mcrpc-patients-receiving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-low-grade-intermediate-risk-non-muscle-invasive-bladder-cancer-with-ugn-102-results-of-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-risk-stratification-in-localized-prostate-cancer-using-an-ai-assisted-framework 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pembrolizumab-pembro-and-accelerated-methotrexate-vinblastine-doxorubicin-cisplatin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-combining-radiotherapy-and-antibody-drug-conjugates-in-advanced-urothelial-and-other-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/upstaging-and-risk-migration-with-blue-light-cystoscopy-for-non-muscle-invasive-bladder-cancer-resu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-relative-dose-intensity-on-efficacy-of-enfortumab-vedotin-monotherapy-in-platinum-and-ici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/apatinib-monotherapy-for-pretreated-advanced-squamous-cell-carcinoma-of-the-penis-a-phase-ii-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inclusion-of-patients-with-reduced-performance-status-ecog-2-or-higher-in-fda-registrational-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-and-safety-of-disitamab-vedotin-dv-combined-with-bacillus-calmette-guerin-bc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-interpath-005-study-v940-mrna-4157-plus-pembrolizumab-with-or-without-enfortumab-vedoti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinically-advanced-prostate-cancer-capc-in-extremely-young-men-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-site-of-metastases-and-survival-stratification-of-the-imdc-classification-in-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-of-complications-after-inguinal-lymph-node-dissection-in-patients-with-penile-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-proteome-based-integrative-prognostic-nomogram-in-metastatic-castrate-resistant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-the-dietary-impact-associations-between-ultra-processed-foods-and-prostate-cancer-in-a-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-community-oncology-based-treatment-patterns-for-first-line-axitinib-plus-pembrolizumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-by-race-in-advanced-urothelial-carcinoma-auc-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-profiling-at-the-single-cell-level-to-evaluate-the-immune-microenvironment-in-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-cost-and-adherence-between-patients-receiving-low-dose-versus-standard-dose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-next-generation-sequencing-ngs-testing-at-the-end-of-life-in-patients-with-metastatic-prosta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-neoadjuvant-chemotherapy-nac-before-bladder-sparing-chemoradiotherapy-crt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-high-ctdna-tumor-fraction-tf-and-detection-of-clinically-significant-copy-number-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-cabozantinib-and-nivolumab-in-metastatic-castration-resistant-prostate-cancer-ca-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heterogeneity-in-subgroup-reporting-across-clinical-trials-assessing-systemic-therapies-in-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-social-vulnerability-on-perceived-health-in-individuals-with-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-analysis-of-high-dose-chemotherapy-hdct-regimens-for-recurrent-germ-cell-tumors-gcts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-prediction-of-prostate-cancer-risk-a-comparative-analysis-with-c-the-signs-in-the-mayo-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chronic-obstructive-pulmonary-disease-mortality-risk-in-renal-cell-carcinoma-a-population-based-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-testicular-cancer-tc-in-hispanic-men-based-on-analyses-from-the-national-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-physicians-awareness-of-prostate-specific-antigen-doubling-time-psadt-on-treatment-tx 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-cardiovascular-cv-toxicity-by-providers-in-advanced-prostate-cancer-pca-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-cotrims-cologne-trial-of-retroperitoneal-lymphadectomy-in-metastatic-seminoma-trial-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-open-label-multicenter-study-of-xaluritamig-in-patients-with-biochemical-recurrence-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-report-of-a-randomized-trial-of-post-prostatectomy-prostate-cancer-radiotherapy-using-either 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-adverse-events-following-t-cell-engaging-bispecific-antibodies-bsabs-and-chimeric-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/docetaxel-rechallenge-versus-cabazitaxel-in-patients-previously-treated-with-docetaxel-for-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enfortumab-vedotin-related-skin-toxicities-in-patients-with-urothelial-carcinoma-a-systematic-revie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-treatment-with-disitamab-vedotin-plus-perioperative-toripalimab-in-patients-with-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-regn4336-alone-or-in-combination-with-cemiplimab-or-nezastomig-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-tumor-response-to-enfortumab-vedotin-withwithout-pembrolizumab-in-patients-with-upper-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-sup177sup-lu-psma-617-psma-in-a-racially-diverse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pet-imaging-for-metastatic-castration-sensitive-prostate-cancer-mcspc-for-patients-with-psa-respon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-testosterone-recovery-after-androgen-deprivation-therapy-on-overall-survival-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-open-label-dose-escalating-study-of-b440-an-oral-cancer-vaccine-using-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-detalimogene-voraplasmid-eg-70-intravesical-monotherapy-for-patients-with-hig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-monitoring-of-prostate-specific-membrane-antigen-psma-positive-recurrent-prostate-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-digital-multimedia-tool-for-prostate-cancer-patient-consultation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-and-safety-of-pelvic-lymph-node-dissection-in-high-risk-prostate-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-based-assessment-of-treatment-patterns-for-high-risk-localized-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-stage-i-testicular-cancer-following-orchidectomy-with-borderline-retroperi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-and-inflammatory-profiling-in-bladder-cancer-insights-into-biomarkers-and-therapeutic-strate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clarify-positron-emission-tomography-using-sup64sup-cu-sar-bispsma-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-androgen-deprivation-therapy-with-postoperative-radiotherapy-after-radical-prostatectomy-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phenotypic-and-genetically-predicted-leukocyte-telomere-length-and-prostate-cancer-risk-results-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hif2a-gene-expression-and-clinical-outcomes-in-patients-with-clear-cell-renal-cell-carcinoma-with-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mental-health-monitoring-in-clinical-trials-for-fda-approved-genitourinary-cancer-treatments-a-deca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-avelumab-first-line-maintenance-1lm-treatment-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-circulating-tumor-dna-and-imaging-surveillance-in-patients-with-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-the-soluble-epoxide-hydrolase-seh-enzyme-to-relieve-painful-docetaxel-induced-peripheral 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-de-novo-mhspc-based-on-hemoglobin-a1c-and-arpi-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-distinct-genomic-transcriptomic-and-immune-landscapes-driven-by-alterations-in-androge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/difference-in-renal-cell-carcinoma-rcc-prevalence-between-kidney-transplant-versus-other-solid-org 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparative-analysis-of-complication-rates-in-urinary-diversions-exploring-the-impact-of-contempo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-treatment-tx-patterns-and-clinical-outcomes-in-patients-pts-with-metastatic-rena 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-nivolumab-nivo-vs-placebo-pbo-for-high-risk-muscle-invasive-urothelial-carcinoma-miuc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-des-amp-expansion-dex-study-to-evaluate-the-safety-amp-efficacy-of-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decipher-risk-stratification-of-radiorecurrent-prostate-cancer-correlative-analysis-of-the-f-sharp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mevrometostat-pf-06821497-in-combination-with-enzalutamide-for-androgen-receptor-pathway-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concomitant-g-csf-use-in-maintaining-an-efficacious-dose-and-safe-delivery-of-docetaxel-in-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostact-global-a-phase-3-study-of-sup177sup-lu-rosopatamab-tlx591-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-liquid-biopsy-based-proteomic-assay-to-identify-circulating-tumor-cell-ctc-derived-druggable-ta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decipher-genomic-classifier-dgc-of-early-prostate-cancer-epc-and-underlying-transcriptomic-prof 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carcinoma-of-prostate-sequencing-of-tumor-and-clinical-endpoints-capstone-clinical-implications-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comorbidity-burden-and-effectiveness-of-immunotherapy-in-patients-with-metastatic-renal-cell-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-post-prostatectomy-radiation-therapy-for-prostate-cancer-within-a-statewide-quality-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-of-tissue-factor-tf-in-penile-squamous-cell-carcinoma-pscc-and-enrichment-in-hpv-nega 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-in-advanced-prostate-cancer-pca-patients-with-visceral-metastasis-a-population-based-see 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-io-tki-vs-io-io-combinations-in-imdc-poor-risk-metastatic-renal-cell-carcinoma-mrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/receipt-of-polyadp-ribose-polymerase-inhibitors-parpi-in-patients-pts-with-metastatic-castrati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-provincial-registry-of-psma-pet-ct-for-recurrent-prostate-cancer-prep-results-for-4 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-the-shutter-speed-mri-model-to-detect-clinically-significant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-sarcomas-of-urinary-bladder-a-seer-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-high-omega-3-low-omega-6-diet-with-fish-oil-for-men-with-prostate-cancer-on-active-surveillance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-bone-modifying-agents-bma-in-patients-pts-with-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modified-transurethral-resection-of-bladder-tumors-a-comparison-study-of-chemotherapy-enhanced-endo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/punch01-interim-results-from-a-phase-ii-study-of-intra-arterial-chemotherapy-iac-combined-with-ti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-insurance-type-on-outcomes-after-radical-cystectomy-for-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-genomic-biomarkers-in-metastatic-clear-cell-renal-cell-carcinoma-mccrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-of-novel-androgen-receptor-axis-targeted-agents-in-non-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-clinical-and-genomic-features-of-androgen-indifferent-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-muscle-invasive-bladder-cancer-treatment-selection-in-an-emerging-treatment-era-a-patient-prefe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bayesian-re-analysis-comparing-radical-cystectomy-with-trimodality-therapy-in-patients-with-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-use-and-outcomes-of-androgen-receptor-pathway-inhibitors-triplet-therapy-for-metastatic-hor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-necrosis-factor-alpha-signaling-activity-and-nccn-risk-adverse-pathology-and-progression-dur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neo-blast-neoadjuvant-therapy-for-bladder-cancer-followed-by-active-surveillance-vs-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-combined-with-toripalimab-as-neoadjuvant-treatment-for-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-first-in-human-clinical-trial-with-plz4-coated-paclitaxel-loaded-micelles-ppm-in-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/g-disco-gemcitabine-docetaxel-intravesical-instillation-synchronous-co-administration-a-phase-i-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-approaches-and-outcomes-in-patients-aged-50-with-germ-cell-tumours 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-metastatic-prostate-cancer-patients-with-ctdna-detected-ispop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-the-area-deprivation-index-on-immunotherapy-outcomes-in-metastatic-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-analysis-of-ar-v7-expression-in-patients-pts-with-metastatic-castration-resistant-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/igi-rate-based-machine-learning-model-to-predict-overall-survival-os-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/theratest-a-multi-centre-observational-cohort-feasibility-study-of-de-escalation-therapies-for-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-in-combination-with-axitinib-ave-axi-for-first-line-1l-treatment-of-advanced-renal-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-precision-oncology-in-renal-cell-carcinoma-rcc-prospective-identification-of-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-window-of-opportunity-study-of-atezolizumab-administered-intravesically-or-direct-injecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-psma-pet-staging-on-initial-treatment-in-newly-diagnosed-prostate-cancer-an-emulated-rand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-fgfr-inhibitors-in-urothelial-carcinoma-a-systematic-review-and-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/state-of-the-genitourinary-medical-oncology-workforce-in-the-united-states-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-protocols-to-monitor-efficacy-of-sup177sup-lulu-psma-radiop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-derived-tumor-volume-from-baseline-mri-and-postprostatectomy-outcomes-follow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-post-treatment-spectct-for-identifying-disease-progression-in-patients-with-mcrpc-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-social-vulnerability-in-prostate-cancer-management-insights-into-utilization-of-watchful 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-related-efficacy-and-safety-of-darolutamide-plus-androgen-deprivation-therapy-adt-and-docetaxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-omaha-004-study-of-cyp11a1-inhibitor-opevesostat-versus-next-generation-hormonal-agent-nha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-survival-in-men-with-metastatic-castration-resistant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-caregiver-preferences-for-the-treatment-of-locally-advanced-or-metastatic-urothelial-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-first-line-1l-avelumab-axitinib-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-chemotherapy-retroperitoneal-lymph-node-dissection-pc-rplnd-for-metastatic-pure-seminoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-incidence-and-outcomes-of-testicular-and-ovarian-germ-cell-tumors-from-2000-2017-using 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-germline-variants-of-uncertain-significance-in-dna-repair-genes-and-their-potential-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-insights-of-low-psa-expressing-high-risk-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-quantitative-psma-pet-parameters-during-chemotherapy-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-germline-deleterious-variants-and-variants-of-uncertain-significance-in-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-versus-low-intermediate-risk-metastatic-renal-cell-carcinoma-mrcc-contemporary-data-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-contribution-of-circulating-tumor-dna-ctdna-towards-magnetic-resonance-imaging-mri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inectin4i-rna-expression-and-clinical-outcomes-with-first-line-1l-platinum-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pro-xl-a-phase-ii-study-of-zanzalintinib-xl092-in-patients-with-metastatic-castration-resistant-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-23-multicenter-trial-evaluating-safety-and-efficacy-of-a-new-mucoadhesive-gemcitabine-suspe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-in-combination-with-abirateroneenzalutamide-for-metastatic-castration-resistant-prosta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-persistence-and-adherence-to-relugolix-rel-in-us-patients-with-nonmetastatic-nm-vs-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-radiomics-as-a-risk-stratification-tool-in-node-positive-penile-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adrenal-androgens-and-overall-survival-os-in-men-with-castration-resistant-prostate-cancer-crpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequent-overexpression-of-nectin-4-in-cns-metastases-from-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-kidney-cancer-exploring-the-impact-of-sex-and-age-on-stage-of-disease-and-prognosis-duri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-pattern-and-clinical-outcomes-among-patients-with-metastatic-renal-cell-mrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-prevalence-and-outcomes-of-androgen-receptor-ligand-binding-domain-mutations-in-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u03-substudy-03b-pembrolizumab-pembro-and-novel-immunotherapy-agents-for-advanced-clear 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-for-sup177sup-lu-psma-617-with-and-without-concurrent-use-of-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-toxicity-and-cosmesis-of-partial-breast-irradiation-honing-in-on-dose-and-patient-select 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-magnetic-resonance-imaging-safely-replace-a-confirmatory-biopsy-in-patients-on-active-surveillan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-and-its-association-with-overall-survival-os-in-muscle-invasive-bladder-cancer-mibc-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-follow-up-of-a-randomized-double-blinded-phase-ii-study-of-ketoconazole-keto-hydrocortis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-profile-of-antibody-drug-conjugate-adc-based-combination-therapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enfortumab-vedotin-plus-pembrolizumab-in-metastatic-urothelial-carcinoma-first-results-on-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ibiia-dose-escalation-and-expansion-study-of-sup212sup-pbpb-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-risk-enabled-therapy-after-neoadjuvant-chemo-immunotherapy-for-muscle-invasive-bl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cobra-assessment-of-the-efficacy-of-sup64sup-cu-sar-bispsma-using-hist-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp1r-expression-in-prostate-cancer-patients-and-effects-of-glp1r-agonism-on-prostate-cancer-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-chatgpt-for-assessing-disease-volume-in-patients-pts-with-metastatic-prostate-cancer-mp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-pandemic-on-the-treatment-of-prostate-cancer-in-brazilian-public-health-system-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-stage-iiaiib-seminoma-treated-with-radiotherapy-and-chemotherapy-should-regio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-by-sex-with-contemporary-advanced-urothelial-carcinoma-auc-therapy-a-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impaired-renal-function-and-cisplatin-based-regimens-as-risk-factors-for-neoadjuvant-chemotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-as-a-prognostic-biomarker-to-predict-retroperitoneal-histology-in-patients-und 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-tumor-immune-microenvironment-dynamics-in-prostate-cancer-induced-by-andr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-a-community-based-prostate-cancer-screening-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-molecular-heterogeneity-of-prostate-cancer-biopsy-sampling-insights-from-the-mast-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-combination-of-vi-rads-based-on-t2wi-and-morphological-features-and-pathological 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-oral-apl-1202-plus-tislelizumab-or-tislelizumab-alone-as-neoadjuvant-therapy-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathogenic-germline-variant-prevalence-and-genetic-testing-outcomes-in-patients-with-urothelial-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nectin-4-and-trop-2-expression-as-potential-therapeutic-target-in-collecting-duct-carcinoma-prelimi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cupid-sup64sup-cu-tlx592-phase-i-pk-biodistribution-and-dosimetry-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-real-world-progression-ttrwp-among-patients-pts-with-relapsedrefractory-rr-testicula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-radium-223-in-men-with-metastatic-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rucaparib-vs-docetaxel-dtx-or-second-generation-androgen-pathway-inhibitor-arpi-therapy-for-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/additional-efficacy-and-safety-outcomes-and-an-exploratory-analysis-of-the-impact-of-pathological-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-combined-with-lenvatinib-for-neoadjuvant-therapy-in-early-stage-renal-cell-carcinoma-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optyx-study-clinical-characteristics-and-preferences-for-initiating-relugolix-in-a-cohort-of-us-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prognostic-model-for-survival-of-patients-with-metastatic-upper-tract-urothelial-carcinoma-with-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-mir-371a-3p-for-clinical-implementation-in-a-clia-certified-laboratory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-15-gene-prognostic-signature-in-metastatic-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-modalities-of-kidney-sparing-treatment-in-a-carefully-selected-cohort-of-localized-hig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-potential-immune-evasion-mechanisms-in-aggressive-small-renal-cell-carcinomas-thro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-psma-pet-and-conventional-imaging-on-contemporary-management-in-patients-with-biochemical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/who-undergoes-cytoreductive-nephrectomy-now-an-analysis-of-perioperative-risk-characteristics-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adding-immunotherapy-to-chemotherapy-for-metastatic-neuroendocrine-bladder-cancer-in-the-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-randomized-trial-of-stereotactic-ablative-radiotherapy-sabr-for-oligometastatic-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-supportive-care-pcsc-program-an-alternative-to-consolidated-framework-for-impleme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-epidemiology-and-clinical-outcomes-of-bladder-cancer-patients-in-spain-blarwe-multicente 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leep-a-randomised-window-of-opportunity-neoadjuvant-trial-examining-the-pharmacodynamic-effects-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-profiles-as-drivers-of-physician-choice-for-first-line-1l-treatment-tx-in-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-androgen-deprivation-therapy-and-kidney-function-in-patients-with-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-genetic-variants-in-cancers-of-the-urothelial-tract-and-association-with-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-dostarlimab-and-niraparib-combination-therapy-in-patients-with-stage-iii-iv-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-disparities-in-prostate-cancer-related-mortality-among-diabetic-adults-in-the-united-stat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tislelizumab-t-combined-with-gemcitabine-and-cisplatin-gc-for-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-an-integrated-germline-polygenic-and-clinical-risk-model-p-care-specifically-for-aggres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-secondary-metastasis-in-patients-with-bladder-cancer-a-5-year-national-inpati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-cytoreductive-radical-prostatectomy-in-the-management-of-patients-with-metastatic-hormon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiographic-progression-without-psa-progression-in-advanced-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-man-van-phase-2-results-mobile-targeted-case-finding-for-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-and-regional-burden-of-kidney-cancer-analysis-and-future-predictions-based-on-gbd-data-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-subtypes-inectin4her2i-expression-and-clinical-outcomes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuropathy-skin-rash-and-hyperglycemia-as-predictors-of-response-to-enfortumab-vedotin-in-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-finding-study-of-cbm588-in-combination-with-nivolumab-and-ipilimumab-in-patients-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/darolutamide-plus-adt-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-mhspc-by-disea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-in-advanced-prostate-cancer-a-cohort-study-using-the-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cell-ctc-expression-patterns-of-cell-surface-targets-in-metastatic-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cabozantinib-c-atezolizumab-a-in-patients-pts-with-metastatic-castration-resistant-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-de-novo-oligometastatic-prostate-cancer-patients-managed-with-radiation-therapy-a-mul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pros-for-tivozanib-tivo-nivolumab-nivo-vs-tivo-monotherapy-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-value-of-ldh-in-patients-with-good-risk-metastatic-seminoma-treated-with-single-agent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctc-and-ar-v7-analysis-in-the-ecog-acrin-8153-chaarted2-randomized-trial-abiraterone-abi-with-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-variant-allele-frequency-vaf-of-itp53i-alterations-and-sign 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-socioeconomic-determinants-of-cytoreductive-nephrectomy-cn-utilization-for-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-monitoring-in-the-assessment-and-prediction-of-the-efficacy-of-parp-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variants-of-unknown-significance-vus-in-dna-repair-genes-in-caucasian-men-with-muscle-invasive-bla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bacillus-calmette-guerin-bcg-treatment-patterns-and-real-world-outcomes-in-high-risk-hr-non-musc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-more-than-tumors-the-impact-of-enfortumab-vedotin-and-pembrolizumab-evp-on-skeletal-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-systemic-treatment-in-patients-pts-with-advanced-upper-tract-urothelia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avenance-real-world-study-of-avelumab-first-line-1l-maintenance-treatment-for-advanced-urothelial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-receptor-activity-in-biopsy-specimens-at-initial-diagnosis-of-prostate-cancer-and-correlati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-salvage-lymph-node-dissection-in-prostate-cancer-patients-with-nodal-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-the-effectiveness-of-io-based-combination-regimens-as-first-line-treatment-for-advanced-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ifosfamide-and-mesna-in-metastatic-castration-resistant-prostate-cancer-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-baseline-psma-pet-in-patients-pts-with-metastatic-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/equal-depth-sequencing-of-white-blood-cells-wbc-and-plasma-from-prostate-cancer-pca-liquid-biops 2026-08-24 monthly 0.7 https://rjrindex.com/articles/casdatifan-cas-monotherapy-in-patients-pts-with-previously-treated-clear-cell-renal-cell-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-rx-patterns-and-attrition-rates-in-patients-pts-with-metastatic-castration-resistant-p-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-enriched-amplicon-circulating-tumor-dna-sequencing-to-detect-minimal-residual-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-randomized-study-of-high-risk-metachronous-oligometastatic-prostate-cancer-with-high-risk-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-real-world-patients-characteristics-treatment-patterns-and-impact-of-bcg-shortage-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-duocarmazine-in-pretreated-human-epidermal-growth-factor-receptor-2-positive-advanced-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-toxicity-profile-of-enfortumab-vedotin-ev-with-or-without-pembrolizumab-p-in-ultra-el 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-and-survival-in-primary-prostate-sarcomas-an-analysis-of-the-seer-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-testing-the-role-of-proactive-coaching-on-patient-reported-outcome-in-advanced-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-utility-of-preoperative-v2-microglobulin-in-patients-with-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-predictive-model-using-changes-in-clinical-and-serum-biomarkers-and-automated-quantitative-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-tumor-organoids-to-model-drug-response-in-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-strategies-and-patient-outcomes-among-lpc-patients-with-persistently-positive-psa-after-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-geospatial-analysis-with-multiplex-immunofluorescence-to-analyze-tumor-immune-microenvironmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-analysis-of-the-immune-microenvironment-and-identification-of-phenotypes-of-prognostic-signi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-evaluating-the-activity-of-tinengotinib-in-combination-with-androgen-receptor-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-biopsy-results-of-the-patrol-study-prostate-screening-for-people-with-inherited-risk-of-dev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-proto-oncogene-n-ras-transcript-level-and-overall-survival-in-node-negative-musc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-study-of-camrelizumab-plus-apatinib-in-combination-with-stereotactic-body-radiot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-ml-models-to-predict-postoperative-outcomes-in-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pparg-protein-expression-in-advanced-urothelial-carcinoma-and-selection-for-response-to-fx-909-a-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-pet-vs-pelvic-mri-in-biochemically-recurrent-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathological-subclassification-of-t3-upper-tract-urothelial-carcinoma-complementary-evidence-for-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-and-impact-of-a-genome-wide-homologous-recombination-deficiency-signature-hrdsig-on-the-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-proficiency-of-chatgpt-4o-in-an-image-based-robot-assisted-radical-prostatectomy-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-maintenance-in-patients-with-metastatic-urothelial-carcinoma-in-a-real-life-expanded-access 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-avelumab-first-line-1l-maintenance-therapy-and-subsequent-treatment-tx-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-pathologic-responses-from-unstructured-pathology-reports-using-large-language-models 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-nadofaragene-firadenovec-in-bcg-unresponsive-non-muscle-invasive-bladder-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-safety-results-from-rad-io-a-multi-stage-trial-of-durvalumab-medi4736-with-chemor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dna-damage-repair-alterations-as-predictive-biomarker-for-platinum-based-chemotherapy-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-the-phase-2-litespark-003-study-of-belzutifan-plus-cabozantinib-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-kidney-injury-molecule-1-kim-1-in-association-with-kidney-injury-biomarkers-and-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-global-disparities-in-clinical-trial-availability-for-renal-cell-carcinoma-rcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/presurgical-treatment-for-inferior-vena-cava-tumor-thrombus-in-patients-with-renal-cell-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-new-prognostic-factors-for-relapse-in-patients-with-clinical-stage-i-seminoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-vascular-patterns-of-clear-cell-renal-cell-carcinoma-and-immune-cell-infiltratio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-canary-histology-classifier-in-prostate-biopsies-for-risk-stratification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/computational-pathology-based-classifier-for-predicting-gleason-grade-group-upgrading-on-radical-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-preliminary-results-of-artificial-intelligence-generated-explainable-treatment-recommendation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/choice-of-androgen-receptor-pathway-inhibitors-arpi-by-disease-volume-and-timing-of-metastases-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-radiographic-trends-in-patients-with-renal-angiomyolipomas-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-statin-use-with-overall-survival-and-cardiac-adverse-events-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-neoadjuvant-futibatinib-plus-durvalumab-for-cisplatin-ineligible-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-hospital-admissions-and-readmissions-due-to-immune-related-adverse-events-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-clinical-tools-to-monitor-cardiovascular-cv-risk-in-men-with-localized-high-risk-or-loc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-gut-microbiota-profiles-in-patients-with-prostate-cancer-the-promise-japan-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-oncopig-bladder-cancer-model-an-innovative-large-animal-platform-for-evaluating-treatment-effec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-geographic-and-demographic-characteristics-on-treatment-with-lu-psma-for-metastatic-castra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-survival-benefits-of-adjuvant-immunotherapy-in-muscle-invasive-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlates-of-immunotherapy-response-in-metastatic-clear-cell-renal-cell-carcinoma-from-circulating 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-23-study-of-bicycle-toxin-conjugate-zelenectide-pevedotin-bt8009-targeting-nectin-4-in-pa-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-natural-language-processing-algorithm-to-extract-mri-and-biopsy-related-phenotypes-for-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/etctn-10483-phase-ib-trial-of-erdafitinib-e-combined-with-enfortumab-vedotin-ev-following-plati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disease-management-costs-and-healthcare-resource-utilization-by-progression-health-state-among-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-overall-survival-os-with-talazoparib-tala-enzalutamide-enza-as-first-line-1l-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hydroxychloroquine-effects-on-tumor-suppressor-par-4-levels-in-patients-with-oligometastatic-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastasis-directed-radiotherapy-in-oligometastatic-bladder-and-upper-tract-cancer-a-single-institu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complications-after-transurethral-resection-of-bladder-tumor-findings-from-the-2022-acs-nsqip-datab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-estrogen-response-pathway-as-a-putative-predictive-biomarker-of-neoadjuvant-pembrolizumab-benefi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-variations-between-early-and-late-recurrence-in-bladder-cancer-post-radical-cyst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chapter-platform-201-phase-2-trial-of-pimitespib-plus-enzalutamide-for-patients-with-metastatic-cas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-observational-study-in-japanese-patients-with-metastatic-castration-sensitive-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addition-of-darolutamide-to-first-line-treatment-of-metastatic-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determining-lung-cancer-screening-eligibility-in-a-surgically-treated-urothelial-carcinoma-populatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyses-on-impact-of-tumor-burden-at-progression-and-changes-in-imdc-from-baseline-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-cardiovascular-mortality-in-older-adults-with-malignant-neoplasms-of-male-genital-organs-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-radiographic-node-positive-prostate-cancer-following-definitive-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-evaluation-of-stereotactic-body-radiation-therapy-sbrt-during-lutetium-177-psma-617-177lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/finding-the-right-partner-triplet-therapy-for-first-line-advanced-biliary-tract-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-highly-aggressive-ductal-prostate-tumours-with-poly-adp-ribose-polymerase-inhibitor-parpi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-perforation-and-fistula-formation-as-adverse-events-in-patients-receiving-tyrosine-kinase-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-apalutamide-in-metastatic-castration-sensitive-prostate-cancer-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-health-and-prostate-cancer-the-influence-of-a-specific-phytochemical-rich-food-capsule-plus-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-legend-a-phase-2-study-of-detalimogene-voraplasmid-eg-70-a-novel-non-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcome-pro-assessment-and-reporting-in-first-line-1l-locally-advanced-or-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-community-social-vulnerability-domains-and-influence-on-treatment-selection-for-men-with-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospitalizations-in-veterans-treated-with-monotherapy-vs-combination-therapy-for-metastatic-hormone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-impact-on-overall-survival-curves-of-patients-with-metastatic-castration-sensitive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-digital-pathology-ai-models-genomics-classifier-and-clinical-variables-in-predicting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-neoadjuvant-therapy-on-the-formation-of-tertiary-lymphatic-structures-and-the-distinct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-survival-prediction-model-for-veterans-with-advanced-bladder-cancer-bc-treated-with-immune-check 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cell-expression-analysis-from-the-phase-2-trial-of-abiraterone-olaparib-or-abira 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-bleomycin-shortage-in-patients-with-advanced-testicular-non-seminoma-germ-cell-tumors-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-management-of-oligometastatic-and-oligoprogressive-renal-cancer-patients-with-extra-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-rc48-adc-in-combination-with-toripalimab-as-neoadjuvant-treatment-in-her 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-burden-or-focality-in-recurrent-low-grade-intermediate-risk-non-muscle-invasive-blad-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-evaluation-of-therapeutic-outcomes-of-percutaneous-usct-guided-bipolar-radiofrequency-ablation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-darolutamide-and-relugolix-combination-preceding-radical-prostatectomy-for-high-risk-loc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-in-clinical-trials-for-fda-approved-drugs-in-renal-cell-carcinoma-an-analysis-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-in-intraductal-prostate-cancer-insights-from-the-genomic-umbrella-neoadjuvant-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mevrometostat-pf-06821497-an-enhancer-of-zeste-homolog-2-ezh2-inhibitor-in-combination-with-en 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-olaparib-ola-plus-abiraterone-abi-versus-placebo-pbo-plus-abi-in-patients-pts-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-trial-of-durvalumab-plus-intravesical-gemcitabine-and-docetaxel-in-bcg-unresponsive-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-for-stage-i-iii-anal-squamous-cell-carcinoma-asco-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-mris-performed-in-a-6-week-interval-on-the-histopathological-detection-of-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-testing-patterns-among-patients-newly-diagnosed-with-prostate-cancer-in-a-community-oncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-mutations-in-homologous-recombination-repair-hrr-pathway-genes-using-liquid-biopsy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinically-advanced-urothelial-bladder-cancer-caubc-in-young-onset-bladder-cancer-youc-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-slide-multiplexed-tissue-imaging-of-prostate-adenocarcinoma-to-investigate-immune-niches-in-hi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-split-dose-gemcitabine-and-cisplatin-gc-use-in-patients-with-locally-advanced-or-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-the-tide-a-study-evaluating-avelumab-ave-plus-intermittent-axitinib-axi-in-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-follow-up-quality-of-life-outcomes-from-an-investigator-initiated-randomized-trial-of-enzalutam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-embark-and-eau-high-risk-biochemical-recurrence-and-prostate-cancer-mortality-a-real-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-different-therapeutic-modalities-for-patients-with-metachronous-oligometastatic-renal-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-non-coding-rna-based-classifier-for-favorable-outcomes-in-clinically-organ-confined-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-online-clustering-algorithm-predicting-model-for-prostate-cancer-based-on-phi-related-variables-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/innovative-diagnostic-approaches-serum-protein-markers-in-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-tissue-based-biomarkers-in-metastatic-clear-cell-renal-cell-carcinoma-perform-better-when-derived 2026-08-24 monthly 0.7 https://rjrindex.com/articles/jccg-all-b12-evaluation-of-intensified-therapies-with-vincristinedexamethasone-pulses-and-asparagi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimation-of-overall-survival-in-immunotherapy-treated-bladder-cancer-using-computer-vision 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-clear-cell-renal-cell-carcinoma-in-the-immune-checkpoint-era-a-retrospective-study-on-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-afu-getug-20-a-randomised-phase-3-trial-of-adjuvant-androgen-deprivation-therapy-with-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-neoadjuvant-therapy-combined-with-vi-rads-re-scoring-in-bladder-preservation-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transdermal-oestradiol-te2-patches-as-androgen-deprivation-therapy-adt-efficacy-and-safety-of-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-pembrozulimab-and-radiation-treatments-in-the-management-of-locally-advanced-bladder-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-from-medication-order-to-administration-of-cabazitaxel-c-vs-lutetium-lu-177-vipivotide-tetra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpath-004-a-phase-2-randomized-double-blind-study-of-adjuvant-pembrolizumab-pembro-with-v94 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-risk-in-clinical-t1a-renal-cell-carcinoma-rcc-with-synchronous-metastasis-sm-a-compar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-in-clinical-trials-for-fda-approved-drugs-in-urothelial-cancer-an-analysis-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-omaha-01a-substudy-of-oral-cyp11a1-inhibitor-opevesostat-alone-or-in-combination-with-othe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psa-based-intermediate-endpoints-to-compare-radiotherapy-and-radical-prostatectomy-for-the-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-changes-in-urinary-function-and-prostate-volume-in-patients-with-localized-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-association-between-bone-pain-and-radiologic-progression-free-survival-rpfs-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-sequence-ts-and-overall-survival-os-in-patients-with-metastatic-urothelial-cancer-muc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lutetium-177-psma-radioligand-therapy-in-taxan-naive-first-and-second-line-metastatic-castration-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-fracture-risk-for-prostate-cancer-patients-initiating-long-term-androgen-deprivation-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-evaluating-duplex-sequencing-of-urinary-dna-as-a-biomarker-for-recurrence-in-non-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characteristics-of-patients-with-metastatic-hormone-sensitive-prostate-cancer-treated-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-next-generation-sequencing-and-associated-next-line-systemic-therapy-use-in-metastatic-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-gut-microbiome-composition-on-treatment-efficacy-and-toxicity-in-bladder-cancer-a-comp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-spectrum-of-disease-within-gleason-grade-group-3-results-from-a-large-institutional 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-characterization-in-mcrpc-patients-with-pathogenic-germline-variants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-correlates-of-clinical-outcomes-in-aggressive-prostate-cancer-subtypes-treated-with-radiati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-clinical-and-pathologic-predictors-for-pathologic-lymph-node-positivity-pn-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-of-acute-gi-and-gu-toxicities-with-dose-escalated-intensity-modulated-proton-therapy-impt-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-real-world-evidence-registry-procare-recurrent-and-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-psa-nadir-on-long-term-survival-in-metastatic-hormone-sensitive-prostate-cancer-final-10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-micropapillary-histology-and-clinical-staging-on-overall-survival-in-bladder-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vasculo-immune-modulatory-effects-of-anti-vegf-therapy-in-metastatic-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/converge-01-dosimetry-randomized-dose-optimization-dose-escalation-and-efficacy-of-ac-225-rosopa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osteonecrosis-of-the-jaw-onj-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-circulating-kidney-injury-molecule-1-kim-1-in-metastatic-renal-cell-carcinoma-mrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-ai-to-identify-optimal-clinical-genomic-and-radiographic-prognostic-features-and-novel-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-positive-tumor-vessels-around-renal-cell-carcinoma-with-high-angiogenic-potential-as-therapeuti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-for-factors-associated-with-development-of-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carboplatin-in-patients-with-metastatic-castration-resistant-prostate-cancer-harboring-somatic-or-ge-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/abca1-and-abcg1-cholesterol-transporters-expression-on-metastatic-renal-cell-carcinoma-impact-on-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-cancer-in-metastatic-renal-cell-carcinoma-mrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-urinary-continence-recovery-post-prostatectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cabozantinib-as-subsequent-therapy-to-an-immune-checkpoint-based-therapy-in-renal-cell-carcinoma-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-in-circulating-tumor-cells-ctcs-and-her2-expression-in-evaluating-the-efficacy-of-neoadjuv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psa-response-and-survival-based-on-metastatic-site-in-patients-with-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-localized-high-risk-prostate-cancer-pc-and-an-androgen-receptor-low-subpopulation-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-concomitant-medication-use-on-treatment-outcomes-in-patients-with-rcc-treated-with-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-and-quality-of-life-with-sup177sup-lu-lu-psma-617-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-treatment-approaches-in-nested-bladder-tumors-a-multicenter-retrospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-immune-checkpoint-inhibitor-rechallenge-in-urothelial-carcinoma-results-from-a-global-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-navigator-assisted-hypofractionation-navah-program-surveys-in-african-american-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-surgical-orchiectomy-in-prostate-cancer-patients-on-long-term-luteinizing-hormone-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psa-response-to-lu177-psma-617-in-patients-experiencing-xerostomia-and-ocular-dryness-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-satisfaction-with-geriatric-and-functional-assessments-and-referral-to-frailty-related-inter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-first-line-dual-immunotherapy-versus-combination-vegf-immunotherapy-in-interm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extensive-necrosis-as-a-prognostic-indicator-in-metastatic-rcc-patients-undergoing-deferred-cytoredu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-risk-groups-by-psma-pet-promise-ppp-results-from-an-international-multi-center-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-dna-repair-gene-variants-in-patients-under-active-surveillance-for-low-grade-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-centre-review-of-the-use-of-adjuvant-pembrolizumab-for-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/muscle-invasive-bladder-cancer-treatment-selection-in-an-emerging-treatment-era-a-patient-preferenc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-pembrolizumab-or-placebo-plus-adjuvant-chemotherapy-with-or-without-radiotherapy-for-newly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-and-their-pathologic-responses-in-high-risk-localized-prostate-cancer-hrlpc-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epic-b-phase-ii-trial-of-cemiplimab-as-first-line-treatment-in-advanced-penile-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-treatment-patterns-of-patients-with-muscle-invasive-bladder-cancer-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-trop2-in-aggressive-variant-and-neuroendocrine-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-circulating-kidney-injury-marker-1-kim-1-as-a-prognostic-and-predictive-biomarker-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-s1815-a-phase-iii-randomized-trial-of-gemcitabine-cisplatin-and-nab-paclitaxel-versus-gemcit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/checkpoint-blockade-as-neoadjuvant-strategy-a-single-arm-meta-analysis-of-dual-pd-1pd-l1-and-ctla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-and-clinical-outcomes-of-androgen-receptor-inhibitors-aris-for-non-metastatic-castration-resis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-patients-pts-with-metastatic-castration-resistant-prostate-cancer-mcrpc-rec-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-in-clinical-trials-for-fda-approved-drugs-in-prostate-cancer-a-post-covid-19-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-resistance-among-novel-androgen-receptor-axis-targeted-agents-in-non-metastatic-castration-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-image-guided-oligometastatectomy-and-radiation-therapy-in-recurrent-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarcopenia-as-a-marker-to-assess-the-surveillance-necessity-after-a-5-year-cancer-free-period-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-study-of-combination-sup177sup-lu-girentuximab-plus-cabozant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-treatment-tx-for-mental-health-illness-mhi-impact-prostate-cancer-pc-tx-and-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-features-of-prostate-cancer-patients-with-and-without-ductal-adenocarcinoma-da-based-on-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-expression-signatures-in-biopsy-cores-as-predictors-of-coexisting-higher-grade-disease-in-gleas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-the-prior-treatment-cohort-of-a-phase-iii-study-of-nivolumab-and-axitinib-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-genomic-instability-gi-by-shallow-whole-genome-sequencing-swgs-to-predict-parp-inhibit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-sabr-with-tki-and-io-therapy-in-patients-with-mrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-psa-in-the-outcomes-of-patients-with-high-risk-localized-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-of-cabozantinib-and-nivolumab-with-abiraterone-cabios-in-metastatic-castration-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-optimizing-deephrd-interpretability-for-enhanced-clinical-decision-making 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peak-corticosteroid-dose-for-immune-related-adverse-events-and-survival-not-the-whole-story 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-of-cancer-of-unknown-primary-cup-with-renal-profile-using-gene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-peak-corticosteroid-dose-for-immune-related-adverse-events-and-survival-not-the-whole-sto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belzutifan-monotherapy-in-chinese-patients-pts-with-von-hippel-lindau-vhl-disease-associated-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-cabold-study-a-real-life-prospective-cohort-evaluating-the-combination-of-cabozantinib-and-nivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-high-risk-prostate-specific-antigen-level-during-active-surveillance-with-targeted-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/late-onset-of-apalutamide-related-skin-toxicity-in-black-men-with-advanced-prostate-cancer-a-divers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-efficacy-of-belzutifan-in-the-treatment-of-renal-cell-carcinoma-associated-with-von-hi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-2012-and-2018-uspstf-statements-on-prostate-cancer-screening-and-metastatic-rates-in-k 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-cross-sectional-survey-to-explore-determinants-of-health-promoting-activities-among-his 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nanosomal-docetaxel-lipid-suspension-in-indian-patients-with-metastatic-castr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-receptor-alterations-and-survival-in-veterans-who-develop-metastatic-castrate-resistant-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/local-definitive-therapy-ldt-utilization-patterns-and-outcomes-in-chromophobe-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paclitaxel-ifosfamide-cisplatin-tip-in-patients-with-advanced-urethral-adenocarcinoma-a-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-therapies-analysis-in-advancedmetastatic-urothelial-carcinoma-prognostic-insights-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-oncological-outcomes-of-the-randomized-phase-ii-trial-arneo-neoadjuvant-degarelix-with-or-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-suppression-with-abiraterone-acetate-leuprolide-parp-inhibition-and-stereotactic-body-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-evolution-of-hrr-gene-alterations-in-metastatic-prostate-cancer-a-ctdna-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-deferred-cytoreductive-nephrectomy-in-the-era-of-the-immunotherapy-in-metastatic-renal-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-circulating-tumor-dna-ctdna-in-locally-advanced-la-and-metastatic-urothelial-cancer-muc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epigenomic-profiling-of-circulating-chromatin-for-early-detection-and-monitoring-of-neuroendocrine-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravesical-gemcitabine-and-docetaxel-combined-with-intravenous-tislelizumab-as-a-durable-strategy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determining-an-immunohistochemical-profile-to-predict-response-to-intravesical-bacillus-calmette-gue 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-trial-of-a-structured-exercise-program-to-lessen-fatigue-in-patients-with-advanced-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-and-preliminary-validity-of-the-functional-assessment-of-cancer-therapy-radionuclid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-significance-of-circulating-tumor-dna-in-prostate-cancer-a-systematic-review-and-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-post-orchiectomy-systemic-inflammatory-indexes-and-tumor-characteristics-in-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/darolutamide-plus-androgen-deprivation-therapy-adt-in-patients-with-high-risk-biochemical-recurren-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/natural-history-and-risk-stratification-of-biochemical-recurrence-in-prostate-cancer-treated-with-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-based-pet-imaging-in-newly-diagnosed-high-risk-localized-prostate-cancer-a-national-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/functional-and-oncological-outcome-of-primary-nerve-sparing-retroperitoneal-lymph-node-dissection-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emetpro-a-multicenter-international-retrospective-analysis-evaluating-patients-pts-with-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-and-adverse-clinical-outcomes-in-prostate-cancer-patients-an-analysis-from-the-radical-pc-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-neoadjuvant-parp-inhibition-followed-by-radical-prostatectomy-rp-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-of-cabozantinib-in-patients-with-advanced-renal-cell-carcinoma-with-bone-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-renal-cell-carcinoma-mrcc-primary-refractory-patients-to-first-line-io-tki-and-io-io-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-emerin-dysregulation-on-the-very-small-nuclear-phenotype-and-neuronal-differentiation-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevention-diagnosis-and-management-of-penile-cancer-in-the-lgbtq-community-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/portos-gene-signature-as-a-predictor-of-risk-of-adverse-events-after-dose-escalated-vs-lower-dose-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radical-prostatectomy-rp-versus-radiotherapy-rt-in-high-risk-prostate-cancer-hr-pca-emulated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-perioperative-lenvatinib-l-with-pembrolizumab-p-in-patients-with-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atezolizumab-plus-chemotherapy-with-or-without-bevacizumab-in-advanced-biliary-tract-cancer-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/closing-the-gap-evaluating-medicares-low-income-subsidy-support-for-optimal-cancer-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-outcomes-in-metastatic-castration-resistant-prostate-cancer-in-the-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extracellular-dna-in-patients-with-urothelial-carcinoma-of-the-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-time-to-next-treatment-ttnt-time-to-castration-resistance-ttcr-and-ov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-targeted-therapies-tt-after-hif-2-inhibitor-based-treatment-in-advanced-renal-cell-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-phase-3-open-label-single-arm-studies-to-evaluate-the-efficacy-safety-and-pharmacokineti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-lenvatinib-plus-everolimus-in-metastatic-renal-cell-carcinoma-after-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-field-progression-following-radiation-therapy-as-a-prognostic-biomarker-for-lutetium-177-psma-617 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bipolar-androgen-therapy-bat-for-nonmetastatic-castration-resistant-prostate-nmcrpc-cancer-progr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/image-based-artificial-intelligence-algorithms-for-molecular-diagnostics-in-prostate-pathology-how 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imtapi-loss-in-primary-kidney-tumors-a-comprehensive-genomic-profiling-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-neoadjuvant-immunotherapy-with-durvalumab-medi-4736-in-combination-with-neo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-tolerability-and-outcomes-of-enfortumab-vedotin-plus-pembrolizumab-in-advanced-urothelial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-based-on-line-of-therapy-and-treatment-trends-with-cabazitaxel-in-patients-pts-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discordance-in-her2-expression-in-primary-and-recurrentmetastatic-lesions-of-upper-tract-urothelial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-center-phase-ibii-study-of-rc48-adc-combined-with-tislelizumab-as-neoadjuvant-treatment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-spatiotemporal-trends-in-prostate-cancer-burden-and-its-socioeconomic-disparities-an-observa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-liquid-biopsies-on-early-detection-monitoring-and-prognostication-in-prostate-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extreme-bipolar-androgen-therapy-alternating-darolutamide-and-testosterone-cypionate-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-primary-malignancy-in-bladder-cancer-a-retrospective-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-cancer-system-characteristics-and-prostate-cancer-outcomes-a-global-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-organoid-based-drug-sensitivity-screening-to-guide-the-treatment-of-mcrpc-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-circulating-tumor-dna-ctdna-burden-and-its-association-with-real-world-overall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-ctdna-alterations-in-lethal-mcrpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-integrated-multi-omics-analysis-to-analyze-prognostic-molecular-subtype-in-collecting-duct-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-repair-mutation-testing-patterns-in-metastatic-castration-resistant-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-ii-embryonal-predominant-nsgct-minimizing-treatment-burden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-relapsed-stage-i-seminomatous-germ-cell-tumor-with-retroperitoneal-or-pelvic-only-rela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-recurrent-prostate-cancer-using-18f-dcfpyl-petct-petct-in-patients-with-minimal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-cabozantinib-in-combination-with-atezolizumab-as-neoadjuvant-treatment-for-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-adjusted-network-meta-analyses-nma-to-evaluate-the-efficacy-of-treatment-alternatives-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-predictors-of-the-late-stage-diagnosis-in-patients-with-prostate-cancer-a-retrospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-control-outcomes-of-metastatic-castration-resistant-prostate-cancer-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-findings-from-a-national-quality-improvement-qi-program-to-address-disparities-in-bladder-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psa-dynamics-enhancing-predictive-models-in-prostate-cancer-follow-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chromosomal-instability-in-tumor-suppressor-genes-altered-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adjuvant-intraarterial-chemotherapy-on-survival-for-patients-with-stage-iiia-iiib-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduction-of-systemic-chemotherapy-by-primary-retroperitoneal-lymph-node-dissection-in-low-volume-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-cabazitaxel-vs-177-lutetium-psma-radioligand-therapy-in-metastatic-castrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-incidence-based-mortality-and-survival-outcomes-in-testicular-cancer-in-adoles 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-relapsed-primary-retroperitoneal-rp-germ-cell-tumor-gct-after-front-line-chemother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-trial-evaluating-the-efficacy-and-safety-of-disitamab-vedotin-plus-tislelizumab-combined 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-long-term-outcomes-following-radical-prostatectomy-using-a-validated-pathology-based-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-first-line-ipilimumab-and-nivolumab-for-patients-with-metastatic-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metabolic-determinants-of-exceptional-response-to-immune-checkpoint-inhibition-in-renal-cell-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/core-008-a-phase-2-multi-arm-multi-cohort-open-label-study-to-evaluate-intravesical-cretostimoge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-language-models-llms-for-inferring-genomic-characteristics-and-facilitating-genomic-literacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cell-rna-biomarker-for-bavdegalutamide-arv-110-in-metastatic-castration-resistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ibii-clinical-trial-of-oncolytic-virus-intravesical-irrigation-for-preventing-recurrence-afte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-profile-of-lutetium-177-in-patients-with-impaired-renal-function-a-retrospective-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mature-phase-1-follow-up-of-alpha-emitter-225ac-j591-with-177lu-psma-iampt-in-advanced-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-analogues-and-prostate-cancer-incidence-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cabozantinib-cabo-and-nivolumab-nivo-with-or-without-cbm588-in-patients-with-metastatic-renal-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-rates-of-surgical-overtreatment-of-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-sup177sup-lu-psma-617-with-or-without-arpis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptional-profiling-of-patients-with-metastatic-hormone-sensitive-prostate-cancer-to-uncover-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-among-metastatic-castration-resistant-prostate-cancer-patients-treated-with-androg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpretable-machine-learning-for-prostate-biopsy-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-clinical-trial-participation-in-patients-with-bladder-and-kidney-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-center-single-arm-clinical-study-of-adjuvant-toripalimab-combined-with-axitin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genome-scale-metabolic-reconstruction-of-urinary-microbiome-pathway-for-personalized-medicine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-clinical-associations-between-genomic-alterations-and-prostate-cancer-lineage-states-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-evaluation-of-gene-expression-based-signatures-for-detecting-tertiary-lymphoid-struc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-real-world-study-of-disitamab-vedotin-combined-with-tislelizumab-versus-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-abnormal-imdc-laboratory-criteria-after-surgery-and-cancer-specific-and-overall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-car-t-cell-therapy-in-penile-and-urethral-carcinomas-a-meta-analysis-of-prel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapies-in-renal-cell-carcinoma-with-brain-metastases-a-comparative-meta-analysis-of-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-open-label-multicenter-study-of-xaluritamig-in-patients-with-newly-diagnosed-localized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radonc-gpt-gpt-4o-versus-human-data-extraction-for-prostate-cancer-clinical-research 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-a-novel-ai-based-digital-pathology-chai-biomarker-with-progression-free-survival-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-impact-of-ureteral-carcinoma-amongst-racial-minorities-analysis-of-the-national-cancer-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-of-first-line-1l-therapies-for-locally-advanced-or-metastatic-urothelial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-levels-and-related-kinetics-as-prognostic-biomarkers-for-clinical-outcomes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lewis-y-antigen-as-a-novel-target-for-car-chimeric-antigen-receptor-t-cell-therapy-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-combined-role-of-hhla2-and-pd-l1-as-biomarkers-in-first-line-nivolumab-therapy-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-0-safety-imaging-pharmacokinetics-and-dosimetry-study-of-sup64 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-nivolumab-plus-ipilimumab-in-t1an0m0-renal-cell-carcinoma-rcc-patients-results-from-3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deciphering-immune-genomic-markers-of-hyperprogression-in-patients-pts-with-metastatic-urothelial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/severity-of-bleomycin-induced-lung-toxicity-in-indian-patients-with-intermediate-and-poor-risk-non-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-prognosis-of-med15-tfe3-rearrangement-renal-cell-carcinoma-an-upda 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-active-surveillance-intensity-and-overtreatment-in-men-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanism-of-action-and-translation-to-the-clinic-of-detalimogene-voraplasmid-eg-70-a-novel-inve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-neutrophil-and-tumor-infiltrating-lymphocyte-count-and-bladder-cancer-stage-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-survival-understanding-the-social-dimensions-of-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-cost-effectiveness-in-the-evolving-treatment-landscape-for-metastatic-urothelial-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-significance-of-prostate-specific-antigen-dynamics-during-abiraterone-therapy-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nsd2-inhibition-as-a-therapeutic-approach-for-treatment-induced-neuroendocrine-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-phase-ii-study-to-evaluate-olaparib-plus-abiraterone-and-prednisone-combination-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-analysis-of-circulating-tumor-cells-and-psma-imaging-metrics-to-predict-efficacy-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paraneoplastic-and-symptomatic-score-for-prediction-of-overall-and-cancer-specific-survival-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institution-experience-of-pneumonitis-in-patients-with-metastatic-renal-cell-carcinoma-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/absence-of-prostate-cancer-events-after-3-years-of-tailored-screening-in-high-risk-individuals-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ihsd3b1i-and-overall-survival-os-in-high-risk-non-metastatic-m0-and-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-perioperative-sacituzumab-govitecan-in-combination-with-zimberelimab-and-domvanalim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-mortality-risk-in-primary-penile-cancer-patients-a-retrospective-cohort-study-from-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-preoperative-fibrinogen-in-metastatic-clear-cell-renal-cell-carcinoma-patients-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characterization-and-treatment-patterns-in-patients-with-metastatic-hormone-sensitive-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-tandem-or-triplet-autologous-stem-cell-transplant-for-refractory-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-prognostic-value-of-cdk12-mutation-in-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-between-veterans-with-metastatic-castration-resistant-prostate-cancer-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-fgfr3-parg248cys-mutation-in-lynch-syndrome-associated-urothelial-carcinoma-a-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kim-1-as-a-circulating-biomarker-in-metastatic-rcc-post-hoc-analysis-of-javelin-renal-101 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-combined-chemotherapy-and-immunotherapy-for-upper-tract-urothelial-carcinoma-preliminar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-androgen-deprivation-therapy-and-acute-kidney-injury-in-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-psma-pet-results-at-biochemical-recurrence-bcr-with-metastasis-free-survival-mfs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-enfortumab-vedotin-and-pembrolizumab-for-patients-previously-treated-with-immune-checkpo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-after-brexucabtagene-autoleucel-administered-as-a-standard-therapy-for-adults-with-relapsed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-and-overall-survival-with-lutetium-lu-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liver-transplantation-for-hepatocellular-carcinoma-an-expanding-cornerstone-of-care-in-the-era-of-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd39-expression-as-a-predictive-biomarker-for-neoadjuvant-treatment-in-muscle-invasive-bladder-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-clinical-impact-of-tumor-volume-on-response-to-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-specific-antigen-psa-response-in-black-patients-with-metastatic-castration-sensitive-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-immune-checkpoint-inhibitors-ici-in-patients-randomized-to-the-control-arm-of-ici-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radical-cystectomy-in-female-patients-does-the-urinary-diversion-type-affect-postoperative-complica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inclusion-of-patients-with-reduced-performance-status-ecog-2-or-higher-in-fda-registrational-trial-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-rspo2-activation-and-its-association-with-outcomes-and-potential-role-as-a-driver-in-doub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-patients-with-metastatic-renal-cell-carcinoma-with-or-without-brain-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intra-patient-comparison-of-urinary-radioactivity-after-sup18sup-f-pifl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-health-related-quality-of-life-hrqol-assessment-and-immune-related-adverse-event-irae 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individual-patient-data-ipd-analysis-of-early-psa-nadir-in-arasens-latitude-and-titan-training 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-incidence-and-clinicopathologic-features-of-secondary-bladder-cancer-after-long-term 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-perioperative-acute-kidney-injury-on-future-renal-outcomes-in-patients-who-undergo-radical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-progression-following-systemic-and-tumor-directed-therapy-for-ide-novoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-physiological-monitoring-for-personalized-prediction-of-physical-function-and-fatigue-in-men 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-clinical-characterization-of-renal-cell-carcinoma-rcc-with-merlin-protein-deficienc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genome-wide-burden-survival-tests-for-patients-with-metastatic-prostate-cancer-on-androgen-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-urinary-cell-free-dna-methylation-assay-to-identify-tumor-fraction-for-early-detection-and-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-assessment-of-pre-and-post-covid-19-pandemic-nephrectomy-outcomes-for-renal-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nivolumab-plus-ipilimumab-nivoipi-in-patients-with-metastatic-variant-hist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surveillance-with-plasma-ctdna-in-non-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-comparison-of-clinical-utility-between-pan-cancer-panel-and-pca-specific-panel-for-mcrpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-safety-outcomes-of-sup177sup-lu-psma-617-in-patients-with-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nexus-01-a-phase-1-study-of-ly4052031-an-antibody-drug-conjugate-targeting-nectin-4-in-participant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-position-as-a-social-determinant-of-health-and-its-effect-on-cardiovascular-outcomes-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peri-operative-treatment-patterns-in-real-world-muscle-invasive-bladder-cancer-patients-undergoing-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-urinary-cell-free-dna-fragmentomics-in-urothelial-carcinoma-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/octopus-a-retrospective-multicenter-study-of-real-world-cabozantinib-treatment-of-patients-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cabozantinib-in-patients-pts-with-non-locally-pretreated-brain-metastases-bm-from-renal-cell-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-discontinuation-and-efficacy-data-of-abiraterone-acetateprednisone-aap-plus-androgen-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/which-patients-with-metastatic-hormone-sensitive-prostate-cancer-mhspc-benefit-more-from-androgen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-clinical-outcomes-in-patients-with-metastatic-urothelial-carcinoma-in-england 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-protein-biomarkers-and-adverse-pathologic-features-in-mri-mapped-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-experience-with-emaco-chemotherapy-in-male-choriocarcinoma-a-single-center-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup18sup-f-psma-1007-petct-for-response-assessment-in-patients-with-metastatic-ren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-3-trial-of-docetaxel-added-to-adt-plus-arta-in-patients-with-metastatic-hormone-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-of-mibc-patients-not-receiving-radical-cystectomy-results-from-a-real-world-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-immune-checkpoint-inhibitor-rechallenge-in-metastatic-fumarate-hydratase-defi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fifteen-year-outcomes-of-external-radiation-with-or-without-6-months-of-neoadjuvant-deprivation-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-long-term-follow-up-from-a-phase-ii-clinical-trial-of-gemcitabine-and-cisplatin-as-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-a-deep-learning-algorithm-for-automated-p53-immunohistochemistry-digital-image-analysis-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preferred-treatment-regimens-for-rare-genitourinary-gu-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-variant-origin-prediction-vop-algorithm-to-distinguish-clonal-hematopoiesis-ch-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-signature-predictor-of-dose-response-to-prostate-radiation-validation-of-portos-in-phase-iii-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-gene-expression-signatures-of-immune-infiltration-on-response-to-sequential-intravesical-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-quality-of-life-in-prostate-cancer-patients-continuous-vs-intermittent-androgen-deprivat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-integrated-multi-omics-profiling-in-renal-cell-carcinoma-to-identify-molecular-subtypes-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastasis-directed-therapy-mdt-plus-androgen-deprivation-therapy-adt-for-oligometastatic-prosta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-outcomes-of-patients-with-metastatic-non-clear-cell-renal-cell-carcinoma-mnccrcc-treated-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-overall-survival-and-new-ctdna-analysis-in-met-driven-advanced-papillary-renal-cancer-calypso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-genitourinary-drug-approvals-by-the-fda-2020-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-mortality-trends-in-genitourinary-cancer-in-southeast-asia-from-1990-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-conventional-imaging-and-piflufolastat-f18-in-newly-diagnosed-and-recurrent-prostate-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-psa-based-igi-rate-and-conventional-psa-metrics-in-veter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chimeric-rna-landscape-in-the-chinese-population-and-the-role-of-isft2d2-tbx19i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-multi-parametric-mri-mpmri-compared-to-diagnostic-transurethral-resection-of-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-safety-and-correlative-analysis-of-a-phase-ii-trial-in-metastatic-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/re-treatment-of-metastatic-castration-resistant-prostate-cancer-patients-with-radium-223-therapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-first-line-1l-maintenance-therapy-in-advanced-urothelial-carcinoma-final-analysis-from-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lucarbo-a-phase-1a1b-trial-of-sup177sup-lu-psma-617-lupsma-with-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-initial-local-therapy-lt-in-the-combination-treatment-era-for-metastatic-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-baseline-and-changes-in-hemoglobin-levels-and-treatment-response-and-prognosis-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-belzutifan-on-anemia-and-hypoxia-in-sporadic-and-ivhli-syndr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/s23psa-as-a-predictor-of-reclassification-of-1st-protocol-biopsy-on-active-surveillance-for-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-in-men-with-metastatic-castration-resistant-prostate-cancer-mcrpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-single-arm-prospective-study-of-high-dose-testosterone-in-combination-with-carboplatin-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-enzalutamide-on-anticoagulant-therapy-with-edoxaban-in-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-of-first-next-generation-sequencing-ngs-testing-at-the-end-of-life-in-patients-pts-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-baseline-and-on-treatment-ctdna-fraction-with-clinical-outcomes-in-patients-with-mcrp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survey-based-study-of-treatment-sequencing-after-first-line-1l-enfortumab-vedotinpembrolizumab-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-mcarh109-a-g-protein-coupled-receptor-class-c-group-5-member-d-gprc5d-targeted-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-renal-cell-cancer-histology-on-outcomes-of-microscopic-positive-surgical-margins-and-impli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-demographic-disparities-in-the-preferred-place-of-death-for-bladder-cancer-patients-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-of-spatial-transcriptomic-analyses-with-distance-associated-transcriptomic-spectrum-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypofractionated-radiotherapy-for-prostate-cancer-hydra-an-individual-patient-data-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kidney-sparing-approach-for-selected-localized-high-risk-upper-tract-urothelial-carcinoma-a-pilot-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-anti-pd-1-and-ctla-4-bispecific-antibody-combined-with-axitinib-for-the-first-line-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-specimen-type-on-digital-histopathology-based-multimodal-artificial-intelligence-mmai-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-clinicogenomic-study-of-androgen-receptor-mutations-and-co-mutations-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-y220c-mutations-in-advanced-urothelial-bladder-cancer-ubc-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-proteomic-profiling-of-plasma-samples-associated-with-response-or-resistance-to-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-neoadjuvantinduction-nac-chemotherapy-in-nonmetastatic-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-practice-gaps-and-challenges-for-immunotherapy-integration-in-treatment-of-metastatic-urot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-intravesical-bacillus-calmette-guerin-instillation-for-superficial-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-androgen-deprivation-therapy-with-enzalutamide-plus-the-glucocorticoid-receptor-modulato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/observational-study-of-tislelizumab-tisle-combined-with-pazopanib-in-reducing-venous-tumor-thrombu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-heterologous-prime-boost-strategy-using-ruti-vaccine-to-improve-the-bcg-response-in-non-muscle-inv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-clonal-hematopoiesis-and-survival-after-nephrectomy-in-patients-with-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-perceptions-about-their-treatment-for-muscle-invasive-bladder-cancer-mibc-over-the-last-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-systemic-therapy-and-surgical-consolidation-in-patients-with-node-positive-upper-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/additivity-and-the-efficacy-of-immune-checkpoint-blockade-based-combination-regimens-in-urothelial-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-ex-vivo-platform-to-model-immunotherapy-in-kidney-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-sociodemographic-marginalization-and-receipt-of-intensified-treatment-for-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-bladder-preservation-therapy-for-very-high-risk-non-muscle-invasive-bladder-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanded-access-program-of-cretostimogene-grenadenorepvec-in-patients-with-non-muscle-invasive-bladd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-cabozantinib-nc-vs-sunitinib-s-for-previously-untreated-advanced-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-pam50-for-predicting-progression-in-active-surveillance-results-from-the-miami-mast-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-clinical-and-pathologic-staging-of-t2a-b-and-t3a-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-ecog-performance-status-ps-using-large-language-models-in-patients-with-advanced-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-role-of-circulating-tumor-dna-ctdna-clearance-as-a-biomarker-in-localized-and-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-in-patients-diagnosed-with-metastatic-castration-resistant-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opar-a-randomized-trial-of-partial-breast-irradiation-in-five-fractions-once-daily-for-early-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-practice-gaps-in-timely-homologous-recombination-repair-gene-mutation-hrrm-tes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-medicare-advantage-ma-on-timely-hormonal-intensification-in-metastatic-hormone-sensitive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-us-county-level-analysis-of-erectile-dysfunction-diagnosis-following-radiation-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-from-a-prospective-study-of-comprehensive-genomic-testing-in-patients-pts-with-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-1-window-of-opportunity-study-of-ultrasound-guided-long-acting-periprostatic-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-impact-of-concomitant-squamous-differentiation-in-upper-tract-urothelial-carcinoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitive-tissue-based-detection-of-ar-v7-and-other-androgen-receptor-alterations-using-combined-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastasis-directed-treatment-mdt-for-patients-pts-with-non-clear-cell-renal-cell-carcinoma-ncc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determining-optimal-patient-selection-for-high-intensity-focused-ultrasound-hifu-for-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-integrating-palliative-care-on-the-uptake-of-advance-care-planning-among-elderly-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-variables-and-risk-factors-associated-with-urinary-leak-following-partial-nephrectomy-insi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-activity-of-inflammasome-genes-and-their-association-with-oncological-outcomes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-extended-interval-dosing-of-denosumab-in-patients-with-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-investigation-of-cpsf3s-role-in-the-progression-of-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-assessment-of-clinical-outcomes-of-first-line-treatment-in-metastatic-papillary-renal-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-hypofractionated-radiotherapy-and-pembrolizumab-in-the-treatment-of-muscle-invasive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ngs-based-molecular-panel-analysis-of-metastatic-prostate-cancer-for-daily-routine-how-often-do-we 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-survival-in-aggressive-variant-prostate-cancer-patients-undergoing-psma-radioligand-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/darolutamide-monotherapy-in-patients-with-castration-sensitive-prostate-cancer-cspc-after-biochemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-pelvic-radiotherapy-on-hematological-outcomes-in-pediatric-genitourinary-rhabdomyosarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-undetectable-psa-nadir-and-outcomes-for-patients-with-metastatic-hormone-sensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-pten-loss-on-outcomes-in-high-very-high-risk-advanced-hormone-sensitive-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-fexagratinib-fexa-in-combination-with-tislelizumab-t-in-a-phase-ii-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subdue-3-sub-urothelial-durvalumab-sirconium-to-investigate-local-and-systemic-distribution-of-durv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rad-sg-adaptive-radiation-therapy-with-concurrent-sacituzumab-govitecan-sg-for-bladder-preservati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-single-vs-combination-therapy-on-survival-outcomes-in-mhspc-patients-strat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/world-wide-oligometastatic-prostate-cancer-ompc-meta-analysis-leveraging-individual-patient-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-survival-outcomes-of-non-clear-cell-and-clear-cell-renal-cell-carcinomas-with-indication 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-follow-up-of-prostate-specific-membrane-antigen-petct-guided-salvage-radiotherapy-followi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-racial-disparities-in-testicular-cancer-survival-evidence-from-a-nationwide-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-diversity-and-disparities-in-a-real-world-locally-advancedmetastatic-urothelial-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progressive-t-cell-exhaustion-and-predominance-of-aging-tissue-associated-macrophages-with-advancing-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-efficacy-and-safety-exposure-response-er-analysis-of-tivozanib-tivo-for-the-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomic-analysis-of-tumor-tissue-from-patients-with-metastatic-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-upstaging-from-ct2a-b-to-pt3a-on-overall-survival-os-among-patients-with-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reflexive-paired-somatic-and-germline-testing-at-time-of-medical-oncology-referral-in-mcspc-impact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-existing-diabetes-mellitus-on-acute-care-use-in-older-patients-with-metastatic-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ifgd1i-splice-variants-as-predictors-of-brain-and-bone-metastatic-organotropism-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-site-of-metastatic-involvement-on-imdc-classification-in-metastatic-renal-cell-carcinoma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-treatment-selection-for-medicare-beneficiaries-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ev-302-updated-analysis-from-the-phase-3-global-study-of-enfortumab-vedotin-in-combination-with-pem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adherence-to-a-remote-exercise-program-on-health-related-quality-of-life-in-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protein-analysis-of-urachal-carcinoma-tissue-based-on-different-antibody-drug-conjugate-therapeutic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-of-jak-inhibition-in-stem-like-prostate-cancer-jasper-a-phase-12-multicenter-study-of-ruxo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/datopotamab-deruxtecan-dato-dxd-in-locally-advancedmetastatic-urothelial-cancer-updated-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-prognosis-of-metastatic-non-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-demographics-and-outcomes-in-hospitalized-patients-with-young-versus-averag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-tumor-microenvironmental-features-of-primary-and-synchronous-liver-metastases-from-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/itp53i-y220c-mutations-in-pancreatic-ductal-adenocarcinoma-pdac-a-genomic-landsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-tu-100-on-hepatocarcinogenesis-and-colorectal-liver-metastasis-in-mash-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-value-of-her2-gene-dosage-and-heterogeneity-at-a-single-cell-resolution-in-gastroesop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-pd-l1-expression-and-the-number-of-biopsy-specimens-in-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multimodal-deep-learning-approach-for-the-prognostic-stratification-of-patients-with-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-characteristics-of-tislelizumab-tis-plus-chemotherapy-chemo-in-first-line-1l-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-role-of-circulating-tumor-dna-for-locally-advanced-esophageal-squamous-cell-carcinoma-bef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pkpd-analyses-of-circulating-tumor-dna-ctdna-in-patients-with-metastatic-colorectal-cancer-mcrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-of-trastuzumab-deruxtecan-with-gastric-cancer-all-patient-post-marketing-surveill 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-biomarker-testing-and-first-line-treatment-patterns-among-locally-advanced-unresectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-therapy-with-nal-iri5-fufa-after-failure-of-gemcitabinenab-paclitaxel-in-advanced-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-characteristics-of-hepatocellular-carcinoma-cholangiocarcinoma-insights-from-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-the-paradigm-early-identification-of-colorectal-cancer-with-c-the-signs-clinical-decision 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-comparative-study-on-mdt-practices-in-the-management-of-hepatocellular-carcinoma-in-high-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-clinical-trial-enrollment-among-lgbtq-individuals-and-its-impact-on-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitizing-k-ras-g12d-mutant-colorectal-patient-derived-organoids-via-ferroptosis-pathway 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-with-or-without-chemotherapy-in-right-sided-metastatic-colorectal-cancer-updated-result 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cycle-neoadjuvant-pembrolizumab-in-patients-with-stage-i-iii-mmr-deficient-colon-cancer-fina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-point-surrogacy-in-first-line-chronic-lymphocytic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-double-window-of-opportunity-trial-evaluating-the-oral-tgf-beta-receptor-i-inhibitor-vact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/herizon-btc-302-a-phase-3-study-of-zanidatamab-with-standard-of-care-soc-therapy-vs-soc-alone-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-combining-pd-l1-and-ctla-4-blockade-with-transarterial-chemoembolization-in-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-marital-status-and-race-on-survival-of-patients-with-well-differentiated-neuroendocrine-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-in-peri-operative-chemotherapy-and-radiation-use-among-patients-with-resected-pancreatic-duc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-trifluridine-tipiracil-monotherapy-ftd-tpi-and-ftd-tpi-bevacizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-of-matched-tumor-samples-in-patients-with-rectal-cancer-undergoing-total-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/robot-assisted-esophagectomy-with-extended-mediastinal-lymph-node-dissection-the-learning-curve-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unbiased-transcriptomic-analysis-of-primary-early-onset-vs-late-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-gut-and-mucosal-microbiomes-in-patients-with-extrahepatic-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-agent-797-invariant-natural-killer-t-cells-botensilimab-fc-enhanced-ctla-4-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uses-of-vegf-inhibitor-bevacizumab-in-appendiceal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-phase-iiiii-randomized-controlled-trials-rcts-to-evaluate-the-incidence-of-hand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-clinical-trial-of-preoperative-docetaxeloxaliplatins-1-dos-combination-therapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vascular-endothelial-growth-factor-receptor-vegfr-tyrosine-kinase-inhibitors-combined-with-progra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-associated-with-recurrence-after-salvage-surgery-for-localized-anal-cancer-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-and-barriers-in-germline-testing-among-patients-with-early-onset-gastrointestinal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-metastatic-colorectal-cancer-crc-using-comprehensive-circulating-tumor-dna-ctdna-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-for-msi-h-colorectal-cancer-with-isolated-peritoneal-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-study-of-an-individualized-neoantigen-targeting-immunotherapy-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-survival-outcomes-in-patients-with-early-vs-late-onset-colorectal-cancer-with-liver-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-the-impact-of-timing-of-biomarker-testing-on-first-line-treatment-choice-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-autologous-cd8-and-cd4-transgenic-t-cells-expressing-high-affinity-kras-g12v-muta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-blood-based-test-for-colorectal-cancer-screening-adjusted-to-the-us-census-age-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-risk-factors-treatment-strategy-and-outcomes-of-early-vs-older-onset-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-for-locally-advancedmetastatic-mismatch-repair-deficient-colorectal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-nectin-4-expression-in-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-inhibitor-sintilimab-and-fruquintinib-plus-sox-as-conversion-therapy-for-initially-unresectab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-peritoneal-limited-metastatic-gastric-cancer-plgc-undergoing-bidirection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-of-response-in-patients-with-gastricgastroesophageal-junction-adenocarcinoma-gea-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-in-patients-with-newly-diagnosed-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-durvalumab-plus-tremelimumab-for-unresectable-hepatocellular-carcinoma-in-tha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-fruquintinib-alternating-with-bevacizumab-plus-capecitabine-as-maintenance-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implication-of-the-novel-microtubule-targeting-agent-aus-001-in-pancreatic-cancer-cellular-signali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/op-tnt-phase-ii-study-of-total-neoadjuvant-chemoradiotherapy-followed-by-local-resection-for-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sirtuin-genes-expression-on-first-line-treatment-outcomes-in-patients-pts-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-education-on-clinical-confidence-utilizing-her2-targeted-therapies-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-anamorelin-in-gastrointestinal-cancer-with-cancer-cachexia-single-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-simultaneous-adaptive-mri-guided-liver-sbrt-in-patients-with-heavily-pretreated-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-in-t3-and-t4-colon-cancer-is-there-a-promising-future 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-with-folfoxiri-for-high-risk-relapsed-locally-advanced-colon-cancer-a-sing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-assessment-of-mdm2-amplification-and-survival-among-patients-with-advanced-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-mesothelin-msln-expression-measured-by-rna-sequencing-rnaseq-and-immunohistochemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-event-free-survival-efs-as-a-surrogate-for-overall-survival-os-in-patients-with-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-utilization-of-colorectal-cancer-screening-modalities-among-patients-with-average-risk-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bifunctional-anti-pd-l1tgf-vrii-agent-shr-1701-plus-chemotherapy-as-first-line-treatment-for-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-burden-of-hepatocellular-carcinoma-recurrence-after-curative-treatment-in-spain 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-double-blind-phase-iii-study-comparing-trifluridinetipiracil-ftdtpi-versus-placeb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-study-investigating-rp2-oncolytic-immunotherapy-in-combination-with-second 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neoadjuvant-radiation-therapy-modalities-on-post-surgical-lymphopenia-in-operable-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-palliative-care-utilization-among-patients-with-anal-cancer-a-ten-year-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leading-the-way-how-leading-chinese-institutions-drive-mdt-excellence-in-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-factors-for-the-efficacy-of-nal-iri-5fulv-therapy-in-patients-previously-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-novel-biomarkers-and-novel-therapies-for-immune-checkpoint-inhibitors-icis-in-genet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-protein-energy-malnutrition-on-outcomes-in-patients-with-cholangiocarcinoma-admitted-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-in-patients-with-advanced-gastrointestinal-stromal-tumor-in-japan-an-administrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cross-sectional-analysis-from-a-real-world-cohort-of-patients-with-microsatellite-instability-colo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cadonilimab-plus-anlotinib-followed-by-surgery-for-locally-advanced-esophageal-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-incidence-and-risk-of-cardiovascular-events-among-gastroesophageal-cancer-patients-receiving-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-sintilimab-in-cancer-of-unknown-primary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-expand-indication-of-her2-targeted-therapies-by-monitoring-of-circulating-tumor-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-cut-off-value-for-lymph-node-harvesting-in-colon-cancer-based-on-tumor-stage-and-sidedness 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bragg-peak-proton-irradiation-and-atm-inhibition-for-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rate-of-gene-fusionrearrangement-identification-in-gi-cancers-as-sequencing-evolved-from-limited-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-nurses-telephone-follow-up-program-tsukiji-call-for-resectable-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-trends-in-small-bowel-adenocarcinoma-sba-from-2000-2019-in-the-united-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-nutritional-status-on-recurrence-free-survival-rfs-in-patients-with-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-outcomes-of-atezolizumab-plus-bevacizumab-treatment-in-patients-with-advanced-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-treatment-in-patients-with-advanced-gastrointestinal-stromal-tumours-gists-in-second-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-nivo-chemotherapy-chemo-vs-chemo-as-first-line-1l-treatment-for-advanced-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-cachexia-and-anti-cancer-therapies-on-gdf-15-levels-in-patients-with-pancreatic-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-clinical-trial-evaluating-the-safety-and-efficacy-of-initial-dose-adjustment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastric-cancer-patient-insights-patient-reported-outcomes-and-real-world-perspectives-from-the-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-pandemic-on-critically-ill-patients-with-colon-cancer-a-population-level-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-blood-based-colorectal-cancer-screening-a-simulation-model-incorporating-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lenvatinib-plus-hepatic-arterial-infusion-chemotherapy-of-oxaliplatin-fluorouracil-and-leucovorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-organ-preservation-op-in-node-negative-nn-low-rectal-cancer-rc-updated-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-screening-outcomes-associated-with-advanced-precancerous-lesion-versus-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-amplitude-modulated-radiofrequency-electromagnetic-fields-am-rf-emf-in-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-study-of-esophago-gastric-adenocarcinoma-egac-in-young-patients-under-the-age-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-deep-learning-based-pathomics-signature-for-prognosis-and-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-overall-survival-os-benefit-be-predicted-from-improvements-in-progression-free-survival-pfs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-radiomics-model-for-preoperative-pancreatic-neuroendocrine-tumor-grade-prediction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-emtansine-as-second-line-therapy-in-her2-positive-advanced-biliary-tract-cancers-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-engagement-in-pancreatic-adenocarcinoma-provisional-results-of-ilsta-study-durvaluma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/update-of-phase-1b2-study-of-muzastotug-adg126-an-anti-ctla-4-safebody-in-combination-with-pembr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-mfolfirinox-efficacy-as-first-and-subsequent-lines-of-advanced-gastrointestinal-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-and-racial-disparities-in-hepatocellular-carcinoma-associated-with-metabolic-syndro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-the-optimal-post-surgical-timing-of-molecular-residual-disease-mrd-detection-in-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-clinically-actionable-alterations-in-baseline-tumor-versus-plasma-samples-in-participant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-right-versus-left-sided-colon-cancer-and-rectal-cancer-in-patients-receiving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-khorana-score-2-molecular-correlates-of-venous-thromboembolism-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5-hydroxymethylcytosine-as-a-liquid-biopsy-biomarker-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ugt1a1-mutation-rates-in-a-minority-rich-comprehensive-cancer-center-a-retrospective-pharmacogenomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ww-vs-tme-in-patients-with-rectal-cancer-with-a-complete-or-near-complete-response-to-tnt-pooled-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-outcomes-in-dmmrmsi-h-andor-tmb-h-metastatic-colorectal-cancer-crc-with-peritoneal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-the-colorectal-cancer-alliances-digital-screening-quiz-and-navigation-model-for-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bxq-350-a-novel-sphingolipid-metabolism-modulator-in-combination-with-mfolfox7-and-bevacizumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-value-and-indications-for-surgery-in-pancreatic-cancer-with-synchronous-liver-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-the-association-of-ictrb2i-exon-6-deletion-with-time-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-study-of-tas-102-combined-with-intermittent-administration-of-fruquintinib-in-the-treatm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-differences-in-colorectal-cancer-across-race-and-ethnicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-neighborhood-deprivation-index-on-survival-in-gastric-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surufatinib-combined-with-locoregional-therapies-and-immune-checkpoint-inhibitor-ici-for-treating 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatially-resolved-protein-profiling-in-pancreatic-adenosquamous-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-imbalance-in-colon-cancer-screening-rates-in-texas-a-population-based-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-clinical-characteristics-of-patients-with-brain-metastases-at-diagnosis-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mediation-of-the-liver-protective-effect-of-the-anti-cancer-drug-candidate-namodenoson-via-adiponect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surufatinib-combined-with-tas-102-as-a-late-line-therapy-in-patients-with-metastatic-pancreatic-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-child-pugh-scores-and-outcomes-of-patients-with-hepatocellular-carcinoma-at-a-high-volume 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-versus-single-immune-checkpoint-blockade-for-patients-with-metastatic-colorectal-cancer-harbori 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-toxicities-and-survival-outcomes-among-patients-with-stage-iii-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-mediastinal-lymph-node-positivity-in-patients-undergoing-robotic-transthoracic-esophage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-sequences-in-patients-with-metastatic-colorectal-cancer-in-japan-real-world-evidence-of-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-treatment-delivery-of-perioperative-flot-therapy-in-locally-advanced-oga-associated-with-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-plogosertib-cyc149462-a-novel-orally-bioavailable-plk1-inhibitor-on-patient-derived 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-circulating-tumor-dna-in-patients-with-unresectable-pancreatic-cancer-using-a-patient-spe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-financial-burden-among-patients-with-pancreatic-cancer-at-a-tertia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-plasma-circulating-tumor-dna-assay-using-highly-sensitive-safe-seqs-technolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-imaging-and-machine-learning-based-radiomics-for-detection-of-mixed-hcc-and-cca-tumors-still-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-unmet-needs-in-colorectal-cancer-insights-from-patient-and-survivor-experiences 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-and-incidence-of-oncogenic-irasi-mutations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-tumor-regression-grade-trg-in-patients-with-gastricgastroesophageal-junction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-retrospective-observational-study-of-outcomes-of-treatment-for-unresectable-neuroendoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-impact-of-postoperative-outcomes-and-quality-of-life-on-decisional-regret-after-resection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-baseline-alterations-in-her2-pathway-oncogenic-drivers-on-response-to-anti-her2-therapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparative-study-of-dosage-strategies-in-hipec-bsa-based-vs-fixed-dose-methods 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-depression-on-esophageal-cancer-outcomes-using-the-national-inpatient-sample-nis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-ivaltinostat-an-hdac-inhibitor-plus-capecitabine-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-metastatic-spread-and-survival-outcomes-for-stage-iv-left-sided-colon-vs-rectal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-novel-therapies-and-circulating-tumor-dna-ctdna-as-a-marker-of-response-in-curatively-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-in-gi-cancer-leading-change-to-meet-the-needs-of-the-gastrointestinal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-in-gene-amplification-between-ierbb2i-and-other-oncogenes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-stereotactic-body-radiation-therapy-to-the-liver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-course-chemoradiation-vs-short-course-radiation-in-total-neoadjuvant-therapy-for-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-in-circulating-tumor-dna-ctdna-and-response-to-telisotuzumab-adizutecan-abbv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retreatment-with-immune-checkpoint-inhibitors-icis-for-patients-with-advanced-gastric-cancer-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-landscape-of-fgfr-variations-and-prognosis-revelance-in-colorectal-cancer-from-circula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iib-study-of-afatinib-with-capecitabine-in-patients-with-refractory-solid-tumors-and-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-immune-checkpoint-inhibitor-utilization-and-pd-l1-testing-in-advanced-gastroesophageal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-2-trial-of-ramucirumab-plus-docetaxel-as-second-line-treatment-for-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-ctdna-monitoring-to-assess-the-recurrence-of-early-stage-pancreatic-cancer-after-surger 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-circulating-tumor-dna-ctdna-testing-in-biliary-tract-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-xtx101-a-tumor-activated-fc-enhanced-anti-ctla-4-monoclonal-antibody-in-combin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-niraparib-and-dostarlimab-for-the-treatment-of-germline-or-somatic-homologous-reco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-immunotherapy-in-metastatic-pancreatic-carcinoma-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiomics-based-prediction-of-hcc-response-to-atezolizumabbevacizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-response-of-phase-iii-study-perioperative-camrelizumab-plus-rivoceranib-and-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-renin-angiotensin-system-inhibitors-on-patients-with-pancreatic-cancer-receiving-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-benefits-of-adjuvant-chemotherapy-after-surgical-resection-of-para-aortic-lymph-node-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-prospective-phase-ii-trial-of-second-line-aflibercept-plus-folfiri-in-patients-with-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-immune-repertoire-sequencing-analysis-to-detect-differences-in-treatment-responses-for-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-the-path-study-adjuvant-therapy-with-donafenib-plus-a-pd-1-inhibitor-for-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-anti-egfr-therapy-across-different-lines-of-treatment-in-irasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tislelizumab-chemotherapy-versus-placebo-chemotherapy-on-patient-reported-symptoms-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-shr-1701-on-chemotherapy-chemo-induced-myelosuppression-data-from-a-phase-3-study-in-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-differences-in-advanced-biliary-tract-cancer-patients-with-ctdna-detected-idh1-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-machine-learning-model-for-mortality-after-curative-gastrectomy-for-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ql1203-vs-placebo-plus-mfolfox6-as-first-line-therapy-in-ras-wild-type-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibrutinib-in-early-stage-chronic-lymphocytic-leukemia-the-randomized-placebo-controlled-double-bl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hormonal-contraception-and-breast-cancer-risk-for-carriers-of-germline-mutations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-of-the-impact-of-artificial-intelligence-in-pancreatic-cancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-specific-responses-to-nivolumab-plus-ipilimumab-in-patients-with-advanced-hepatocellular-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-randomized-controlled-trials-rcts-to-evaluate-the-incidence-of-hemorrhage-and-ven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-real-world-outcomes-of-single-versus-multi-agent-preoperative-chemoradiotherapy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-dose-intensity-di-and-time-to-adverse-events-aes-in-a-commercial-database-during-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kras-status-in-lung-oligometastases-treated-with-sbrt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/annual-incidence-of-colorectal-cancer-among-patients-with-average-risk-in-the-united-states-between 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomics-and-lethality-associated-stromal-remodeling-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-relapse-free-survival-in-stage-iii-gastric-cancer-patients-treated-with-postoperative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trifluridinetipiracil-and-bevacizumab-ftdtpibev-in-patients-with-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/what-is-the-optimal-treatment-strategy-of-salvage-line-treatment-after-progression-on-anti-epidermal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-nalirifox-compared-to-other-first-line-treatments-for-metastatic-pancreatic-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-dose-escalationexpansion-study-of-gsk5764227-gsk227-a-b7-homolog-3-b7-h3-protein-ta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-and-meta-analysis-on-evaluating-the-efficacy-and-safety-of-netupitantpalonosetr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd8-supsup-t-cell-proximity-analysis-of-the-tumor-microenvironment-tm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-serum-and-urine-mirnas-as-biomarkers-of-cancer-cachexia-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-early-onset-colorectal-cancer-related-mortality-among-adults-in-the-united-states-from-199 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparison-of-real-world-outcomes-by-mismatch-repair-status-in-patients-with-stage-iiiii-rectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-folfiri-with-low-dose-irinotecan-plus-ramucirumab-as-second-line-treatment-in-japa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-implication-of-body-composition-changes-in-patients-with-borderline-resectablelocally-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-therapy-with-somatostatin-analogs-for-recurrent-gastric-neuroendocrine-tumors-type-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-infusion-chemotherapy-and-embolization-taice-as-a-pre-operative-therapy-for-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-trial-of-systemic-chemotherapy-with-or-without-trastuzumab-followed-by-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-duration-of-neoadjuvant-chemotherapy-prior-to-crshipec-for-colorectal-cancer-an-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/provider-perspectives-on-non-medical-barriers-to-gi-cancer-care-at-a-regional-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-unplanned-readmission-to-the-same-facility-within-30-days-following-robot-assisted-and-lap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aflibercept-afl-vs-ramucirumab-ram-based-therapy-in-patients-with-advanced-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-role-of-circulating-tumor-dna-ctdna-in-stage-iii-colon-cancer-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-transarterial-chemoembolization-plus-atezolizumab-and-bevacizumab-in-unresectable-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-the-colorectal-tumor-immune-microenvironment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-of-nivolumab-nivo-plus-ipilimumab-ipi-vs-nivo-monotherapy-for-microsatellite-insta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digesting-danger-a-two-decade-study-exploring-the-association-between-food-processing-and-colon-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-qualitative-study-of-the-home-based-time-burdens-faced-by-persons-affected-by-gi-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-study-of-gevokizumab-gevo-in-combination-with-standard-of-care-soc-anticancer-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-modified-m-folfoxiri-plus-cetuximab-versus-bevacizumab-for-irasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-immunotherapy-trials-network-12-pembrolizumab-in-hiv-associated-kaposi-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-radiological-progression-in-participants-pts-with-embolization-eligible-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-regulatory-approval-of-a-new-systemic-targeted-therapy-for-advanced-hepatocellular-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-pd-l1-assays-28-8-and-sp263-and-their-respective-scoring-algorithms-in-procured 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-haip-therapy-in-metastatic-colorectal-cancer-efficacy-safety-and-progno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-her2-targeted-therapies-in-biliary-tract-cancer-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-preoperative-lynch-syndrome-diagnosis-on-surgery-in-patients-with-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pattern-and-predictors-of-d3-lymph-node-station-positivity-in-patients-undergoing-curative-surgery-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-anti-her2-agents-in-the-treatment-of-biliary-tract-cancers-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-durvalumab-d-with-or-without-tremelimumab-t-in-routine-clinical-practice-according-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ibii-study-of-fruquintinib-plus-5-fluorouracilleucovorin-after-progression-on-fruquintinib-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-and-nonoperative-management-of-dmmr-gastroesophageal-adenocarcinoma-gea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uncovering-the-role-of-oncogenic-iher2i-variants-as-drivers-of-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-alter-h006-a-phase-ii-study-of-benmelstobart-pd-l1-inhibitor-plus-anlotinib-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-gender-and-socioeconomic-disparities-in-survival-outcomes-of-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicology-and-clinical-protocol-development-of-duo-207-an-ultrasmall-nanomedicine-co-delivering-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-modulation-of-sorafenib-sor-induced-autophagy-using-hydroxychloroquine-hcq-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-trial-of-olaparib-pembrolizumab-vs-olaparib-alone-as-maintenance-therapy-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-social-support-discrimination-and-perceived-health-in-patients-with-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-phase-2-study-of-atezolizumab-plus-bevacizumab-atezobev-combination-therapy-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hlx22-plus-trastuzumab-and-xelox-for-first-line-treatment-of-her2-positive-locally-advanced-or-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-powered-analysis-of-tumor-infiltrating-lymphocytes-tils-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individual-patient-data-ipd-pooled-analysis-on-the-optimal-therapeutic-management-of-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clarity-gastric-01-a-randomized-phase-3-study-of-azd0901-a-claudin182-cldn182-targeted-antibod 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-baseline-geriatric-and-quality-of-life-assessments-on-treatment-outcomes-in-ecog-acrin-ea2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-and-phase-12-data-of-the-chk1-inhibitor-bbi-355-in-development-for-esophageal-and-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folfiri-ramucirumab-folfiri-ram-versus-ramucirumab-paclitaxel-ram-pac-in-the-second-line-2l-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-microsatellite-instability-testing-using-a-multiplex-assay-including-long-mononucleotide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-mrp4-levels-on-clinical-outcomes-in-biliary-tract-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iia-clinical-trial-of-first-line-cyclical-therapy-alternating-gemcitabine-cisplatin-and-du 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-oncogenomic-analysis-of-metastatic-squamous-cell-carcinoma-of-the-anus-utilizing-whole 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-liver-cancer-risk-and-outcomes-in-the-lgbtq-community-a-literature-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-management-of-locally-advanced-rectal-cancer-with-total-neoadjuvant-therapy-in-an-unders 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatotoxicity-following-external-radiotherapy-in-patients-with-hepatocellular-carcinoma-treated-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-of-durvalumab-plus-gemcitabine-and-cisplatin-in-patients-with-advanced-biliary-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-liquid-biomarker-analysis-from-the-neonax-trial-for-response-prediction-to-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-demographics-mortality-outcomes-and-resource-utilization-in-early-onset-versus-later 2026-08-24 monthly 0.7 https://rjrindex.com/articles/focusing-on-clinical-trial-ineligibility-nivolumab-plus-chemotherapy-for-patients-with-advanced-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-of-signet-ring-cell-src-gastric-carcinoma-gc-compared-with-other-histological-subtypes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-importance-of-treatment-handling-and-compliance-on-overall-response-rate-in-a-phase-iii-study-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telotristat-ethyl-to-promote-weight-stability-in-patients-with-advanced-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-centered-adverse-event-reporting-in-clinical-trials-a-novel-approach-using-ecog-acrin-e2211 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-treatment-patterns-among-patients-pts-with-metastatic-colorectal-cancer-mcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1a-dose-escalation-study-of-bgb-b167-a-cea-x-4-1bb-bispecific-antibody-as-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-fog-001-a-first-in-class-direct-v-catenintcf-inhibitor-in-patients-with-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-defactinib-in-combination-with-avutometinib-in-patients-with-advanced-diffuse-type 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-tislelizumab-tis-plus-chemotherapy-ct-vs-placebo-pbo-plus-ct-in-advancedmetas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-folinic-acid-fluorouracil-oxaliplatin-bevacizumab-botensilimab-balstilimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-liquid-biopsy-comprehensive-genomic-profiling-to-identify-the-molecular-landscape-of-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-the-role-of-interferon-stimulated-neutrophils-a-promising-biomarker-for-immunotherapy-ef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-nivolumab-nivo-plus-chemotherapy-chemo-vs-chemo-in-patients-pts-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adagrasib-ada-cetuximab-cetux-for-ikrasi-supg12csup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-implications-and-therapeutic-response-in-gnas-mutated-colorectal-adenocarcinoma-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-chemoradiation-combined-with-immunotherapy-for-patients-with-high-risk-resectable-extrahepa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-receipt-of-guideline-concordant-pancreatic-cancer-care-among-older-adults-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insight-a-phase-3-randomized-open-label-study-of-ripretinib-vs-sunitinib-in-patients-with-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-factors-related-to-survival-in-gastroenteropancreatic-neuroendocrine-tumors-gep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-prophylactic-tetracycline-use-among-patients-with-metastatic-colorectal-cancer-underg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trajectories-of-premorbid-healthcare-contact-days-in-veterans-with-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-pathogenic-variants-in-a-cohort-of-individuals-with-biliary-tract-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pancreatic-tumour-biomechanics-on-diagnosis-and-post-operative-complications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-laurens-subtype-in-locally-advanced-gastric-cancer-lagc-prognosis-a-call-for-change 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-mutational-landscape-in-primary-and-metastatic-pancreatic-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-frailty-risk-assessment-in-long-term-survivors-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-intrathecal-targeted-drug-delivery-itdd-on-oral-morphine-equivalents-and-pain-scores-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-isdc2i-gene-in-conjunction-with-iseptin9 2026-08-24 monthly 0.7 https://rjrindex.com/articles/btn1a1-expression-in-colon-cancer-implications-for-immunotherapy-and-patient-stratification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-nanoliposomal-irinotecan-and-fluorouracil-with-folinic-acid-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tislelizumab-chemotherapy-versus-placebo-chemotherapy-on-patient-reported-symptoms-and-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-cost-of-care-of-immune-oncology-treatments-for-unresectable-hepatocellular-carcinoma-a-singap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-perioperative-chemotherapy-combined-with-pd-1-inhibitor-versus-chemotherapy-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-immune-cell-abundance-across-hepatocellular-carcinoma-disease-stages-i-iii-findings-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-phase-11b-dose-expansion-results-of-the-bifunctional-egfrtgfv-inhibitor-ficerafusp-alf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-mid-chemoradiation-ctdna-results-and-clinical-complete-response-to-total-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-scrt-followed-by-fruquintinib-plus-adebrelimab-and-capox-in-the-total-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-events-aes-derived-biomarker-in-predicting-clinical-outcomes-in-patients-with-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-the-northstar-response-a-novel-quantitative-methylation-ctdna-monitoring-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-matched-targeted-therapy-on-survival-in-advanced-biliary-tract-cancer-an-inter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-analysis-of-paired-primary-and-metastatic-pancreatic-ductal-adenocarcinoma-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-biomarker-assessment-of-st316-a-novel-peptide-antagonist-of-ss-catenin-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-a-randomized-open-label-phase-2-study-of-botensilimab-bot-with-or-witho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-botensilimab-bot-plus-balstilimab-bal-in-resectable-mismatch-repair-proficient-pmmr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-and-efficacy-of-upfront-folfoxiri-and-bevacizumab-with-cadonilimab-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-malignant-portal-vein-thrombosis-in-patients-with-pancreatic-cancer-a-retrospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-novel-gene-fusions-in-gastrointestinal-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-study-to-assess-colonic-microbiome-changes-in-response-to-energy-drink-consumption-rosan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-comparison-of-second-line-treatment-strategies-for-patients-with-rasraf-wild-ty 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-surveillance-in-patients-with-intraductal-papillary-mucinous-neoplasms-ipmns-who-teste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-preferences-in-advanced-pancreatic-ductal-adenocarcinoma-pdac-from-qualitative-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-contrast-mri-as-a-surveillance-tool-for-recurrent-hepatocellular-carcinoma-after-curative-treatm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-organ-preservation-rate-for-high-risk-stage-i-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-vascularity-as-a-predictor-of-fgfr-inhibitor-response-in-fgfr2-fused-intrahepatic-cholangiocar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-nivo-plus-ipilimumab-ipi-vs-lenvatinib-len-or-sorafenib-sor-as-first-line-1l-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surrogacy-between-pathological-complete-response-and-overall-survival-an-individual-patient-data-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-botensilimab-bot-with-or-without-balstilimab-bal-for-patients-with-resectable-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-prospective-observational-study-of-chemotherapy-in-elderly-patients-with-biliary-trac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-retrospective-study-of-salvage-surgery-for-patients-with-residual-or-recurrent-esophag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-visceral-adipose-tissue-radiodensity-and-overall-survival-among-older-adults-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-disparities-in-allograft-access-in-the-era-of-post-transplant-cyclophosphamide-based-misma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/claudin-182-determination-in-locally-advanced-gastric-and-gastroesophageal-adenocarcinoma-treated-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-protein-energy-malnutrition-on-clinical-outcomes-in-hospitalized-gastric-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tetravalent-death-receptor-5-dr5-agonist-ozekibart-inbrx-109-folfiri-in-2l-colorectal-adenoca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-candidate-biomarkers-for-gastric-cancer-by-bioinformatics-analysis-of-pooled-micro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-multicenter-open-label-study-of-allostim-in-situ-cancer-vaccine-immunotherapy-as-3l-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-clinical-benefits-of-anti-cancer-drugs-approved-by-food-and-drug-administration-for-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-insurance-status-on-mortality-following-surgical-treatment-of-colorectal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-intravenous-pembrolizumab-and-intratumorally-injected-autologous-dendritic-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bevacizumab-plus-mfolfox6folfiri-sequential-bevacizumab-plus-capecitabine-maintenance-in-ras-mutate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-body-fat-and-ai-ensemble-technique-and-the-influence-on-false-positive-rate-in-ai-second-obs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-multi-site-translational-study-investigating-the-association-of-gut-microbiome-gm-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcome-of-radiofrequency-ablation-in-elderly-hepatocellular-carcinoma-patients-over-80-yea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-imeti-genomic-alterations-in-colorectal-cancer-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prevalence-of-lynch-syndrome-and-associated-clinicopathologic-features-in-patients-with-mismatch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-genomic-testing-performance-in-colorectal-cancer-crc-the-multiteam-systems-framework-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-analysis-of-pathological-complete-response-after-neoadjuvant-therapy-for-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-single-center-open-label-dose-de-escalation-and-expansion-study-of-ivosidenib-mfolfir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tas102-in-combination-with-oxaliplatin-tasox-for-refractory-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-rural-vs-urban-colon-cancer-mortality-in-texas-a-seer-database-analysis-from-201 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-to-surgery-on-outcomes-in-patients-with-advanced-esophageal-squamous-cell-carcinoma-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-exercise-in-gastric-cancer-patients-undergoing-gastrectomy-a-randomized-controlled-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-relapse-based-on-the-molecular-profiling-of-japanese-patients-with-stage-ii-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/care-delivery-and-biomarker-testing-for-people-with-colorectal-cancer-receiving-4r-care-sequence-pla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-12-study-mychelangelo-i-of-first-in-class-epigenomic-controller-otx-2002-tar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-glecirasib-jab-21822-monotherapy-and-in-combination-with-cetuximab-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-neoadjuvant-chemotherapy-with-fluorouracil-leucovorin-oxaliplatin-and-docetaxel-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcome-after-complete-response-with-immunotherapy-in-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-and-surgical-conversion-following-immunotherapy-in-msi-h-biliary-tract-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lapis-randomized-phase-3-trial-of-chemotherapy-ctx-with-and-without-pamrevlumab-pam-for-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anthracyclines-in-early-breast-cancer-the-long-goodbye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/goblet-platform-study-preliminary-safety-and-tumor-response-results-for-the-relapsed-anal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-for-detection-of-molecular-residual-disease-mrd-in-patients-pts-with-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-a-low-cost-minimally-invasive-screening-test-for-dihydropyrimidine-dehydrogenase-mutation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-randomized-phase-ii-study-of-osimertinib-with-and-without-ramucirumab-in-ty 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-neoadjuvant-therapy-with-folfox-plus-bevacizumab-and-short-course-radiotherapy-for-ras-mutant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-first-line-nivolumab-plus-chemotherapy-for-her2-negative-advanced-gastric-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/positive-homologous-recombination-signature-hrdsig-and-the-genomic-landscape-of-intrahepatic-chol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-time-to-first-therapy-ttft-variable-on-survival-outcomes-of-neoadjuvant-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-prognostic-model-for-advanced-gastric-and-oesophageal-carcinoma-ago 2026-08-24 monthly 0.7 https://rjrindex.com/articles/costs-of-generic-vs-branded-nab-paclitaxel-np-during-first-line-1l-treatment-of-metastatic-panc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-safety-and-short-term-efficacy-of-induction-dcf-plus-nivolumab-therapy-in-patients-with-unresect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-clinical-value-and-barriers-to-use-of-new-investigational-targeted-agents-in-the-commu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-racial-disparities-in-social-determinants-of-health-among-patients-with-gi-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-of-trop2-nectin-4-and-folr1-cell-surface-markers-in-biliary-tract-cancers-is-it-time-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/galeterone-monotherapy-in-advanced-pancreatic-ductal-adenocarcinoma-results-from-a-phase-two-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-atezolizumab-plus-bevacizumab-a-b-in-hispanic-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-immune-based-score-and-its-immune-contexture-exploration-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alternative-dosing-regimens-of-tislelizumab-proposed-using-modeling-and-simulation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-study-of-the-homologous-recombination-deficiency-signature-hrdsig-status-of-advanced-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/universal-screening-for-mismatch-repair-deficiency-in-gastrointestinal-cancers-in-a-reference-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-in-small-intestine-carcinoid-tumors-a-seer-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-experiences-and-decision-making-among-patients-with-metastatic-colorectal-cancer-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/goblet-study-results-of-the-safety-run-in-for-first-line-metastatic-pancreatic-ductal-adenocarcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-observational-study-to-evaluate-the-efficacy-of-trifluridinetipiracil-bevacizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/q-twist-analysis-of-pembrolizumab-plus-trastuzumab-and-chemotherapy-for-patients-with-metastatic-her 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-feasibility-safety-and-tumor-control-in-two-first-in-human-trials-of-a-novel-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-cabozantinib-and-nivolumab-in-refractory-metastatic-microsatellite-stable-mss-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/statistical-perspectives-and-meta-analytic-approaches-in-surrogate-end-point-evaluation-for-chronic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-analysis-of-a-phase-2-study-of-fruquintinib-plus-trifluridinetipiracil-tas-102-as-third-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-intraperitoneal-paclitaxel-in-eosinophil-activation-and-recruitment-in-the-peritoneal-cavity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-status-and-treatment-outcomes-of-intraductal-papillary-mucinous-carcinoma-in-korea-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-peritoneal-recurrence-following-laparoscopic-versus-open-surgery-for-stage-ii-or-iii-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-pathological-response-versus-recist-assessment-in-predicting-relapse-free-survival-following 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-and-long-term-outcomes-of-conversion-surgery-for-initially-unresectable-advanced-gastric-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-changes-in-body-composition-following-endoscopic-submucosal-dissection-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/birth-cohort-effects-in-appendiceal-adenocarcinoma-incidence-across-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-combined-with-penpulimab-and-nab-paclitaxel-as-first-line-treatment-for-advanced-esophagea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoradiotherapy-with-ipilimumab-and-nivolumab-in-rectal-cancer-chinorec-a-prospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-profiling-of-gastroenteropancreatic-gep-neuroendocrine-tumors-nets-an-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-irasbrafi-and-ipik3cai-mutations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mdm2-amplification-in-patients-with-biliary-tract-cancer-in-retud-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-multicenter-open-label-study-of-allostim-combined-with-anti-pd-l1immunotherapy-as-4l-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-treatment-patterns-and-clinical-outcomes-of-patients-treated-with-sequential-regoraf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-safety-and-short-term-efficacy-of-neoadjuvant-chemotherapy-in-elderly-patients-with-resectable-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-durvalumab-and-gemcitabine-based-chemotherapy-combined-with-or-without-lenvat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-liquid-biopsy-analysis-of-exosomal-mirna-to-detect-lymph-node-metastasis-in-early-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-residual-tumor-following-removal-of-a-malignant-colorectal-polyp-with-high-risk-features 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-socioeconomic-and-clinical-factors-contributing-to-treatment-delay-in-earl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-an-alteration-of-the-gut-microbiome-increase-risk-of-gastrointestinal-malignancies-insights-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-surufatinib-in-unresectable-or-metastatic-grade-3-pancreatic-neuroendocrine-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-for-a-colorectal-cancer-detection-blood-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-her2-positivity-on-prognosis-and-targeted-therapeutic-outcomes-in-advanced-biliary-tract-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-tissue-modified-viral-ttmv-hpv-dna-as-a-biomarker-of-treatment-efficacy-for-definitive-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-a-phase-2-study-of-triplet-blockade-of-the-il-27-pd-l1-and-vegf-pathways-with-casdo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-the-multicenter-randomized-phase-iii-trial-science-comparing-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-selection-for-advanced-or-metastatic-pancreatic-cancer-using-machine-learning-models-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-long-term-outcomes-for-neoadjuvant-chemoradiation-na-crt-followed-by-surgery-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-targeted-therapies-and-local-interventions-in-braf-v600e-mutated-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-prediabetes-on-cerebrovascular-risk-among-patients-with-gastrointestinal-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-the-prognostic-value-of-early-induction-of-s-1-postoperative-adjuvant-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-mucin-5ac-muc5ac-as-a-predictor-of-outcomes-and-microscopic-distant-metastasis-in-pancreatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-tisle-combined-with-pofi-irinotecan-paclitaxel-oxaliplatin-and-5-fulevoleucovorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-and-other-outcomes-of-hospitalizations-due-to-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-molecular-and-clinical-study-of-patients-with-young-onset-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-artificial-intelligence-in-colorectal-cancer-and-polyp-detection-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-5-fluorouracil-leucovorin-bevacizumab-as-second-line-therapy-in-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-ni-in-patients-pts-with-pancreatic-cancer-pc-with-ibr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-method-for-classifying-colorectal-cancer-and-gastricesophageal-cancer-using-blood-based-testing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-dose-adjustments-on-overall-survival-os-in-patients-with-metastatic-pancreatic-ductal-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acquired-gene-alterations-potentially-related-to-resistance-to-anti-her2-therapy-in-her2-positive-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-csf1r-as-a-potential-prognostic-biomarker-in-colorectal-cancer-alliance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-relative-treatment-efficacy-of-cd40-agonist-mitazalimab-in-combination-with-mfolfirin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-secondary-metastasis-in-patients-with-hepatocellular-carcinoma-a-5-year-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-results-of-askb589-combined-with-capox-and-pd-1-inhibitor-as-first-line-treatment-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-randomized-study-of-jmt101-in-combination-with-irinotecan-and-sg001-versus-regorafenib-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-as-a-marker-of-recurrence-risk-in-stage-iii-colorectal-cancer-the-a-correct-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-clinical-trial-design-to-mitigate-racial-disparities-in-pancreatic-cancer-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cetuximab-and-vemurafenib-plus-liposomal-irinotecan-ii-leucovorin-and-fluorouracil-for-braf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-early-tumor-shrinkage-with-survival-in-patients-with-her2-positive-advanced-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/more-isnt-always-better-expanding-and-refining-prognostic-methylation-signatures-for-pancreatic-du 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-tumoral-collagen-width-with-overall-survival-and-tumoral-collagen-straightness-with-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-an-automated-high-throughput-platform-to-generate-comprehensive-clinical-amp-molecular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-stereotactic-radiotherapy-in-brain-metastases-from-gastrointestinal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-mutations-and-cytotoxic-chemotherapy-response-for-advanced-solid-tumors-a-detailed-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-in-borderline-resectable-and-resectable-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-comparative-study-on-real-world-clinical-and-genomic-differences-in-advanced-biliary-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-disease-aetiology-on-outcomes-for-unresectable-hcc-treated-with-lenvatanib-or-atezobev-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-study-of-clinical-and-molecular-features-in-patients-with-metastatic-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-large-scale-pdo-based-assays-to-optimize-antibody-drug-conjugate-efficacy-in-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-prospective-study-to-evaluate-the-efficacy-of-resection-for-initially-unresectable-hep-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/everest-2-a-seamless-phase-12-study-of-a2b694-a-logic-gated-tmod-chimeric-antigen-receptor-t-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-skeletal-muscle-morphometrics-and-overall-survival-among-older-adults-with-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-osimertinib-and-vascular-endothelial-growth-factor-receptor-inhibitors-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-tolerability-of-different-total-neoadjuvant-therapy-strategies-in-patients-with-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-the-trastuzumab-deruxtecan-t-dxd-54-mgkg-triplet-combination-of-destiny-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-trends-of-early-onset-colorectal-cancer-eocrc-in-the-united-states-by-age-sex-race-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exclusive-liver-invasion-as-prognostic-indicator-in-t3-gallbladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-analysis-using-neoadjuvant-rectal-score-in-patients-with-locally-advanced-rectal-cancer-who 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-outcomes-of-pancreatic-cancer-hospitalizations-a-ten-year-trend-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-literature-review-slr-of-prognostic-factors-pfs-in-locally-advanced-rectal-cancer-la 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-clinical-and-molecular-characteristics-of-class-ii-and-iii-braf-mutations-and-thei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/selective-internal-radiation-therapy-with-yttrium-90-resin-microspheres-followed-by-lenvatinib-plus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/q-twist-analysis-of-pembrolizumab-or-placebo-plus-chemotherapy-for-patients-with-advanced-her2-negat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop2-expression-in-small-bowel-adenocarcinoma-a-potential-target-for-novel-therapeutic-strategies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-neuroendocrine-tumors-in-the-historically-underserved-population-of-bronx-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-variation-in-trajectories-of-colon-cancer-mortality-2012-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-subgroup-analysis-of-first-line-serplulimab-plus-bevacizumab-and-xelox-versus-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-impact-of-lymph-node-ratio-on-survival-in-patients-with-pancreatic-cancer-undergoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-surgery-and-overall-survival-in-non-metastatic-anal-cancer-a-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sil-204-sirna-encapsulated-in-extended-release-microparticles-for-the-treatment-of-localized-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanzalintinib-xl092-alone-or-in-combination-with-atezolizumab-in-patients-pts-with-refractory-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-iparomlimab-and-tuvonralimab-ql1706-or-iparomlimab-ql1604-bevacizumab-bev-for-unr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-dose-escalation-trial-of-gemcitabine-and-nab-paclitaxel-in-combination-with-lixumistat-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/niraparib-in-patients-with-ibrcai-mutated-unresectable-or-recurrent-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-docetaxel-and-cyclophosphamide-with-or-without-epirubicin-for-early-breast-cancer-final-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-cfdna-and-dna-integrity-index-dii-in-colon-cancer-in-response-to-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-chemotherapy-or-chemo-radiation-in-gallbladder-cancer-a-phase-iii-randomized-controlled-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-adjuvant-chemoradiotherapy-in-pancreatic-adenocarcinoma-with-r1-resection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/moonray-01-a-phase-1-study-of-ly3962673-a-potent-orally-bioavailable-and-selective-kras-g12d-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-trial-of-intraperitoneal-ip-mesothelin-msln-targeted-car-t-cell-therapy-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paclitaxel-oral-solution-versus-paclitaxel-injection-as-a-second-line-therapy-in-advanced-gastric-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-next-generation-sequencing-in-advanced-gastrointestinal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tyra-430-first-reversible-fgfr43-inhibitor-designed-to-overcome-current-challenges-in-fgf19-driven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-tis-chemotherapy-chemo-vs-placebo-pbo-chemo-as-first-line-1l-treatment-in-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kirros-a-phase-ii-trial-in-progress-of-first-line-atezolizumab-atezo-with-or-without-bevacizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physical-activity-and-sedentary-behavior-patterns-after-early-onset-colorectal-cancer-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-gastric-cancer-patients-with-positive-peritoneal-cytology-who-underwent-upfro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-study-of-fluoropyrimidine-chemotherapy-dosing-and-toxicity-in-patients-with-screen-det 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-neoadjuvant-nalirifox-followed-by-chemoradiation-with-paclitaxel-and-carboplatin-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alteration-of-gut-microbiota-in-patients-with-advanced-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/encorafenib-and-cetuximab-withwithout-binimetinib-therapies-for-patients-with-ibraf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-combined-with-pd-1-inhibitors-and-chemotherapy-in-the-first-line-treatment-of-her2-nega 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-mixed-methods-evaluation-of-the-canopy-cancer-collectives-implementation-of-network-wide-screenin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversion-from-radical-esophagectomy-to-definitive-chemoradiotherapy-after-neoadjuvant-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-phase-ii-trial-of-low-dose-decitabine-and-sintilimab-combined-with-chemotherapy-in-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-malnutrition-at-diagnosis-with-survival-among-older-adults-with-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-20-year-population-wide-cohort-study-on-association-of-aspirin-and-risk-of-gastrointestinal-and-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-preoperative-treatment-strategy-for-conversion-surgery-in-unresectable-locally-advanced-panc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-the-her3-directed-antibody-drug-conjugate-patritumab-deruxtecan-mk-1022-as-mono 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-neoadjuvant-therapy-followed-by-total-mesorectal-excision-and-selective-lateral-lymph-node-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-multi-target-stool-dna-test-in-the-us-asian-population-from-2017-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-methylation-based-tissue-agnostic-test-for-the-detection-of-molecular-residual-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-mortality-and-financial-burdens-in-patients-with-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-interval-circulating-tumor-dna-ctdna-kinetics-as-a-predictor-of-tumor-response-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-olaparib-in-patients-with-advanced-pancreatic-acinar-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-irasi-and-ibrafi-heterogeneity-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-patients-pts-with-metastatic-colorectal-cancer-mcrc-who-received 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distribution-of-lymph-node-metastasis-and-prognosis-in-duodenal-bulb-tumors-a-multicenter-retrospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-gene-expression-profiling-to-examine-association-between-muc1-and-claudin-18-in-gastrointesti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncomine-panel-testing-in-the-clinical-management-of-colorectal-cancer-an-irish-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-multicenter-retrospective-cohort-study-evaluating-the-safety-and-efficacy-of-ftdtpi-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hcc-in-the-rio-grande-valley-outcomes-in-a-predominant-latino-community 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-endoscopic-retrograde-cholangiopancreatography-ercp-vs-percutaneous-transhe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-healthcare-resource-utilization-hcru-and-costs-in-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-predictors-of-multi-target-stool-dna-test-completion-in-an-underserved-primary-care-popu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-long-term-chemotherapy-ctx-on-outcomes-in-pancreatic-ductal-adenocarcinoma-pdac-a-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-the-2018-world-cancer-research-fundamerican-institute-for-cancer-research-wcrfaicr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-features-of-the-morphological-subtypes-in-advanced-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/agitg-spar-a-randomized-placebo-controlled-phase-ii-trial-of-simvastatin-in-addition-to-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/young-onset-gastrointestinal-cancer-a-needs-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-insights-into-immune-related-adverse-events-irae-in-gastrointestinal-gi-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-cancer-related-deaths-in-patients-with-resectable-locally-advanced-esophageal-squamous-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalised-use-of-repurposed-non-anticancer-drugs-in-colorectal-cancer-based-on-up-regulated-signa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breakwater-analysis-of-first-line-encorafenib-cetuximab-chemotherapy-in-braf-v600e-mutant-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-of-combination-therapy-with-everolimus-plus-lanreotide-versus-everolimus-monothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-antitumor-activity-and-circulating-tumor-dna-ctdna-changes-with-rmc-9805-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/refining-colorectal-cancer-screening-strategies-using-polygenic-risk-scores-and-classical-risk-facto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-immunotherapy-for-real-world-patients-with-her2-negative-advanced-gastric-cancer-between 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u06-phase-12-umbrella-platform-study-of-trop2-antibody-drug-conjugate-sacituzumab-tirumot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-gut-microbiota-profiles-among-normal-colorectal-mucosa-adenomatous-and-hyperplastic-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-and-prognostic-impact-of-ignasi-mutations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-lysis-syndrome-in-colorectal-cancer-a-systematic-review-of-clinical-characteristics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-plus-best-supportive-care-for-patients-with-metastatic-colorectal-cancer-characterizat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-neoadjvuant-chemotherapy-versus-chemoradiation-for-esophageal-adenocarcinoma-a-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-cabozantinib-alone-or-in-combination-with-panitumumab-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-of-circulating-tumor-dna-ctdna-tumor-fraction-with-prognosis-in-patients-with-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-study-of-immunotherapy-with-ex-vivo-pre-activated-and-expanded-cbnk-cells-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-synergistic-effects-in-trials-of-combination-therapies-with-immune-checkpoint-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-pharmacogenetic-testing-in-the-management-of-gastrointestinal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-pd-l1-cps-and-clinical-outcomes-in-patients-treated-with-first-line-nivolumab-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-intraperitoneal-paclitaxel-based-regimens-in-patients-with-gastric-cancer-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/agx101-a-tm4sf1-directed-tubulin-inhibitor-conjugate-in-ongoing-first-in-human-trial-including-gi-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-formulated-favezelimab-plus-pembrolizumab-versus-standard-of-care-in-previously-treated-pd-l1-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envafolimab-in-combination-with-lenvatinib-and-albumin-paclitaxel-for-previously-treated-advanced-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optical-coherence-tomography-and-elastography-for-the-visualization-of-architecture-and-stiffness-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-on-colorectal-cancer-screening-using-medicare-centers-for-medicare-and-medicaid-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-result-of-a-phase-ib-study-efficacy-and-safety-of-fg-m108-plus-gemcitabinenab-paclitax 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-for-predicting-complete-response-to-total-neoadjuvant-therapy-in-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intraperitoneal-and-intravenous-paclitaxel-plus-s-1-versus-intravenous-paclitaxel-plus-s-1-in-gastri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-tumor-immune-microenvironment-time-and-somatic-landscape-in-gastrointestin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thoracic-radiotherapy-improves-the-survival-in-patients-with-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-relevance-of-tumor-fraction-assessment-from-circulating-tumor-dna-in-metastatic-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-circulating-tumor-dna-for-progression-free-survival-in-patients-with-locally-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-adjuvant-component-of-perioperative-chemotherapy-and-survival-outcomes-in-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-anti-epidermal-growth-factor-receptor-agents-in-elderly-patients-age-70-years-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/muc5ac-levels-as-predictors-of-adjuvant-therapy-outcomes-in-pancreatic-ductal-adenocarcinoma-a-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-for-patients-with-neoadjuvant-treatment-between-2019-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-icis-in-deficient-mismatch-repair-dmmrmicrosatellite-instability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-adebrelimab-combined-with-chemotherapy-for-locally-advanced-resectable-esophageal-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-inpatient-palliative-care-on-end-of-life-care-among-patients-with-early-onset-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mek-inhibitor-based-therapy-in-metastatic-pancreatic-adenocarcinoma-with-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-trends-demographic-disparities-and-survival-outcomes-of-gastrointestinal-malignancies-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-escalated-radiation-for-locally-advanced-unresectable-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/challenges-in-patient-selection-for-surgical-options-in-v600e-braf-mutated-metastatic-colorectal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-status-of-physicians-perception-of-hcc-conversiondownstaging-therapy-a-nationwide-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diverse-stromal-phenotypes-at-spatial-resolution-in-colorectal-cancer-peritoneal-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-communication-barriers-impacting-postoperative-decision-regret-in-patients-with-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-molecular-characteristics-of-patients-with-locoregional-ampullary-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nimotuzumab-combined-with-chemotherapy-plus-immunotherapy-as-first-line-treatment-for-advanced-esoph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serial-monitoring-of-circulating-tumor-dna-as-a-marker-of-response-to-immune-checkpoint-blockade-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/itp53i-y220c-mutations-in-colorectal-carcinoma-crc-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-protein-based-blood-panel-test-for-the-early-detection-of-colorectal-cancer-and-advanced-neoplasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-oncopig-hepatocellular-carcinoma-model-an-innovative-large-animal-platform-for-evaluating-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-agent-olaparib-in-advanced-oesophago-gastric-cancer-primary-results-from-the-solar-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-organ-preserving-strategy-in-patients-with-esophageal-squamous-cell-carcinoma-treated-with-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ck2-expression-gastrointestinal-cancer-exploring-clinical-characteristics-and-cancer-genetics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-a-phase-ii-study-of-acalabrutinib-venetoclax-and-obinutuzumab-avo-in-a-treatment-naive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-preoperative-pembrolizumab-for-msi-high-or-msspd-l1-gastric-cancer-followed-by-surgery-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-camrelizumab-rivoceranib-vs-sorafenib-cares-310-as-first-line-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-following-complete-clinical-response-to-chemoradiotherapy-for-rectal-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unitepanc-using-organoids-to-predict-efficacy-of-adjuvant-treatment-to-improve-outcome-in-resectabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanded-biomarker-analysis-of-an-international-open-label-phase-2-study-of-regorafenib-plus-pembro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-medicine-and-multidisciplinary-care-in-gastric-and-gastroesophageal-junction-ggej-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-by-transarterial-chemoembolization-tace-modality-from-participants-pts-with-embolizatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-aspirin-to-reduce-recurrence-rate-in-colorectal-cancer-patients-with-pi3k-pathway-alteratio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-plus-benmelstobart-as-adjuvant-therapy-in-patients-with-esophageal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-and-risk-factors-for-recurrence-of-hepatocellular-carcinoma-after-initial-complete-remission-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-validation-of-the-khorana-risk-score-in-gastric-cancer-patients-receiving-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redefining-the-use-of-a-first-line-folfirinox-like-regimen-in-older-patients-with-metastatic-pancrea-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-prospective-analysis-of-the-relationship-between-nanoliposomal-irinotecan-and-fluoroura 2026-08-24 monthly 0.7 https://rjrindex.com/articles/seven-year-efficacy-and-safety-in-a-randomized-phase-iii-trial-investigating-duration-of-adjuvant-ox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-computed-tomography-ct-based-staging-of-mismatch-repair-deficient-dmmr-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-target-stool-dna-test-adherence-in-average-risk-african-americans-from-2017-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-neratinib-nera-in-combination-with-chemotherapytrastuzumabpembrolizumab-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-adherence-to-nccn-and-bclc-treatment-guidelines-on-survival-in-hcc-a-single-center-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cetuximab-every-second-week-in-combination-with-daily-encorafenib-in-patients-with-braf-v600e-mutate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-colorectal-cancer-ct-imaging-features-involving-microsatellite-instability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-eol-outcomes-and-healthcare-utilization-for-patients-with-hepatocellular-carcinoma-hc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nelmastobart-hstc810-combined-with-capecitabine-therapy-in-metastatic-colorectal-cancer-with-resis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-and-outcomes-of-patients-with-brafv600e-mutant-metastatic-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-safety-trial-of-antibiotic-fecal-microbiota-transplantation-for-esophageal-and-gastric-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nirogacestat-in-patients-with-desmoid-tumors-and-mutations-of-adenomatous-polyposis-coli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-sequential-petct-imaging-to-predict-complete-response-after-definitive-chemoradiotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-checkpoint-inhibitors-in-patients-with-advanced-pancreatic-nets-displaying-high-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/definitive-local-therapy-in-solitary-liver-metastatic-anal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-atg-022-in-patients-with-advancedmetastatic-gastric-cancer-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-immunotherapy-for-advanced-melanoma-how-to-choose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institution-retrospective-study-evaluating-mitomycin-dosing-during-chemoradiation-in-anal-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-nucleotyping-and-tumor-stroma-ratio-to-predict-prognosis-in-patients-with-resected-intestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-trf-28-zj47d112z4dz-on-the-pathogenesis-of-gastric-cancer-through-targeting-cyclin-d1cdk4 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-study-of-radiotherapy-combined-with-tegafur-bolus-synchronization-in-the-treatment-of-inope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-trifluridinetipiracil-tas-102-plus-irinotecan-in-combination-with-bevacizumab-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-adebrelimab-plus-chemotherapy-for-resectable-locally-advanced-esophageal-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immune-checkpoint-blockade-in-resectable-hepatocellular-carcinoma-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-immunogenomic-landscape-of-primary-and-metastatic-gastroesophageal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-2-2-5-5-model-for-stratifying-liver-metastasis-burden-in-patients-with-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-in-digestive-tumors-with-mismatch-repair-deficiency-or-microsatellite-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-care-disparities-in-an-urban-diverse-population-a-tale-of-two-hospitals-in-the-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-between-neoadjuvant-chemotherapy-followed-by-surgery-and-definitive-chemoradiotherapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-of-early-onset-versus-average-onset-gastroesophageal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-hypofractionated-radiotherapy-5x5-gy-with-a-simultaneous-integrated-boost-5x 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-restricted-mean-survival-time-rmst-analysis-of-survival-in-advanced-hepatocellular-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-shr-1701-a-bifunctional-anti-pd-l1tgf-vrii-agent-combined-with-chemoradiotherapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-in-physical-cognitive-and-sexual-health-in-early-onset-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-the-phase-ibii-study-of-fruquintinib-combined-with-sox-and-toripalimab-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-and-socioeconomic-disparities-in-cancer-free-and-all-cause-survival-in-cholangiocarcinoma-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-amplification-ratio-for-established-and-emerging-biomarkers-in-gastroesophageal-ge-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cabozantinib-for-advanced-gastrointestinal-gi-neuroendocrine-tumors-net-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-molecular-residual-disease-mrd-testing-with-measurement-of-circulating-tumor-dna-ctdna-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-alter-h004-study-anlotinib-combined-with-tace-as-adjuvant-therapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-institutional-retrospective-study-evaluating-clinical-outcomes-and-prognostic-factors-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-the-randomized-trial-on-open-versus-laparoscopic-surgery-for-primary-tumor-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soxfolfoxnivolumab-followed-by-conversion-surgery-for-her2-negative-primary-gastric-or-gastroesoph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-postoperative-complications-after-neoadjuvant-therapy-followed-by-esophagectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anlotinib-as-a-later-line-treatment-for-advanced-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-and-impact-of-a-genome-wide-homologous-recombination-deficiency-signature-hrdsig-on-the-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-total-neoadjuvant-treatment-tnt-for-locally-advanced-rectal-cancer-maria-sk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-metastatic-dmmr-immunotherapy-commit-study-a-randomized-phase-iii-study-of-atez-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-variants-and-clinical-factors-affecting-the-response-to-5-fluorouracil-based-treatment-in-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-expression-of-metabolic-genes-on-patient-pts-outcomes-in-metastatic-colorectal-cancer-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-incidence-and-mortality-of-colorectal-cancer-in-appalachian-kentucky 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-presenting-symptoms-of-patients-with-appendiceal-malignant-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-target-stool-dna-test-adherence-among-average-risk-45-to-49-year-old-patients-from-2017-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-biomarker-testing-patterns-first-line-treatment-and-drivers-of-treatment-choice-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-homologous-recombination-deficiency-on-survival-and-chemotherapy-response-in-small-bowel-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-peri-operative-novottf-200tp-in-combination-with-gemcitabine-and-nab-paclitaxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-effect-of-the-gut-microbiome-on-tumour-response-to-anti-cancer-treatment-in-patients-diagn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/highly-accurate-detection-of-early-stage-colorectal-cancer-using-tumor-and-immune-extracellular-vesi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-based-total-neoadjuvant-therapy-combined-with-tislelizumab-in-the-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-changes-in-body-composition-and-sociodemographic-factors-on-colon-cancer-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-microscopic-residual-disease-mrd-monitoring-with-circulating-tumor-dna-ctdna-in-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amber-part-2f-cobolimab-in-combination-with-dostarlimab-in-treatment-naive-patients-with-locally-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-metastatic-gastric-cancer-gc-in-patients-aged-80-years-or-older-immediate-and-long-term-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-human-epidermal-growth-factor-receptor-2-her2-status-by-immunohistochemistry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-associated-with-metastatic-early-onset-colorectal-cancer-among-black-patients-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/valemetostat-and-trastuzumab-deruxtecan-t-dxd-in-previously-treated-advanced-or-metastatic-human-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-features-of-epstein-barr-virus-associated-gastric-cancer-based-on-pd-l1-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-biological-divergence-of-upper-gastrointestinal-adenocarcinomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-and-ethnic-disparities-in-hepatocellular-carcinoma-trends-in-incidence-rates-across-us-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-chemotherapy-regimen-matter-for-first-line-immunochemotherapy-in-low-programmed-cell-death-liga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-among-us-adults-with-unresectable-hepatocellular-carcinoma-uhcc-el 2026-08-24 monthly 0.7 https://rjrindex.com/articles/xpo1-inhibition-as-a-clinically-viable-strategy-to-enhance-durability-of-response-to-kras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-study-evaluating-the-genomic-landscape-of-anal-squamous-cell-carcinoma-using-liquid-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-target-stool-dna-test-for-colorectal-cancer-screening-and-effects-on-health-and-economic-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-analysis-of-medicare-expenditure-and-utilization-of-egfr-inhibitors-from-2018-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-pd-1-inhibitor-plus-chemotherapy-versus-chemotherapy-in-advanced-esophageal-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-risk-stratification-in-older-intensively-treated-patients-with-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b-portion-of-the-action-1-phase-1b3-trial-of-ryz101-in-gastroenteropancreatic-neuroendocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intra-arterial-gemcitabine-versus-intravenous-gemcitabine-pharmacokinetic-sub-study-of-the-tiger-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-the-alter-e009-study-efficacy-and-safety-of-anlotinib-combined-with-radiothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversion-effects-of-pd-1-inhibitor-camrelizumab-cam-combined-with-nab-pof-regimen-in-patients-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-determinants-of-targeted-therapy-tt-outcomes-in-biliary-tract-cancer-btc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-combined-with-folfirimfolfox6-as-second-line-treatment-in-patients-with-ras-mutant-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiationscrt-followed-by-6-cycles-of-cadonilimab-plus-mfolfox6-as-neoadjuvant-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-first-in-human-study-of-tyra-200-in-advanced-intrahepatic-cholangiocarcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-thermo-ablation-of-liver-metastases-in-colon-cancer-a-maltese-perspective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-genomic-profiles-and-survival-outcomes-in-patients-with-her2-positive-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-site-blinded-validation-of-a-deep-learning-approach-for-clinical-grade-msidmmr-detection-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-analysis-and-clinical-validation-to-identify-biomarkers-for-trifluridinetipiracil-ftd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-of-surveillance-ct-scan-ordering-in-patients-with-stage-iiiii-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-tas-102-and-chemotherapy-rechallenge-in-the-third-line-setting-and-beyond-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/observational-study-of-the-extent-of-lymph-node-metastasis-among-patients-who-underwent-pancreatoduo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-benefits-of-asymptomatic-primary-tumor-resection-after-bevacizumab-plus-folfiri-as-first-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-protocol-for-pretreatment-testing-for-antibodies-to-galactose-alpha-13-galactose-to-mitigate-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-immune-related-adverse-events-and-prognosis-after-immune-checkpoint-inhibitor-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemotherapy-with-either-s-1-or-5-fluorouracil-plus-oxaliplatin-and-docetaxel-for-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-combined-resection-of-pancreas-on-long-term-survival-in-patients-with-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extra-hepatic-ehcca-and-intra-hepatic-cholangiocarcinomas-icca-a-genomic-landscape-comparison-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/equity-gi-a-prospective-study-to-enhance-quality-inclusivity-and-trial-participation-in-black-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-to-assess-the-safety-and-efficacy-of-flx475-tivumecirnon-combined-with-pembrolizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biological-and-therapeutic-impact-of-tumor-mutational-burden-in-microsatellite-instabilitymismatch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-fruquintinib-plus-sintilimab-as-a-second-line-therapy-for-advanced-gastric-and-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-nutritional-status-in-elderly-patients-with-gastroesophageal-cancer-a-post-hoc-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prevalence-and-prognostic-significance-of-ikras-g12ci-mutation-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-characteristics-of-high-risk-recurrent-or-metastatic-endometrial-cancer-tha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-tace-combined-with-camrelizumab-and-apatinib-versus-tace-alone-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-crossover-of-the-bevacizumab-and-panitumumab-survival-curves-in-the-paradigm-study-a-clue-to-ti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histopathological-growth-patterns-of-gastric-cancer-liver-metastasis-and-their-association-with-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-plus-camrelizumab-combined-with-paclitaxel-liposome-and-nedaplatin-as-first-line-treatm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-benmelstobart-plus-anlotinib-combined-with-sox-in-the-first-line-treatment-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-trends-and-outcomes-of-appendiceal-cancers-a-national-cancer-database-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-second-primary-cancer-among-patients-with-a-first-primary-appendiceal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-tab-eoao-study-trends-in-use-and-benefit-of-adjuvant-chemotherapy-between-early-onset-and-avera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-outcomes-of-patients-with-early-onset-versus-average-onset-small-bowel-neuroendo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-predictive-factors-for-detecting-kras-mutations-in-pancreatic-cancer-using-liquid-biopsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-pathologic-characteristics-in-young-patients-with-metastatic-colorectal-cancer-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-inpatient-palliative-care-consultation-on-end-of-life-care-among-patients-with-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-impact-of-islfn11i-gene-expression-in-metastatic-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-ctdna-levels-timing-of-blood-collection-and-overall-survival-in-metastatic-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-the-trophoblast-cell-surface-antigen-2-trop2-antibody-drug-conjugate-adc-saci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-value-of-para-aortic-lymph-node-dissection-in-gastric-cancer-with-extensive-lymph-node-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-versus-adjuvant-therapy-in-resectable-pancreas-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-atezolizumab-bevacizumab-atezobev-or-durvalumab-tremelimumab-durvatreme-in-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-and-biliary-tract-cancers-changing-epidemiology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-proteinuria-with-atezolizumab-plus-bevacizumab-versus-lenvatinib-in-first-line-systemic-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-low-dose-regorafenib-with-pembrolizumab-for-patients-with-msi-h-colorectal-cancer-regpem-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-methylation-signature-for-gemcitabine-sensitivity-in-pancreatic-ductal-adenocarcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cohort-level-patient-derived-organoid-assays-and-prediction-of-clinical-trial-outcomes-in-pdac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-and-biomarker-analysis-of-the-efficacy-and-safety-of-pd-1-inhibitor-combined-with-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanidatamab-dose-optimization-in-patients-with-her2-positive-biliary-tract-cancer-btc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-plus-chemotherapy-versus-placebo-plus-chemotherapy-in-patients-with-advanced-her2-nega 2026-08-24 monthly 0.7 https://rjrindex.com/articles/communication-of-cancer-biomarker-testing-results-what-patients-need 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-os-of-patients-with-metastatic-pancreatic-ductal-adenocarcinoma-mpdac-treated-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-ex-vivo-pharmacotyping-of-patient-derived-tumor-organoids-and-personalized-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eortc-1203-gitc-innovation-integration-of-trastuzumab-t-with-or-without-pertuzumab-p-into-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-assessed-by-a-10-item-index-from-comprehensive-geriatric-assessment-fi-cga-10-versus-oncol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-safety-of-immune-checkpoint-inhibitors-prior-to-liver-transplant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-the-randomized-phase-2-part-of-the-aspen-06-study-a-phase-23-study-of-evorpacept 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-link-between-liver-cirrhosis-and-liver-metastasis-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-tolerability-and-preliminary-efficacy-of-tinodasertib-as-a-monotherapy-or-in-combination-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matching-adjusted-indirect-comparison-maic-of-sup177sup-lu-dotatate-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-treatment-results-for-oligo-recurrence-of-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-real-world-first-line-1l-use-of-single-dose-tremelimumab-regular-interval 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-conversion-therapy-for-metastatic-esophageal-cancer-exploratory-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-gastric-cancer-registry-a-multi-omic-cellular-and-molecular-resource-for-cancer-biomarker-and-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemoimmunotherapy-for-patients-with-gastric-or-gastroesophageal-junction-cancer-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-rates-of-attrition-and-barriers-to-surgical-resection-in-patients-undergoing-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-data-review-on-community-physicians-treatment-preferences-in-frontline-esophageal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoradiotherapy-crt-followed-by-sequential-tislelizumab-tis-capox-and-tis-monotherapy-for-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-relationship-between-the-tumor-microenvironment-of-hepatocellular-carcinoma-and-apparent-diffusi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-gpr120-and-ngf-with-perineural-invasion-in-cholangiocarcinoma-clinical-and-experimen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-pdacai-v20-in-predicting-relative-benefit-from-frontline-folfirinox-ffx-and-gemcita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-incidence-and-survival-in-anal-adenocarcinoma-a-seer-study-of-racial-and-age-disparities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-literature-review-of-studies-assessing-first-line-1l-treatments-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-socioeconomic-disparities-and-the-likelihood-of-multimodal-treatment-utilization-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-legal-and-administrative-burden-support-collabs-a-pilot-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pd-1-blockade-in-mismatch-repair-deficient-or-microsatellite-instability-high-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-development-of-the-lipid-nanoparticle-based-mrna-vaccine-with-multiple-natural-t-cell-ep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-outcomes-of-90-yttrium-radioembolization-in-combination-with-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-outcomes-for-early-and-late-drainage-of-malignant-ascites 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-trial-of-encorafenib-cetuximab-and-nivolumab-in-microsatellite-stable-ibr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-immunotherapy-response-in-deficient-mismatch-repair-colorectal-cancers-using-an-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-treatment-outcomes-for-metastatic-early-onset-small-bowel-adenocarcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-as-predictive-biomarkers-for-cancer-associated-thrombosis-cat-in-biliary-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peak-part-1-summary-a-phase-3-randomized-open-label-multicenter-clinical-study-of-bezuclastinib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mek-inhibitor-based-therapy-in-metastatic-pancreatic-adenocarcinoma-with-ikrasi-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-mortality-in-upper-gastrointestinal-tract-cancer-using-long-short-term-memory-neural-netw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-or-placebo-plus-chemotherapy-for-advanced-her2-negative-gastric-or-gastroesophageal-ju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-pathological-characteristics-follow-up-and-survival-of-patients-with-early-onset-vs-late 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-and-molecular-mechanism-of-gdf5-in-regulating-cell-migration-and-angiogenesis-via-the-hippo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-late-recurrence-of-colorectal-cancer-crc-among-older-long-term-survivors-using-claim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-combined-with-immunotherapy-and-prognosis-of-unresectable-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-role-of-bispecific-and-car-t-cell-therapies-in-gastric-cancer-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blood-tctp-as-a-biomarker-associated-with-immunosuppressive-features-and-resistance-to-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-characterization-of-ifapi-and-ispp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prompt-initiation-of-durvalumab-and-tremelimumab-treatment-for-unresectable-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disease-free-survival-as-a-surrogate-endpoint-for-overall-survival-in-adults-with-early-stage-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avutometinib-plus-cetuximab-after-chemotherapy-in-patients-with-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chidamide-plus-envafolimab-combined-with-s-1-as-second-line-treatment-in-advanced-and-metastatic-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-targeting-ctmp-on-immunogenicity-of-msi-l-colon-adenocarcinoma-cells-by-metabolism-and-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-extracolonic-malignancies-in-patients-with-familial-adenomatous-polyposis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zimberelimab-platform-study-safety-and-efficacy-of-zimberelimab-in-combination-with-futibatinib-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-excess-costs-associated-with-hematologic-adverse-events-haes-during-first-line-1l-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/p53-pathway-genes-mutations-as-prognostic-factors-in-patients-pts-with-metastatic-pancreatic-duct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-the-delay-of-surgery-in-localized-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-race-on-end-of-life-care-among-patients-with-esophageal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tinengotinib-in-patients-with-advanced-metastatic-cholangiocarcinoma-overall-survival-results-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-single-arm-single-center-clinical-trial-of-all-trans-retinoic-acid-bevacizumab-and-atezo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-results-of-a-phase-1-trial-evaluating-a-her2-directed-car-t-product-selective-for-the-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatocellular-carcinoma-a-30-year-trend-analysis-of-global-burden-stratified-by-risk-factors-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-study-of-first-line-sotorasib-panitumumab-and-folfiri-versus-folfiri-with-or-without-bev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-of-patients-with-liver-single-organ-metastases-updated-survival-results-of-bbcapx-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eortc1527jcog1609intesso02-diffusion-weighted-magnetic-resonance-imaging-dw-mri-assessment-of-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-survival-results-of-zl-irian-irinotecan-plus-anlotinib-or-in-combination-with-penpulimab-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/increasing-ras-mutation-result-availability-in-newly-diagnosed-patients-with-metastatic-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-supportive-medications-to-prevent-and-manage-key-adverse-events-during-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-patients-with-locally-advanced-rectal-cancer-in-the-total-neoadjuvant-therapy-tnt-er 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-adjuvant-radiotherapy-after-endoscopic-resection-of-early-esophagus-cancer-to-prevent-new 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-characteristics-of-gastric-and-pancreatic-cancers-in-latin-america-gaspar-lacog-02 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-lipogenic-and-metabolic-subtypes-and-survival-outcome-in-patients-with-pancreatic-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proto-oncogene-hras-transcript-level-and-overall-survival-in-stage-ii-and-iii-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fg-m108-plus-capecitabine-and-oxaliplatin-capox-for-first-line-treatment-of-cldn182her2-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-i-trial-with-antibody-drug-conjugate-adct-701-in-neuroendocrine-tumors-and-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cross-sectional-analysis-from-a-real-world-cohort-of-patients-with-microsatellite-instability-colo-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-randomized-study-evaluating-safety-efficacy-and-optimal-dose-of-abbv-400-in-combination-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/man-versus-machine-comparative-analysis-of-chatgpts-colon-cancer-guidance-and-expert-opinion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/agitg-ascend-randomised-double-blind-phase-ii-study-of-certepetide-or-placebo-added-to-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-to-evaluate-chm-2101-an-autologous-cadherin-17-cdh17-chimeric-antigen-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-cytokine-induced-killer-cell-immunotherapy-in-hepatocellular-carcinoma-extended-follow-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrate-iia-phase-iii-study-regorafenib-for-refractory-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-in-advanced-hepatocellular-carcinoma-with-child-pugh-b-a-multicenter-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-on-treatment-circulating-tumor-dna-ctdna-changes-from-a-phase-1-study-of-rmc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcome-of-radiation-related-esophageal-stricture-from-endoscopic-dilation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-stage-of-diagnosis-of-colon-cancer-differences-by-hispanic-background-race-and-eth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-cancer-stage-at-diagnosis-among-older-adults-with-gastrointestinal-cancers-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-locally-advanced-unresectable-and-de-novo-metastatic-pancreatic-duct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-and-timing-of-decreased-adherence-to-s-1-in-postoperative-docetaxel-s-1-therapy-for-gastri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-immune-related-adverse-events-and-clinical-outcomes-in-patients-treated-with-fir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-pembrolizumab-in-advanced-esophageal-carcinoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-shallow-whole-genome-sequencing-profiling-in-patients-with-i-ras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-phase-iiiii-randomized-controlled-trials-rcts-to-determine-the-incidence-of-hype 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-a-gastroesophageal-adenocarcinoma-gea-multicohort-using-next-generation-seq 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-disease-characteristics-in-young-vs-older-adults-with-colorectal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b-study-of-futibatinib-plus-pembrolizumab-in-patients-with-esophageal-carcinoma-evaluating-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dmmrmsi-tumour-occurrence-during-follow-up-of-patients-with-lynch-syndrome-treated-with-immune-chec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-antibiotic-use-and-survival-among-patients-receiving-first-line-immunotherapy-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modified-frailty-index-mfi-5-as-a-prognostic-tool-of-mortality-complications-and-readmissions-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumour-free-ctdna-detection-as-a-decision-tool-to-support-organ-preservation-in-node-negative-rectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-allograft-access-in-the-era-of-post-transplant-cyclophosphamide-based-mismatched-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alterations-in-gut-microbiome-in-age-and-diet-induced-colorectal-cancer-crc-progression-in-a-prec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-experience-with-atezolizumab-bevacizumab-ab-for-the-treatment-of-unresectable-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-arm-phase-ii-trial-of-trastuzumab-deruxtecan-in-patients-with-gastrooesophageal-adenocarcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-and-stereotactic-radiotherapy-combined-in-subjects-with-advanced-hcc-a-phase-ii-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-nivolumab-use-on-the-efficacy-of-second-line-taxane-based-chemotherapy-in-advanced-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-homologous-recombination-deficiency-on-survival-in-patients-with-metastatic-colorectal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adequate-racial-and-ethnic-representation-in-cancer-clinical-trial-enrollment-real-world-evidence-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-capecitabine-in-resected-biliary-tract-cancers-real-life-data-from-a-multicenter-study-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-ketorolac-on-serum-gdf-15-and-il-8-in-patients-with-pancreatic-cancer-with-cachexia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-trends-in-incidence-and-mortality-of-pancreatic-cancer-an-analysis-of-the-surveillance-epi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-efficacy-and-safety-of-pd-1-and-pd-l1-antibodies-in-combination-with-hepatic-arterial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoimmunotherapy-plus-radiotherapy-in-advanced-esophageal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beamion-bcgc-1-a-phase-ibii-trial-of-the-her2-selective-tyrosine-kinase-inhibitor-tki-zongertini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-synchronous-vs-metachronous-primary-tumor-resection-on-prognosis-of-braf-v600e-mutant-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-pathologic-response-in-the-colorectal-cancer-cohort-of-the-imhotep-phase-ii-trial-of-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-the-spear-scoring-model-and-predicting-overall-survival-in-unresectabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-landscape-of-cell-free-dna-alterations-in-patients-with-advanced-biliary-tract-cancer-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-new-therapeutic-strategies-to-enhance-the-effectiveness-of-irinotecan-in-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/natural-history-study-of-patients-with-pancreatic-acinar-cell-carcinoma-a-3-year-prospective-longit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-native-hawaiians-and-other-pacific-islanders-with-early-onset-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-albumin-bound-docetaxel-vs-docetaxel-in-patients-with-previously-treated-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-open-label-study-of-sacituzumab-govitecan-in-patients-with-previously-treated-locally-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-episwitch-in-predicting-immunotherapy-response-in-hepatocellular-carcinoma-and-gastroi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vegf-a-as-a-prognostic-indicator-in-advanced-gastric-and-colorectal-cancers-and-correlation-with-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-ctdna-measurements-for-treatment-response-monitoring-in-patients-with-metastatic-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-neoadjuvant-flot-and-chemoradiation-for-trimodality-therapy-of-esophagealgej-aden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg-gi007-secondary-endpoints-of-safety-assessment-and-clinical-complete-response-ccr-of-chemorad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-iugt1a128i-polymorphism-on-tolerability-in-patients-with-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-safety-and-efficacy-data-of-sup212sup-pbvmt-a-net-in-somatos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-dur-effectiveness-in-advanced-biliary-tract-cancer-abtc-patients-based-on-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intra-tumoral-cd40-antibody-with-irreversible-electroporation-ire-in-locally-advanced-pancreas-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-tumor-treating-fields-ttfields-with-folfirinox-on-brca-wt-pancreatic-cancer-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-dna-methylation-analysis-of-cadonilimab-combined-with-taxane-and-cisplatin-as-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-the-multi-target-stool-dna-test-in-the-us-hispanic-population-from-2016-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-social-deprivation-and-colon-cancer-mortality-a-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pamrevlumab-plus-nab-paclitaxelgemcitabine-pam-ga-as-first-and-second-line-therapy-in-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immulab-a-phase-ii-trial-of-immunotherapy-with-pembrolizumab-in-combination-with-local-ablation-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-dkk1-to-remodel-the-tumor-microenvironment-and-enhance-immune-checkpoint-blockade-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/datopotamab-deruxtecan-versus-docetaxel-for-previously-treated-advanced-or-metastatic-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glofitamab-in-relapsedrefractory-mantle-cell-lymphoma-results-from-a-phase-iii-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dkn-01-in-combination-with-tislelizumab-and-chemotherapy-as-first-line-therapy-in-advanced-gastric-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-study-for-the-combination-of-doxorubicin-dacarbazine-and-nivolumab-as-the-upfront-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-we-find-a-place-for-trophoblast-cell-surface-antigen-2-targeted-antibody-drug-conjugates-in-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-or-placebo-plus-adjuvant-chemotherapy-with-or-without-radiotherapy-for-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/air-pollution-and-breast-cancer-incidence-in-the-multiethnic-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-retrofit-lessons-from-sotorasibs-dosing-conundrum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-y-liang-et-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-associated-with-first-line-procarbazine-ccnu-and-vincristine-or-temozolomide-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-p-de-boissieu-et-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iugt1a1i-testing-for-the-risk-of-nanoliposomal-irinotecan-related-toxicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefit-of-whole-pelvis-radiation-for-patients-with-muscle-invasive-bladder-cancer-an-inverse-proba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/misleading-reporting-of-a-negative-randomized-clinical-trial-may-affect-clinical-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/datopotamab-deruxtecan-versus-chemotherapy-in-previously-treated-inoperablemetastatic-hormone-recep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/growing-evidence-for-the-role-of-air-pollution-in-breast-cancer-development 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-comparison-of-magnetic-resonance-imaging-versus-transurethral-resection-for-staging-new-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimally-invasive-assessment-of-peripheral-residual-disease-during-maintenance-or-observation-in-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/denosumab-prevents-bone-loss-and-microarchitectural-deterioration-in-premenopausal-women-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-participation-in-medicares-oncology-care-model-with-spending-utilization-and-quali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-iii-sierra-trial-of-sup131sup-i-apamistamab-before-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncology-care-model-and-ripple-effects-of-value-based-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/episteme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-treatment-intensification-with-either-fludarabine-arac-g-csf-and-idarubicin-or-cladribin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-roxadustat-for-anemia-in-patients-receiving-chemotherapy-for-nonmyeloid-malig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-reneu-a-pivotal-phase-iib-trial-of-mirdametinib-in-adults-and-children-with-symptomatic-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-risk-of-subsequent-neoplasms-in-5-year-survivors-of-childhood-neuroblastoma-a-dutch-child 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-nivolumab-for-localized-renal-cell-carcinoma-at-high-risk-of-recurrence-after-nephrectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-c-fuchao-et-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iterti-expression-and-clinical-outcome-in-pulmonary-carcinoids 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-evaluation-of-treatment-combinations-in-three-arm-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/will-prolyl-hydroxylase-inhibitors-supplant-erythropoiesis-stimulating-agents-and-iv-iron-in-the-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-immune-checkpoint-inhibition-in-melanoma-and-pd-l1-expression-the-jury-is-still-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sexual-health-and-quality-of-life-in-patients-with-low-risk-early-stage-cervical-cancer-results-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-medication-related-osteonecrosis-of-the-jaw-in-patients-with-breast-cancer-during-a-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/on-the-nose-reducing-nasopharyngeal-cancer-related-mortality-using-risk-based-epstein-barr-virus-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surveillance-systemic-imaging-after-curative-intent-for-breast-cancer-a-double-standard 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-or-double-induction-with-7-3-containing-standard-or-high-dose-daunorubicin-for-newly-diagno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-nivolumab-in-high-risk-muscle-invasive-urothelial-carcinoma-expanded-efficacy-from-checkma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-we-monitor-cardiac-health-in-breast-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/menin-inhibition-with-revumenib-for-ikmt2ai-rearranged 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advances-in-vulvar-cancer-biology-and-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiac-dysfunction-among-breast-cancer-survivors-role-of-cardiotoxic-therapy-and-cardiovascular-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-for-small-cell-lung-cancer-asco-guideline-rapid-recommendation-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/underrated-but-significant-risk-factors-of-osteoradionecrosis-of-the-jaw-in-patients-with-head-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-e-topkan-et-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revumenib-revises-the-treatment-landscape-for-ikmt2ai-r-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-ho-al-shamsi-et-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-an-epstein-barr-virus-serology-based-screening-program-on-nasopharyngeal-carcinoma-mortali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-racialized-approaches-to-opioid-use-disorder-and-opioid-misuse-management-hamper-pharmacoequity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-onvansertib-in-combination-with-chemotherapy-and-bevacizumab-in-second-line-treatment-of-kr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-imlunestrant-an-oral-selective-estrogen-receptor-degrader-as-monotherapy-and-in-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-on-travel-distance-of-a-statewide-regionalization-policy-for-initial-breast-cancer-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-adjuvant-abemaciclib-plus-endocrine-therapy-for-hormone-receptor-positive-human-epidermal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-a-cardiovascular-health-electronic-health-record-application-for-cancer-survivors-i 2026-08-24 monthly 0.7